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1. Summary 
 
In most eukaryotes the histone methyltransferases SU(VAR)3-9, G9a and their orthologues 
play major roles in transcriptional regulation. Histone H3 lysine 9 methylation is associated to 
transcriptional silencing in vivo. SU(VAR)3-9 is the main H3K9 HMTase in Drosophila 
heterochromatin whereas G9a was found to be an euchromatic H3K9 methyltransferase in 
mammalian cells. In this work SU(VAR)3-9 and a new HMTase homologous to G9a were 
characterized in vitro.  
 
A detailed analysis of the reaction products shows that recombinant SU(VAR)3-9 adds three 
methylgroups to full-length H3 and only two methylgroups to an H3-tail peptide. The transfer 
of two methylgroups to an unmethylated H3-tail peptide is achieved in a nonprocessive 
manner. The full-length enzyme elutes with an apparent molecular weight of 160 kDa from a 
gel filtration column, which indicates the formation of a dimer. The N-terminus was shown to 
be required for this dimerisation and to retrieve full activity in vitro. We show that the 
interaction occurs by domain swapping of two motifs within the N-terminus. The fact that the 
N-terminus is responsible for a concentration dependent dimerisation of SU(VAR)3-9 may 
indicate a role for this domain in the dosage-dependent effect on position effect variegation.  
 
Drosophila G9a adds three methyl groups to unmethylated H3 in vitro as has been described 
for mouse G9a. In vitro, a N-terminal truncation of dG9a adds three methylgroups toward 
H3K9 and K27, with a preference for K9.  Surprisingly, dG9a also methylates H4 with 
specificity for K8, K12 or K16. In vivo, dG9a is present in complexes with a molecular mass 
of 440-670 kDa and we show that it specifically interacts with the histone deacetylase Rpd3. 
 
HP1a is predominantly associated with centromeric heterochromatin in Drosophila. 
Supporting the histone code hypothesis, the chromo domain of HP1 recognises and binds 
H3K9 methylated peptides. Here we show the mechanism for binding to H3K9Me chromatin 
by recombinant Drosophila HP1a.  HP1a requires a bimodal interaction of the chromo 
domain with H3K9Me and a simultaneous interaction of the chromo shadow domain with 
auxiliary factors (SU(VAR)3-9 and ACF) for stable association with H3K9Me chromatin. 
The two HP1 paralogs HP1a and HP1c bind to distinct chromatin structures and we identify 
distinct interaction partners for these two proteins. 
                                                                                                                      Introduction 
2. Introduction 
 
2.1 Chromatin 
 
The compaction of eukaryotic DNA into a complex structure known as chromatin is 
necessary to fit it into the nucleus. More than thirty years ago a proposal was made 
that the structural repeating unit of chromatin in eukaryote organisms is the 
nucleosome (Kornberg, 1974). The nucleosome consists of an octamer, containing a 
central tetramer of histones H3 and H4 and two dimers of histones H2A and H2B. 
Wrapped around each histone octamer is 146 bp of DNA in 1.65 turns of flat, left-
handed superhelix (Luger et al., 1997). The DNA connecting two nucleosome core 
particles is called linker DNA and can vary in length. Linker histone H1 binds to 
linker DNA, and DNA entering and exiting nucleosome (Thomas, 1999).  Histone H1 
facilitates the transition from the 10 nm filament to the 30 nm chromatin fiber and 
stabilizes both the nucleosome and chromatin higher order structure (Figure 2.1) 
(Ramakrishnan, 1997). The core histones are small basic proteins with N-terminal tail 
domain, a central histone fold and a C-terminal tail. The N-terminal tail domains and 
some C-terminal tail domains of the core histones protrude out of the nucleosome 
(Luger et al., 1997). Particularly the core histones are among the most conserved 
proteins known, suggesting for a strong selective pressure against mutations. Histone 
H4 has evolved the slowest, however different H4 genes coding for the same 
polypeptide sequence have been shown to have differential regulated expression 
during the cell cycle (Akhmanova et al., 1996). Within the classes of histones H1, 
H2A, H2B and H3, there are amino acid variations resulting in histone variants 
(Doenecke et al., 1997; Malik and Henikoff, 2003). Some histone variants are more 
diverse in sequence, for example, CENP-A is a H3 variant specifically localizing to 
centromeres (Palmer et al., 1991). Another such variant is macroH2A, which is 
enriched on the inactive human X-chromosome (Chadwick and Willard, 2002). 
Histone variants have different expression patterns, some are highly expressed during 
replication others has a low expression throughout the cell cycle, and the different 
histone variants participate in many nuclear events such as DNA repair, 
transcriptional regulation, heterochromatin barriers and genome stability (For recent 
review, see (Kamakaka and Biggins, 2005).  
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Figure 2.1 Packaging of eukaryotic DNA, from (Felsenfeld and Groudine, 2003). 
 
Chromatin within the eukaryotic nucleus can be cytologically divided into 
euchromatin and heterochromatin (Elgin and Grewal, 2003; Henikoff, 2000; Richards 
and Elgin, 2002). If a gene is located in a domain where the DNA is less densly 
packed (euchromatin) it has the potential to be transcriptionally active. Often when a 
gene is within or adjacent to a more densly compact domain (heterochromatin) it is 
silenced. A significant portion of the genome with low gene density is permanently 
packed in an inactive form called constitutive heterochromatin and this silenced state 
persists through cell divisions. Changes in gene expression alter the relationship 
between euchromatin and heterochromatin and therefore correlate with cellular 
differentiation. Control of individual gene expression may involve local changes in 
nucleosomal compaction. The nucleosome structure can be regulated through 
 12
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assembly/disassembly by histone chaperones, replacement of histone variants, 
nucleosome remodeling and post-translational modifications of the histones (Becker 
and Horz, 2002; Fischle et al., 2003b; Workman, 2006). 
 
The chromosomes in the nucleus are organized into distinct territories (chromosome 
territory; CT) (For recent review see (Cremer et al., 2006)). Actively transcribed 
genes are often at the CT surface and adjacent to mostly DNA-free channels and 
lacunas between the CTs (interchromatin compartment; IC) where it is presumed that 
the transcription factories travel to access DNA (Cremer and Cremer, 2001; Cremer et 
al., 2006; Mahy et al., 2002). It has recently been shown that these ICs are dynamic 
and that the size of ICs depend upon compaction of the surrounding chromosome 
domains (Albiez et al., 2006).  
 
Transcriptionally active and silent regions may be positioned adjacent to each other: 
Therefore boundaries must exist to prevent two neighboring regions from influencing 
each other. These borders are called insulators and are DNA elements that prevent 
stimulation of transcription or silencing from one region to another (West et al., 
2002).  Binding of proteins to the insulator sequences is necessary for effective 
borders. In Drosophila an example of such a protein is a zink finger protein Su(Hw), 
which binds gypsy retrotransposon sequences (Gerasimova et al., 2000). In vertebrates 
a conserved zink finger protein, CTCF, is shown to bind to the chromatin insulator 
domain of the H19 imprinting control region (ICR) (Pant et al., 2004) but also many 
other genome wide target sites (Mukhopadhyay et al., 2004). There are two 
alternative molecular mechanisms proposed for how an insulator works to prevent 
repression, a passive barrier model or a active anti-silencing model (Fourel et al., 
2004). The passive model suggests that a large and stable bound protein complex 
function as a physical block, whereas the active model suggests that insulator 
sequences and proteins serve as binding sites for enzymatic activities that actively 
interfere with silencing (Fourel et al., 2004). Insulators also blocks enhancers for 
transcription, and it was shown that the enhancer blocking of the insulator gypsy in 
Drosophila depends on the number of binding sites for Su(Hw) and the strength of the 
enhancer (Scott et al., 1999). 
 
 
 13
                                                                                                                      Introduction 
2.2 Position-Effect Variegation 
 
Position-Effect Variegation (PEV) is a observed phenomenon when a euchromatic 
gene is artificially relocated next to heterochromatin, and the gene that get in close 
proximity to heterochromatin has variegated expression. Silencing of certain genes 
may lead to phenotypic variegation in tissues.  
 
In Drosophila, expression of the gene white gives red eye pigments. However, the 
In(1)wm4 strain features a phenotype red-white mottled eyes (Figure 2.2). In(1)wm4 
stands for white mottled four and was obtained by X-irradiation of Drosophila 
melanogaster (Muller, 1930). A segment containing the white gene on the X 
chromosome got inverted, such that the white gene was only 25 kb from centromeric 
heterochromatin (Tartof et al., 1984). White was repressed due to spreading of 
heterochromatin factors over the region. The inactivation of the relocated euchromatic 
gene occurs early in development and is inherited through cell division (Becker, 
1957).        
            
Figure 2.2 A schematic illustration of white variegation in the X chromosome of the Drosophila 
line In(1)wm4. (A) Wild type flies have red-pigmented eyes, because white (W+) is expressed and 
positioned distal to heterochromatic centromeres (C) and telomeres (T). Heterochromatin-specific 
complexes (illustrated by colored symbols) cannot spread due to the presence of a barrier (B). (B) In 
In(1)wm4, the white gene brought close to heterochromatin by chromosome rearrangement. This results 
in variegated expression of the white gene and the eye has a mottled appearance. Some groups of 
ommatidia (facets) become colorless because white is repressed by spreading of heterochromatin-
proteins from the proximal heterochromatin. The illustration is taken from (Grewal and Elgin, 2002). 
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Position-effect variegation of white in Drosophila is an excellent genetic tool to 
screen for functions of chromosomal proteins. The In(1)wm4 line can be used for 
secondary site mutations that either suppress or enhance variegation in the fly eyes. 
Mutation in genes for suppressor of position-effect variegation (SU(VAR)) results in 
increased expression of white and thereby red eyes. Colorless/white eyes are the effect 
of mutations of enhancer of position-effect variegation (E(VAR)) genes (reviewed in 
(Reuter and Spierer, 1992)).  Selective screens allowed the isolation of PEV modifier 
mutations that led to about 150 genes, not all of them are known (Schotta et al., 
2003). 
 
Suppressor of position effect variegation 2-5 (SU(VAR)2-5) encodes for a 
heterochromatin protein (HP1a) and was isolated as dominant suppressor of PEV 
(Eissenberg et al., 1990). Two other dominant suppressors of PEV are SU(VAR)3-9 
(Tschiersch et al., 1994) and SU(VAR)3-7 (Cleard et al., 1997; Reuter et al., 1990). 
SU(VAR)3-9 encodes the major heterochromatin histone H3K9 methyltransferase 
(Aagaard et al., 1999; Schotta et al., 2002), whereas the SU(VAR)3-7 protein contains 
seven zink fingers and was shown to interact with HP1a (Cleard et al., 1997; Delattre 
et al., 2000). All these three genes were characterized to have haplo-suppressor and 
triplo-enhancer dosage dependent effect on PEV (Locke et al., 1988; Wustmann et al., 
1989). An extra copy of SU(VAR)2-5, SU(VAR)3-7 or SU(VAR)3-9 results in reduced 
expression of the white gene, therefore an enhancer effect.  
 
The genetic interactions between SU(VAR)3-9, SU(VAR)2-5 and SU(VAR)3-7 can be 
tested by adding additional gene copies of one gene (three instead of two; triplo) to a 
null mutation of another gene. The suppressor effect of SU(VAR)3-9 is dominant over 
the triplo-dependent enhancer effects of SU(VAR)2-5 and SU(VAR)3-7, indicating its 
importance in heterochromatin formation. However, SU(VAR)3-9 is not an essential 
gene because homozygous null mutants are viable and fertile (Schotta et al., 2002). 
Interestingly SU(VAR)2-5 null mutants survive only until the late third instar larvae 
stage due to maternal contribution of HP1a (Lu et al., 2000).  
 
PEV has also been studied in other model organisms. In Schitzosaccharomyces pombe 
classical PEV has been observed within the centromeres (Allshire et al., 1994), 
telomeres (Nimmo et al., 1994) and mating-type locus (Grewal and Klar, 1996).  
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The homologues of SU(VAR)3-9 and HP1 in S. pombe  are called Clr4 and Swi6 
(Ivanova et al., 1998; Lorentz et al., 1992). Both proteins were identified as modifiers 
of centromeric PEV in S. pombe (Allshire et al., 1995; Ekwall et al., 1996), 
suggesting of a conservation of their heterochromatin role.  
 
Another gene that has been shown to have a suppressor of position-effect variegation 
phenotype is ACF1. ACF1 and ISWI are the subunits of ACF (ATP-utilizing 
chromatin assembly and remodeling factor) that catalyzes the ATP-dependent 
assembly of periodic nucleosome arrays in vitro. 
  
2.3 ATP dependent nucleosome remodeling  
 
Chromatin is a dynamic structure that is accessible for large transcription and 
replication machineries, DNA repair and other chromatin modifying complexes. This 
can be achieved through ATP-dependent nucleosome remodeling, which facilitates 
repositioning of nucleosomes to neighboring DNA segments (Becker and Horz, 
2002). Nucleosome remodeling factors are multisubunit complexes containing a 
member of the SWI/SNF2 ATPase family (Eisen et al., 1995). SWI/SNF proteins was 
first identified in screens in Saccharomyces cerevisae for specific gene regulations 
(Breeden and Nasmyth, 1987; Neigeborn and Carlson, 1984; Stern et al., 1984). The 
SWI/SNF2 family is further divided into at least four classes according to the domain 
structure of the catalytic ATPases: SWI2, ISWI, CHD and Ino80 (reviewed in 
(Eberharter and Becker, 2004)).  
 
ATPases of the SWI2 class feature a bromodomain (Horn and Peterson, 2001; 
Martens and Winston, 2003). The bromodomain can bind to acetylated lysine residues 
(Dhalluin et al., 1999; Jacobson et al., 2000). Acetylated histones are generally 
associated with transcriptionally active chromatin (Fischle et al., 2003b). Indeed, it 
was found that yeast SWI/SNF can function in concert with Gcn5 acetyltransferase in 
yeast for activation of specific genes (Pollard and Peterson, 1998). In Drosophila 
Brahma is homolog of yeast SWI/SNF (Kal et al., 2000). 
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The domain that characterizes the CHD class of ATPases is the chromo domain. The 
first DNA-helicase protein was identified in mouse (CHD1) (Delmas et al., 1993). In 
Drosophila two chromo domain containing ATPases dCHD1 and dMi-2 have been 
characterized (Bouazoune et al., 2002; Lusser et al., 2005). The chromo domain dMi-
2 was shown to interact with nucleosomal DNA and is required for nucleosome 
mobilization (Bouazoune et al., 2002). CHD1 regulate nucleosome spacing and 
support NAP1-mediated chromatin assembly in vitro (Lusser et al., 2005). 
 
Ino80 proteins have a characteristic split ATPase domain and are part of large 
multisubunit complexes in Saccharomyces cerevisiae (Ebbert et al., 1999; Krogan et 
al., 2003; Shen et al., 2000). Ino80 and Swr1 complexes are involved in response to 
double strand DNA damage during cell cycle by regulating the incorporation of 
different H2A variants (Papamichos-Chronakis et al., 2006). 
 
The ISWI class of proteins contain a SANT domain and the structure comprising the 
HAND to SANT domain of Drosophila ISWI has been solved (Grune et al., 2003). 
Several complexes are described that contain ISWI (See table 2.1). The Drosophila 
ISWI has been purified in three complexes; NURF (Tsukiyama and Wu, 1995), ACF 
(Ito et al., 1997), and CHRAC (Varga-Weisz et al., 1997). These complexes differ in 
subunit composition and function: while NURF has been implicated in transcriptional 
regulation (Badenhorst et al., 2002), CHRAC/ACF are mainly involved in chromatin 
assembly (Fyodorov et al., 2004).  
 
A feature common for the Drosophila and human ISWI complexes is the presence of 
subunits with ACF1 or proteins with homologous domains to ACF1 (underlined in 
table 2.1). Drosophila ACF was purified from embryos and shown to catalyze 
chromatin assembly (Ito et al., 1997; Ito et al., 1999). Loss of acf1 resulted in loss of 
nucleosomal periodicity supporting a role in assembly of chromatin (Fyodorov et al., 
2004). Mammalian ISWI homologs are SNF2H and SNF2L with distinct expression 
patterns during embryogenesis (Aihara et al., 1998; Lazzaro and Picketts, 2001). 
Human ACF1 interacts with SNF2H, and was shown to be required for DNA 
replication through heterochromatin in mammalian cells (Collins et al., 2002). The 
human NURF was the first complex purified that contained the ATPase SNF2L 
(Barak et al., 2003). Recently, another SNF2L complex was purified from mouse cells 
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comprising a bromodomain containing transcription factor CECR2 and SNF2L and 
CECR2 is specifically expressed in neuronal tissues (Banting et al., 2005).  
 
Table 2.1. Summary of known ISWI-containing nucleosome remodeling complexes in Drosophila 
and human 
Drosophila 
complexes Complex composition 
Human 
complexes Complex composition 
ACF ISWI, ACF1 ACF SNF2H, ACF
  WICH SNF2H, WSTF
  RSF SNF2H, RSF
CHRAC ISWI, ACF1, CHRAC14, CHRAC16 CHRAC 
SNF2H, hACF1, CHRAC15, 
CHRAC17 
NURF ISWI, NURF301, p55, NURF38 NURF SNF2L, BPTF, RbAP46, RbAP48 
  NorC SNF2H, TIP5
  CERF SNF2L, CECR2
ACF, ATP-utilizing chromatin assembly and remodeling factor; CERF, CECR2-containing remodeling 
factor; CHRAC, chromatin accessibility complex; NorC, nucleolar remodeling complex; NURF, 
nucleosome remodeling factor; ISWI, imitation switch; SNF, sucrose nonfermenters; TIP5, TTF-I- 
interacting protein 5; WICH, WSTF ISWI chromatin remodeling complex; WSTF, Williams syndrome 
transcription factor. Underlined are the subunits containing domains homologous to ACF1. 
 
In Drosophila the remodeling activity of ISWI requires and is influenced by the 
histone H4 tail (Clapier et al., 2001; Clapier et al., 2002; Corona et al., 2002). The 
interaction domain of ISWI with ACF1 has been mapped to the C-terminus of ISWI 
(Grune et al., 2003) and a central region (DDT-BAZ2 domain) of ACF1 (Eberharter 
et al., 2004). ACF1 has a functional role in ISWI nucleosome remodeling. It 
stimulates nucleosome mobility and the directionality of nucleosome sliding by ISWI 
by interacting with the core histones (Eberharter et al., 2001; Eberharter et al., 2004). 
The CHRAC subunits (p14-p16 in Drosophila/ p15-p17 in human) are histone fold 
proteins and facilitates nucleosome remodeling of the CHRAC complex through 
DNA interaction (Corona et al., 2000; Hartlepp et al., 2005; Kukimoto et al., 2004). 
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2.4 Histone modifications  
 
The chromatin accessibility can also be regulated by post-translational modification 
of histones (for review, see (Nightingale et al., 2006)). Many proteins that interact 
with histone tails have been identified and characterized to have enzymatic activities 
that covalently modify them. Post-translational modifications such as acetylation, 
phosphorylation, methylation and ubiqitinylation are best studied in the tail domains 
of histones but modifications such as H3K79 methylation exist in the globular region 
(Figure 2.3) (Ng et al., 2002; van Leeuwen et al., 2002). Many more globular post-
translational modifications have been identified (Cocklin et al., 2003; Freitas et al., 
2004; Zhang et al., 2002a; Zhang et al., 2003a). The most characterized histone 
modification is acetylation and it has long been known to be connected to 
transcriptional regulation (Brownell and Allis, 1996; Grunstein, 1997). 
          
Figure 2.3 Post-translational modifications of histones within the nucleosome core particle, 
modified from (Turner, 2005). The arrows indicate the N-terminal domains of the four core histones. 
 
The histone code hypothesis proposed that post-translational modifications to the 
histones provide specific signals that are recognized by proteins and thereby affects 
gene expression and other chromatin functions (Hebbes et al., 1994; Turner, 1993; 
Turner et al., 1992). Several studies in the past decade have proven evidential for a 
histone code to exist (for recent review, see (Nightingale et al., 2006)). 
 19
                                                                                                                      Introduction 
2.4.1 Acetylation 
 
Acetylation of histones open chromatin to allow transcription factors to gain access 
(Fischle et al., 2003b). Hence, acetylation reduces the positive charge of the histone 
tails and reduces thereby the binding to negatively charged DNA (Hong et al., 1993; 
Workman and Kingston, 1998). Enzymes responsible for transfer of an acetyl group 
of Acetyl-CoA to histone lysines are called histone acetyltransferases (HATs) and are 
generally part of multiprotein complexes. The HATs can be divided into different 
families according to histone substrate binding and catalysis (Santos-Rosa and Caldas, 
2005). The Gcn5/PCAF family and the p300/CBP family have different size of HAT 
domains and in addition a bromodomain. Transcriptional activators containing 
bromodomains recognize and bind acetylated lysines (Dhalluin et al., 1999; Jacobson 
et al., 2000). The MYST family features addition to the HAT domain a MYST 
domain and are involved in a wide range of functions including transcriptional 
activation and silencing, cell cycle progression and dosage compensation (Santos-
Rosa and Caldas, 2005). Histone acetylation is mainly described on the histone tails 
of H3 and H4 (Figure 2.3). Newly synthesized H4 are acetylated at lysine 5 and 12 
(Chang et al., 1997).  Acetylation of H4K16 is accumulated on the hyperactive male 
X-chromosome in Drosophila (Bone et al., 1994; Smith et al., 2000; Turner et al., 
1992). Recently, lysine 56 within the globular domain of H3 was shown to be 
acetylated (Masumoto et al., 2005; Ozdemir et al., 2005; Xu et al., 2005). Lysine 56 
acetylation was shown to facilitate recruitment of the SWI/SNF remodeling complex 
(Xu et al., 2005), and is also involved in DNA damage response (Masumoto et al., 
2005). The histone of human H2B N-terminal tail is highly charged and four of the 
lysines can be acetylated (K5, K12, K15 and K20) (Spencer and Davie, 1999) and has 
been shown to be involved in transcriptional activation in yeast (Parra et al., 2006).  
 
Acetylation is a short-living modification. Enzymes responsible for removing acetyl 
groups from lysines are called histone deacetylases (HDACs). These enzymes are 
classified into three different groups (I, II, II) on the basis of sequence homology to 
the yeast HDACs and generally interacts with multiple proteins (Kouzarides, 1999). 
HDACs functions as corepressors and abnormal expression of HDACs are often 
involved in cancer (reviewed in (Santos-Rosa and Caldas, 2005)). 
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2.4.2 Phosphorylation 
 
Phosphorylation is another dynamic and reversible post-translational modification of 
histones. Most studied are phosphorylation of H3 and H4 (Figure 2.3). However, 
phosphorylation of Tetrahymena linker histones is well known to change the charge 
of H1 that modulate interaction with DNA and thereby up regulate gene expression 
(Dou and Gorovsky, 2000; Dou and Gorovsky, 2002; Dou et al., 1999; Sweet et al., 
1996). Serine 10 phosphorylation (S10P) of H3 has opposite functions during cell 
cycle. Firstly, S10P is correlated with pericentric heterochromatin condensation by 
recruiting condensins in interphase nuclei. Secondly, it is involved in chromosome 
compaction in transition to mitosis, and lastly in euchromatic regions that is correlated 
with chromatin relaxation and gene expression (for review, see (Prigent and Dimitrov, 
2003). Phosphorylation of H3S10 prevents methylation of K9 by the histone 
methyltransferase SUV39H1 (SU(VAR)3-9 homolog 1) (Rea et al., 2000). 
 
2.4.3 Other histone post-translational modifications 
 
Other modifications that affect histones are ubiquitinylation, ADP-ribosylation, 
SUMOylation and biotinylation. Ubiquitin and the ubiquitin like SUMO are small 
proteins that are covalently but reversibly attached to lysines of histones (Belz et al., 
2002; Shiio and Eisenman, 2003). Polyubiquitinylation of H2A and H2B is a mark for 
proteolysis (Pickart and Cohen, 2004). Monoubiquitinylation of histone H2B on K123 
is a signal for methylation of histone H3 on K4 and leads to silencing of genes near 
the telomere (Dover et al., 2002). SUMOylation of yeast histones have been 
implicated in transcriptional repression (Nathan et al., 2006).   
 
Biotinylated histone H1, H2A, H2B, H2B, H3 and H4 has been observed in human 
lymphocytes (Pickart and Cohen, 2004). Sites of biotinylation has been identified in 
vitro in human histone H4 (K8, K12) (Camporeale et al., 2004), H3 (K4, K9, K18) 
(Kobza et al., 2005) and H2A (K9, K13, K125, K127, K129) (Chew et al., 2006). 
Biotinylation of histones is a rather new discovery and the functions need to be 
further elucidated. 
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In contrast to biotinylation, ADP-ribosylation has been long known. ADP-ribosylation 
occurs on arginine and glutamate residues of histones, where a poly-ADP-Ribose 
polymerase attaches up to 250 ADP-ribose units (Hassa et al., 2006). Mono-ADP-
ribosylation of histones is linked to DNA repair processes and cell proliferation 
(Boulikas, 1993; Kreimeyer et al., 1984). 
 
2.5 Methylation  
 
Histones may be methtylated on either arginine (R) or lysine (K) (Figure 2.4). The ε-
amino groups of lysine residues may be mono-, di- or trimethylated, whereas the 
guanidion nitrogen atoms of arginine may be mono- or dimethylated (symmetrical of 
assymetrical) (Zhang and Reinberg, 2001). The methyl donor for most methylation 
reactions is S-Adenosyl methionine (SAM/AdoMet), which is converted into S-
Adenosyl homocysteine (SAH/AdoHcy) (Figure 2.4).   
 
 
 
Figure 2.4 Arginine and lysine methylation, from (Zhang and Reinberg, 2001). A) The mechanism 
of arginine methylation. The product is mono- or dimethylated arginine. Dimethylated arginine can be 
assymmetric or symmetric. B) The mechanism of lysine methylation. The product is mono-, di- and 
trimethylation. AdoMet, S-Adenosyl methionine; AdoHcy, S-Adenosyl homocysteine. 
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Histone H3 has been shown to be methylated on lysine residues K4, K9, K27, K36 
and K79 whereas in histone H4, K20 is methylated (Fischle et al., 2003b; Lachner et 
al., 2003). Histone arginine residues methylated in H3 are R2, R8, R17 and R26 are 
methylated in H3, and in H4 R3 (Zhang et al., 2003a). There may still be additional 
methylation sites within the histones proteins. 
 
2.5.1 Arginine methylation 
 
Arginine methylation is an abundant post-translational modification. There are two 
major types (I and II) of protein arginine methyltransferases (PRMTs) that transfer a 
methyl group to the guanidino group of arginines (Lee et al., 1977). PRMTI and 
PRMTII both monomethylate, but the catalysis of dimethylation is assymmetric and 
symmetric respectively (See figure 2.4). Seven mammalian PRMT genes have been 
reported so far: PRMT1-PRMT7 Homologs are found from yeast to plant and 
Drosophila ((Cheng et al., 2005) and references therein). Three arginine 
methyltransferases methylate histones (Table 2.2). Human PRMT5 interacts with 
SWI/SNF chromatin remodelers, and methylates H3 arginine 8 and H4 arginine 3 (Pal 
et al., 2004). The authors found that H3R8 methylation by PRMT5 has repressive 
effect on some tumour suppressor genes. On the other hand, methylation of H3 
residues by PRMT4/CARM1 is involved in transcriptional activation (Koh et al., 
2002). Acetylation of H3 at K18 facilitates its methylation at R17 (Bauer et al., 2002; 
Daujat et al., 2002). CARM1 functions as a transcriptional coactivator for E2F 
stimulated transcription of Cyclin E1 genes by methylating H3R17 and H3R26 (El 
Messaoudi et al., 2006). Similarly, CARM1 and PRMT1 act as transcriptional 
coactivators of tumour suppressor gene p53 (An et al., 2004).  
 
Table 2.2 Histone arginine methyltransferases and deiminases 
Specificity Methyltransferase Function of methylation Deiminase 
H3R2 CARM1 (Mm, Hs)  PADI4 (Hs) 
H3R8 PRMT5 Repressor PAID4 (Hs) 
H3R17 CARM1 (Mm, Hs) Activator PAID4 (Hs) 
H3R26 CARM1 (Mm, Hs) Activator PAID4 (Hs) 
H4R3 PRMT1 Activator  
 PRMT5   
The table is modified from (Bannister and Kouzarides, 2005). Mm, Mus musculus; Hs, Homo sapiens. 
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Arginine methylation can be removed. The peptidyl arginine deiminase 4 (PADI4) 
converts histone arginine to citrulline and thereby antagonizes arginine methylation 
(Cuthbert et al., 2004). The authors showed that PADI4 deiminates arginine residues 
R2, R8, R17, and R26 in the H3 tail. The specificity is for both activating and 
repressing marks and a putative deiminase for the H4 tail has yet to be discovered. 
 
2.5.2 Lysine methylation 
 
Heterochromatin and euchromatin may be indexed according to histone methylation 
marks present. Lysine methylation at H3K4 and H3K36 marks transcriptionally active 
chromatin, whereas methylation of H3K9, H3K27 and H4K20 trimethylation defines 
repressed chromatin domains (Peters et al., 2003; Rice et al., 2003; Santos-Rosa et al., 
2002). In Drosophila pericentric heterochromatin contains accumulated H3K9 mono-, 
di- and trimethylation, H3K27 mono-, di- and trimethylation and H4K20 methylation 
(Ebert et al., 2006; Ebert et al., 2004; Schotta et al., 2004a). Active chromatin states 
are enriched with H3K4 and H3K36 methylation (Ebert et al., 2006). Dimethylation 
of lysine 79 on Drosophila polytene chromosomes is found at some active chromatin 
sites (interbands and puffs) but also at some inactive sites (bands) (Shanower et al., 
2005). 
 
The functional consequences of histone lysine methylation are thought to be due to 
recruitment of proteins that recognize (read) specific marks (Figure 2.5). Hence, more 
and more readout proteins are being discovered which gives support to the histone 
code hypothesis described above. Repressive proteins carrying a chromo domain, 
HP1 and Polycomb respectively bind repressive marks such as H3K9 and H3K27 
methylation (Bannister et al., 2001; Cao et al., 2002; Jacobs and Khorasanizadeh, 
2002; Jacobs et al., 2001; Lachner et al., 2001; Min et al., 2003; Nielsen et al., 
2002b). The chromo domain protein, chromo domain helicase DNA-binding protein 
(CHD1), binds the active mark H3K4Me (Pray-Grant et al., 2005). Tudor domain 
proteins were predicted to bind methylated lysines (Maurer-Stroh et al., 2003). A 
mammalian p53 binding protein (p53BP1) binds methylated H3K79, whereas in yeast 
the ortholog protein Cut5-Repeat-Binding protein (CRB2) recognizes H4K20Me 
(Huyen et al., 2004; Sanders et al., 2004). Another protein, a JMJD2a containing a 
double tudor domain and a JmjC domain, binds methylated H3K4 and H4 K20 
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(Huang et al., 2006b). Both p53BP1 and CRB2 were shown to be recruited to sites of 
DNA damage. Recently it was shown that a WD40 repeat and a PHD finger bind 
H3K4Me (Wysocka et al., 2005; Wysocka et al., 2006). WDR5 is part of a histone 
H3K4 methyltransferase complex containing Set1 and was postulated to mediate 
binding to H3K4Me chromatin (Wysocka et al., 2005). However, recent crystal 
structures of the WDR5 WD40 domain with methylated H3K4 peptides have given 
contradicting results (Couture et al., 2006; Ruthenburg et al., 2006; Schuetz et al., 
2006). The first study reported that WDR5 could bind unmodified H3 peptide, but 
only H3K4 dimethylated peptide mediated stronger interaction (Schuetz et al., 2006). 
On the other hand, two other studies could find no preferred binding of WDR5 to 
methylated K4 (Couture et al., 2006; Ruthenburg et al., 2006). There are many 
challenges ahead to understand the mechanisms of proteins that are capable of 
specific interactions with differently methylated lysine residues within the histone tail 
and their biological function.  
 
 
Figure 2. 5 Proteins that bind methylated histones. Modified from (Bannister and Kouzarides, 
2005). 
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Histone methylation was long thought to be a stable mark. Replication independent 
assembly during active transcription of another H3.3 variant was proposed as a model 
for removal of (silent) histone methylations ((Henikoff et al., 2004) and references 
therein). In the past two years there has been a number of histone demethylases 
discovered. The first one was the FAD (flavin adenine dinucleotide)-dependent lysine 
specific demethylase 1 (LSD1) which demethylates mono- and di- but not 
trimethylated H3K4 (Shi et al., 2004). The activity of LSD1 can be regulated by 
associated proteins, such as CoREST which enables LSD1 to demethylate 
nucleosomes (Lee et al., 2005; Shi et al., 2005). Interaction of LSD1 with the 
androgen receptor results in demethylation of H3K9 mono- and dimethylation 
resulting in androgen-receptor-dependent gene activation (Metzger et al., 2005). 
Another group of demethylase were found to contain jumonji (Jmj) C domain 
(Trewick et al., 2005). JmjC domain containing histone demethylase 1 (JHDM1) is a 
Fe(II) and alpha-KG (alpha-ketoglutarate)-dependent dioxygenase that demethylates 
specifically dimethylated H3K36 (Tsukada et al., 2006). Jumonji genes are conserved 
from bacteria and fungi to plant and vertebrates (Takeuchi et al., 2006). Another 
jumonji protein, JHDM2A, demethylates mono- and dimethyl H3K9 (Yamane et al., 
2006), whereas a third, JHDM3A is a H3K9 and H3K36 trimethyl demethylase 
(Klose et al., 2006). The functional significance of histone demethylation is to be 
unraveled, and discovery of more potential demethylases will increase understanding 
of this mechanism. 
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2.6 The SET domain 
 
Histone methyl transferases (HMTases) responsible for lysine methylation all contain 
a catalytic SET domain, except for Dot1 (Ng et al., 2002). The SET domain consists 
of approximately 130 amino acids and it was originally identified in three Drosophila 
proteins: Suppressor of position effect variegation 3-9, SU(VAR)3-9; Enhancer of 
zeste, E(Z) and Trithorax, Trx (Jenuwein et al., 1998). The enzymatic activity of the 
SET domain was first discovered in a mammalian homolog of SU(VAR)3-9, 
SUV39H1 which was shown to methylate histone H3 at lysine 9 (H3K9) (Rea et al., 
2000). The crystal structure of different SET domains has been solved (Figure 2.6) 
(Jacobs et al., 2002; Kwon et al., 2003; Min et al., 2002; Trievel et al., 2002; Wilson 
et al., 2002; Xiao et al., 2003a; Zhang et al., 2002b).  
 
 
Figure 2.6 The SET domain and surrounding preSET and postSET domains. The structure of the 
SET domain of the SU(VAR)3-9 homolog protein DIM-5 from Neurospora crassa, solved by (Zhang 
et al., 2002b). The figure is taken from (Cheng et al., 2005). A) The preSET region of DIM-5 contains 
nine invariant cysteines and the postSET domain three. Both forms zink fingers (right, preSET with 
Zn3Cys9 cluster; and left, postSET with Zn1Cys4 (plus one cystein is from motif III)). In the middle, a 
ribbon diagram of the DIM-5 SET domain with the conserved motifs indicated by arrows. The binding 
of the H3 peptide and S-Adenosyl homocystein (AdoHcy) is indicated. 
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Four conserved sequence motifs, termed motif I-IV, within the SET domain were 
identified when different HMTase sequences were aligned (Figure 2.6.A) (Cheng et 
al., 2005). These four motifs cluster together and constitute the active site (Figure 
2.6.B, DIM-5 SET domain in the middle) that participates in binding of SAM and 
targets lysines for catalysis of methyl transfer. The three cysteines in the postSET 
domain of DIM-5 together with a cysteine from motif III coordinate a zink ion near 
the active site and form a narrow channel to accommodate the target lysine binding 
(Figure 2.6.A and B to the right) (Zhang et al., 2003b). Indeed, the postSET domain 
was shown to be essential for the activity of DIM-5 (Zhang et al., 2002b; Zhang et al., 
2003b). This three-cystein domain is present in SET domain proteins of the SUV, 
SET1 and SET2 family. On the other hand, SET domain proteins such as human 
SET7/9 (Kwon et al., 2003; Xiao et al., 2003a) and Rubisco MTase (Trievel et al., 
2002) do not have a cysteine rich postSET domain, but rather by pack an α-helix onto 
the active site (Zhang et al., 2003b). The preSET domain coordinates three zink ions 
(Figure 2.6.A and B to the left), and has a role in stabilizing the structure of the SET 
domain (Xiao et al., 2003b). However, the number of cysteines in the preSET 
domains differs between HMTases. Both the preSET and postSET domain contributes 
to activity SUV39H1 (Rea et al., 2000). 
 
Discovery of more HMTases indicated that the structure of the different SET domains 
confer the specificity (Table 2.3).  However, the surrounding sequences of the SET 
domain also contribute to specificity and are conserved within major classes 
(Baumbusch et al., 2001; Zhang et al., 2003b). The largest class is the SUV family, in 
addition comes SET1, SET2, EZ and RIZ families. The histone methyltransferases 
SET8 and SET7/9 do not fit into any of these families (Zhang et al., 2003b). 
 
 
 
 
 
 
 
 
 
 
 28
                                                                                                                      Introduction 
Table 2.3 An overview of lysine specific histone methyltransferases.  
Specificity S. Cerevisiae S. Pombe D. Melanogaster Mammals  Ref(s) 
H3K4 Set1 Set1 Trithorax 
Set1/MLL / 
ALL-1 
(Milne et al., 2002; 
Nakamura et al., 
2002; Roguev et al., 
2001)  
   Ash1  (Beisel et al., 2002) 
    Set7/91 (Nishioka et al., 2002) 
H3K9 Absent Clr4 SU(VAR)3-9 SUV39H1/ 2 
(Rea et al., 2000; 
Schotta et al., 2002) 
   Ash1  (Beisel et al., 2002) 
   dG9a G9a/ GLP 
(Ogawa et al., 2002; 
Stabell et al., 2006; 
Tachibana et al., 
2001) 
    
SETDB1 
(ESET)2
(Schultz et al., 2002; 
Yang et al., 2002) 
    RIZ1 
(Schultz et al., 2002; 
Yang et al., 2002)  
   E(Z)  (Czermin et al., 2002) 
H3K27 Absent  E(Z) Ezh2 
(Czermin et al., 2002; 
Kuzmichev et al., 
2002) 
   dG9a G9a 
(Stabell et al., 2006; 
Tachibana et al., 
2001) 
H3K36 Set2 Set2  Set2 (Strahl et al., 2002) 
    NSD1 
(Huang et al., 1998b; Ra
et al., 2003) 
    Smyd2 (Brown et al., 2006) 
H3K79 Dot1  Grappa Dot1L 
(Feng et al., 2002; 
Shanower et al., 
2005) 
H4K20 Absent Set9 PR-Set7 
PR-Set7 
(SET8) 
(Fang et al., 2002; 
Rice et al., 2002; 
Sanders et al., 2004) 
   Ash1 NSD1 
(Beisel et al., 2002; 
Huang et al., 1998b; 
Rayasam et al., 2003) 
   SU(VAR)4-20 Suv4-20h1/h2 (Schotta et al., 2004b) 
H4 other 
K?   dG9a  (Stabell et al., 2006) 
H1K26    Ezh2 
(Kuzmichev et al., 
2004) 
The table is modified from (Sims et al., 2003) including recent updates. ALL-1, acute lymphoblastic 
leukemia 1; Ash1, absent small or homeotic discs1; Dot1, disrupter of telomeric silencing; Dot1L, 
Dot1 like; ESET, SET domain bifurcated 1; E(Z), enhancer of zeste; Ezh2, E(Z) homolog 2; MLL, 
mixed lineage leukemia; NSD1, nuclear receptor binding SET domain protein 1; PR-Set7, PR-SET 
domain containing protein 7; RIZ, retinoblastoma protein-interacting zinc finger; SETDB1, SET 
domain bifurcated 1; Set1/2/9, SET domain containing 1, 2 or 9; Smyd2, SET and MYND 2; 
SU(VAR)3-9, suppressor of position effect variegation 3-9; Suv39, SU(VAR)3-9 homolog; Trx, 
trithorax. 1) Also called Set9; 2) ESET is the mouse homolog. 
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DIM-5 adds three methylgroups to H3K9 (Tamaru et al., 2003), whereas SET7/9 
mainly monomethylates H3K4 (Kwon et al., 2003; Xiao et al., 2003a). By 
engineering different variants of DIM-5 and SET7/9 the ability to add methylgroups 
can drastically changed (Zhang et al., 2003b). Amino acids that lie within the lysine-
binding channel cause steric hindrance that limits the methylation to the monomethyl 
state. Tyrosine 305 in SET7/9 was shown to cause this steric hindrance, and by 
mutating it with phenylalanine 281 who in the same structural position of DIM-5 to a 
tyrosin, DIM-5 (F281Y) was converted to a mono-MTase. The specificity as well as 
the number of methyl residues that is added to a lysine residue may also depend on 
the presence of co-factor proteins. The HMTase ERG-associated protein (ESET) 
dimethylates H3-K9, but is converted into a trimethylating enzyme by its association 
with a mouse-activating transcription-factor-associated modulator (mAM) (Wang et 
al., 2003). Another example is mammalian Ezh2, which requires the presence of the 
co-factors Suppressor of zeste-12 (SUZ12) and embryonic ectoderm development 
(Eed) for tri-methylation of H3-K27 (Cao and Zhang, 2004). It was also shown for the 
Drosophila homolog E(Z) that the presence of ESC (an Eed homolog) improved the 
enzymatic activity (Czermin et al., 2002). In human there are several Eed isoforms, 
and Eed1 was shown to change the HMTase specificity of Ezh2 towards histone H1 
K26 (Kuzmichev et al., 2004).  
 
Not all SET domain proteins methylate lysines within histones. Pea chloroplast 
Rubisco (Ribulose-1,5-bisphosphate carboxylase/oxygenase) large subunit MTase 
was shown to methylate K14 of Rubisco large subunit (Ying et al., 1999). SET7/9 
methylates the non-histone proteins p53 and TAF10 (Chuikov et al., 2004; Kouskouti 
et al., 2004). Interestingly, SET7/9 was shown to methylate K372 in p53 whereas a 
HMTase called Smyd2 (SET and MYND 2) methylated K370 within the same protein 
(Huang et al., 2006a). The methylation of K372 and K370 have opposite 
transcriptional effects on p53 regulated genes: SET7/9 mediated K372 methylation 
enhance association of p53 with promoters and thereby transcription whereas Smyd2 
K370 methylation results in dissociation of p53 to DNA and causes repression 
(Huang et al., 2006a). TFIID, a complex comprising the TATA box binding protein 
(TBP) and 13 TBP-associated factors (TAFs), plays a role in nucleation in the 
assembly of the RNA polymerase II preinitiation complexes on protein-encoding 
genes (for review see (Albright and Tjian, 2000)). Methylation of TBP-associated 
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TAF10 increases its affinity for interactions with the RNA polymerase (Kouskouti et 
al., 2004).  
 
2.6.1 SU(VAR)3-9 
 
SU(VAR)3-9 (Suppressor of position effect variegation 3-9) is the main 
heterochromatin H3K9 HMTase in Drosophila (Ebert et al., 2004). It is conserved in 
eukaryotes from Schitzosaccharomyces pombe to mammalian organisms (Table 2.3). 
As described above, Clr4 and SU(VAR)3-9 are both suppressors of PEV and function 
in heterochromatin mediated gene-silencing (Ivanova et al., 1998; Schotta et al., 
2002). There are two mammalian orthologs of SU(VAR)3-9, Suv39h1 and Suv39h2  
(SU(VAR)3-9 homolog 1 and 2) (human SUV39H proteins have capital letters). 
Mouse Suv39h1 and Suv39h2 proteins are shown to be important for heterochromatic 
H3K9 methylation and genome stability (Peters et al., 2001). SUV39H1 shares 42 % 
homology with SU(VAR)3-9 (Figure 2.7) (Aagaard et al., 1999). Human SUV39H1 
and mouse Suv39h1 share 95% homology (Aagaard et al., 1999), and localize to 
heterochromatic foci in interphase mammalian cells with transient accumulation at 
centromeric positions during mitosis (Aagaard et al., 2000). On the other hand, 
Suv39h2 having 59% identity with Suv39h1 and is highly expressed in human testes 
(O'Carroll et al., 2000). Mouse Suv39h2 shares 41% identity with SU(VAR)3-9 
(O'Carroll et al., 2000).  
 
In addition to the SET domain, SU(VAR)3-9 contains a chromo domain that was first 
identified in Polycomb and HP1 (Paro and Hogness, 1991) (See chapter 2.7.1). The 
major difference between the Drosophila and human proteins is that SUV39H1 lacks 
about 155 amino acids within the N-terminus of SU(VAR)3-9. This is because 
SU(VAR)3-9 forms a bi-cistronic unit with the gene eIF2 (Krauss and Reuter, 2000) 
which probably originated from retrotransposition of the SU(VAR)3-9 transcript into a 
conserved intron of eIF2 (Schotta et al., 2002). 
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Figure 2.7 Alignment of SU(VAR)3-9 and its human orthologs. The amino acid sequences of 
SU(VAR)3-9, SUV39H1 and SUV39H2 were aligned using T-coffee and imported into the Boxshade 
program to highlight identities (dark shading) and similarities (light shading) at each position. The 
SU(VAR)3-9 chromo-, preSET- and SET domains are indicated. 
 
Even though the N-terminus is moderately conserved, it is important for the 
interaction with silencing proteins HP1 and SU(VAR)3-7 (Schotta et al., 2002; 
Yamamoto and Sonoda, 2003). As described above, Drosophila SU(VAR)3-9, 
SU(VAR)2-5 (HP1a) and SU(VAR)3-7 also interact genetically (Schotta et al., 2002). 
The N-terminus was also shown to be important for targeting of SUV39H1 to 
heterochromatin in vivo (Melcher et al., 2000). In addition, mutations both in the 
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chromo and SET domain of Clr4 have been shown to impair silencing in 
Schitzosaccharomyces pombe (Ivanova et al., 1998).  
 
Localization of Drosophila SU(VAR)3-9 was studied in salivary gland nuclei using a 
polyclonal antibody and heat shock inducible EGFP-tagged fusion proteins in 
transgenic flies (Schotta et al., 2002). Both endogenous and EGFP-proteins 
accumulate in heterochromatic regions such as the chromocenter and the fourth 
chromosome. SU(VAR)3-9 also localizes at telomeres and several euchromatic 
regions (Schotta et al., 2002). A study of Suv39h1 and Suv39h2 double null 
embryonic stem cells revealed a dramatic decrease in H3K9 trimethylation (Peters et 
al., 2003; Rice et al., 2003). The trimethylation could be restored by reintroducing 
Suv39h1 or Suv39h2 into the cells (Rice et al., 2003). Specific H3K9 activity of 
SU(VAR)3-9 was showed using a myc-tagged protein from Drosophila embryos and 
a truncated bacterially expressed variant (Czermin et al., 2001; Schotta et al., 2002). 
In Su(var)3-9 null flies, H3K9 dimethylation at the chromocenter is completely lost 
(Schotta et al., 2002). Genome-wide mapping of SU(VAR)3-9 in Drosophila KC cells 
confirmed the localization observed by fluorescent microscopy (Greil et al., 2003). 
The authors found that one third of SU(VAR)3-9 target genes are male-specific and 
had a higher expression level in males than females. Another third displays elevated 
expression during embryogenesis whereas the last third is a heterogeneous group of 
genes predominantly expressed during larval stages (Greil et al., 2003). Mammalian 
SUV39 has also been linked to silencing of euchromatic genes. Retinoblastoma (Rb) 
protein recruits SUV39H1 and HP1 to promoter of S-phase genes (Nielsen et al., 
2001b). Indeed, methylation by Suv39h1 was shown to terminally silence S-phase 
genes in differentiating, but not cycling cells (Ait-Si-Ali et al., 2004). 
 
Methylation by the SET domain is not mandatory for silencing when SUV39H1 is 
tethered to DNA in vivo (Firestein et al., 2000). This may be due to direct interaction 
of SU(VAR) with silencing proteins such as histone deacetylases (HDACs) (Czermin 
et al., 2001; Vaute et al., 2002) and HP1 (Schotta et al., 2002; Yamamoto and Sonoda, 
2003). H3K9 methylation has also been shown to be sufficient for transcriptional 
suppression without recruitment of HP1 through a mechanism involving histone 
deacetylation (Stewart et al., 2005). 
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In Arabidopsis thaliana, 10 genes encode SUV homologs (Baumbusch et al., 2001). 
Methylation of H3K9 by both Arabidopsis SUVH4 (KRYPTONITE) and Neurospora 
crassa DIM-5 (Defect In DNA Methylation) recruits DNA methylases (Jackson et al., 
2002; Tamaru et al., 2003).  Human SUV39H1 was also shown to directly interact 
with DNA methylases Dnmt1 and Dnmt3a from HELA cell extracts (Fuks et al., 
2003). Studies described above show that H3K9 methylation is prerequisite for DNA 
methylation, however other studies indicate that H3K9 methylation occur after DNA 
methylation. For example it has also been described that methyl-CpG binding domain 
(MBD) proteins interact with a SUV39H1-HP1 complex (Fujita et al., 2003). MBD1 
also recruits another H3K9 HMTase called SETDB1 (Sarraf and Stancheva, 2004). 
The crosstalk between H3K9 methylation and DNA methylation needs to be further 
elucidated. Recently it was shown that another H3K9 methyltransferase, G9a, directly 
interact with Dnmt1 (Esteve et al., 2006). 
 
2.6.2 G9a 
 
The major euchromatic histone H3K9 methyltransferase described in higher 
eukaryotes is G9a. This was determined by studies of G9a-deficient mice and 
embryonic stem (ES) cells (Tachibana et al., 2002). The authors found that H3K9 
methylation is drastically decreased in euchromatic regions, resulting in severe 
growth retardation and early lethality. The loss of G9a mainly affects mono- and 
dimethylation of H3-K9 (Peters et al., 2003; Rice et al., 2003). However, G9a has also 
recently been found at heterochromatic loci (Esteve et al., 2005). Dimethylation of 
H3K9 by G9a is associated with the silencing of euchromatic genes (Stewart et al., 
2005). G9a has a closely related homolog in mammals, called G9a related protein 
(GLP/Eu-HMTase1) (Ogawa et al., 2002). G9a and GLP were recently shown to be 
part of a multimeric E2F6 complex responsible for silencing of Myc- and E2F- 
responsive genes (Ogawa et al., 2002). Both enzymes have H3K9 methyltransferase 
activity in vitro (Ogawa et al., 2002; Tachibana et al., 2001), and G9a-GLP 
heterodimers have been shown to work cooperatively to exert their enzymatic activity 
in vivo (Tachibana et al., 2005). Indeed, G9a-GLP heterodimers have also been 
identified in other silencing complexes such as CtBP1 (Shi et al., 2003) and CDP/cut 
(Duan et al., 2005; Nishio and Walsh, 2004). 
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C-terminal binding proteins (CtBP) are predominantly transcriptional repressors, but 
have also recently been shown to act as transcriptional activators and play important 
roles during development (For review see (Chinnadurai, 2003)). The repression of a 
CtBP complex was shown to be mediated by G9a methyltransferase activity (Shi et 
al., 2003). Recent biochemical studies reported that the zink finger protein Wiz binds 
strongly to G9a-GLP heterodimer and links the histone methyltransferases to CtBP1 
and 2 (Ueda et al., 2006).  
 
The CCAAT displacement protein/cut homolog (CDP/cut), a transcription factor 
involved in development and cell-cycle progression, has been shown to recruit G9a 
and GLP to the promoter of p21 (Nishio and Walsh, 2004). This results in repression 
of the p21 gene.  However, it has also recently been reported that another protein 
called growth factor independent 1 (Gfi1) also recruits G9a to the p21 promoter 
(Duan et al., 2005). Gfi1 is a transcription factor that regulates self-renewal of 
hematopoietic stem cells (For review see (Duan and Horwitz, 2005)). The p21 gene is 
repressed due to association of Gfi-1, G9a and HDAC1 to the promoter.  
 
G9a-/- mice are embryonic lethal (Tachibana et al., 2002). A developmental 
homeobox gene, Oct-3/4, that is expressed at high levels in early embryonic cells and 
is necessary for the totipotent phenotype in ES cells (Brehm et al., 1998; Nichols et 
al., 1998; Pikarsky et al., 1994) is regulated by G9a (Feldman et al., 2006). Retinoic 
acid (RA) induced differentiation of ES cells resulted in transcriptional repression of 
Oct-3/4 (Ben-Shushan et al., 1995; Okamoto et al., 1990; Pikarsky et al., 1994). The 
repression is followed by methylation of H3K9 by G9a and de novo DNA 
methylation that prevents reactivation of Oct-3/4 (Feldman et al., 2006). GLP -/- 
embryos were mostly identical to G9a -/- embryos suggesting that G9a-GLP 
coordinates common functions during embryonic development (Tachibana et al., 
2005). 
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Figure 2.8 The domain organization of Drosophila G9a. (A) Sequence alignment of the preSET and 
SET domain of Drosophila and mouse G9a methyltransferases. The degree of conservation is 
distinguished by shade, where the darkest shade is most conserved. (B) Domain organization of dG9a. 
Modified from (Stabell et al., 2006). 
 
Recently the Drosophila CG2995 was characterized as an euchromatic H3K9 
HMTase (Stabell et al., 2006).  CG2995 was also shown to be a suppressor of PEV 
(Mis et al., 2006). Alignment of the preSET and SET domain of CG2995 and mG9a 
resulted in high sequence conservation (Figure 2.8). When comparing the 
preSET/SET/postSET domains of different Drosophila HMTases with mG9a, 
CG2995 was the closest ortholog and was named dG9a (Table 2.4). dG9a also share 
the same domain organization with mG9a having a N-terminal nuclear localization 
sequence and a C-terminal ankyrin repeat (Figure 2.8). An AT-hook was identified in 
the N-terminus of dG9a (Stabell et al., 2006). 
 
Table 2.4 Comparison of preSET/SET/postSET regions of Drosophila HMTases with mouse G9a 
HMTase Identity Similarity 
mG9a 100% 100% 
dG9a 47% 68% 
SU(VAR)3-9 37% 55% 
SET2 36% 50% 
Data assembled from (Stabell et al., 2006). 
 
Transcripts of dG9a are present in 0-3 hour embryos due to maternal contribution. 
Later during development (between 6 and 21 hours) dG9a is expressed in low 
amounts. In adult flies the expression of dG9a is restricted to the gonads both in 
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males and females (Stabell et al., 2006). Immunostainings revealed that the dG9a 
protein is found throughout oogenesis, embryogenesis and larval development 
whereas in the adult fly it is solely in the gonads (Stabell et al., 2006). Stabell and co-
workers showed that in specific knockdowns of dG9a during the development, dG9a 
is involved in ecdysone mediated signaling. dG9a is suggested to be involved in 
regulation of genes involved in onset of metamorphosis and wing development 
because knockdown larvae fail to pupariate and removal of dG9a in the wing disc 
results in wing defects (Stabell et al., 2006). The data of dG9a correlates well with 
findings of murine G9a and GLP data.  Both knockout mice were embryonic lethal 
and that mG9a was highly expressed in testes (Tachibana et al., 2002; Tachibana et 
al., 2005).  
 
2.7 Heterochromatin protein 1 
 
Heterochromatin protein 1 (HP1) was first identified when monoclonal antibodies 
were generated against a fraction of Drosophila nonhistone nuclear proteins (James 
and Elgin, 1986). Immunofluorescence staining of polytene chromosome showed 
localization to centric heterochromatin. A few years later the gene encoding HP1, 
SU(VAR)2-5, was isolated as a suppressor of position-effect variegation (PEV) 
(Eissenberg et al., 1990; Wustmann et al., 1989). HP1 homologues can be found in 
almost all eukaryotes ranging from Schitzosaccharomyces pombe (Ekwall et al., 1995; 
Klar and Bonaduce, 1991; Lorentz et al., 1992) to mammals and higher plants 
(Saunders et al., 1993; Singh et al., 1991). In vertebrates at least three different 
paralogs of HP1 (HP1α, HP1β and HP1γ) exist, whereas D. melanogaster has 5 
paralogs (HP1a-e, Figure 2.9) (Minc et al., 1999; Smothers and Henikoff, 2001; 
Vermaak et al., 2005).  
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Figure 2.9 Alignment of Drosophila melanogaster HP1 proteins. The amino acid sequences of 
HP1a, HP1b, HP1c, HP1d and HP1e were aligned using T-coffee and imported into the Boxshade 
program to highlight identities (dark shading) and similarities (light shading) at each position. The 
chromo domain and the chromo shadow domain are indicated according to (Smothers and Henikoff, 
2001). 
 
The HP1 like proteins have different sub-nuclear localization; HP1α/a and HP1β/b 
are primarily found within centromeric heterochromatin, whereas HP1γ/c is enriched 
 38
                                                                                                                      Introduction 
at euchromatic sites (Greil et al., 2003; Minc et al., 1999; Minc et al., 2000; Smothers 
and Henikoff, 2001). On the other hand, Drosophila HP1d and HP1e are expressed 
predominantly in ovaries and testes respectively. In Drosophila Schneider cells (SL2), 
HP1d localizes to heterochromatin but with a distinct pattern from HP1a and HP1b 
(Vermaak et al., 2005). All HP1 like proteins share a conserved architecture 
consisting of a chromo domain and a chromo shadow domain separated by a flexible 
hinge region (Aasland and Stewart, 1995; Kellum, 2003). D. melanogaster HP1 like 
proteins are aligned in Figure 2.9.  Differences between the different HP1 paralogs are 
readily apparent when comparing to HP1a. First, the chromo- and chromo shadow 
domains are conserved with HP1b sharing most identity with HP1a and HP1d the 
least. Second, HP1e has the shortest hinge region and HP1d the longest. Third, HP1b 
and HP1c both have an extended C-terminus with little significant sequence 
similarity. And fourth, N-termini are present in HP1a, HP1d and HP1e. Drosophila 
HP1a shares approximately total 50% identity with mammalian orthologs and only 
25% with the Schitzosaccharomyces pombe ortholog, Swi6 (Li et al., 2002). 
 
2.7.1 The chromo domain 
 
Paro and Hogness found that the Drosophila Polycomb protein shared a homologous 
domain with HP1a. Since both proteins are involved in chromatin regulation they 
named it the chromo domain (chromatin organization modifier) (Paro and Hogness, 
1991). About 20 proteins in Drosophila contains chromo domain(s) (Li et al., 2002) 
and the molecular functions of the different chromo domains are diverse (See table 
2.5). The HMTase SU(VAR)3-9 and the ATP-dependent chromatin remodeling factor 
Mi-2 described above, both contain a chromo domain (Table 2.3) (Brehm et al., 2000; 
Tschiersch et al., 1994). Best studied is the chromo domain of HP1. It was shown to 
interact specifically with a peptide resembling the N-terminus of H3 that was di- or 
trimethylated at K9 (Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs 
et al., 2001; Lachner et al., 2001; Nielsen et al., 2002b). This discovery supported the 
histone code theory which postulated that different histone modifications are 
recognized by chromatin proteins (Jenuwein and Allis, 2001; Turner, 1993). 
Supporting this idea the chromo domains of Chd1 and Polycomb were shown to bind 
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the H3 tail methylated at lysine 4 and 27 respectively (Cao et al., 2002; Min et al., 
2003; Pray-Grant et al., 2005).  
 
Table 2.5 Chromo domain proteins studied in Drosophila and their molecular function 
Name Abbreviation 
Number 
of CD 
Molecular function of 
the CD 
Heterochromatin protein 1 
HP1a, HP1b, 
HP1c 21 H3K9me binding 
Polycomb Pc 1 H3K27me binding 
Chromo-ATPase/helicase-DNA-binding CHD1 2 H3K4me binding 
Mi-2 Mi-2 2 
Nucleosomal DNA 
binding 
Males-absent on the first MOF 1 roX RNA binding 
Male-specific-lethal 3 MSL3 2 roX RNA binding 
Suppressor-of-position-effect variegation 3-9 SU(VAR)3-9 1 ? 
Kismet KIS-L/-S 2 ? 
Modified from (Brehm et al., 2004). CD, Chromo domain and 1) HP1 also contains a chromo shadow 
domain (see below).  
 
The crystal structure of the HP1 chromo domain together with the methylated H3 tail 
revealed that the recognition of the methylated lysine involved a conserved aromatic 
pocket (Figure 2.10, residues are highlighted in purple) (Jacobs and Khorasanizadeh, 
2002; Nielsen et al., 2002b). Four amino acids within the Drosophila HP1a chromo 
domain; Glu23, Val26, Asn60 and Asp62 interact with the H3 peptide to form a β-sheet 
(Figure 2.10; A) β-strands B0 and B4, B) residues highlighted in orange). The 
interaction with the H3K9 methylated tail is highly conserved among different HP1 
like proteins and when a conserved Val26 was mutated to a methionine the binding to 
H3K9 methyl was abolished (Bannister et al., 2001; Lachner et al., 2001; Platero et 
al., 1995). The same mutation in a SU(VAR)2-502 allele showed diminished HP1a 
localization to centric regions, but retained association to euchromatic and telomeric 
sites (Fanti et al., 1998) resulting in a loss of function allele (Platero et al., 1995).  
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Figure 2.10 The chromo domain of Drosophila HP1a. Models of the chromo domain structure in 
complex with a histone H3 tail peptide (blue). Figure taken from (Brehm et al., 2004). The 
dimethylated K9 is shown in blue wireframe. (A) Secondary structures are shown; β-sheet (red arrows) 
and α-helix (green ribbon). (B) Residues that are structurally and functionally important are indicated 
with their carbon atoms shown as colored spheres. Labeled in yellow are conserved residues that form 
the hydrophobic core. 
 
The affinity towards the H3K9 methylated peptide is rather weak (Table 2.6). 
Although it is 100-fold stronger then the affinity towards the H3K4 methylated 
peptide, (Table 2.4; compare rows 4 and 5 with 6). HP1a still binds H3-tail peptide 
containing both K4 and K9 methylation with a 2.5 fold weaker affinity than a peptide 
with only H3K9Me (Table 2.4; compare row 4 and 7). Isothermal titration calorimetry 
(ITC) measurements revealed that binding to H3K9 methylated peptide occurs in 
absence of significant change of the conformation of HP1a (Jacobs et al., 2001).  The 
affinity for H3K9Me2 was improved when only the chromo domain was used 
compared to an N-terminal stretch including the chromo domain (Table 2.4; compare 
row 1 with 8 and 9), suggesting that the intact HP1 has a weaker affinity. 
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Table 2.6 In vitro HP1 binding studies 
 Isoforms Peptide Method kD  Reference 
 
 
1. 
HP1a CD 
(aa 17- 76) 
H3 (aa 1-15) 
K9Me2 ITC1 6.9 + 0.2 μM 
(Jacobs and 
Khorasanizadeh, 2002) 
 
2. 
HP1a CD 
(aa 17-76) 
H3 (aa 1-15) 
K9Me3 ITC1 2.5 + 0.1 μM 
(Jacobs and 
Khorasanizadeh, 2002) 
 
3. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K9Me2 FA 2 120 + 12 μM (Jacobs et al., 2001) 
 
4. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K9Me2 FA 2 120 + 12 μM (Jacobs et al., 2001) 
 
5. 
HP1a 
intact 
H3 (aa 1-15) 
K9Me2 FA 2 133 + 11 μM (Jacobs et al., 2001) 
 
6. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K4Me2 FA 2 1.9 + 0.5 mM (Jacobs et al., 2001) 
 
7. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K4/K9Me2 FA2 268 + 25 μM (Jacobs et al., 2001) 
 
8. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K9Me2 ITC2 105 + 24 μM (Jacobs et al., 2001) 
 
9. 
HP1a CD 
(aa 1-84) 
H3 (aa 1-15) 
K9Me2 ITC1 59 + 8 μM (Jacobs et al., 2001) 
Drosophila HP1a binding to premodified H3-tail peptides has been studied using different methods. 
Results were obtained at 15°C (1) and 25°C (2). kD, dissociation constant; ITC, isothermal titration 
calorimetry and FA, fluorescence anisotropy 
 
Recently, the chromo domains of mammalian HP1α/β/γ have been shown to interact 
specifically with the linker histone isoform 1.4 when it is methylated at K26 (Daujat 
et al., 2005). The surrounding amino acids of K26 (KKARKSA) are similar to the 
amino acids surrounding K9 (QTARKST). H1.4 was shown to be methylated by 
Polycomb Repressive Complex 2 (PRC2) containing the HMTase Ezh2 and a specific 
EED isoform (Kuzmichev et al., 2004). This suggests that HP1 can be tethered to 
chromatin that lacks H3K9 methylation.  
 
It has been reported that some proteins interact with the chromo domain of HP1 (See 
Table 2.7). Mouse HP1β was shown to interact with the nuclear envelope suggesting 
a role for HP1 in nuclear architecture (Kourmouli et al., 2000). The interaction with 
lamina-associated polypeptide 2β  (LAP2β) and lamin B receptor (LBR) was mapped 
to the chromo domain. However, HP1β interaction with LBR was shown to be 
bridged by H3/H4 tetramers (Polioudaki et al., 2001). In addition, the chromo domain 
of mouse HP1α was shown to interact with the histone fold domain of bacterially 
expressed H3 (Nielsen et al., 2001a), suggesting that H3 may contribute to the 
interaction with the nuclear envelope.  
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The chromo domain of Drosophila HP1a interacts with origin recognition complexes 
(ORCs) (Pak et al., 1997). Another HP1/ORC associated protein (HOAP) (Shareef et 
al., 2001) has been described to interact with the hinge and chromo shadow domain 
(Badugu et al., 2003), suggesting that HP1 has a dual association with the ORC multi-
protein complex. The ORC2 subunit is maternally deposited and enriched in centric 
heterochromatin of early embryos. In addition, HOAP and ORC2 mutants suppress 
heterochromatin-induced silencing and display defects in HP1 localization in centric 
heterochromatin (Huang et al., 1998a; Pak et al., 1997). These data suggest a role for 
ORC and HOAP in heterochromatin silencing. 
 
2.7.2 The chromo shadow domain 
 
Unique for HP1 is a second C-terminal motif, the chromo shadow domain (Aasland 
and Stewart, 1995; Koonin et al., 1995). The chromo shadow domain bears 
resemblance with the chromo domain (Compare figure 2.10 and 2.11). Residues 
within the hydrophobic core that form an anti-parallel β- sheet and a α-helix are 
conserved between the different chromo shadow and chromo domains (Brasher et al., 
2000).  The most striking difference between the two domains are 2-3 residues in the 
chromo shadow central block forming a second α-helix (Cowieson et al., 2000). A 
proline (HP1β Pro156) that lies in the turn between the two helices is conserved in the 
chromo shadow domain family and only present in some chromo domains (Cowieson 
et al., 2000). The chromo shadow domain was reported to be responsible for 
dimerisation of HP1 (Brasher et al., 2000; Cowieson et al., 2000; Jacobs et al., 2001; 
Zhao et al., 2000). Hence, the chromo domain was found to be monomeric, whereas 
the chromo shadow domains formed a dimer. The interface between the two dimers 
involves the C-terminal α-helices of each monomer (Brasher et al., 2000).  
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Figure 2.11 The structure of chromo shadow domain of mouse HP1β as a dimer or in a complex 
with CAF-1.  Laue and colleagues dissolved the free chromo shadow domain structure in 2000, and 
the illustration is taken from (Thiru et al., 2004). The structure shows chromo shadow residues 110-172 
and amino acids 214-232 of CAF-1. The side chains of Trp-170 that stabilizes the C-terminus of the 
chromo shadow domain. 
 
Another interaction domain within HP1 is the chromo shadow domain, which interact 
with a variety of factors (see Table 2.7; reviewed in (Li et al., 2002)). In order to 
determine how chromo shadow domains interact with other proteins, a phage display 
method was used to enrich for peptides with sufficient affinity (Smothers and 
Henikoff, 2000). The screen resulted in a pentapeptide motif (PxVxL) that was 
identified in the amino acid sequence of HP1 interacting factors as well as in the 
chromo domain itself. Mouse HP1α was shown to interact with the large subunit of 
CAF1 through a PxVxL motif (Murzina et al., 1999). This interaction provided a link 
to the replication machinery and led to a model in which HP1 is targeted to replication 
foci by its interaction with CAF-1 and subsequently “handed-over” to methylated 
chromatin (Murzina et al., 1999). Immunofluorescence studies of replicating mouse 
cells revealed that a specific pool of HP1 (α and γ) coincide with CAF-1 during 
replication of heterochromatin domains (Quivy et al., 2004). In the structure of the 
chromo shadow domain with a CAF-1 peptide (Figure 2.11), the PxVxL motif forms 
a parallel β-sheet with the C-terminal tail of one monomer and an antiparallel β-sheet 
with the C-terminal tail of the other (Thiru et al., 2004). This is similar to the chromo 
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domain interaction with the H3 tail that also forms an intermolecular β-sheet (Jacobs 
and Khorasanizadeh, 2002; Nielsen et al., 2002b). The difference is that the chromo 
domain is monomeric and that two strands from the same domain forms an 
antiparallel β-sheet with the H3 peptide whereas the dimeric chromo shadow domain 
forms a mixed β-sheet with the PxVxL peptide (Thiru et al., 2004). The loose 
specificity of the chromo shadow domain allows interaction with different 
pentapeptide-motif proteins ranging from chromatin modifiers, transcriptional 
activators and transcriptional repressors (See Table 2.7). 
 
 
 
Table 2.7 HP1 interaction and candidate partners 
Protein Organism HP1 variant Methodology 
HP1 
domain Reference(ses) 
Histones      
H1 
Mouse, 
Drosophila HP1α/a rPD Hinge 
(Nielsen et al., 
2001a) 
H1- 
Chromatin Xenopus HP1α, HP1γ rPDchr Hinge (Meehan et al., 2003) 
Methylated 
K26 of H1.4 Human HP1α, HP1β, HP1γ rPD, IF CD (Daujat et al., 2005) 
HP1-BP74 H1 
like Mouse HP1α 
Y2H, FW, 
rPD Hinge 
(Le Douarin et al., 
1996; Nielsen et al., 
2001a) 
H3 Mouse HP1α, HP1β, HP1γ FW, rPD,exIP CD 
(Nielsen et al., 2001a; 
Polioudaki et al., 
2001) 
H3 Drosophila HP1a rPD nd 
(Nielsen et al., 
2001a) 
Methylated 
K9 of H3 S. pombe Swi6 rPD, ChIP CD 
(Bannister et al., 
2001; Nakayama et 
al., 2001) 
Methylated 
K9 of H3 Drosophila HP1a IF, ITC, NMR CD 
(Jacobs and 
Khorasanizadeh, 
2002; Jacobs et al., 
2001) 
Methylated 
K9 of H3 Mouse HP1α, HP1β, HP1γ rPD, NMR CD 
(Bannister et al., 
2001; Nielsen et al., 
2002b) 
Methylated 
K9 of H3 Human HP1α, HP1β, HP1γ rPD,SPRA CD (Lachner et al., 2001) 
H4 Mouse HP1β IF nd 
(Polioudaki et al., 
2001) 
H4 Drosophila HP1a 
In vitro cross- 
linking CSD (Zhao et al., 2000) 
MacroH2A1.2
* Mouse HP1β IF nd (Turner et al., 2001) 
H2A.X & H4- 
Chromatin Mouse HP1α ChIP, SED nd (Fan et al., 2004) 
Nucleosome/ 
trypsinized  Drosophila HP1a NS nd (Zhao et al., 2000) 
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HP1 
domain Reference(ses) 
Chromatin 
modifying 
enzymes/ 
Transcript-
ional 
regulation     
SU(VAR)3-9 Drosophila HP1a 
IF, Y2H, exIP, 
rPD CSD 
(Eskeland et al., 
2004; Schotta et al., 
2002) 
Suv39h1 Mouse HP1β IF, exIP, SED nd 
(Aagaard et al., 1999; 
Czvitkovich et al., 
2001) 
SUV39H1 Human HP1β IF, exIP, SED nd 
(Aagaard et al., 1999; 
Czvitkovich et al., 
2001) 
Suv39h1 Mouse HP1α rPD, Y2H CSD 
(Yamamoto and 
Sonoda, 2003) 
SU(VAR)3-7 Drosophila HP1a IF, Y2H, exIP CSD 
(Cleard et al., 1997; 
Delattre et al., 2000) 
SU(VAR)4-20 Mouse HP1α, HP1β, HP1γ transPD nd 
(Schotta et al., 
2004b) 
SuUR Drosophila HP1a IF nd 
(Koryakov et al., 
2006) 
Suz12 Human HP1α, HP1γ IF,exIP, rPD CSD 
(Yamamoto et al., 
2004) 
JmjC S. pombe Swi6 IF nd 
(Zofall and Grewal, 
2006) 
KAP-1/TIF1β Human HP1α, HP1γ 
IF, rPD, exIP, 
SPRA, GFC CSD 
(Lechner et al., 2000; 
Lechner et al., 2005; 
Nielsen et al., 2001a; 
Ryan et al., 1999) 
KAP-1/TIF1β Mouse HP1α, HP1β, HP1γ 
IF, rPD, exIP, 
GFP, Y2H CSD 
(Brasher et al., 2000; 
Le Douarin et al., 
1996; Murzina et al., 
1999; Nielsen et al., 
1999; Ryan et al., 
1999) 
TRF1/PIN2 Mouse HP1β IF nd (Netzer et al., 2001) 
TAFII130 Human HP1α, HP1γ 
Y2H, transPD, 
exPD CSD 
(Vassallo and Tanese, 
2002) 
TIF1α Mouse HP1α, HP1β, HP1γ Y2H, rPD CSD 
(Le Douarin et al., 
1996; Nielsen et al., 
1999) 
Rb Human HP1α, HP1γ 
Y2H, exPD, 
exIP, ChIP nd 
(Nielsen et al., 
2001b; Williams and 
Grafi, 2000) 
Rb Maize HP1γ rPD, Y2H nd 
(Williams and Grafi, 
2000) 
Dnmt3a 
Mouse 
cells HP1α IF nd 
(Bachman et al., 
2001; Fuks et al., 
2003) 
Dnmt3b 
Mouse 
cells HP1α IF nd 
(Bachman et al., 
2001; Fuks et al., 
2003) 
SNF2β/BRG1 Mouse HP1α Y2H CSD 
(Nielsen et al., 
2002a) 
BRG1 Human HP1α exIP CSD (Lechner et al., 2005) 
ATRX/HP1-
BP38 Mouse HP1α, M31 Y2F, IF CSD 
(Le Douarin et al., 
1996; McDowell et 
al., 1999) 
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HP1 
domain Reference(ses) 
NIPBL Human HP1α exIP, rPD, 
Y2H, rPD  
CSD (Lechner et al., 2005; 
Murzina et al., 1999) 
Pim-1 Human HP1γ 
Y2H, exIP, 
rPD CSD (Koike et al., 2000) 
CKII Drosophila HP1a 
In vitro 
phosphorylatio
n nd 
(Zhao and 
Eissenberg, 1999) 
dAF10 Drosophila HP1a transPD CSD (Linder et al., 2001) 
MBD1 Human HP1α IF, exIP nd (Fujita et al., 2003) 
EMSY Human HP1β 
NMR, ITC, 
GFC CSD 
(Ekblad et al., 2005; 
Huang et al., 2006c) 
 
DNA 
replication and repair     
CAF-1 p150 Mouse HP1α, HP1β 
IF, Y2H,, rPD, 
GFC, NMR CSD 
(Brasher et al., 2000; 
Murzina et al., 1999; 
Thiru et al., 2004) 
CAF-1 p150 Human HP1α rPD, exIP CSD 
(Lechner et al., 2000; 
Lechner et al., 2005) 
Ku70 Human HP1α,  HP1γ 
Y2H, rPD, 
exIP, IF CSD 
(Lomberk et al., 
2006; Song et al., 
2001) 
BRCA-1* Human HP1α IF nd (Maul et al., 1998) 
ORC1, ORC2, 
ORC3, ORC4, 
ORC5, ORC6 Drosophila HP1a 
IF, exPD, 
exIP, transIP CD, CSD 
(Badugu et al., 2003; 
Pak et al., 1997; 
Shareef et al., 2003; 
Shareef et al., 2001) 
Xorc1 Xenopus HP1α, HP1γ Y2H nd (Pak et al., 1997) 
HOAP Drosophila HP1a 
IF, exIP, 
transIP 
CSD, 
Hinge 
(Badugu et al., 2003; 
Cenci et al., 2003; 
Shareef et al., 2001) 
 
Nuclear 
architecture      
Lamin B 
receptor Human HP1α, HP1β, HP1γ 
Y2H, rPD, 
exPD, 
transPD, exIP, 
rPD CSD 
(Lechner et al., 2000; 
Lechner et al., 2005; 
Polioudaki et al., 
2001; Ye et al., 1997; 
Ye and Worman, 
1996) 
LAP (amino 
peptidase) Mouse HP1α, HP1β Y2H CSD 
(Le Douarin et al., 
1996) 
Lamin B and 
LAP2β Mouse HP1β BA CD 
(Kourmouli et al., 
2000; Polioudaki et 
al., 2001) 
 
Other nuclear 
proteins      
Psc3 S. pombe Swi6 
IF, Y2H, 
exPD, ChIP CD  (Nonaka et al., 2002) 
Arp4/dArp6 Drosophila HP1a IF nd 
(Frankel et al., 1997; 
Kato et al., 2001; 
Ohfuchi et al., 2006) 
INCENP Human HP1α, HP1γ Y2H, transPD Hinge  
(Ainsztein et al., 
1998) 
Ki-67 Human HP1α, HP1β, HP1γ 
Y2H, exPD, 
IF CSD 
(Kametaka et al., 
2002) 
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HP1 
domain Reference(ses) 
SP100B Human HP1α, HP1β, HP1γ 
IF, Y2H, rPD, 
transPD, exIP CSD 
(Lechner et al., 2000; 
Lechner et al., 2005; 
Lehming et al., 1998; 
Seeler et al., 1998) 
The table is taken from (Li et al., 2002) with recent published data included. BA, binding assay; CD, 
chromo domain; Chip, chromatin immunoprecipitation; CSD, chromo shadow domain; exIP, co-
immunoprecipitation using extract; exPD, pull-down assay using extracts; FAITC, fluorescence 
anistropy, isothermal titration calorimetry; FW, far Western analysis; GFC, gel filtration 
chromatography; IF, Immunofluorescence colocalization; nd, not detected; NS, nucleosomal shift 
assay; rIP, co-precipitation using recombinant proteins; rPD, pull-down assay using recombinant 
proteins; transIP; immunoprecipitation with in vitro  translated protein; transPD, pull-down assay using 
in vitro translated protein; SED, sedimentation assay; SPRA, surface plasmon resonance analysis; 
Y2H, yeast two-hybrid assay. * Denotes cell cycle-dependent association.  
 
2.7.3 HP1 targeting to chromatin 
 
The HP1 family members behave as chromatin “hubs” with their two protein 
interaction modules. Genetic complementation assays (Powers and Eissenberg, 1993) 
as well as structural data (Thiru et al., 2004) showed that both globular domains are 
required for proper targeting of HP1. However, targeting of HP1 is not only 
dependent on the chromo and chromo shadow domain. Targeting of Drosophila HP1a 
to heterochromatin was shown to be dependent of both the flexible hinge and chromo 
shadow domain, whereas the chromo shadow domain alone can target HP1c to 
euchromatin (Smothers and Henikoff, 2001). A conserved portion of the mouse HP1α 
hinge region was reported to bind nuclear RNA in vitro (Muchardt et al., 2002). The 
authors showed that single domains of HP1α could not be targeted to pericentric 
heterochromatin, but that the intact chromo and hinge domain was sufficient. If 
mammalian tissue culture cells were treated with RNAse, HP1α was de-localized 
from heterochromatin (Muchardt et al., 2002) arguing for a bimodal targeting. 
However, in mammalian cells the Suv39h dependent H3K9 methylation decrease 
upon RNAse treatment (Maison et al., 2002), indicating that there are less binding 
sites for the HP1 chromo domain. The hinge region of mouse HP1α has also been 
shown to directly interact with the linker histone H1 (Nielsen et al., 2001a), and the 
hinge of Xenopus HP1α and not HP1γ  was able to pull-down native H1 containing 
chromatin (Meehan et al., 2003).  In addition, mouse HP1α was shown to interact 
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with the histone variant H2A.Z when incorporated into nucleosomal arrays (Fan et al., 
2004). The binding of recombinant Drosophila HP1a to mononucleosomes required 
the presence of the full length protein suggesting that individual domains are not able 
to maintain a stable binding to a nucleosome (Zhao et al., 2000). The interaction of 
HP1a with chromatin could be independent of the core histone tails (Meehan et al., 
2003; Zhao et al., 2000). 
 
In vivo data suggest that binding of HP1 to chromatin is dependent on H3K9 
methylation, but the results described above indicate that the targeting of HP1 is more 
complex: First, the chromo domain interacts with the N-terminal H3 K9Me but has 
also been shown to bind the globular domain of H3, H1 K26Me, and the ORC 
complex. Second, the hinge region mediates interaction with RNA molecules and H1. 
Third, the chromo shadow domain interacts with various chromatin proteins involved 
in chromatin assembly and transcriptional regulation arguing that these different 
factors are important for localization of HP1. Lastly, the interaction of HP1 with 
chromatin requires full-length protein or at least two domains (chromo-hinge domain, 
chromo shadow-hinge domain or chromo-chromo shadow domain) with the exception 
of Drosophila HP1c which localization to euchromatin depends on the chromo 
shadow domain.  
 
When targeted to chromatin, it was long thought that HP1 binding was static and that 
HP1 behaves as a molecular glue in heterochromatin. Surprisingly, photo-bleaching 
experiments of living mammalian cells with green fluorescent protein-tagged HP1s 
(GFP-HP1) revealed that HP1 was rather dynamic (Cheutin et al., 2003; Festenstein et 
al., 2003; Schmiedeberg et al., 2004). The rapid exchange was observed for all three 
paralogs in both heterochromatin and euchromatin, although a small fraction of more 
static HP1 was observed in pericentric heterochromatin. A similar observation was 
made for Swi6 in fission yeast (Cheutin et al., 2004). The mobility of HP1 may be 
regulated through interaction of different factors with the chromo, chromo shadow 
and hinge domain. However, it is particularly interesting that HP1 interaction protein 
SUV39H1 that sets the H3K9 mark is less mobile than HP1 (Krouwels et al., 2005). 
A substantial part of SUV39H1 was immobile at pericentric heterochromatin and the 
binding was mediated by the SET domain, although enzymatic activity was not 
necessary (Krouwels et al., 2005). This suggests that the small fraction of static HP1 
 49
                                                                                                                      Introduction 
may be so due to interaction with SUV39H1, and the dynamic HP1 can rapidly 
exchange interaction partners. 
 
2.7.4 Methyl/Phospho Switch and a subcode within the histone code 
 
HP1 mobility can also be influenced by post-translational modifications of HP1 itself 
and of surrounding the H3K9Me binding site. As described above, the amino acids 
surrounding lysine 9 on the H3 tail can be phosphorylated (S10P) and acetylated 
(K14Ac). In vitro studies showed that S10 phosphorylation significantly reduces the 
binding of the chromo shadow domain to H3K9Me (Fischle et al., 2003a). 
Phosphorylation of S10 by Aurora B kinase in mitosis and concomitant delocalization 
of HP1 supported this idea (Fischle et al., 2005; Hirota et al., 2005). Unexpectedly 
Muchardt and colleagues reported that K9Me in combination with S10P and K14Ac 
delocalizes HP1α in mouse cells (Mateescu et al., 2004). The authors proposed that 
pericentromeric delocalization of HP1 observed at the G2/M transition (Murzina et 
al., 1999), coincides with a wave of S10 phosphorylation and a gradual increase of 
K14 acetylation (Mateescu et al., 2004). Muchardt and colleagues also reported that 
combination of K9MeS10P favors HP1 association with chromatin in vivo (Mateescu 
et al., 2004) which is contradictory to other studies (Fischle et al., 2005; Hirota et al., 
2005).   
 
HP1 homologs have also been reported to become phosphorylated (Eissenberg et al., 
1994; Huang et al., 1998a; Minc et al., 1999; Zhao and Eissenberg, 1999). Different 
kinases have been shown to phosphorylate HP1, namely casein kinase II, protein 
kinase A and Pim-1 (Koike et al., 2000; Lomberk et al., 2006; Zhao and Eissenberg, 
1999). However, specific functions of HP1 phosphorylation are diverse and need to 
be further investigated. Phosphorylation of HP1γ Serine 83 was demonstrated to 
interact with Ku70 and serve as a marker for transcription elongation (Lomberk et al., 
2006). This fits well with the observation that HP1γ is recruited to actively transcribed 
chromatin (Vakoc et al., 2005). A recent study suggest that sumoylation may 
participate in heterochromatin stability (Shin et al., 2005). The authors show that the 
S. pombe HP1 homologs (Swi6 and Chp2) as well as the histone H3K9 
methyltransferase Clr4 get sumoylated and that disrupted sumoylation of Swi6 or 
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Chp2 result in a modest silencing defect. Urrutia and colleagues proposes that post-
translational modifications of HP1 provide a second regulatory layer to the histone 
code, and that this subcode needs to be deciphered (Lomberk et al., 2006). 
 
2.7.5 HP1 in euchromatin 
 
As discussed above the mammalian HP1γ and Drosophila HP1c localize to 
euchromatin (Minc et al., 2000; Smothers and Henikoff, 2001).  Genome-wide 
mapping of HP1a in Drosophila KC cells revealed that it bound regions outside 
heterochromatin (Greil et al., 2003). Although HP1a/α action in euchromatic regions 
generally results in transcriptional repression (Ayyanathan et al., 2003; Hwang et al., 
2001; Li et al., 2003), an increasing number of observations link HP1 to gene 
activation events. Gene expression analysis of SU(VAR)2-5 mutant larvae revealed 
that hundreds of genes are up- and downregulated showing that HP1a have a role in 
euchromatic gene expression (Cryderman et al., 2005). Another study report that 
HP1a is essential for maintenance of active transcription of nearly one-third of genes 
involved in cell-cycle regulation (De Lucia et al., 2005). The heterochromatin genes 
light and rolled also require HP1 for active transcription (Clegg et al., 1998; Hearn et 
al., 1991). HP1a was also shown to be recruited to ecdysone- activated and heat-shock 
induced puffs when these genes are transcribed (Piacentini et al., 2003). Taken 
together these data suggest that HP1 can be present at sites of transcription. 
 
2.7.6 Other functions of HP1 
 
HP1 has also been shown to play a role in maintaining the nuclear structure. 
Centromeres in eukaryotes contain repetitive DNA elements. The 
Schitzosaccharomyces pombe centromeres are composed of a central core region of 
non-repetitive DNA containing the CENP-A H3 variant (called kinetochore) flanked 
by inverted repeat regions containing H3 that is methylated at K9 and the HP1 
homolog Swi6 (Pidoux and Allshire, 2005). During cell division, the two sister 
chromatids segregate to opposite side of the cell, thereby transferring copies of 
chromosomes into each of the two daughter cells. The sister chromatids are pulled 
apart by microtubuli connected to the kinetochore. To keep the transferring of 
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chromosomes organized, corresponding sister chromatids are held together by a 
cohesin complex until cleavage of cohesin in anaphase (Nasmyth, 2002; Nasmyth, 
2005). Swi6 is required for efficient cohesion (Bernard et al., 2001). The cohesion 
complex in fission yeast is composed of three subunits, Rad21, Psc3 and Pms1 (For 
nice overview of the cohesion apparatus in different organisms, see (Dorsett, 2006)). 
Interaction assays revealed that Swi6 interacts with Psc3 (Nonaka et al., 2002). Thus, 
in a swi6 mutant strain less binding of Psc3 at centromeres and mating-type loci was 
observed (Nonaka et al., 2002) and loss of chromosomes occurred more frequently 
(Ekwall et al., 1995).  
 
In Drosophila, HP1a is also required for correct chromosome segregation (Kellum 
and Alberts, 1995). Moreover, human Nipped-B-Like protein (NIPBL) that is 
required for loading of the cohesion complex, interact with HP1α through a PxVxL 
motif (Lechner et al., 2005). Taken together, these data suggest that HP1 is involved 
in loading cohesion and chromosome segregation. 
 
In addition to HP1 involvement in mitotic cohesion, it has been demonstrated that 
HP1β co-localize with macroH2A1.2 in centromeric heterochromatin during male and 
female meiosis (Turner et al., 2001). The authors suggested that HP1β and 
macroH2A1.2 might have a role in kinetochore assembly. Knockout mice for Suv39h 
null mice have high frequency of non-homologous pairing in male meiosis (Peters et 
al., 2001). During S. pombe meiosis, the Rad21 subunit is replaced with a meiosis-
specific cohesin subunit Rec8 whereas Rec11 replaces Psc3 at the chromosome arms 
but the meiotic cohesin complex in the vicinity of centromeres contain Psc3 (for 
review see (Watanabe, 2004)). This suggests that Psc3 at the centromeres links 
Swi6/HP1 to meiosis.  
 
Immunolocalization studies on Drosophila polytene chromosomes showed that HP1a 
localizes not only to the chromocenter but also to many euchromatic bands and all 
telomeres (Fanti et al., 2003; Fanti et al., 1998; James et al., 1989). At the telomeres 
conventional polymerase machineries cannot complete their replication and therefore 
specific telomere complexes extend the terminal DNA. A second function essential to 
protect the telomeres from being degraded or fused is a capping mechanism (de 
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Lange, 2002). In most other organisms, a specialized reverse transcriptase termed 
telomerase extends the terminal DNA using a sequence specific RNA template 
(Nugent and Lundblad, 1998). The telomeres in Drosophila are maintained by 
transposition of three specialized retrotransposons (Abad et al., 2004; Mason and 
Biessmann, 1995; Pardue, 1994).  Observations that mutant SU(VAR)2-5 cells had 
multiple telomere-telomere fusions led to the conclusion that HP1a is required for 
telomere protection (Fanti et al., 1998). The chromo domain was not necessary for 
telomere capping (Fanti et al., 1998), rather direct binding of HP1a to telomeric DNA 
(Perrini et al., 2004). The authors also showed that HP1a binding to H3K9Me on 
telomeres was necessary for telomeric silencing (Perrini et al., 2004).  Supporting 
HP1a`s involvement in telomere capping it was recently found that the HP1-
interacting HOAP protein is required for telomere capping (Cenci et al., 2003). Taken 
together, these results support an important role of HP1 in capping and silencing of 
telomeres that involves interactions with DNA, specific proteins and H3K9Me. 
Whether HP1 has a role in telomere protection in higher eukaryotes remains to be 
seen. Cenci et al. propose that there are unexpected similarities between the capping 
mechanisms of Drosophila and human (Cenci et al., 2003).  Studies in mice revealed 
that the three HP1 homologs are components of telomeres and that their presence 
depends on Suv39h dependent H3K9 methylation (Cenci et al., 2003). However, it is 
not known whether HP1 is a stable component of telomeres and if it interacts with the 
telomere machinery. 
 
Returning to Drosophila, recent data suggest that HP1a has also a sex-specific role. 
Severe reduction of HP1a and SU(VAR)3-7 results in polytene chromosome 
phenotypes with a bloated X and an expanded chromocenter of males and females 
(Spierer et al., 2005). In addition, a genetic interaction between the HP1 interacting 
SU(VAR)3-7 and the DCC complex (mle) was also reported (Spierer et al., 2005). 
Genome wide mapping showed that HP1a binds along most of the X-chromosome in 
male but not female flies (de Wit et al., 2005). Similarly, when SU(VAR)3-7 is 
overexpressed, HP1a is found preferentially associated with the male X polytene 
chromosome (Delattre et al., 2004). Conditional depletion of HP1 in flies also resulted 
in preferential male-specific lethality (Liu et al., 2005). It has also been described that 
mutation of Jil-1, a histone H3S10 kinase shown to physically interact with the 
dosage compensation complex (Jin et al., 2000; Wang et al., 2001), resulted in 
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spreading of H3K9di methyl and HP1a to the chromosome arms with a pronounced 
increase on the X chromosomes (Zhang et al., 2006). The involvement of HP1a on the 
male X needs to be elucidated. 
2.8 The Aim 
Genetic events such as PEV have led to the understanding that the neighboring region 
affects gene expression. This is thought to be due to spreading of factors that affect 
chromatin structure. Several factors involved in gene silencing have been identified to 
covalently modify histone tails and their modifications act as receptors for non-
histone proteins. However, it is not yet clear how these non-histone proteins 
specifically recognize these marks and how a modification can be accessed within a 
chromatin context.  
 
The main goal of this work was to get a better understanding of specific recognition 
of chromatin modifications with a focus on methylation of H3K9 and binding of HP1. 
Therefore, recombinant, highly purified factors thought to be involved in gene 
silencing such as Drosophila histones, dG9a, SU(VAR)3-9 and HP1a were used.  
Bacterially expressed histone molecules completely devoid of any post-translational 
modification (unmodified chromatin) were used to generate chromatin carrying only 
the H3K9 mark. In order to retrieve highly H3K9 methylated chromatin it was 
necessary to characterize the recombinant HMTases SU(VAR)3-9 and dG9a. Using 
the highly active SU(VAR)3-9 allowed us to establish an in vitro system where  HK9 
methylated chromatin is linked to paramagnetic beads. This chromatin could be used 
to study binding of recombinant HP1a. We found that HP1a alone cannot bind 
efficiently to H3K9 methylated chromatin even if it contained more than 85% 
methylation. HP1a is depending on interaction with other factors that target it to 
chromatin and stabilize the binding to the K9 methyl. Since the factors that enhance 
HP1a binding to H3K9Me chromatin specifically interact with HP1a, it was of 
interest to identify more interaction partners. To do so, stable SL2 cell-lines 
expressing Flag-tagged HP1a and HP1c were used. 
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3. Material and Methods 
3.1 Material 
 
3.1.1 Chemicals, material and radioactive isotopes 
 
Unless otherwise stated, all common chemicals and materials were ordered by 
Amersham / Pharmacia (Freiburg), E. Merck (Darmstadt), NEN / Perkin Elmer 
(Rodgau), Pierce (Bonn), Promega (Mannheim), Roche (Mannheim), Roth 
(Karlsruhe), Serva (Heidelberg) and Sigma (Deisenhofen). Radioactive S-Adenosyl-
L-[methyl-3H] Methionine (81 Ci/mmol) and [35S] methionine/cysteine mix (7.15 
mCi/ 500 µl) were purchased from Amersham.  
 
3.1.2 Enzymes and Kits 
Product Received from 
Cellfectin Reagent Invitrogen 
Effectene Transfections Kit Qiagen 
ECL™ Kit (enhanced chemoluminescence) Amersham 
Expand High Fidelity Kit Roche 
GFX PCR DNA and Gel Band Purification Kit Amersham 
Kilobase Binder Dynal 
Klenow  Roche 
Maxiprep kit Quiagen 
Mnase (S7 Nuclease) Sigma 
Proteinase K Genaxxon 
Quick Change Mutagenesis Kit Stratagene 
Rabbit Reticulocyte Lysate System Promega 
Restriction endonucleases NEB 
Rnasin Promega 
Shrimp alkaline phosphatase NEB 
Taq polymerase  Genaxxon 
T4 DNA ligase NEB 
TOPO TA Cloning® Invitrogen 
T7 RNA Polymerase Promega 
Trypsin (Sequencing grade) Promega 
QIAquick Gel Extraction Kit Qiagen 
Qiagen maxiprep kit Qiagen 
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3.1.3 Chromatographic material 
Resin/Column Received from 
Biorex 70 Resin Bio-Rad 
DEAE Sepharose Amersham 
DynaBeads M280 Dynal 
Gelfiltration columns (Superose 6, Superdex 200) Amersham 
Gluthathione-Sepharose-4B Amersham 
Heparin Hi-Trap column Amersham 
Hydroxyl apatite resin Bio-Rad 
Chitin-Agarose Beads NEB 
M2-agarose (Flag-beads) Sigma 
MonoQ HR 5/5 Amersham 
Protein A/G Sepharose Amersham 
Resource Q Amersham 
Sephadex G50 spin columns Roche 
SP-Sepharose FF Amersham 
Talon beads BD Biosciences 
 
3.1.4 Vectors 
 
Vectors Features Resistance Received  
pET15b 6x his tag Ampicillin Novagen 
pFASTBac1 Baculoexpression wo tag Ampicillin and Gentamycin Invitrogen 
pPacFLAG Flag tag Ampicillin G. Chen 
pGEX4T1 GSTtag Ampicillin Amersham 
 
3.1.5 Oligonucleotides 
 
All oligonucleotides were ordered from MWG. 
 
 Oligo name Sequence Description 
1. SUV39N-NdeI5 5`-TAGTGTACATATGGCCACGGCTGAA-3` 
Cloning into 
pET15b 
2. SUV39C-XhoI3` 5`-AGTTGGCTCGAGAAAGAGGACCTTT-3 
Cloning into 
pET15b 
3. 
SUV39Nchrom-
SacI3` 5`-CTCCACAACGAGCTCTCCTTTGGGC-3` 
Cloning into 
pET15b 
4. 
SUV39Cchrom-
SacI5` 5`-ACCACTGAGCTCGAGAAGCAGCT-3` 
Cloning into 
pET15b 
5. 
SUV39Cchrom-
SacI3` 5`-AGCTGCTTCTCGAGCTCAGTGGT-3` 
Cloning into 
pET15b 
6. 
SUV39NpreSET-
SacI5` 5`-GGATTGTGAGCTCAAGTGCACTGA-3` 
Cloning into 
pET15b 
7. Suv39Npre-SacII3` 5`-ATCCCCGCCCGCGGCTTGGGCAC-3` 
Cloning into 
pET15b 
8. Suv39Cpre-SacII5` 5`-GATGGGGGCGGCGGGCCGCAACTG-3` 
Cloning into 
pET15b 
                                                                                                                            Material 
 57 
 Oligo name Sequence Description 
9. pgexHP1aNtXmaI5 5`-GTAGACCCGGGTGGCAAGAAAATCG-3` 
Cloning into 
pGEX4T-1 
10. pgexHP1aCtXhoI3 
5`-TCTCACTCGAGTTAATCTTCATTATC-
3` 
Cloning into 
pGEX4T-1 
11. pgexHP1cNtXmaI5 5`-ACACACCCGGGTGTTAAAAACGAG-3` 
Cloning into 
pGEX4T-1 
12. pgexHP1cCtXhoI3 5`-TGCTCCTCGAGTTATTGATTTTCCG-3` 
Cloning into 
pGEX4T-1 
13. pPacHP1aNtKpnI5 5`-CCCCAGGTACCGGCAAGAAAATCGA-3` 
Cloning into 
pPacFLAG 
14. pPacHP1aCtXhoI3 
5`-GTCTCCTCGAGTTAATCTTCATTATCA-
3` 
Cloning into 
pPacFLAG 
15. pPacHP1cNtKpnI5 
5`-CCAGAAGGTACCGTTAAAAACGAGCC-
3` 
Cloning into 
pPacFLAG 
16. pPacHP1cCtSacI3 
5`-CTGCTCCTCGAGTTATTGATTTTCCG-
3`  
Cloning into 
pPacFLAG 
17. HP1aW200ABstNI 
5`-
CGAAGAGCGCCTATCCGCGTACTCTGATAAT
GAAG-3` 
Point mutation 
HP1W200A 
18. 
HP1aW200ABstNI
rev 
5`-
CTTCATTATCAGAGTACGCGGATAGGCGCTC
TTCG-3` 
Point mutation 
HP1W200A 
19. Flagfwd5 5`-GACTACAAGGACGACGAT-3` Sequencing 
20. HP1V26MNcoIfwd 
5`-
GAGGAGGAGTACGCCATGGAAAAGATCATCG
-3` 
Point mutation 
HP1V26M 
21. HP1V26MNcoIrew 
5`-
CGATGATCTTTTCCATGGCGTACTCCTCCTC
-3` 
Point mutation 
HP1V26M 
22. 
cg2995H1536KBst
NIfwd 
5`-
ATGGAAATGTAACCAGGTTTTTTAACAAGTC
GTGTGAGCCGAATG-3`  
Point mutation 
dG9aH1536K 
23. 
cg2995H1536KBst
NIrev 
5`-
CATTCGGCTCACACGACTTGTTAAAAAACCT
GGTTACATTTCCAT-3` 
Point mutation 
dG9aH1536K 
24. cg2995rewBamHI 5`-TGGATCCTACGCGTGTCCAAT-3` Sequencing 
25. SUV39RNAi5 
5`-
GAATTAATACGACTCACTATAGGGAGACGAC
ATAGCCGATTCCG-3` 
RNAi of 
SU(VAR93-9 
26. SUV39RNAi3 
5`-
GAATTAATACGACTCACTATAGGGAGATACA
AATTGGGCCCGC-3` 
RNAi of 
SU(VAR93-9 
27. GSTRNAi5 
5`-
TTAATACGACTCACTATAGGGAGAATGTCCC
CTATA-3` RNAi control 
28. GSTRNAi3 
5`-
TTAATACGACTCACTATAGGGAGAACGCATC
CAGGC-3` RNAi control 
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3.1.6 Plasmids 
 
Clone Backbone Description Primers  Received  R. sites 
dSU(VAR)3-9 
wt pET15b 
Bacterial 
expression, 
purification over 
Talon beads  B. Czermin 
NdeI - 
XhoI 
dSU(VAR)3-9 
mutants: Δ152,  
Δ213,  Δ279,  
Δ409,  Δ487, 
ΔSET and  ΔC pET15b 
Bacterial 
expression, 
purification over 
Talon beads  B. Czermin 
NdeI - 
XhoI 
dSU(VAR)3-9 
Δ152  pMyb2 
Bacterial 
expression, 
purification over 
Chitin beads  B. Czermin 
NdeI - 
XhoI 
dSU(VAR)3-9 
Δchromo pET15b 
Bacterial 
expression, 
purification over 
Talon beads 1, 2, 3, 4  
NdeI - 
XhoI 
dSU(VAR)3-9 
Δ(285-412)  pET15b 
Bacterial 
expression, 
purification over 
Talon beads 1, 2, 5, 6  
NdeI - 
XhoI 
dSU(VAR)3-9 
ΔpreSET  pET15b 
Bacterial 
expression, 
purification over 
Talon beads 1, 2, 7, 8  
NdeI - 
XhoI 
Flag dG9a pFASTBac1 
For baculovirus, 
purification over 
Flag beads  M. Stabell 
SpeI - 
KpnI 
Flag dG9a 
H1536K pFASTBac1 
For baculovirus, 
purification over 
Flag beads 23, 24  
SpeI - 
KpnI 
H3 K9A, 
K27A, 
K9/K27A pET28 
Bacterial 
expression  
D. 
Reinberg  
H4 K20A  
Bacterial 
expression  
T. 
Jenuwein  
dHP1a pET11a 
Bacterial 
expression  
J. 
Eissenberg 
XbaI -
BamHI 
dHP1a 
(W200A) pET11a 
Bacterial 
expression 17, 18  
XbaI -
BamHI 
dHP1a (V26M) pET11a 
Bacterial 
expression 20, 21  
XbaI -
BamHI 
GST dHP1a pGEX4T1 
Bacterial 
expression, 
purification over 9, 10  
XmaI - 
XhoI 
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Clone Backbone Description Primers  Received  R. sites 
glutathione beads 
Flag dHP1a pPacFlag 
For SL2 stable 
transfection, 
purification over 
Flag beads 13, 14  
KpnI - 
XhoI 
dHP1c pOT2 cDNA  
BGDP EST 
project 
EcoRI - 
XhoI 
GST dHP1c pGEX4T1 
Bacterial 
expression, 
purification over 
glutathione beads 11, 12  
XmaI - 
XhoI 
Flag dHP1c pPacFlag 
For SL2 stable 
transfection, 
purification over 
Flag beads 15, 16  
KpnI - 
SacI 
 
3.1.7 E. coli strains 
 
DH5α (Invitrogen) 
E. coli F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169 deoR recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 λ- thi-1 gyrA96 relA1 (Hanahan, 1983). 
 
BL21(DE3)pLysS (Stratagene) 
E. coli B F- dcm ompT hsdS(rb-, mb-) galλ (DE3) (Studier et al., 1990) 
 
3.1.8 Insect cell lines 
 
Cell line Origin Phenotype Description  Reference 
Kc  Drosophila 
melanogaster 
female semi adherent cell line 
embryos, 6 to12 h 
(Echalier 
and 
Ohanessian, 
1970) 
SL2 Drosophila 
melanogaster 
male adherent  
Oregon R embryos, 20 to 24 h  
(Schneider, 
1972) 
SF9 Spodoptera 
frugiperda 
 adherent Novagen 
 
3.1.9 Fly lines 
 
Drosophila embryo extracts were prepared from cultures with Drosophila 
melanogaster (Canton R). 
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Drosophila melanogaster yw flies are described in FlyBase 
(http://flybase.bio.indiana.edu) 
 
Drosophila melanogaster Su(var)3–906 (Tschiersch et al., 1994). 
 
 3.1.10 Antibodies 
 
Antibodies Received from 
Dilutions for Western 
blots 
Secondary 
antibody 
α−ACF1 3B7  A. Eberharter (1:500) α-rat 
α−flag Sigma (1:2000) α-mouse 
α−dG9a M. Stabell (1:500) α-rabbit 
α−HP1 C1A9 S. Elgin (1:200) α-mouse 
α−HP1 S. Elgin (1:1500) α-rabbit 
α-ISWI J. Tamkun (1:5000) α-rabbit 
α-Jil1 C. Regnard (1:1000) α-rabbit 
α-myc 9E10 purified in the lab (1:1000) α-mouse 
α−p55  J. Kardonaga (1:10 000) α-rabbit 
α-RPD3 A. Brehm (1:5000) α-rabbit 
α- SU(VAR)3-9 6C9 E. Kremmer  (1:5 sup) (1:250) α-rat 
α- SU(VAR)3-9 3D9 E. Kremmer (1:5 sup) (1:1000) α-rat 
α- SU(VAR)3-9 G. Reuter (1:1000) α-rabbit 
α- SUZ12 J. Larson (1:1000) α-chicken 
α-rabbit-HRP Amersham (1:10 000)  
α-mouse-HRP Amersham (1:10 000)  
α-rat-HRP Amersham (1:5000)  
α-chicken-HRP Amersham (1:5000)  
α-rabbit-IRDye 800 Biomol (1:10 000)  
α-mouse-IRDye 800 Biomol (1:10 000)  
α-rat-IRDye 800 Biomol (1:5000)  
 
3.1.11 DNA and Protein markers 
 
Name Received 
GeneRuler 1 kb DNA ladder, MBI Fermentas 
peqGOLD Prestained Protein Marker IV PeqLabBiotechnologie 
peqGOLD Protein Marker II PeqLabBiotechnologie 
smart ladder Eurogentec 
123 bp ladder Invitrogen 
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3.2 Methods 
 
3.2.1 General molecular biology methods 
 
3.2.1.1 Standard PCR setup  
The concentration of DNA template was in general: 5-10 ng plasmid DNA. A normal 
PCR reaction contained 0.5 U Taq DNA plolymerase, 0.2 mM of each dNTP, 0.2 µM 
primers in 10 mM Tris-HCl (pH 9 at 25°C) , 50 mM KCl, 0.1 % Triton X-100 and 1.5 
% MgCl2. After initial denaturation of 1 minute at 94 °C, 30 amplification cycles (94 
°C, 30 sec; 59-70 °C [primer dependent], 30 sec; 72 °C, [1 minute pr kb of desired 
PCR product]) were carried out with a final extension for 5 minutes at 72 °C.  
 
3.2.1.2 Spectrophotometric concentration measurements of DNA and RNA 
The concentration of a nucleic acid sample was measured using a DU 640 
spectrophotometer (Beckman). At A260 an absorbance unit of dsDNA corresponds to 
50µg/ml while an absorbance unit of RNA corresponds to 40 µg/ml. The purity of 
DNA or RNA sample was controlled by checking the ratio between absorption at 260 
nm and 280 nm. A DNA sample is pure if the ratio is approximately 1.8, while RNA 
is pure if the ratio is approximately 2.1.  
 
3.2.1.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to analyse the quality of DNA and to separate 
fragments by size (Sambrock and D.W.Russell, 2001). Depending on the size of the 
DNA molecules (kb) agarose solutions from 0.8 to 2% (w/v) in 1 x TBE buffer (90 
mM Tris, 90 mM Boric acid, 2 mM EDTA) were used. Ethidium bromide was added 
to a final concentration of 0.25 µg/µl. The samples to be analysed were mixed with 1 
x loading dye (5x loading dye: 50% v/v Glycerine, 10 mM EDTA, 0.05% (w/v) 
orange G). The voltage applied depended on the distance between the electrodes. In 
general the voltage applied was between 4-5 V/cm. As size standards: smart ladder, 1 
kb ladder or 123 bp ladder were used. The DNA or RNA was visualized by UV light. 
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3.2.1.4 Isolation of DNA fragments from agarose gels 
The desired DNA band was cut out from the agarose gel on a UV transilluminator and 
transferred into a 1.5 ml tube. For the purification QIAquick Gel Extraction Kit 
(Qiagen) was used. 
 
3.2.1.5 Preparation of competent cells 
Glycerol stocks of the E. coli bacteria were streaked on LB plates and incubated o/n at 
37°C. Using one colony from this plate, a 3 ml LB pre-culture was grown o/n at 37°C. 
The next day 500 ml LB medium was inoculated with 1 ml of the pre-culture and 
grown to an OD at 600 nm of 0.6. The culture was chilled on ice for 10 min and then 
centrifuged (15 min, 4000 rpm, 4°C). The pelleted cells were gently resuspended in 
200 ml ice cold TBPI (30 mM KAcetate, 100 mM KCl, 10 mM CaCl2, 15% (v/v) 
Glycerol) and incubated on ice for 5 min. The centrifugation step was repeated. The 
cell pellet was then resuspended in 20 ml ice cold TBPII (10 mM PIPES pH 6.5, 75 
mM CaCl2, 10 mM KCl, 15% (v/v) Glycerol). Aliquots of 200 µl were transferred 
into 1.5 ml tubes, flash frozen in liquid nitrogen, and stored at -80°C. This preparation 
yielded an efficiency of 107 cfu/µg. 
 
3.2.1.6 Transformation of competent cells 
Immediately after thawing, a volume of 200 µl appropriate bacteria was added to the 
ligation mix/ plasmid of interest. The sample was mixed carefully and left on ice for 
45 minutes. After heat shocking the cells for 1 minute at 42 °C the sample were 
immediately put on ice for 5 minutes. SOB medium was added (500 µl), mixed and 
the suspension was incubated for 45 minutes at 37 °C. Aliquots were plated out on 
selective LB plates with appropriate antibiotics and incubated at 37 °C over night. For 
cloning: 40 µg/ml X-gal and 0.5 mM IPTG was added.  
 
3.2.1.7 Isolation of Plasmid DNA from E. coli 
I) Plasmid miniprep 
Plasmid DNA were extracted from E.coli with the help of alkaline lysis (Birnboim 
and Doly, 1979). Colonies were picked from an agar plate and used to inoculate 3 ml 
growth medium supplemented with the appropriate antibiotics. The cultures were 
incubated o/n at 37°C at 200 rpm. 1.5 ml of each o/n culture was transferred in a 1.5 
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ml reaction tube and centrifuged (10 min, 9000 rpm, RT) to pellet the bacteria. The 
cell pellet was resuspended in 250 µl P1 (50 mM Tris pH 8.0, 10 mM EDTA, 100 
µg/ml RNase A), lysed by adding 250 µl P2 (200 mM NaOH, 1% (w/v) SDS) and 
mixed by immediately inverting the tube for 5 times. After incubation at RT for 5 min 
the reaction was stopped by adding 350 µl P3 (3 M KAcetate). The tube was inverted 
again for 5 times and then left on ice for 10 min and centrifuged (10 min, 13000 rpm, 
RT). The plasmid DNA in the supernatant was transferred in a new 1.5 ml tube and 
600 µl of isopropanol was added. The tube was incubated on ice for 30 min and then 
centrifuged (20 min, 13000 rpm, 4°C) to pellet the plasmid DNA. The pellet was 
washed with 70% ethanol and centrifuged (5 min, 13000 rpm, 4°C). The supernatant 
was carefully aspirated and finally the pellet was air dried and redisolved in 25 µl TE 
(10 mM Tris, 1mM EDTA). 
II) Plasmid maxiprep 
To obtain 100 µg plasmid DNA or more, 500 ml LB medium and the appropriate 
antibiotics was inoculated with the bacterial glycerol stock of interest and incubated 
o/n at 37°C at 200 rpm. The plasmids were purified using a Qiagen maxiprep kit. 
 
3.2.1.8 Site-directed mutagenesis 
Site-directed mutagenesis was performed using the QuickChange kit (Stratagene) 
according to manufacturer’s protocol. 
 
3.2.2 General protein-biochemistry methods 
 
3.2.2.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Pouring and electrophoresis of SDS-polyacrylamide gels was performed using the 
Novex system (pre-assembled gel cassettes). Stacking gels were prepared according 
to standard protocols using ready-to-use polyacrylamide solutions from Roth (Rotigel, 
30%, 49:1). For electrophoresis, protein samples were mixed with SDS-PAGE sample 
buffer, heat-denatured for 5 min at 95°C and directly loaded onto the gel. Proteins 
were separated at 200V until the dye front had reached the end of the gel. The 
molecular weight of proteins was estimated by running pre-stained or non-stained 
marker proteins (Peqlab, peqgold protein marker) in parallel. Following 
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electrophoresis, proteins were stained with either Coomassie Brilliant Blue, Silver or 
subjected to Western blotting. 
 
3.2.2.2 Coomassie Blue staining of protein gels 
Polyacrylamide gels were fixed for at least 30 min in fixation solution (50% methanol 
/ 10% acetic acid) and stained for 60 min to overnight on a slowly rocking platform 
with Coomassie staining solution (0.025% Coomassie Blue R in 10% Acetic acid). To 
visualize proteins, gels were destained in 10% acetic acid. After documentation, the 
gels were dried onto a Whatman paper at 80°C for 1 hr on a gel dryer (BioRad). 
 
In order to analyze proteins by Mass Spectrometry, gels were stained with a Colloidal 
Coomassie staining kit (Merck). Briefly, gels were fixed for at least 2 hrs in fixation 
solution (50% methanol /10% acetic acid) and incubated overnight in staining 
solution. Destaining of the gels was performed using ddH2O. After documentation, 
the bands were excised with a scalpel and stored in 0.2 ml PCR tubes with 150 µl of 
ddH2O at -20°C. Mass Spectrometry analysis of the proteins by MALDI-TOF or 
nano-spray-LC-MS/MS was carried out in a core facility 
(http://proteinanalytik.web.med.uni-muenchen.de/index.php/home/). 
Staining solution: 10 ml Stainer A, 2.5 ml Stainer B, 10 ml Methanol and 27.5 ml 
ddH2O 
 
3.2.2.3 Silver staining of protein gels 
The staining of protein gels with silver nitrate solution was carried out according to 
the protocol of Blum. The gel was fixed in 50% ethanol / 10% acetic acid for at least 
2 hrs and washed three times in 30% ethanol (20 min each), incubated for 1 min in 
0.02% Na2S2O3 (sodium thiosulfate), washed three times with water (ddH2O, 20 sec 
each) and stained with 0.2% AgNO3 solution for 1 hr. Afterwards, the gel was washed 
with water (three times, 20 sec each) and developed using developing solution (3% 
Na2CO3, 0.05% H2CO, 0.0004% Na2S2O3) until the desired proteins were visible 
(typically, after 5 to 10 min). After a short wash in water (1 min) the reaction was 
stopped by incubating the gel in 0.5% glycine stop solution (more than 5 min). After a 
final water wash (>30 min), the gel was documented and dried onto a Whatman paper 
at 80°C for 1 hr on a gel dryer (BioRad). 
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3.2.2.4 Western Blotting 
Proteins were separated by SDS-PAGE and transferred to PVDF membranes 
(Millipore) using the BioRad “Wet Blot system”. The gel was placed onto a 
membrane and sandwiched between gel-sized Whatman paper soaked in transfer 
buffer (25 mM Tris, 192 mM glycine, 20% methanol). The proteins were then 
transferred onto the membrane for 1.5 hrs (400 mA constant) at room temperature. 
The transfer reaction was cooled by the addition of an ice block into the transfer 
chamber. After transfer, the PVDF membranes were incubated for 1 hr in blocking 
solution (PBS/0.1% Tween-20/5% dried milk) in order to reduce the non-specific 
background. Membranes were sealed in a plastic bag and incubated overnight on a 
horizontal shaker in the coldroom with an appropriate dilution of the primary 
antibody directed against the protein of interest. PVDF membranes were washed three 
times in PBS/0.1% Tween-20 (10 min each) and incubated for one additional hr with 
horseradish peroxidase-coupled secondary antibody at room temperature. After three 
washes (10 min each, in PBS/0.1% Tween-20) antigen-antibody complexes were 
detected using the Enhanced Chemi-Luminescence Kit (ECL, Amersham) and 
autoradiography according to the manufacturer´s instructions. 
 
3.2.2.5 Li-Cor 
Proteins were transferred to a PVDF memebrane (millipore) as described above. After 
transfer, the PVDF membranes were incubated for 1 hr in blocking solution (TBS 5% 
BSA) in order to reduce the non-specific background. Membranes were sealed in a 
plastic bag and incubated overnight on a horizontal shaker in the coldroom with an 
appropriate dilution of the primary antibody directed against the protein of interest (in 
TBS/0.05% Tween-20/5% BSA). PVDF membranes were washed three times in 
TBS/0.0.5% Tween-20 (10 min each) and incubated fluorescently labeled secondary 
antibodies (in TBS/0.05% Tween-20/3% BSA). After three washes (10 min each, in 
TBS/0.05% Tween-20) antigen-antibody complexes were quantified with an Odyssey 
system (Li-Cor). For quantification the background method was set to median, border 
with 1 and Top/ Bottom segment.  
 
For quantification of HP1, both the monoclonal mouse (C1A9) and polyclonal rabbit 
antibodies were tested for linearity. The detection of polyclonal rabbit antibody was 
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linear in the range of 15-150 ng of HP1 protein and was therefore used for Li-Cor 
quantification (Figure3.1). 
 
Figure 3.1 Test of HP1 antibodies on Western Blot. 
 
3.2.2.6 Trichloroacetic acid (TCA) precipitation of proteins 
TCA was added to the protein sample at a final concentration of 20%, mixed and 
incubated for 10 min on ice. After spinning the sample at 13000 rpm and 4°C for 10 
min, the supernatant was removed and the pellet washed twice with 500 µl of cold 
acetone by centrifuging it at 13.000 rpm and 4°C for 5 min. The protein pellet was 
dried and resuspended in 1 x SDS-PAGE loading buffer and 1/40 volume of 1 M Tris 
pH 8.0.  
 
3.2.2.7 Determination of protein concentration 
Protein concentration was determined using the colorimetric assay Bradford. The 
concentration of purified proteins was also estimated according to protein standards 
with a known concentration (e.g. BSA) in SDS-PAGE followed by Coomassie blue 
staining. 
 
3.2.2.8 In vitro translation 
In vitro transcription and translation (IVT) reactions were performed for 2 hours at 
30° with the TNT rabbit reticulocyte lysate System (Promega) using 1 µg of plasmid 
DNA and 10 µCi of [35S] methionine in a 25 µl reaction.  
 
3.2.3 Tissue culture methods 
 
3.2.3.1 Cultivation of Drosophila cell lines 
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Drosophila cell lines SL2 was kept in Schneiders Drosophila Medium in medium 
sized tissue culture flasks at 26°C. SL2 cells were split in a sterile hood every 3 to 4 
days in a ratio 1:3 or 1:4 then moved to a new flask and provided with fresh medium 
in a total volume of 30 ml. In doing so attention was paid that the cells always grew 
adherently to the surface. Kc and SF4 cells posses a higher doubling rate and needed 
to be split every 3 days in a ratio 1:6 to prevent a totally detachment of the cells. 
Every two month a new frozen cell stock was thawed. 
 
3.2.3.2 Generation of SL2 stable cell-lines 
The SL2 cells were split the day before transfection and seeded out (5 x 106) in 60 
mm dish. The plasmid DNA of interest (1.8 µg) together with antibiotic selective 
plasmid (0.2 µg) (in general pNeo was used) was diluted in 300 µl Buffer EC 
(Effectene Transfection kit, Qiagen) and left at room temperature for 2-5 minutes. 
The mixture was shortly centrifuged down and 60 µl of Effectene (Qiagene) reagent 
was added. Then it was vortexed for 10 seconds and incubated for 10 min at room 
temperature. To the mixture 3 ml of Schneiders Drosophila Medium was added and 
then carefully pipetted onto of the SL2 cells. The transfected cells were left at 26°C 
for 2 days and transferred to a medium sized tissue culture flask with fresh medium 
and selective antibiotics (in general puromycin (1:1000). Selection of the cells lasted 
approximately 3 weeks. 
 
3.2.3.3 Generation of Baculoviruses and protein expression 
Protein of interest was cloned into pFastBacTM1 with an N-terminal flag tag. Then it 
was transformed into DH10Bac (Invitrogen) and bacemids were purified according to 
manufacturers protocol (Invitrogen). A monolayer of Sf9 (Spodoptera frugiperda) (9 
x105) was transfected with 1 µg bacemid using Cellfectin Reagent (Invitrogen) and 
cells were left for 7 days at 26ºC. The supernatant was amplified 2-3 times and 
recombinant viruses were used for test expression. Amplification was undertaken to 
preserve the virus stock and to gain a higher titer of virus (typical 107 to 108 plaque 
forming units (pfu/ml)) of the initial virus stock. A 15 cm diameter plate with 1.2x107 
Sf9 cells (attached) was infected with 0.5 to 1 ml of virus and incubated at 26°C. The 
plate was sealed with parafilm (NAS) to prevent dehydration. The supernatant was 
collected after 7 days of cultivation (check for high level of virus infection by 
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comparing to mock transfected cells) and kept at 4°C in the dark. The cells stopped 
growing and cells lysed. For test expression: Forty-eight hours post-transfection cell 
extracts were checked for fusion protein expression using anti-FLAG monoclonal 
antibody (Sigma). For routine protein expression 10 x150 mm Petri dishes were 
infected and the cells kept at 26ºC.  
 
3.2.4 Recombinant protein expression and purification 
 
3.2.4.1 Expression and purification of recombinant Drosophila His-SU(VAR)3-9 
Transform 1 µl peT15b-plasmid into 200 µl BL21(DE3)pLys cells and plate on 
amp/chloramphenicol (or suitable antibiotics) plate. Incubate at 37° overnight. The 
next day, inoculate several colonies from the plate in about 50 ml of LB (+ antibiotics 
(amp/chl)) and incubate overnight at 37°C with shaking. On day three, expand 20 - 40 
ml of the preculture to 2 -4 litre of LB (+ antibiotics). Incubate bacteria at 37° C, 
shaking at 200 rpm and measure OD (600nm). When the culture reaches 0.8 (it will 
take 2 to 4 hours according to volume of pre-culture), induce cells with IPTG to a 
final concentration of 1 mM. The cultures were left shaking at 18° C overnight. The 
following day the bacteria was centrifuged down (7000 g/4 °C/ 15 –20 min) and the 
pellet resuspended in 25 ml to 40 ml of Lysis Buffer 1 mM Imidazole (20 mM Tris 
pH 8, 200 mM NaCl, 0.05% NP40 and protease inhibitors like “complete tablets”, or 
a mixture of leupeptin, aprotinin, pepstatine, PMSF) and transferred in a 50 ml falcon 
tube. The solution was quick frozen in liquid nitrogen and stored at - 80° C. For 
purification the solution was thawed at 37° C for 15 to 20 min. Thereafter the bacteria 
solution was sonicated 6 times for 30 seconds, amplitude 50% on ice. Centrifuge in 
Sorvall centrifuge for 30 min at 18-20 000 rpm, 4°C, SS 34 rotor. Talon beads 
(Clontech) were prepared: take about 4 ml of the mixture, and wash 2 times in Lysis 
buffer 1 mM Imidazole . Then make a 1:1 slurry of the beads in lysis buffer 1 mM 
Imidazole. The supernatant was transferred in a new tube, and 1 ml of Talon bead 
slurry per 2 l of bacterial culture (i.e. 2 ml slurry per 4 l of culture) was added. The 
slurry was incubated for 2 hours in the cold room rotating. After the incubation 
centrifuge down beads for 10 min, 4° C at 1000 rpm. Work in coldroom and take off 
supernatant, add 5 ml lysis buffer 1 mM Imidazole (with protease inhibitors) to the 
beads and transfer them into a small single-use plastic column (for example Poly-Prep 
from BioRad). Wash beads for 2 - 3 times with 10 ml lysis buffer 1 mM Imidazole, 1 
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x with 5 mM Imidazole and 2 x with 15 mM Imidazole. The protein was eluted with 
lysis buffer 100 mM Imidazole (+ protease inhibitors) and 0.5 ml fractions collected 
(collect about 10 fractions). The protein will be most concentrated in fraction 2, 3 and 
4. Load 5-10 µl of each fraction onto a SDS gel for a Coomassie staining and for a 
western blot 
 
For enzymatic activity would I add 10% glycerol in the Elution Buffer and add BSA 
to (100 ng/ul) to each fraction before freezing. After testing activity; thaw active 
fractions and pool them. Work in cold room and very quick. Aliquot in 50- 100 ul and 
flash frozen in liquid nitrogen. Store at - 80 ° C. 
 
3.2.4.2 Expression and purification of recombinant Drosophila HP1  
Bacterial expression of un-tagged HP1 proteins was performed as described in 
3.2.4.1. Only 1 liter of culture is efficient to retrieve several mg of protein. 
Recombinant HP1 and point mutants were purified according to (Zhao and 
Eissenberg, 1999) and dialysed against BC100 (25 mM HEPES  (pH 7.6), 100 mM 
NaCl, 1 mM MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 10% (v/v) glycerol, 1 mM DTT 
and 0.2 mM PMSF). All HP1`s were quantified by Bradford (Bio-Rad) and 
Coomassie stained proteins was quantified using the ImageMaster 1D Elite v3.01 
software package (Amersham) using BSA as a standard.  
 
3.2.4.3 Purification of Flag-dG9a 
The cells were harvested 48 hours post-infection and washed once with cold 1x 
phosphate-buffered saline. For purification of FLAG-dG9a protein, infected cells (1.2 
x108) were resuspended in 4 ml of BC300 (25 mM HEPES (pH 7.6), 300 mM NaCl, 
1mM MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 10% (v/v) glycerol, 1 mM DTT, and 
protease inhibitors) containing 0.05% (v/v) NP40. The cells were sonicated on ice 2 
times 15 seconds at 50% amplitude using a Branson sonifier and centrifuged at 15000 
rpm for 30 minutes. 100 µl 1:1 slurry of M2 anti-FLAG agarose beads (Sigma) was 
added to the supernatant and incubated for 2 hours at 4ºC. After washing three times 
with BC300 (containing 0.05% (v/v) NP40) for 10 minutes each, and once with 
BC100 (0.05% (v/v) NP40) the bound protein was eluted with 0.5 mg/ml FLAG 
peptide BC100 (0.05 % (v/v) NP40) for 2 hours. The purity of the protein was 
checked by SDS-PAGE. Eluates were stored at -80ºC. 
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3.2.4.4 Expression and purification of GST-tagged proteins 
Expression of GST-proteins were performed as described in chapter 3.2.4.1. In 
general 500 ml to 1 liter is sufficient for several mg of protein. Centrifuge down 
culture at 4000 rpm for 15 minutes at 4 degrees and redisolve pellet in ca 10ml 
Column buffer pr 500 ml culture (20 mM Tris pH8, 300 mM NaCl, 0.5 mM EDTA 
and complete protease inhibitors, 1mM DTT). Freeze in liquid nitrogen; even if you 
plan to continue the prep the same day or store at -70. Thaw at 37 degrees waterbath 
for approximately 10-15 min. Sonicate on ice 7x at 50 % on ice and add 0.5 % NP40. 
Then centrifuge for 30 minutes at 18000 rpm, 4 degrees. (SORVALL).After 
centrifugation transfer supernantant to a new Falcon tube (50 ml). During the 
centrifugation wash Glutathion-Sepharose 4B beads in Column buffer in 15 ml 
falcon. Prepare a 1:1 slurry. Add 400 ul slurry pr 500 ml LB and leave rotating in the 
cold room for 2 hours. Centrifuge down beads at 2000 rpm for 10 min. Remove 
supernantant (keep aliqote for gel to see if you have bound everything)  and add 10ml 
Column buffer and transfer beads into column (for example Poly-Prep from BioRad). 
Wash 2x 10 ml Wash buffer I (20 mM Tris pH8, 1000 mM NaCl, 0.5 mM EDTA, 0.1 
% NP40 and complete protease inhibitors, 1mM DTT) , 2 x 10 ml Wash buffer II 
(Same as Wash buffer I with 500 mM NaCl ) and 1x 10 ml Wash buffer III (Same as 
Wash buffer I with 200 mM NaCl and without NP40) let all buffer run out by gravity. 
Put the yellow cap on the column. Add 200 ul Elution buffer (200 mM Tris pH 8, 40 
mM reduced glutathione, 200 mM NaCl and 10% glycerol. Prepared fresh the same 
day) per initial 400 ul slurry (ie 1200 slurry- 600 Elution bf). Add lid and rotate for 1 
hour at 4 C. If the beads are stuck in the lid a gentle short centrifugation putting the 
column in a 50 ml Falcon 1000 rpm 10 sec should help. Elute all in one tube and 
quick freeze. Usually a second elution with the same elution volume is recommended 
1 hour-ON. 
 
3.2.5 Histone purification and octamer preparation 
 
3.2.5.1 Expression and purification of Drosophila histones 
Recombinant histone expression and purification was undertaken according to Luger 
and colleagues (Luger et al., 1999). Briefly, individual recombinant histones were 
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expressed in BL21(DE3)pLys as described in 3.2.4.1 with a total volume of 9 litres of 
LB. Inclusion bodies containing the histones were prepared. The proteins were 
unfolded in urea buffer and the histones were purified via SP-Sepharose 
chromatography. The histones were dialyzed against water, lyophilized and stored at -
80°C.  
 
3.2.5.2 Purification of Native Drosophila histones 
Native histones were purified according to (Simon and Felsenfeld, 1979). 
Approximately 50 g of (0-12 hour) Drosophila embryos were collected and 
dechorinated. The dried embryos were resuspended in 40 ml Glycine buffer (15 mM 
Hepes-KOH pH 7.6, 10 mM KCl, 5 mM MgCl2, 0.05 mM EDTA, 0.25 mM EGTA, 1 
mM DTT, 0.2 mM PMSF, 10% glycerol and 1 tablet complete/ 50 ml). The embryos 
were homogenized 6 times with a Yamamoto homogenisator at 1000 rpm, 4°C. After 
filtering the homogenized embryos through a miracloth, the solution was 
centrifugated for 10 min at 8 krpm in a HB-4 rotor at 4°C. The nuclear pellet was 
resuspended in a final volume of 50 ml SUC buffer (15 mM Hepes-KOH pH 7.6, 10 
mM KCl, 5 mM MgCl2, 0.05 mM EDTA 0.25 mM EGTA, 350 mM Sucrose,. 1 mM 
DTT, 0.2 mM PMSF and 1 tablet complete/ 50 ml). The nuclei solution were 
centrifuged again (10 min; 8 krpm; HB-4 rotor; 4°C) and the nuclei was resuspended 
in 30 ml SUC buffer. Then 90 ml of 1M CaCl2 was added and the solution was heated 
up for 5 minutes at 26°C. Then add 125 ml MNase 50 u/ml and incubated for 10 min 
at 26°C. The reaction was stopped with 600 ml 0.5 M EDTA and centrifuged again 
(10 min; 8 krpm; HB-4 rotor; 4°C). The pellet was resuspended in 6 ml TE pH 7.6 
including 1 mM DTT, 0.2 mM PMSF and complete protease inhibitors and rotated  
for 30-45 min at 4°C. Then centrifuge for 30 min at 12 krpm in a HB-4 rotor at 4°C. 
The pellet was the chromatin. Adjust salt to 0.63 M NaCl with the 2 M NaCl/ 100 
mM K-PO4 (pH7.2) solution and centrifuge again (for 30 min at 12 krpm in a HB-4 
rotor at 4°C). Afterwards the histones were loaded on a 30 ml Hydroxylapatite 
column (BIO RAD #130-0150 Bio gel HT) and wash column with 5 volumes of 0.63 
M NaCl/ 100 mM K-PO4 (pH 7.2) and elute histones with 2 M NaCl/ 100 mM 
NaPO4. Histones were concentrated (Centricon 30 K; 7000 rpm, SS34 rotor (Sorvall), 
at 4°C successive 20 min) and 50%  (vv) glycerol was added. The glycerol stock were 
stored at  –20°C. The histones were checked on a 18% SDS PAGE 
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3.2.5.3 Native H1 purification 
H1 was purified from Drosophila embryos (0-12 hrs) according to (Croston et al., 
1991) and its identity was verified by MALDI TOF. 
 
3.2.5.4 Octamer preparation 
The histone octamer reconstitution was prepared according to Luger with minor 
modifications (Luger et al., 1999). Lyophilized recombinant histones were 
resuspended in unfolding buffer (7 M Guanidinium HCl, 20 mM Tris pH 7.5, 10 mM 
DTT) in a final concentration of about 2 mg/ml. The exact protein concentration was 
calculated from the UV-absorption at 275 nm using the specific absorption coefficient 
of each histone (Luger et al., 1999). Equal amounts of histones were mixed and a 
similar volume of unfolding buffer was added. This mixture was dialyzed 3 times 
(twice 1 hour and once o/n) against one liter of refolding buffer (2 M NaCl, 10 mM 
Tris pH 7.5, 1 mM EDTA, 5 mM β-mercaptoethanol). Aggregates were removed by a 
short centrifugation step (10 min, 15000 rpm, SS34 rotor (Sorvall)). The supernatant 
was concentrated to less than 2 ml by centrifugation in concentration tubes (Centricon 
30 K; 7000 rpm, SS34 rotor (Sorvall), at 4°C successive 20 min). The concentrated 
sample was purified over a Superdex 200 gel filtration column in order to separate the 
refolded octamer from incomplete forms and precipitates (flow 1 ml/min, 2 ml-
fractions, running in refolding buffer). Individual fractions were analyzed on a 18% 
SDS gel and the suitable fractions containing stochiometric histone octamers were 
finally concentrated by centrifugation (conditions as above) down to 1 ml. One 
volume of glycerol was added and the recombinant histone octamers were stored at -
20°C.  
 
3.2.5.5 Generation of H3K9 methylated octamer 
120 µg of recombinant octamer was incubated in the presence of 9 µg of active 
recombinant Drosophila SU(VAR)3-9 (Eskeland et al., 2004) to retrieve 60 µg of a 
70-80% H3K9 di- and tri-methylated octamer. The reaction was incubated at 30 °C 
for 90 minutes in the presence of 40 µM S-adenosylmethionine (New England 
BioLabs) as methyl donor and 40 mM NaCl. After incubation concentrations were 
adjusted to 100 mM NaCl, 0,2 mM PMSF and 2 mM DTT. To 1 ml total volume, 80 
µl (1:1 slurry) of Biorex70 beads (Bio-Rad) were added. The reaction was rotated at 4 
°C for 4 hours and washed 5 times with TEN200 (200 mM NaCl, 10 mM Tris, 1 mM 
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EDTA, 0.2 mM PMSF and 1 mM DTT) and 5 times with TEN400. The methylated 
octamer was eluted with TEN2500, and 4 µl (2 µg) was analyzed by a 15% SDS 
PAGE and stained by Coomassie blue. 
 
3.2.6 Nucleosome assembly  
 
3.2.6.1 Nucleosome assembly by salt dialysis 
This protocol is adapted from (Luger et al., 1999). Salt dialysis is performed in 
bags/dialysis tubes (siliconised) of Spectra/membranes with a cutoff of MW 6000-
8000 at 4°C. It was important to make sure the bag rotates freely during dialysis. The 
DNA and histones were mixed in presence of BSA and 2 M NaCl (High Salt). Low 
salt is pumped into the High salt buffer (while being stirred) o/n  (16-20 hrs) at a 
speed of approx 2-3 ml pr ml. For every new batch of histone and/ or DNA a titration 
was performed. For example: for 60 µg DNA was titrated with following 
concentration of octamer to find the right ratio: 48 µg (0.8), 54 µg (0.9), 60 µg (1), 72 
µg (1.2), 84 µg (1.4). In general a DNA-histone mix contains: 60 µg DNA, 50 µg 
BSA, Octamers (recombinant of native) for ratios: Check above, 2M NaCl final 
concentration and TE buffer to total volume of 500 µl. 
 
To check the nucleosomes after dialysis, an MNase was perfomed. To 20 µl of 
nucleosomes 17 µl MNase mix (5 mM CaCl2, 0.2 U MNase, EX100 buffer) was 
added by pipetting up and down constantly to mix well. After 20 seconds, 60 seconds 
and 120 seconds 12 µl was transferred to a tube ready prepared with 5 µl STOP buffer 
(4 % SDS and 100 mM EDTA). To each tube1 µl of Proteinase K (10 mg/ml) was 
added and the reaction incubated for 30 minutes at 37 °C. For precipitation 1 µl of 
glycogen, 16 µl NH4Ac (7.5 M) and 80 µl EtOH (100%) was added. The mixture was 
incubated on ice for 30 min, centrifuged at max speed for 30 minutes at 4°C and 
washed with 70% EtOH. The pellets were very loose so care had to be taken when 
removing the EtOH. Dried pellet were redisolved in 10 µl 1x DNA loading dye and 
separated on an 1.3 % Agarose gel. 
 
MNase Sigma: 500 U lyophilized vial was resuspended in 850 µl EX50 buffer and 
aliqoted in 50 µl aloqotes: Concentration is 50 U / µl (Boerhinger units). 
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3.2.7 Extract preparations 
 
3.2.7.1 Preparation of chromatin assembly extract from Drosophila embryos 
Drosophila embryo extract (DREX) assembly was performed as described (Becker 
and Wu, 1992).  
 
3.2.7.2 Preparation of nuclear extract from Drosophila embryos 
0-12 hours Drosophila embryos were collected over a period of 4-5 days. The 
embryos were washed and dechorienated. The dried embryos were weighed and 
resuspended in 1ml NUI buffer per gram embryos (15 mM Hepes-KOH pH 7.6, 10 
mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.5 mM EGTA, 350 mM Sucrose, 1 mM 
DTT, 0.2 mM PMSF). The embryos were homogenized 6 times with a Yamamoto 
homogenisator at 1000 rpm, 4°C. After filtering the homogenized embryos through a 
miracloth, the solution was centrifugated for 15 min at 8 krpm in a HB-4 rotor at 4°C. 
The nuclear pellet was resuspended in 1ml NUII buffer (15 mM Hepes pH 7.6, 110 
mM NaCl, 5 mM MgCl2, 0.1 mM EDTA pH 8)/gram embryos. To the nuclear mix, 
1/10 volume of 4M (NH4)2SO4 pH 7.9 was added and the tube inverted and rotated 
for 20 min at 4°C. After rotation, the sample was centrifueged for 1 hour in a Ti60 
rotor at 35K, 4°C. The clear supernatant was saved, then 0.3g/g embryos of solid 
(NH4)2SO4  was added during continuous stirring and then left for 10-15 min. The 
extract was centrifuged at 15K for 15 min in SS34, 4°C. After centrifugation the 
supernatant was discarded and the pellet could be stored at 4°C for 3-5 days. The 
pellet was resuspended by adding 190 µl of HEMG 40 (25 mM Hepes pH 7.6, 40 mM 
NaCl, 12.5 mM MgCl2, 0.1 mM EDTA, 10% (v/v) glycerol, 1 mM DTT and 0.2 mM 
PMSF) per g embryo, and carefully douncing until everything was disolved. The 
nuclar extract was dialysed in 2 litres of HEMG 40, and followed by 3 subsequent 
dialysis in HEMG 100. Then the extract was centrifuged for 15 min at 15 K in SS34, 
4°C, and flash frozen. Store at -70 °C. 
 
3.2.7.3 Preparation of nuclear extract from SL2 cells 
This protocol was obtained from A. Hocheimer. The stable SL2 cell lines were grown 
up to 1 liter (in two roller bottles) within 1 month.  When harvesting the cells they 
were counted and the smell of the culture was checked. The cells were harvested at 
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2.5 K for 10 minutes in the Hearaeus centrifuge. Then the cells were collected in a 50 
ml falcon and washed 3 times in cold 1x PBS (40 ml). The cell pellet got whiter. The 
packed cell volume (PCV) was estimated and the cells resuspended in 3x PCV ice 
cold Buffer A (10mM Hepes pH 7.6, 15 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 1 
mM DTT and freshly added complete protease inhibitors). After resuspending by 
pipetting (avoid air bubbles), the cells were left on ice for 30 min. Then the cells were 
dounced 15 times with a tight pestle, agian avoiding air bubble formation. Quickly 
thereafter, 1/10 of Buffer B (50 mM Hepes pH 7.6, 1 M KCl, 30 mM MgCl2, 0.1 mM 
EDTA, 1 mM DTT and freshly added complete protease inhibitors) was added and 
the mixture was centrifuged for 15 min at 8 K (in SS34) at 4°C. The supernatant was 
removed and the packed nuclear pellet volume (PNV) estimated (approximately 1-
1.5x PCV).  A volume of 4x PNV Buffer A/B (9 volumes Buffer A and 1 volume 
Buffer B) was added and the nuclei were dounced 2 x. Afterwards 1/10 volume of 4M 
(NH4)2SO4 pH 7.9 was added and the tube inverted and rotated for 20 min at 4°C. 
After rotation, the sample was centrifueged for 2 hours in a Ti45 rotor at 35K, 4°C. 
The clear supernatant was saved, then 0.3g/ml of solid (NH4)2SO4  was added during 
continuous stirring and then left for 10-15 min. The extract was centrifuged at 15K for 
15 min in SS34, 4°C. After centrifugation the supernatant was discarded and the 
pellet could be stored at 4°C for 3-5 days. For dissolving the pellet, 0.2-0.5 PCV 
volumes of Buffer C (25 mM Hepes pH 7.6, 150 mM KCl, 12.5 mM MgCl2, 0.1 mM 
EDTA, 10% (v/v) glycerol, 1 mM DTT and freshly added complete protease 
inhibitors) was added and then dounced carefully.  The nuclear extract was dialysed 
in 3x 1 liter (for a total of 3-4 hours) of Buffer C. Then the extract was centrifuged for 
15 min at 15 K in SS34, 4°C, aliquoted in 50-100 µl aliquots, flash frozen. Store at -
70 °C. 
 
3.2.8 Histone methyltransferase assays 
 
3.2.8.1 The “Spot and count” method 
The total reaction volume was 40 µl. SU(VAR)3-9 reaction was diluted in H2O, 
dG9a/mG9a in 12.5 mM Tris-HCl pH 8.8, 1 mM DTT, 50 mM NaCl, 50 ng/µl BSA, 
and 2.5 mM MgCl2. To the reaction 1 µg H3 peptide, 2 µg histones, 4 µg octamers or  
2 µg Nucleosomes were added together with 500 nCi S-Adenosyl (methyl 3H)-L-
methionin (25 µCi/ml) (Amersham). The reaction was started by addition of 100ng – 
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1 µg of HMTase. After incubation at 30 °C for 30 min to 2 hours, 30 µl of the 
reaction was spotted onto a p81 filter paper and washed 3 times 10 min in Na2CO3 pH 
9.2. After drying the filter papers, the amount of 3H-methyl groups was measured by 
adding Scintilization liquid and read in a Scintilator. The total amount of product that 
formed was measured in counts per minute (cpm) 
 
3.2.8.2 HIM Assay measured by autoradiograph 
The HIM assay was performed as described in 3.2.8.1. After incubation at 30 °C, the 
reaction was stopped by adding SDS PAGE loading buffer. The histones were 
separated on a 15% SDS PAGE and Coomassie stained. After destaining, the gel was 
incubated in Amplifyer (Amersham) for 30 min. The gel was dried and visualized by 
Autoradiography. The exposure time depended on the efficiency of the enzyme and 
ranged from over night till 2 weeks. 
  
3.2.8.3 MALDI-TOF analysis of in vitro methylated histones 
Methylation reactions were carried out as described above with 0.5 µg histone H3 or 
H4 and 40-250 µM S-Adenosylmethionine (New England BioLabs). Incubation 
ranged from 30 minutes to 2 hours. The reaction was stopped by addition of SDS 
PAGE loading buffer and the histones were separated by 15 % SDS PAGE. The 
Coomassie stained bands corresponding to H3 and H4 were excised and subjected to 
chemical modification (Propionylation) to derive free amino groups of lysine residues 
as described (Taipale et al., 2005). H3 and H4 were digested over night with 100 ng 
of sequencing-grade trypsin (Promega) in a total volume of 40 µl according to 
manufacturer`s protocol. In order to purify the methylated peptides from 
contaminating salts or acryl amide the peptide solution was passed over a pipette tip 
containing C18/SCX material (ZipTip, Millipore) and eluted 50% ACN/ 0.3 % TFA 
on to a target plate and 1 µl alpha-cyano4-hydroxycinnamic acid (Sigma) was added 
on top. The MALDI spectra were acquired and analyzed as described (Bonaldi et al., 
2004). Reaction mix without enzyme was used for calibration. For quantification of 
the differentially methylated peptides, the corresponding peaks were monoisotoped 
and integrated. The total cluster area of each isoform of a single peptide was set to 
100% and thereby the percentage of each peptide isoform could be calculated. 
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3.2.8.4 MALDI-TOF analysis of in vitro methylated histone H3 peptides 
Methylation reactions were carried out as described above with 1 µg histone H3 
peptide and 40 µM S-Adenosylmethionine (New England BioLabs). The reaction was 
stopped by adding 10% acetic acid. The peptides were purified from contaminating 
salts using C18 material and eluted as described above. The MALDI spectra were 
acquired and analyzed as described (Bonaldi et al., 2004). 
 
3.2.8.5 SU(VAR)3-9 kinetics 
Kinetic assays were carried out as described in 3.2.8.1 with varying the concentrations 
of SAM (5-60 µM) (H3 peptide 1 µg) or H3 molecules (0.82-3.1 µM) (SAM 40 µM). 
To avoid that the products (dimethylated peptide or S-adenosyl homocystein (SAH)) 
have inhibitory effects, the incubation was 1 or 5 minutes. The reaction was stopped 
by adding 10% acetic acid and spotted as described in 3.2.8.1.  
 
The amount of product that formed was measured in counts per minute (cpm). The 
product (3HCH3) concentration (pmol) was calculated:  ((cpm-Background) x total 
volume of reaction x S-Adenosyl (methyl 3H)-L-methionin concentration (pmol) x 
dilution factor of SAM (S-Adenosyl (methyl 3H)-L-methionin/ SAM) / (Spotted 
volume x total of S-Adenosyl (methyl 3H)-L-methionin cpm). 
 
To obtain values for Km and Vmax, a Lineweaver-Burk plot was generated. This 
equation was obtained by inverting the Michaelis-Menten equation: 
 
V= Vmax x [S]/ Km + [S]  
 
Where V is velocity, Km is the Michaelis-Menten constant, Vmax is the maximum 
reaction velocity and [S] is substrate concentration. 
 
The y-intercept of the Lineweaver-Burk plot (Figure 3.2), is equivalent to the inverse 
of Vmax. The x-intersept represent -1/Km. The slope, as the equation shows, is 
Km/Vm. 
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Figure 3.2 Lineveawer Burk plot 
 
3.2.9 Pull-down assays 
 
3.2.9.1 ACF and ACF1 pull-downs 
ACF1-FLAG and ISWI were expressed in Sf9 cells as described previously 
(Eberharter et al., 2001) The ACF complex was generated by coexpression of ACF1-
FLAG with untagged ISWI. Sf9 cells were suspended in BC500 containing 0.05% 
(v/v) NP40, 1 mM DTT, 0.2 mM PMSF and protease inhibitors. The cells incubated 
on ice were sonicated 2 times 15 seconds at 50% amplitude and centrifuged at 
maximum speed on a table top centrifuge for 30 minutes. A total of 500 ng of the 
expressed proteins were immobilized on M2 anti-FLAG agarose beads and blocked 
with 1 µg/µl BSA. Recombinant HP1 or HP1 mutants were added at a concentration 
of 1 µg of in a total volume of 200 µl BC100 containing 0.05% (v/v) NP40, 100 µg 
BSA and 5 µg ethidium bromide. After 30 minutes incubation at room temperature, 
the beads were washed 2 times in the same buffer without ethidium bromide and 
BSA, containing 100 mM NaCl and 4 times in a buffer containing 200 mM NaCl. The 
bound proteins were eluted with SDS sample buffer analyzed by SDS PAGE and 
transferred onto a PVDF membrane (Millipore). 
 
3.2.9.2 Peptide pull-downs 
Various H3 peptides (aa from to 1-19) were coupled to Thiolink beads (BioRad) and 
resuspended as 1:1 slurry in BC100. 20 µl of this slurry was incubated with 1 µg of 
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recombinant HP1 in a total volume of 200 µl BC100. The incubation was performed 
on a rotating wheel at 4 °C for 2 hrs. After washing three times with BC100 
(containing 0.05% (v/v) NP40) for 10 minutes each, the bound protein was eluted 
with 30 µl acidic elution buffer (100 mM Glycine pH 2.5, 500 mM NaCl) for 20 min 
at 4 °C. The eluted proteins were analyzed by 12% SDS PAGE and Coomassie 
stained. 1 µg biotinylated H3 peptides: unmodified aa 1-21 (WT) and trimethylated at 
K9 aa 1-21 (H3K9tri) (Upstate) were mixed with 2 µg HP1 (WT or mutant proteins) 
and incubated for 1 hour at 4 ºC. Then 10 µl 1:1 slurry of paramagnetic beads (Dynal) 
(pre blocked in BSA) was added and incubated for 1 hour at 26 ºC in BC100 
(containing 0.05% (v/v) NP40). The paramagnetic beads were concentrated on a 
Magnetic Concentrator (Dynal) and washed once with BC100 + 0.05% (v/v) NP40 
and twice with BC200 + 0.05% (v/v) NP40. Bound proteins were separated on a 12% 
SDS PAGE and Coomassie stained. 
 
3.2.9.3 GST pull-down 
Gluthathione Sepharose 4B (Pharmasia Biothech) beads were washed in 10 ml NTEN 
100 buffer (20 mM Tris HCl pH 8, 100 mM NaCl, 1mM EDTA, 0.5 % NP40, 1 mM 
DTT and protease inhibitors) and a 1:1 slurry prepared. 
 
Ca 2-3 ug of GST fusion protein or GST control was added to 30 µl Gluthathione 
Sepharose 4B beads in a total volume of 530 µl NTEN 100. The samples were rotated 
at 4 °C for 45-60 minutes and washed 4 times with 1 ml NTEN100 buffer and 1 time 
with NTEN200 buffer. Then the beads were pre-blocked with 10 ul BSA (10 mg/ml) 
and 90 ul NTEN100 buffer, rotating at 4 °C for 30 min. The beads were washed 2 
times 1ml NTEN100 buffer and 2- 5 µl of S35 labeled in vitro translated protein was 
added plus: 10 ul BSA (10 mg/ml), 0.5 ul Ethidium bromide (10 mg/ml) in a total 
volume 200 ul NTEN100. The reaction was rotated for 30 minutes at 20 °C. After 
incubation, the reaction was washed 4 times with NTEN100 and 2 times NTEN200. 
Then 2X loading dye buffer was added and the sample was boiled for 5 min. The 
reactions were separated on SDS PAGE, Comassie stained and destained. Afterwards 
the gel was incubated in Amplifyer (Amersham) for 30 min. The gel was dried and 
visualized by Autoradiography. 
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3.2.10 Chromatin on paramagnetic beads assays  
 
3.2.10.1 Preparation of biotinylated DNA  
This protocol was optimized for digest of 500 µg PAI61 DNA where the end product 
was a biotinylated insert and vector (which will not bind to paramagnetic streptavidin 
beads). The first digestion in a total volume of (500 µg PAI61, 75 µl BSA (1 µg/µl), 
75 µl Buffer 1 (10x NEB), 10 µl SacI (NEB) and x µl ddH2O) was incubated reaction 
for 3 hours in a 37 °C incubator (the one where we keep bacterial plates) to avoid too 
much evaporation. Each hour, the tube was vortexed shortly. Then 0.5 ul was checked 
on a 0.8% agarose gel, loading 300 ng of undigested vector as control. It was 
important that all the plasmid was linearized. For digestion 2 a total volume of 800 µl 
was prepared containing: (Digestion 1, 5 µl BSA (1 µg/µl), 10 µl XbaI (NEB), 5 µl 
Buffer 2 (10x NEB), 7.5 µl NaCl (5M) and 22.5 µl ddH2O). The mixture was 
incubated for 3 hours in a 37 °C incubator as described above.1 µl was kept for 
agarose gel later. After the incubation, the DNA was precipitated by addition of 85 µl 
NaOAc (3M) pH 5.2 and 600 µl Isopropanol and then mixed and incubated on ice for 
30 min. The tube was centrifuged for 30 minutes at max speed at 4 °C. The pellet was 
washed once with 70% Ethanol and dried. The pellet was carefully redisolved by 
adding 252.9 µl ddH2O.For the Biotinylation reaction the 252.9 µl DNA was mixed 
with 30 µl Buffer 3 (NEB), 0.8 µl dCTP (100 mM), 0.8 µl dGTP (100 mM), 3 µl 
biotinylated dUTP (1 mM), 7.5 µl biotinylated dATP (0.4 mM) and 5 µl Klenow 
(Roche 2U/µl) and incubated for 2 hours at 37 °C. To inactivate the Klenow enzyme, 
the reaction was incubated at 70 °C for 20 minutes. It was important to remove the 
biotinylated nucleotides, which was not incorporated. This was done by using 3 
sepharose G50 columns (Roche).  The columns were centrifuged once for 1 minute at 
1000 rpm in a Beckman centrifuge for falcons. The flow through and the sample was 
carefully transferred to the top (in the middle) of the columns, and 100 µl of the 
biotinylation reaction. Then the columns were centrifuged for 2 minutes at 1000 rpm 
and the flow through was collected. The last digestion was performed in a total 
volume of 750 µl: X µl Biotinylated DNA, 45 µl Buffer 3 (NEB), 75 µl BSA (1 
µg/µl), X µl ddH2O and 10 µl PstI). It was incubated for 3 hours or ON at 37 °C. The 
restriction was checked on a 0.8 % agarose gel. Store Biot. DNA at -20 °C. 
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3.2.10.2 Chromatin assembly on immobilized DNA and micrococcal nuclease 
digestion 
The assembly reactions for immobilized DNA were performed according to 
(Sandaltzopoulos et al., 1994). In short; 2 µg DNA was immobilized to 0.8 mg 
paramagnetic streptavidin beads (Dynal) and after extensive washing blocked for 30 
minutes at 4 °C with BSA (1 µg/µl) in EX50 (10 mM HEPES pH 7.6, 50 mM NaCl, 
1.5 mM MgCl2, 0.5 mM EGTA, 10% (v/v) glycerol, 0.2 mM PMSF, 1 mM DTT) 
containing 0.05% (v/v) NP40 before assembly. Recombinant or H3K9Me histone 
octamers (2 µg) were mixed with the assembly extract at time point zero together with 
an ATP regenerating system (3 mM ATP, 30 mM creatine phosphate, 10 µg creatine 
kinase pr. ml, 3 mM MgCl2, and 1 mM DTT). HP1 was then added at a concentration 
of 2 µg (8.3 ng/µl) and the reaction left rotating for 6 hours at 26 ºC. For circular 
DNA: 900 ng of circular DNA, 12 µl McNAP (30 mM MgCl2, 10 mM DTT, 30 mM 
ATP, 300 mM creatine phosphate, 10 µg/ml creatine phosphate kinase) and varying 
amounts of Drosophila embryo extract (20-70 µl, depending on extract). The volume 
was increased with EX-80 to a final volume of 120 µl. Micrococcal nuclease (MNase) 
digestions was performed as described in (Sandaltzopoulos et al., 1994) with 30 
Boehringer Units of  MNase (Sigma). For MNase digestion of chromatin assembled 
onto circular DNA, 150 Boerhringer Units were used. The 123 bp ladder (Invitrogen) 
was used as a size marker. 
 
3.2.10.2 Immobilization of salt assembled chromatin and HP1 binding assay 
Salt assembled recombinant or H3K9Me chromatin (1 µg) was immobilized onto 0.4 
mg paramagnetic streptavidin beads (Dynal) in TEN100 buffer containing 0.05% 
(v/v) NP40 and 250 ng/µl BSA. After 2 hours rotation at 4 °C the chromatin on 
paramagnetic beads was concentrated on a Magnetic concentrator (Dynal) and 
washed once with EX100 buffer containing 0.05% (v/v) NP40. Chromatin was 
immediately resuspended in total volume of 80 µl containing 60 µl Ex100 0.05% 
(v/v) NP40, BSA (100 ng/µl), ATP regenerating system (3 mM ATP, 30 mM creatine 
phosphate, 10 µg creatine kinase pr. ml, 3 mM MgCl2, and 1 mM DTT) and 2 µg (25 
ng/µl) HP1. Purified SU(VAR3-9) WT and Δ213 was added in a total concentration 
of 100 ng. FLAG eluted ACF at a total concentration of 50 ng was added in presence 
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of ATP or absence of ATP. Drosophila assembly extract was added at a concentration 
of 100 µg in presence of ATP or non-hydrolysable ATP-gamma-S analog. 
3.2.10.3 Chromatin washes and HP1 detection 
Assembled chromatin was concentrated on a Magnetic Concentrator (Dynal) and 
supernatant removed. The chromatin beads were washed once with 100 µl EX100 (10 
mM HEPES pH 7.6, 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM EGTA, 10% (v/v) 
glycerol, 0.2 mM PMSF, 1 mM DTT) containing 0.05% (v/v) NP40 and twice with 
same buffer containing 200 mM NaCl. The bound proteins were eluted with 10 µl 
SDS loading dye and separated on a 15% SDS PAGE. The proteins on the gel smaller 
than 20 kDa including the histones were subjected to Coomassie staining, whereas the 
rest of the gel was transferred to PVDF (Millipore). Blots were probed with HP1 
polyclonal rabbit antibody and incubated with fluorescently labeled secondary 
antibodies, and visualized using the Odyssey system (Li-Cor) as described above. 
 
3.2.11 Bioinformatics tools 
Database searches were performed using BLASTP, TBLASTN and PSI-BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/). Amino acid sequence alignments were 
created using TCoffee (http://www.ch.embnet.org/software/TCoffee.html) with 
default parameters. To change the output file of alignment Boxshade was used 
(http://www.ch.embnet.org/software/BOX_form.html). Drosophila gene and protein 
sequences were obtained from: flybase (http://flybase.bio.indiana.edu/) 
 
3.2.12 Size exclusion column chromatography and molar mass determination 
Recombinant HP1 (128 µM/ 145 µg) was loaded onto a Superdex 200 column (HR 
10/30, Amersham Pharmacia). The column was run isocratically with 0.2 ml/min in 
BC200 buffer for 1.4 CV. 0.5 ml fractions were collected. To determine the absolute 
molar mass directly the eluant was monitored using a multiangle laser light scatter 
detector (Wyatt Technology Corporation), and a UV detector. The molar mass was 
determined using the Astra software supplied by Wyatt Technology Corporation. 
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3.2.13 Cross-linking assay 
Bacterially expressed HP1 (0,17 µM) was cross-linked using 250 µM DTSSP (3,3`-
Dithiobis(sulfosuccinimidylpropionate)) (Pierce) and incubated on ice for 2 hours in 
BC100 buffer without DTT. The reaction was stopped by adding 100 mM Tris and 
boiled in SDS-PAGE sample buffer with or without β- mercaptoethanol. After 
separation by electrophoresis, the proteins were transferred to a PVDF membrane 
(Millipore). 
 
Figure 3.3 Chemical structure of DTSSP 
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  4. Results 
4.1 The N-terminus of Drosophila SU(VAR)3-9 mediates dimerisation 
and regulates its methyltransferase activity 
 
The SET domain was initially identified as an evolutionary conserved domain in 
SU(VAR)3-9, Enhancer of Zeste and Trithorax (Jenuwein et al., 1998; Tschiersch et 
al., 1994).  It was shown to be the catalytic domain responsible for histone lysine 
methylation in the human SU(VAR)3-9 homolog SUV39H1 (Rea et al., 2000). A 
myc-tagged SU(VAR)3-9, isolated from Drosophila embryo extracts, was shown to 
methylate H3K9 in our lab (Czermin et al., 2001). A recombinant N-terminally 
truncated SU(VAR)3-9 was shown to methylate the N-terminus of  H3 (Schotta et al., 
2002). The aim was to characterize a recombinant SU(VAR)3-9 and its enzymatic 
properties in vitro. 
 
4.1.1  Purification of recombinant SU(VAR)3-9 
 
Full length SU(VAR)3-9 was cloned into pET15b by B. Czermin modified with an N-
terminal 6x his-tag. His-SU(VAR)3-9 was soluble when expressed in bacteria. It was 
purified over Talon beads and eluted with 100 mM imidazol. The expressed protein 
had the expected molar mass of  74 kDa (Figure 4.1).  
 
 
Figure 4.1 Purification of recombinant Drosophila SU(VAR)3-9. Elution of recombinant, His-
tagged SU(VAR)3-9 eluted with 100 mM Imidazol from Talon beads. 15 μl of the first eight fractions 
(lanes 1-8) were loaded onto a SDS-10% polyacrylamid-gel-electrophoresis (PAGE) and stained with 
Comassie blue R250. 
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4.1.2 Full length SU(VAR)3-9 is an active histone methyltransferase 
 
Recombinant his-SU(VAR)3-9 was incubated with histone molecules in the presence 
of S-Adenosyl [methyl-3H] methionine (SAM) to test for histone methyltransferase 
activity. His-SU(VAR)3-9 methylated H3 molecules better in a mixture of free 
histones than in reconstituted nucleosomes (Figure 4.2.A). In order to confirm the 
specificity of SU(VAR)3-9 was incubated with various H3 peptides (amino acids 1-
19) pre-modified at lysine 4 and 9. The methyltranferase (MTase) activity was 
inhibited when lysine 9 was either dimethylated or acetylated (Figure 4.2.B). 
 
Figure 4.2 The substrate specificity of recombinant SU(VAR)3-9 (A) In vitro SU(VAR)3-9 
methylation reactions using 600 ng  potein, 0.17 μM S-Adenosyl [methyl-3H] methionine and different 
histone substrates. Nucleosomal arrays (2 μg) (lane 1) were reconstituted on pBS(KS) (Strategene) by 
salt dialysis using recombinant octamers (lane 2), which were reconstituted from equimolar amounts of 
histones produced in E.coli and purified by gel-filtration chromatography. Lane 3 corresponds to 0.5 
μg H3. The reaction products were then loaded onto a SDS-18% polyacrylamide (PAA) gel and the gel 
was stained with Coomassie blue R250, dried, and exposed to a X-ray film (autoradiograph) for 24h. 
(B) Peptides containing the first 19 amino acids of H3 (1 μg) were methylated by 600 ng of 
recombinant SU(VAR)3-9 in the presence of 0.17 μM S-Adenosyl [methyl-3H] methionine. 
Unmodified peptide (wt), a peptide dimethylated at K4 (K4Me2) or at K9 (K9Me2) and a peptide 
acetylated at K9 (K9Ac) was used as substrates. Incorporated radioactivity was measured by a filter-
binding assay. (C) In vitro methylation reaction using either wt recombinant H3 (lane 1), H3 mutated at 
lysine 9 (lane 2), at lysine 27 (lane 3) or at both sites (lane 4). Histones were methylated by 
recombinant SU(VAR)3-9 in the presence of radioactive SAM, separated by SDS-PAGE and analyzed 
by autoradiography. 
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The amino acids surrounding lysine 9 in the H3-tail (QTARKS) are similar to the 
amino acids surrounding lysine 27 (KAARKS). Other H3K9 HMTases have been 
shown to also methylate H3K27, such as mG9a (Tachibana et al., 2001; Tachibana et 
al., 2002) and E(Z) (Czermin et al., 2002). Therefore H3 molecules with a mutation of 
lysine 9 or lysine 27 to alanine or both were used for in vitro methylation assays. No 
activity toward H3 molecules mutated at K9 was detected and it could therefore be 
concluded that recombinant SU(VAR)3-9 was a K9 specific HMTase (Figure 4.2.C). 
This was in good agreement with the finding of Czermin in this lab (Czermin et al., 
2002) and in vivo data from SU(VAR)3-9 null mutant flies, where the H3K9 
methylation at the chromocenter was strongly reduced (Schotta et al., 2002). 
 
Lysines exist in mono-, di- or trimethylated states. Studies with specific antibodies 
against different H3K9 methylated states revealed that there is an enrichment of 
mono- and dimethylation in silent euchromatic regions, whereas trimethylation was 
enriched in pericentric heterochromatin within the mammalian genome (Peters et al., 
2003; Rice et al., 2003). In Drosophila melanogaster, immunostainings of SU(VAR)3-
9 null mutant salivary glands chromosomes revealed that SU(VAR)3-9 catalyses 
mono- to dimethylation in the chromocenter and trimethylation in the chromocenter 
core (Ebert et al., 2006; Ebert et al., 2004; Schotta et al., 2002). To analyze the 
processivity of recombinant SU(VAR)3-9 was incubated with H3 peptides and a time 
course was analyzed by MALDI-TOF (Figure 4.3).  Because one methyl group is 14 
daltons, the mass shift for mono-, di- and trimethylation will be 14, 28, and 42 daltons 
respectively. For the reaction with unmodified peptide, after 5 minutes about 20% of 
the peptides were monomethylated and no dimethylation could be observed (Figure 
4.3.A). The dimethylated peptide appears after 10 minutes when almost 50% of all the 
peptide was monomethylated. Almost all of the unmethylated peptides were 
converted into either mono- or dimethylated form after 80 minutes. No significant 
trimethylation could be observed under these conditions. In the time course with the 
monomethylated peptide as a substrate, a similar kinetic as with the unmodified 
peptide (Figure 4.3.B) was observed. After 5 minutes, about 20% of the 
monomethylated peptides were converted into dimethylated peptide. There was no 
significant trimethylation observed after 80 minutes, although almost all the 
monomethylated peptide was converted into dimethylated form.  
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Figure 4.3 MALDI analysis of SU(VAR)3-9 reaction products. A MALDI-TOF analysis of a time-
course reaction using 600 ng SU(VAR)3-9, 40 μM SAM and 1 μg of a H3 peptide, which was 
unmethylated (A), or monomethylated (B) at K9. The methylation reaction was stopped at different 
time points and reaction products analyzed by MALDI-TOF. 
 
To exclude the possibility that SU(VAR)3-9 needs a premodified peptide to be able to 
convert it into trimethylated form, a H3K9 dimethylated peptide was used as substrate 
(Figure 4.4). No significant trimethylation was observed, even after long incubation 
time.  
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Figure 4.4 SU(VAR)3-9 has very poor activity towards a H3 peptide methylated at K9. The same 
methylation reaction as described in Figure 4.3, using the H3 peptide dimethylated at K9. Only 0 min 
and 80 min time points are shown. 
 
The same time course as described in Figure 4.3 and 4.4 was monitored in the 
presence of 40 μM SAM and S-Adenosyl [methyl-3H] methionine (0.4% of total 
SAM) to determine the linearity of product formation with time (Figure 4.5). The 
reactions were measured by a filter-binding assay. For unmodified (wt) and K9 
monomethylated H3 peptide, the reaction remained linear for 60 minutes with a 
similar slope. The formation of trimethylated with K9 dimethylated peptide as 
substrate was not significant. 
 
 
Figure 4.5 Linearity of methylation reaction by recombinant SU(VAR)3-9. A time course of a 
methylation reaction as described in Figure 4.3 with total 40 μM SAM  (0.17 μM S-Adenosyl [methyl-
3H] methionine), measured by a filter-binding assay.   
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4.1.3 SU(VAR)3-9 adds three methyl groups onto H3 lysine 9 
 
T. Bonaldi developed a method to analyze the modifications of full length H3 by 
MALDI-TOF (Bonaldi et al., 2004). To determine the methylation status on histone 
H3, recombinant SU(VAR)3-9 was incubated with histone octamer (Figure 4.6). 
Histone H3 was excised from a SDS-15% PAA gel and subjected to chemical 
modification of the lysines (Figure 4.6.A). The lysines that were unmodified or 
monomethylated, were propionylated (a shift of 56 daltons). Di- and trimethylated 
lysines were not chemically modified and had a lower mass than the unmodified 
peptide (Figure 4.6.B). Under these conditions a significant amount of di- (54 %) and 
trimethylation (33%) were observed.  
 
Figure 4.6. SU(VAR)3-9 adds three methyl groups onto histone 3 K9 (A) 300 ng SU(VAR)3-9 was 
incubated with 4 μg of recombinant histone octamer and 40 μM SAM for 40 minutes. SU(VAR)3-9, 
SAM and the reaction product S-Adenosyl homocysteine (SAH) was purified away by using a cation 
resin. To the left is a Coomassie blue stained SDS-15% PAA gel of reconstituted recombinant- (lane 1 
and 2) and purified H3K9 methylated octamers (lane 3 and 4). (B) A MALDI TOF analysis of H3 
peptide 9-17 from recombinant H3 (top) and H3 methylated by SU(VAR)3-9 at K9 (bottom). As an 
internal standard H3 peptide 41-49 is shown. Unmodified, mono-, di-, and trimethylated peptides with 
corresponding mass are labeled with arrows. (C) A quantification of the MALDI TOF analysis in (B) is 
shown in the upper right panel. 
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4.1.4 Deletion of the N-terminus of SU(VAR)3-9 impaired its activity 
 
In order to investigate the influence of the N-terminus on the SU(VAR)3-9 enzymatic 
activity, various his-tagged constructs were expressed in bacteria and purified over 
talon beads (Figure 7.A and B).  
 
Figure 4.7 Expression and purification of SU(VAR)3-9 mutants. (A) Scheme of SU(VAR)3-9 
mutants generated and expressed in bacteria. (B) Coomassie-stained gel of Talon purified SU(VAR)3-9 
mutant proteins. (C) Comparison of HMT activity of SU(VAR)3-9 wild type and mutants on a H3 
peptide. For a better comparison, the inset of panel C shows the activities of the N-terminal deletions 
and a point mutation within the SET domain. (D) To compare different activities on intact H3 
molecules, an autoradiograph of a 1-day (mid panel) and a 7-day (bottom panel) exposure is shown. 
Coomassie stained H3 is shown in top panel. 
 
In Drosophila SU(VAR)3-9 mRNA is generated by alternative splicing of the 
translation initiation factor (eIF2) RNA leading to an additional 81 amino acids at the 
N-terminus of the protein, which are common between eIF2 and SU(VAR)3-9.  A 
point mutation within the conserved SET domain of SUV39H1 (H324K), abolished 
enzymatic activity (Rea et al., 2000). The same amino acid was mutated in 
SU(VAR)3-9 (H561K) and the activity abolished (Figure 4.7.C and D). The N-
terminal SU(VAR)3-9 deletion mutants (Δ152 and Δ213)  were still able to methylate 
H3 peptides and histone, but the specific methyltransferase activity was  more than 
10-fold lower than for the full-length SU(VAR)3-9. If the chromo domain was deleted 
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(Δ279), the histone methyltransferase activity declined even more despite the 
presence of the SET domain. The conclusion was therefore that the N-terminus and 
the chromo domain of SU(VAR)3-9 were utilized for catalytic activity. 
 
4.1.5 Kinetic parameters of recombinant SU(VAR)3-9 full length 
and Δ213 
 
In order to define the kinetic parameters of SU(VAR)3-9, the enzyme-catalyzed  
reaction at steady state was analyzed. Initial rate means the rate of product formation 
(in this case methylation of H3) was observed in a reaction with an enzyme 
(SU(VAR)3-9) and substrates. The reaction rate depends on the concentration of the 
substrates SAM and H3. To avoid that the products; dimethylated peptide or S-
Adenosyl homocysteine (SAH) have inhibitory effects, the incubation was 1 or 5 
minutes when less than 5% of product were formed (see Figure 4.3). It was verified 
that SAH at low concentration did not have significant inhibitory effects (data not 
shown and Figure 4.13). The kinetic parameters Km and Vmax were obtained (for 
calculations see Methods 3.2). Kcat is the number of molecules turned over in time 
(seconds or hours) and can be calculated from Vmax. Recombinant SU(VAR)3-9 had a 
Vmax of  95.2 nmol min-1 mg protein-1, Kcat of 0.11 s-1 and a Km[SAM] of 25.9 μM 
(Figure 4.8.A). The N-terminal mutant Δ213, which was shown to have 16 fold lower 
methyltransferase activity then full-length, had approximately the same Km[SAM] 
value (24.6 μM). The substrate affinity for SAM was not reduced when deleting the 
N-terminus, but the Kcat was 22 fold reduced to 0.005 s-1.  
 
Several attempts were made to determine the Km for histone H3 or H3 peptide. Figure 
4.8.B shows the rate of methylation catalyzed by Δ213 measured over a range of 
histone H3 concentrations. The double reciprocal plot showed a nonlinear relationship 
between 1/V and 1/H3 that became nearly vertical at high concentrations. Because the 
plot was nonlinear, it was impossible to give a precise estimate of Km. High 
concentrations of H3 have an inhibitory effect on SU(VAR)3-9, this was also shown 
for SUV39H1 (Chin et al., 2006). At lower concentrations of H3, the variability 
between assays gave a Km[H3] from 1.2 – 15.7 μM (data not shown). Histones are 
known to be “sticky” proteins, and at low concentrations they stick to pipette tips and 
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the walls of the eppendorf tube. Even if there was BSA present in the reactions, it was 
not enough to prevent “stickiness” of H3 and thereby variability within the assays. 
 
Figure 4.8 Kinetic parameters for recombinant SU(VAR)3-9 full length and Δ213. (A) 
Lineweaver- Burk plot. A comparison of in vitro methylation reactions with SU(VAR)3-9 wt (0.5 μg) 
or a N-terminally truncated protein (Δ213; 1 μg). By changing the concentrations of SAM (5, 6, 10, 20, 
40 μM) and keeping H3 peptide (aa 1-19) concentrations saturating and constant (11.5 μM), Km for 
SAM could be determined. Reaction time was 1 minute. Methyl group incorporation was measured by 
filter binding; 0.17 μM of the total SAM was S-Adenosyl [methyl-3H] methionine. (B) A double 
reciprocal plot for SU(VAR)3-9 Δ213 (1 μg) with variable  recombinant H3 concentrations (0.82, 0.98, 
1.31, 1.64, 2.46, 3.28, 4.92, 6.55, 9.83, 13.1 μM)  and SAM 40 μM (0.17 μM of the total SAM was S-
Adenosyl). Reaction time was 5 minutes. A total of 800 ng of BSA was present in the reaction to block 
the histone H3 from sticking to the side of the tube during the incubation. Methyl group incorporation 
was measured by filter binding. 
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Full-length SU(VAR)3-9 had higher turnover numbers than other SET domain 
containing enzymes in vitro (Table 4.1).  The turnover rates of mG9a and pea Rubisco 
large subunit methyltransferase (LSMT) was approximately 4.5 and 2.5 fold lower 
than SU(VAR)3-9 respectively (Patnaik et al., 2004; Trievel et al., 2002). SU(VAR)3-
9 Δ213 had a similar turnover rate as wild type SUV39H1 and SET7/9  (Chin et al., 
2005; Trievel et al., 2002). Both SU(VAR)3-9 and SUV39H1 had higher Km[SAM] 
values than mG9a and hSET7/9, suggesting that the methylation of H3 in 
heterochromatin may be regulated by the local concentration of SAM in vivo. 
 
Table 4.1 Comparison of steady-state kinetic parameters for SU(VAR)3-9 and other SET domain 
containing methyltransferases 
Enzyme Substrate Kcat (h-1) Km [SAM] (μM) Ref. 
SU(VAR)3-9WT H3 (1-19) 396 25.9 tw 
SU(VAR)3-9Δ213 H3 (1-19) 18 24.6 tw 
SUV39H1 H3 (1-18) 12 + 0.5 12.3 + 0.6 1 
SUV39H1 rH3 8 + 0.8 6 + 0.6 1 
mG9afl H3 (1-18) 88 + 4 1.8 + 0.2 2 
mG9afl rH3 46 + 1 2.65 + 0.2 2 
human SET7/9 rH3 14 + 1 6.0 + 1.4 3 
pea LSMTb rubisco 153 + 9a 6.0 + 1.3 3 
Clr4 H3(1-15) 36 + 1  4 
H3 (1-19) is the first 19 aminoacids of the N-terminus of histone H3, rH3 is recombinant histone H3, 
(tw) is this work. The references are: (1) (Chin et al., 2006), (2) (Patnaik et al., 2004),  and (3) (Trievel 
et al., 2002) (4) (Collazo et al., 2005). The Kcat is displayed in hours-1. a average of Kcat  for SAM and 
Rubisco. b pea Rubisco large subunit methyltransferase. 
 
4.1.6 The N-terminus of SU(VAR)3-9 is important for dimerisation 
and activity in vitro 
 
Multimeric enzymes often show an increased catalytic efficiency expressed in 
substrate molecules converted per molecule of enzyme (Bheemanaik et al., 2003; 
Salminen et al., 1999). The substantial high catalytic efficiency of full-length 
SU(VAR)3-9, may be due to conformational change or an association of monomeric 
enzymes into multimers. Therefore a relationship between the velocity of the reaction 
and the concentration of full-length SU(VAR)3-9 was determined (Figure 4.9).  
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Figure 4.9 A concentration-dependent increase of SU(VAR)3-9 activity. (A) Different 
concentrations of wt and N-terminally truncated SU(VAR)3-9 were incubated with 1 μg H3 peptide 
and 20 μM SAM for 30 min. After stopping the reaction, the amount of incorporated radioactivity was 
measured and plotted against the concentration of enzyme. (B) The ratio of the incorporated 
radioactivity to the concentration of enzyme present was replotted against the enzyme concentration to 
determine the increase in specific activity. 
 
When the rate of methyl peptide formation was plotted against corresponding enzyme 
concentration, a nonlinear curve was obtained.  However plotting the same relation 
for the N-terminal deletion mutants (Δ152, Δ213 and Δ279) only showed a linear 
dependence of methyltransferase activity on enzyme concentration. Replotting the 
number of methyl groups incorporated per enzyme molecule revealed a steady 
increase of activity until specific activity reached a plateau at a concentration of 0.3 
μM for full-length SU(VAR)3-9 (Figure 4.9.B). This increase was not observed for 
the N-terminal deletion mutants. It can therefore be concluded that SU(VAR)3-9 can 
form multimers which have a higher catalytic activity than monomers.  
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Formation of multimers were concentration dependent, and at 0.3 μM virtually all 
SU(VAR)3-9 molecules exists as multimers. 
 
In order to test the hypothesis that SU(VAR)3-9 has a multimeric conformation, the 
molar mass of the recombinant protein was analyzed by gel filtration chromatography 
and density gradient centrifugation (Figure 4.10). Full-length SU(VAR)3-9 eluted 
with an apparent molar mass of 160 kDa on a Superdex 200 column (Figure 4.10.A 
top panel). This was indicative of a dimer. The N-terminal mutation Δ213 eluted with 
an apparent molar mass of 60 kDa, corresponding to monomeric form (Figure 4.10.A 
bottom panel). To further confirm the dimerisation of SU(VAR)3-9, the recombinant 
protein was loaded onto a 5-20% sucrose gradient.  The full-length protein was found 
in fractions corresponding to higher molar mass than Δ213. However under 
denaturing conditions the two SU(VAR)3-9 proteins behaves identical. The BSA and 
Δ213 has an apparent shift of one fraction in presence of urea. From these data it can 
be concluded that full-length SU(VAR)3-9 was a dimer in vitro. 
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Figure 4.10 Molar mass determination of SU(VAR)3-9. (A) Elution profiles of wt SU(VAR)3-9 (top 
panels) and the N-terminal deletion construct  Δ213  (bottom panels). Retention of the molar mass 
standards is indicated at the top. (B) Profile of a 5-20% sucrose gradient in the presence (panels 2 and 
4) or absence of 3 M urea (panels 1 and 3). The position of the 66-kDa marker protein is indicated as a 
black triangle at the top of each gel. Note the slight shift (1 fraction) of the 66-kDa marker and the 
Δ213 protein in panel 4, which is due to the presence of urea in the buffer. In comparison there is a 
significant shift in case of the wt protein (>3 fractions) in panel 2. 
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4.1.7 Mapping of the interaction domain of SU(VAR)3-9 
  
Deletion of the first 152 amino acids lead to a 90% loss of activity compared to full 
length SU(VAR)3-9 (shown in chapter 4.1.4). Therefore the first 152 amino acids 
were expressed as a GST fusion protein and used it for pull-down experiments. HP1 
has been shown to interact with the N-terminus of SU(VAR)3-9 and SUV39H1 
(Schotta et al., 2002; Yamamoto and Sonoda, 2003).  This was confirmed 
biochemically by pull-down (Figure 4.11.B). To map the interaction responsible for 
SU(VAR)3-9 dimerisation, in vitro translated constructs (Figure 4.11.A) were 
incubated with the bound fusion protein. Full-length SU(VAR)3-9 interacted 
efficiently with the first 152 amino acids, suggesting a role for this amino acid stretch 
in inter- or intramolecular interaction (Figure 4.11.C). Four N-terminal deletion 
constructs were no longer able to interact with the first 152 amino acids (Figure 
4.11.C and D).  The interaction domain was mapped to amino acids 152-213.  This 
suggests that the interaction of the first 152 amino acids with amino acids 152-213 
can mediate an intra as well as intermolecular interaction.  
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Figure 4.11 Mapping of the dimerisation domain of SU(VAR)3-9. (A) SU(VAR)3-9 constructs used 
for in vitro translation. (B) GST pull down with bacterially expressed HP1a. HP1a was detected by 
Western blotting using a monoclonal antibody against HP1 (C1A9). (C) GST and GST-SU(VAR)3-9 
(1-152) pull down with in vitro translated SU(VAR)3-9 constructs. SU(VAR)3-9 constructs was 
detected by autoradiography. (D) Quantification of the binding affinities of the various SU(VAR)3-9 
proteins. Error bars represent the variations of at least three different experiments. 
 
To confirm the interaction domain described above, a GST fusion protein consisting 
of amino acids 152-213 were used to performed pull-down assays with SU(VAR)3-9 
full length and N-terminal truncations. As expected, the SU(VAR)3-9 fusion protein 
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(aa 152-213) was able to interact with full length protein, but deletion of the first 152 
amino acids weakened the interaction (Figure 4.12). SU(VAR)3-9 interacts with itself 
via two domains in the N-terminus. 
                               
Figure 4.12 The dimerisation domain of SU(VAR3-9 lies within the first 213 amino acids (A) GST 
pull downs with a SU(VAR)3-9 GST fusion protein covering amino acids 152-213 and two N-
terminally truncated versions of SU(VAR)3-9. (B) Corresponding quantification of the pull down with 
SU(VAR)3-9 proteins. Error bars represent the variations of at least three different experiments. 
 
4.2 Inhibitors of SU(VAR)3-9 HMTase activity 
 
The end product of an enzymatic reaction may inhibit the enzyme if it has enough 
affinity for the active site to block the binding of the substrate molecule. In both 
figure 4.2.B and 4.4 it was shown that the dimethylated H3K9 peptide inhibited the 
histone methyltransferase activity of SU(VAR)3-9. When SU(VAR)3-9 transfers a 
methylgroup from SAM towards H3K9 the end product formed is S-Adenosyl 
homocysteine (SAH). SAH was shown to be a competitive inhibitor of SAM for 
mG9a (Patnaik et al., 2004) and for SUV39H1 (Chin et al., 2006). Therefore it was 
necessary to investigate the inhibition of SAH for SU(VAR)3-9 in vitro. The 
concentration of unmodified H3 peptide and SAM was held constant with different 
fixed amounts of SAH added. Although SAH inhibited the histone methyltransferase 
activity of SU(VAR)3-9, it was not a very strong inhibitor. The half maximal 
inhibitory concentration, represents the concentration of an inhibitor that is required 
for 50% inhibition (IC50) had a value for SAH around 40 μM.  Adenosylornithine 
(AO), is a metabolite of Streptomyces griseolus. It was a strong competitive 
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inhibitor of methyltransferases which use SAM as the methyl group donor to yield 
methylated products such as 5-methylcytosine or N6-methyl adenosine on DNA and 
RNA (Barbes et al., 1990). AO was incubated with SU(VAR)3-9 as described for 
SAH. AO had weaker inhibitory effect on SU(VAR)3-9 than SAH with an IC50 of 100 
μM (Figure 4.13.A).  
 
In order to identify specific inhibitors of SU(VAR)3-9, D. Greiner screened a small 
natural compound library provided by Hans-Knöll institute in Jena. One of the 
strongest specific inhibitors identified was a mycotoxin, called chaetocin (Greiner et 
al., 2005). Chaetocin inhibited SU(VAR)3-9 with an apparent IC50 of 0.6 μM. 
Chaetocin also had a strong inhibitory effect on other K9 histone methyltransferases 
such as SUV39H1, G9a and DIM5 (Greiner et al., 2005).  In order to test the effect of 
chaetocin over time, a time course with Δ213 and two different concentration of 
chaetocin was performed (Figure 4.13.B). To avoid the possibility that chaetocin had 
an inhibitory effect on dimerisation of full-length SU(VAR)3-9 Δ213 was used in the 
assays. The time course was analyzed by MALDI-TOF, and the relative values of 
differentially modified H3 peptides (amino acids 1-19) were calculated according to 
total input concentration. The reaction of Δ213 was linear for at least 10 minutes in 
absence of chaetocin. After 20 minutes most peptides were dimethylated. Adding 1.5 
μM chaetocin to the reaction, fewer methylgroups were transferred. After 20 minutes 
reaction, the amount of methylated peptides were the same as for 5 minutes 
incubation without chaetocin. Chaetocin at a concentration of 4.5 μM inhibited the 
histone methyltransferase activity of SU(VAR)3-9 after 5 minutes, and addition of 
methylgroups were no longer detected. Chaetocin was shown to be a competitive 
inhibitor of SAM (Greiner et al., 2005) and higher concentrations blocks the active 
site and thereby the binding of SAM for enzymatic activity. 
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Figure 4.13 In vitro inhibition of SU(VAR)3-9 (A) Inhibition curves of SU(VAR)3-9 with increasing 
amounts of S-(5`-adenosyl)-L -homocysteine (SAH) and  Adenosylornithine (AO). 250 ng of 
SU(VAR)3-9 was incubated with a H3 peptide monomethylated at K9 in the presence of 20 μM SAM 
and 0.17 μM S-Adenosyl [methyl-3H]  methionine for 30 minutes. The activity was measured by a 
filter-binding assay. The y-axis represents % activity where reaction without inhibitor set to 100%. (B) 
A time course of SU(VAR)3-9 Δ213 in the presence of the specific inhibitor chaetocin at 0, 1.5 and 4.5 
μM. One μg of SU(VAR)3-9 Δ213 was incubated with a H3 peptide (1 μg, unmodified) in the presence 
of 40 μM SAM. The reaction was stopped by adding 10% acetic acid and analyzed by MALDI-TOF. 
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4.1 Characterization of monoclonal antibodies directed against 
SU(VAR)3-9 
 
SU(VAR)3-9 specific rabbit antisera were generated by G. Schotta (Schotta et al., 
2002). However, the rabbit antibody was not able to immunoprecipitate SU(VAR)3-9. 
Therefore a new attempt was made to generate monoclonal rat antibodies that 
recognize SU(VAR)3-9. The monoclonal antibodies were raised against his-tagged 
Δ213, purified over three consecutive columns as described in the thesis of B. 
Czermin (chapter 4.2.2) (Figure 4.14.A). E. Kremmer tested hybridoma cell 
supernatants in ELISA and got 9 positive. These were further analyzed by Western 
blotting on recombinant SU(VAR)3-9, Drosophila embryo nuclear extract (0-12 h) 
and on total cell extract from Drosophila SL2 cells (data not shown). All monoclonal 
antibodies gave a specific signal for recombinant protein, however two antibodies 
gave a signal in the nuclear extract with an expected size of the endogenous 
SU(VAR)3-9. 
 
4.3.1 Recognition of recombinant SU(VAR)3-9 and mapping of 
epitopes 
 
To map the epitopes of rat 6C9 and 3D9, recombinant expressed his-tagged proteins 
(Figure 4.7.A and B) and in vitro translated proteins (Figure 4.11.A) were used.  As a 
control to confirm that it was not the his-tag that was recognized, Δ152 expressed 
with a C-terminal intein tag and purified having its intein tag cleaved off was used. 
Another control was a mock in vitro translation. The epitope of 6C9 antibody was 
mapped to a region within amino acids 285 and 492. This region contains a cysteine 
rich region also called the pre-SET domain. This domain is similar between 
SU(VAR)3-9 and SUV39H (See Figure 2.7) and has been shown to be important for 
histone methyltransferase activity. On the other hand 3D9 mapped to the SET 
domain. It would therefore be expected to give higher background because it may 
recognize other SET domain proteins. 
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Figure 4.14 (A) A Coomassie stained SDS-12% PAA gel of his-tagged SU(VAR)3-9 Δ213 purified 
over 3 consecutive columns. E. Kremmer used this protein for generation of rat monoclonal antibodies. 
(B) Mapping of the epitope of the two selected monoclonal antibodies: α-6C9 (also denoted SUV4) 
and α-3D9 (also denoted SUV5). Lanes 1-5 is bacterially expressed SU(VAR)3-9 proteins (50 ng), his 
purified except Asterisks indicates Δ152 which had an intein tag cleaved off. Lanes 6-9 is cold in vitro 
translated (5 μl) SU(VAR)3-9 proteins. Lane 10 is a mock IVT. 
 
4.3.2 Immunoprecipitation of recombinant SU(VAR)3-9 
 
In order to test if 6C9 and 3D9 were able to immunoprecipitate SU(VAR)3-9, the 
supernatants were incubated with in vitro translated full-length protein. As a control a 
α-myc (9E10) antibody was used. Both antibodies were able to immunoprecipitate 
SU(VAR)3-9.                               
                                 
Figure 4.15 The monoclonal antibodies can immunoprecipitate SU(VAR)3-9 . 
Immunoprecipitation of in vitro translated SU(VAR)3-9 (5 μl). Monoclonal antibodies 6C9 and 3D9 
were used with α-myc (9E10) as control. SU(VAR)3-9 was detected by autoradiograpy. 
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4.3.3 Recognition of endogenous SU(VAR)3-9 
 
E. Kremmer purified 6C9 and 3D9 over protein A beads. Different dilutions were 
tested on western blots with recombinant SU(VAR)3-9 and Drosophila embryo 
nuclear extract. Purified 6C9 seemed to be very specific, but recognized the 
endogenous SU(VAR)3-9 protein very weakly. On the other hand, 3D9 gave a high 
background and detected a protein of approximately 80 kDa at much lower antibody-
dilutions.  
 
Figure 4.16 Western blots of 6C9 and 3D9. Test of monoclonal antibodies on recombinant 
SU(VAR)3-9 (25 ng) and  10, 20 and 100 μg of 0-12 hour Drosophila Nuclear Extract. The purified 
monoclonal antibodies and used in concentrations 1:250 for 6C9 (exposure time: 1 hour) and 1:1000 
for 3D9 (exposure time: 1 minute). 
 
The 3D9 antibody gave high background, and it was therefore necessary to confirm 
its specificity. A western blot of Drosophila SL2 cells treated with RNA interference 
(RNAi) against SU(VAR)3-9 showed reduced levels of SU(VAR)3-9 compared to 
GST RNAi treated cells when probed with polyclonal SU(VAR)3-9 antibody (Figure 
4.17.A). Probing the same western blot with 3D9 antibody showed no difference 
between SU(VAR)3-9 and GST RNAi. To further confirm this result, embryos from 
SU(VAR)3-906 null flies  (Schotta et al., 2002) were blotted together with embryos 
from wild-type strain used,  yw (yellow “white”) (Figure 4.17.B). Although the lanes 
were smeary due to presence of DNA in the samples, no SU(VAR)3-9 protein could 
be detected in the null flies. No change in protein levels was detected for the 3D9 
antibody. It was not clear whether endogenous SU(VAR)3-9 was detected, or if the 
signal was masked by other SET domain proteins detected by 3D9 antibody. 
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Figure 4.17 SU(VAR)3-9 monoclonal antibody 6C9 do not specifically recognize the endogenous 
protein. (A) Antibody α-6C9 tested on SL2 cells subjected to GST or SU(VAR)3-9 RNAi for 9 days.  
As a loading control 20 μg of Drosophila Nuclear Extract was used. The western blot was stripped and 
reprobed with SU(VAR)3-9 polyclonal antibody (a gift from G. Reuter) (B) Test of 6C9 on Drosophila 
dechorionated embryos from yellow white (as control) and SU(VAR)3-906flies (flies provided by C. 
Chioda). The embryos were boiled in SDS loading dye. The western blot was stripped and reprobed 
with the Drosophila SU(VAR)3-9 polyclonal antibody. 
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4.4 In vitro characterization of dG9a HMTase activity 
 
SU(VAR)3-9 was shown to be the main H3K9 methyltransferase in Drosophila. 
Immunostaining of  Su(var)3-906 null mutant embryos there is still detectable amounts 
of K9 dimethyl is only slightly reduced in other regions than the chromocenter (Ebert 
et al., 2004; Schotta et al., 2003b). In mammalian cells mG9a was found to be a 
euchromatic H3K9 methyltransferase (Esteve et al., 2005; Peters et al., 2003; Rice et 
al., 2003) but a Drosophila G9a was not yet characterized. In collaboration with M. 
Stabell and A. Lambertson dG9a was studied in vivo and in vitro (Stabell et al., 2006). 
 
4.4.1 Expression and purification of Flag-dG9a Sf9 cells 
 
In order to investigate the enzymatic properties of dG9a, a Flag-tagged N-terminal 
fragment (aa 789 - 1637) was expressed using a baculovirus system. The purified 
dG9a was soluble and had the expected molar mass of 95 kDa (Figure 4.18).  
                           
Figure 4.18 Expression and purification of recombinant dG9a. Eluted Flag-tagged dG9a (aa 789-
1637) was separated by SDS -12 % PAGE and stained with Coomassie blue G250.  
 
4.4.2 dG9a methylates histone H3K9 and K27 and H4 K8, K12 or 
K16 
 
To confirm that dG9a has HMTase activity, it was incubated with H3-S-adenosyl 
methionine (SAM) and different substrates (Figure 4.19). Drosophila G9a methylated 
H3 and H4 present as free histones but had no detectable activity on nucleosomal 
arrays.  
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Recombinant as well as native H3 and H4 were methylated by dG9a (Figure 4.19.A). 
Mouse G9a methylated H3 alone and H3 in a mixture of recombinant and native 
histones and had a very low activity on reconstituted nucleosomes (Figure 4.19.B).  
 
Figure 4.19 Characterization of recombinant dG9a. (A) In vitro methylation reactions using dG9a 
(lanes 1-6), no enzyme (lane 7) and SU(VAR)3-9 (lane 8). In the reaction 1 µg of different histones 
were used: recombinant histone H3 (lane 1), recombinant histone H4 (lane 2), recombinant (lane 3) and 
native histone octamer (lane 5) and recombinant and native nucleosomes (lane 4 and 6) reconstituted 
on circular pBS(KS) from equimolar amounts of histones. The upper panel shows Coomassie stained 
gel and the lower panel the autoradiograph. (B) Activity of recombinant mouse G9a expressed in 
baculovirus infected cells (a kind gift from S. Pradhan). HMTase activity on 1 µg of different histone 
substrates: recombinant histone H3 (lane 1), recombinant histone H4 (lane 2), recombinant and native 
histone octamers (lane 3 and 5) and recombinant and native nucleosomes (lane 4 and 6). Mock control 
(lane 7) is incubation of recombinant octamer without enzyme. The Coomassie gel is shown at the top 
and the corresponding autoradiograph at the bottom. 
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Mouse G9a methylated only H3 whereas dG9a methylated H3 and H4. In order to 
exclude that the activity towards H4 was due to a contaminating activity co-purifying 
with dG9a, a corresponding enzyme carrying a H1536K mutation within the 
conserved SET domain was expressed. The same mutation in SU(VAR)3-9 abolished 
its enzymatic activity (Figure 4.7).  The mutated enzyme had no activity towards H3 
and H4 indicating that both were methylated by dG9a (Figure 4.20). It cannot be 
excluded that the H4 activity may be due to the deletion of the N-terminus of dG9a. 
                                            
Figure 4.20. The H1536 mutation abolished the enzymatic activity of dG9a.  Activity of Flag-dG9a 
wild type versus dG9a containing a H1536K mutation in the conserved region of the SET domain. The 
upper panel shows a western blot of the two proteins. Recombinant octamer (2 μg) was used as 
substrate for 25, 50 and 100 ng of wt (lane 1-3) and H1536K mutant (lane 4-6). The corresponding 
autoradiograph is shown in the lower panel. 
 
Mouse G9a has been shown to methylate H3K9 and K27 (Tachibana et al., 2001; 
Tachibana et al., 2002). To define substrate specificity of dG9a, H3 molecules 
carrying a lysine to alanine replacement at position 9 and 27 or both were used 
(Figure 4.21). Decreased methylation efficiency on H3K9A and H3 K27A compared 
to wild type H3 was observed. In a filter binding assay a 70% reduction for the K9 
mutant and a 50% reduction for the K27 mutant was observed. When both H3 lysine 
residues were mutated (K9A and K27A) a lower activity was observed (efficiency of 
27%) indicating that in absence of K9 and K27 dG9a was also able to methylate other 
lysines.  When a highly active full-length mG9a (Patnaik et al., 2004) was used, it 
methylated wild type H3 and the H3 molecules carrying a single mutation on K9 or 
K27 with a similar efficiency. Mouse G9a also showed a decreased activity (27%) 
towards the double mutant (K9A/K27A). However, it can not be excluded that K9 
was methylated faster than K27, as initial rate kinetics were not performed (Collins et 
al., 2005; Esteve et al., 2005). 
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Figure 4.21 dG9a methylates H3K9 and K27. (A) In vitro methylation of 2 µg of recombinant H3 
(lane 1), H3 mutated at lysine 9 (lane 2), H3 mutated at lysine 27 (lane 3) or both (lane 4) using dG9a 
and a mock purification. Coomassie stained H3 is shown in the upper panel and a corresponding 
autoradiography in lower panel. A corresponding filter binding assay is shown to the right. The y-axis 
displays the percent radioactivity incorporated on 2 µg histone H3 and H3 mutants K9A, K27A and 
K9/K27A with radioactivity incorporated on H3 wt set to 100 % and the background is subtracted. (B) 
HKMTase activity of mG9a on histone H3 molecules and H3K9A, H3 K27A and the double mutant 
K9A/K27A. A gel of Coomassie stained histones and the corresponding autoradiography is shown. On 
the right, a filter-binding assay showing percent radioactivity incorporated on two µg histone H3 and 
H3 mutants K9A, K27A and K9/K27A. The y-axis displays the percent radioactivity incorporated with 
activity on H3 wt set to 100 % and the background is subtracted. 
 
Interestingly dG9a was also able to methylate histone H4 (Figure 4.19 and 4.20). This 
activity was not shown for mouse G9a (Figure 4.19.B) (Tachibana et al., 2001). The 
only lysine residue shown to be methylated in H4 is lysine 20 and the first HMTase 
identified with this activity was hPR-Set7/dSET8 (Fang et al., 2002; Rice et al., 
2002). Other HMTases in Drosophila shown to methylate H4 lysine 20 are Ash1 and 
Suv4-20 (Beisel et al., 2002; Schotta et al., 2004).  
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Ash1 was in addition able to methylate lysine 4 and 9 in histone H3 (Beisel et al., 
2002). Comparing the similarity within the SET domain, mouse NSD1 has closest 
homology to SET family member Ash1 (Huang et al., 1998) and NSD1 SET domain 
methylate H3K36 and H4K20 in vitro (Rayasam et al., 2003). The data indicated that 
dG9a also was a multi-catalytic histone methyltransferase with specificity for lysine 9 
and 27 on H3 and possibly lysine 20 on histone H4. Surprisingly when dG9a was 
incubated with H4 carrying a mutation of lysine 20 to alanine no reduction of activity 
was observed (Figure 4.22). To further investigate the specificity, dG9a activity was 
tested on different N-terminal H4 mutants (Clapier et al.,2002). dG9a could methylate 
the H4 N-terminus when the first five amino acids were deleted, excluding K5 as a 
possible substrate. However, the activity was lost when a H4 Δ10 mutant was used 
(Figure 4.22). This suggests that the substrate was K8, but knowing that the minimal 
substrate specificity for mG9a surrounding K9 contains seven amino acids 
(TARKSTG) (Chin et al., 2005) the substrate could also be K12 or K16.  
 
 
Figure 4.22 dG9a methylates H4 K8, K12 or K16. Amino acid sequence of the H4 N-terminus is 
shown at the top. Asterisk indicates possible substrates for dG9a in vitro.   dG9a methylation assay 
with 2 μg of recombinant H4 (lane 1), H4 K20A (lane 2), H4Δ5 (lane 3), H4Δ10 (lane 4), H4Δ15 (lane 
5) and globular H4 (lane 6).  Mock control (lane 7) is incubation of wt H4 without enzyme. 
 
Using MALDI-TOF analysis to measure the activity of dG9a on H3 confirmed the 
finding that K9 was the major substrate (Figure 4.23). Four times more activity 
towards K9 compared to K27 was observed. As shown for mG9a (Patnaik et al., 
2004, Collins et al., 2005) dG9a was able to add three methylgroups to H3K9.         
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Tri-methylation of H3 peptide 27-40 was very inefficient and could only be detected 
when 200 ng of enzyme was used (data not shown). This was consistent with 
MALDI-TOF data of mouse G9a where H3 K27 methylated peptides were slowly 
generated (Collins et al., 2005). All visible peptides by MALDI-TOF of methylated 
H3 and H4 were analyzed and no other modified lysines were detected (data not 
shown). Peptide 4-17 on H4 methylated by dG9a, was mono-, di-, and trimethylated 
providing a proof of a lysine methylation (Figure 4.23).  This was a novel finding that 
a SET domain HMTase can methylate another lysine in the H4 N-terminus than K20. 
There is yet no strong evidence of any of these methyl marks being present on the H4 
N-terminus in vivo, and it remains to be seen to what level these lysines are 
methylated and what the function of this methylation is. 
 
Figure 4.23 MALDI-TOF analysis of dG9a in vitro methylated H3 and H4. A MALDI-TOF 
analysis of 500 ng H3 and H4 methylated by 100 ng dG9a.  Peptides spanning amino acids 9-17 and 
27-40 of H3 and 4-17 of H4 is represented by graphs. Mono-, di- and trimethylation is shown as 
percent of total H3 or H4. This figure is representative for at least three different methyltransferase 
assays.  
 
4.4.3 dG9a methylates histone H1 
 
Mouse G9a methylates histone H1 (Tachibana et al., 2001). The histone H1 family is 
the most divergent class of the histones (for review see (Doenecke et al., 1997)). 
There is only one histone H1 protein in Drosophila melanogaster, which can purified 
from 0-12 hours embryos (Croston et al., 1991).  When incubated with dG9a or mG9a 
Drosophila H1 gets methylated (Figure 4.25). This indicates that G9a methylates a 
more conserved lysine within the H1 family.  
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Figure 4.24 dG9a methylates histone H1. dG9a methylates Drosophila histone H1. Drosophila and 
mouse G9a (100 ng) was incubated for 1 hour with 500 ng H1 or two µg recombinant octamer in the 
presence of 0.17 μM S-Adenosyl [methyl-3H] methionine. 
 
4.5 Purification of dG9a from Drosophila nuclear extract 
 
Mouse G9a has been shown to heterodimerise with a G9a related protein (GLP also 
known as EuHMTase1 in human) (Tachibana et al., 2005) which forms a part of a 
large complex called E2F6.com (Ogawa et al., 2002). G9a–GLP heterodimer was 
recently shown to interact with a zink finger protein called Wiz in mouse ES cells 
(Ueda et al., 2006). 
 
4.5.1 Native dG9a is present in complexes of 440-670 kDa 
In order to search for dG9a interaction partners, a specific polyclonal antibody 
generated by M. Stabell was used (Stabell et al., 2006). The dG9a antibody 
recognized a single band with the predicted size of approximately 180 kDa (Figure 
4.25) in Drosophila 0-12 hours nuclear extract. 
                               
Figure 4.25 Antibody against dG9a raised in rabbit are specific and recognize a single band of 
approximately 180 kDa as predicted on a western blot of 1 and 2 μl Drosophila nuclear extract. 
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The Enhanzer of zeste (E(Z)) complex was purified from Drosophila nuclear extract, 
and chromatographic purification revealed that at least five distinctive HMTase 
activities, including SU(VAR)3-9 and E(Z), was identified in the 250 mM fraction of 
the Biorex 70 column (Czermin et al., 2002). Probing the fractions from the Biorex 70 
column with dG9a antibody revealed that dG9a was mainly present in the 500 mM 
fraction (Figure 4.26.A and B).  
 
In order to identify dG9a interaction proteins, the Biorex70 500 mM fraction was 
purified over another 3 successive columns (Heparin agarose, Mono Q and Superose 
6 gel filtration column) (Figure 4.26.A). The presence of dG9a was followed by 
probing the fractions transferred to western blots with dG9a antibody and by 
measuring the histone methyltransferase activity (Figure 4.27A and B). dG9a and 
methyltransferase activity was detected in fractions 26-30 from the Superose 6 
column. This indicated that dG9a was present in a complex with a size of 440 to 670 
kDa. Judging from the silver-stained polyacrylamide gel of these fractions, there was 
more than one protein complex present in each fraction. Indeed MALDI-TOF analysis 
of fraction 29 revealed the presence of the ORC complex, the transcription factor 
TFIIH complex and other well-known proteins such as Jil-1 and SUZ12 (Figure 
4.27.C). Using antibodies present in the laboratory for the proteins RPD3, SUZ12, 
p55 and ISWI indicated that these proteins also peak in fraction 29 (Figure 4.27.A). 
Another approach was necessary to identify proteins that interact with dG9a. 
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Figure 4.26 Purification of native dG9a (A) A schematic representation of the purification. (B) 
Immuno blotting of fractions from the first column. A total of 20 µg of proteins were loaded in each 
lane and the western blot was probed with dG9a antibody. 
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Figure 4.27 (A) 20 µl of fractions eluted from a Superose 6 gelfiltration column were analyzed by 
silver stain and western blot using α-dG9a, α-ISWI, α-SUZ12, α-RPD3 and α-p55 antibodies as 
indicated. Arrows indicate molar mass markers. (B) A filter binding assay where 20 µl of fractions 
indicated from (A) were incubated with 2 µg of recombinant histone octamer in the presence of 0.17 
μM S-Adenosyl [methyl-3H] methionine. The y-axis represents counts per minute, after background is 
subtracted. (C) A larger volume (100 µl) of fractions # 28-31 were precipitated and separated by SDS-
8% PAGE. Bands peaking in # 29, indicated by asterisk, were analyzed by MALDI-TOF. 
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4.5.2 Co-immunoprecipitation of dG9a and RPD3 
 
It was intriguing that three of the components of the E(Z) complex (Czermin et al., 
2002) co-purified together with dG9a. To confirm whether dG9a was present in a 
similar complex a co-immunoprecipitation was performed (Figure 4.28.A). However, 
only RPD3 (also known as HDAC1) but not SUZ12, was pulled down by the dG9a 
antibody. On the other hand RPD3 pulled down SUZ12 and dG9a. This may indicate 
that RPD3 interacts with dG9a in the absence of SUZ12. Mammalian G9a was found 
to be in a complex with HDAC1 and Gfi1 responsible for repression of p21 (Duan et 
al., 2005). However mG9a was shown to transcriptional repress a reporter gene in 
HELA cells without HDAC activity (Tachibana et al., 2002). Jil1, a histone S10 
kinase that was shown to regulate H3K9 methylation (Ebert et al., 2004) did not 
interact with dG9a (Figure 4.28.A).  The CG7946 co-purifying in fraction 29 (Figure 
4.27.C) interacts with JIL1 (C. Regnard personal communication) and may therefore 
be excluded from interaction with dG9a.  
 
The immunoprecipitated dG9a was also tested for histone methyltransferase activity 
of recombinant histone octamers and nucleosomes (Figure 4.28.B). Mainly free 
histone H3 but also H4 was methylated which indicate that the results obtained for 
recombinant dG9a is also happening in vivo (Results 4.4.2). On nucleosomes only 
histone H4 was methylated and since recombinant dG9a showed no detectable 
activity towards nucleosomes, one may speculate that this activity was due to a 
nucleosomal H4 methyltransferase co-purifying with dG9a. 
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Figure 4.28 dG9a interacts with RPD3 (A) Drosophila nuclear extract were precipitated with 
antibodies directed against dG9a, RPD3 and rabbit IgG. The immunoprecipitations were transferred 
onto a PVDF membrane and analyzed with specific antibodies as indicated on the right. Input (Inp) is 
2% nuclear extract. (B) Immunoprecipitations with α-dG9a and α-myc were incubated with 2 µg of 
recombinant histone octamer or 1 µg of nucleosomal arrays in the presence of 0.17 μM S-Adenosyl 
[methyl-3H] methionine. The Coomassie gel is shown at the top and the corresponding autoradiograph 
at the bottom. 
 
To further identify dG9a interacting proteins, immunoprecipitated dG9a was loaded 
onto a SDS-4-20% PAA gel and stained with colloidal blue. Bands were cut and 
subjected to peptide mass fingerprint. Most of the bands contained dG9a, suggesting 
that this protein was prone to proteolytic cleavages. The ATPase ISWI, the catalytic 
subunit of at least three chromatin remodeling complexes in Drosophila: ACF, 
CHRAC and NURF (for review see (Bouazoune and Brehm, 2006)), was pulled down 
with dG9a (Figure 4.29). ISWI was also co-eluting with dG9a from the Superose 6 
column (Figure 4.27.A). Both dG9a and NURF301 are involved in the ecdysone 
regulatory pathway (Badenhorst et al., 2005; Stabell et al., 2006).   
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Fibrillarin, a protein present in the nucleoli and involved in 35S RNA processing 
(Tollervey et al., 1991), and 40S Ribosomal protein was also identified interacting 
with dG9a. However, immunofluoescence analysis of mouse G9a and GLP revealed 
that both proteins co-localized in the nucleus but were largely excluded from the 
nucleoli (Ueda et al., 2006) suggesting that Fibrillarin may be a contaminant in the 
purification. The 40S ribosomal protein is part of the 80S ribosome responsible for 
translating mature mRNA in the cytoplasm (for review see (Pestova et al., 2001)). 
The interaction with G9a may not be excluded since immunostaining and in situ 
hybridization show that the translation apparatus was present at sites of Ecdysone-
induced transcription in the nucleus (Brogna et al., 2002).  
 
Figure 4.29 Immunoprecipitation of dG9a. Immunoprecipitation from Drosophila nuclear extract 
(NE) using the dG9a antibody was separated by SDS-4-20% PAGE and analyzed by MALDI-TOF. 
Bands are indicated by asterisk the identified proteins are shown on the right. MW, molecular weight 
markers are shown to the right. 1) Topoisomerase was also identified in the IgG immunoprecipitation 
and is therefore considered a contaminant. 
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4.6 HP1a binding to H3K9 methylated chromatin is enhanced by 
auxiliary factors 
 
Drosophila heterochromatin protein 1 (HP1) was first identified as an abundant 
protein localizing to pericentric heterochromatin (James et al., 1989).  There are five 
paralogs present in Drosophila melanogaster, named HP1a-e (Vermaak et al., 2005). 
The HP1 proteins carry a N-terminal chromo domain and a C-terminal chromo 
shadow domain separated by a hinge region (Aasland and Stewart, 1995; Eissenberg 
and Elgin, 2000; Paro and Hogness, 1991; Singh et al., 1991). In vitro studies 
revealed that the chromo domain binds H3 peptides methylated at K9 (Bannister et 
al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs et al., 2001; Lachner et al., 2001; 
Nielsen et al., 2002). In addition in vivo reports supports these data; in a mutant 
background of the H3K9 HMTase SU(VAR)3-9/Clr4 methylated H3 and HP1 
localization to heterochromatin was reduced (Bannister et al., 2001; Nakayama et al., 
2001; Schotta et al., 2002). However, little was known about the mechanism of HP1 
binding to H3K9 methylated nucleosomes. 
  
4.6.1 Bacterially expressed HP1a dimerises 
 
In order to generate chromatin fibers containing HP1a, bacterially expressed 
Drosophila HP1a was purified over four consecutive columns as described before to 
(Zhao and Eissenberg, 1999) (Figure 4.30).  
  
Figure 4.30 Purified recombinant HP1a. Untagged recombinant HP1a was purified over four 
successive columns. A Coomassie stained SDS-12% PAA gel of 5 μl of fractions 9-19 from the last 
column, a MonoQ, is depicted. fxn, fraction. 
 
Structural analysis revealed that the chromo shadow domain forms dimers (Brasher et 
al., 2000; Cowieson et al., 2000).  To confirm that the recombinant HP1a was folded 
properly to form dimers, the protein was analyzed on a Superdex 200 column (Figure 
4.31.A). HP1a eluted with an apparent mass of a dimer.  
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This was confirmed by multi angle light scattering (Figure 4.31.B). To further 
examine the dimeric state of HP1a, the recombinant protein was cross-linked with 
DTSSP and separated by SDS-PAGE. Because DTSSP is cleaved in the presence of a 
reducing agent, cross- linked proteins would be split into their monomeric form. In 
the absence of reducing agent, cross-linked HP1a was detected by Western blotting as 
monomer and dimer. In presence of reducing agent more monomer could be detected. 
 
 
Figure 4.31 Bacterially expressed HP1a dimerises. (A) Purified recombinant HP1a was loaded onto 
a gel-filtration column (Superdex 200) and the elution profile (A280) of HP1 is shown. Molar mass 
standards (Bovine Serum Albumin 66 kDa and Carbonic Anhydrase 29 kDa) are labeled with arrows. 
(B) A molar mass of HP1a as it elutes from the size-exclusion column in (A). The molar mass (kDa) 
was determined by multi angle light scatter (dots). (C) In vitro cross-linking of HP1a using DTSSP 
(DSS). Recombinant HP1a before (lane 3) or after (lanes 1 and 2) cross-linking was subjected to a 
SDS-12% PAGE, transferred to a PVDF membrane and detected with HP1 (C1A9) antibody. The 
DTSSP cross-linking can be partially reversed by reductive cleavage of the disulphide-containing 
cross-linking molecule (lane 2). The cross-linking revealed dimeric HP1.  
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4.6.2 Recombinant HP1a binds the H3-tail methylated at K9 
 
HP1 specifically recognizes methylation of lysine 9 on histone H3 (Bannister et al., 
2001; Lachner et al., 2001).  Therefore, the binding of recombinant HP1a to H3 
peptides unmodified, dimethylated at K4 or K9 were tested (Figure 4.32). HP1a 
bound only to the H3 peptide methylated at K9.   
                      
Figure 4.32 Recombinant HP1a was assayed for binding to H3 peptides containing the first 19 
amino acids of H3 immobilized onto Sulfolink Sepharose. The substrates were: unmodified peptide 
(lane 3), peptide dimethylated at K4 (K4Me2; lane 4) and peptide dimethylated at K9 (K9Me2; lane 5). 
Bound HP1a was visualized by Coomassie staining.  
 
4.6.3 Reconstitution of recombinant and H3K9 methylated  
chromatin and binding of HP1a 
 
In order to study binding of HP1a to chromatin, recombinant Drosophila histones 
were assembled onto DNA fragments containing 11 repeats of the 5S nucleosome 
positioning sequence by salt dialysis (Luger et al., 1999) (Figure 4.33).  The level of 
assembly was tested by micrococcal nuclease digestion (Figure 4.33.B).  To analyze 
chromatin bound HP1a, the DNA fragments were biotinylated on one strand and 
immobilized using streptavidin coupled magnetic paramagnetic beads. Chromatin 
assembly was more efficient on unbound DNA; therefore the nucleosomal arrays 
were coupled to paramagnetic beads and washed with 100 mM salt to get rid of 
unbound fragments. As described in results section 4.1.3, recombinant SU(VAR)3-9 
trimethylates histone H3K9. After incubation of SU(VAR)3-9 with reconstituted 
octamers and SAM, the histones were separated from SU(VAR)3-9, SAM and SAH 
by a cation-exchange resin. The histones were eluted from the resin with 2.5 M NaCl, 
which favors formation of octamers. The efficiency of H3K9 methylation was 
analyzed by MALDI-TOF and octamers with H3 molecules carrying at least 80% di- 
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and trimethylation (See figure 4.6) were used for salt dialysis (Figure 4.33.B lanes 2-
4).  
 
Figure 4.33 Generation of H3K9 methylated chromatin. (A) A scheme of the chromatin 
reconstitution protocol. The DNA used for chromatin reconstitution was a literalized biotinylated 
fragment containing 11 repeats of the 5S nucleosome positioning sequence (Tse and Hansen, 1997). 
(B) Micrococcal digestion pattern of salt-reconstituted chromatin with recombinant or in vitro 
methylated histones is shown to the right. 
 
HP1a was incubated with either recombinant or H3K9 methylated nucleosomes at a 
molar ratio of 4:1. Despite the high content of methylated histone H3, HP1a showed 
only a weak binding that was independent of methylation and similar to the affinity to 
DNA (Figure 4.34.A). HP1a was reported to bind to nucleosomes, but the HP1 to 
nucleosome ratio was very high  (500:1) (Zhao et al., 2000). The linker histone (H1) 
bound very efficient to chromatin fibers even at a ratio of 2:1 (Figure 4.34.B). 
Therefore it may be concluded that HP1a either binds to methylated histone H3 before 
assembly or it requires additional factors for the binding to chromatin fibers. 
 
Figure 4.34 (A) HP1 was assayed for binding to recombinant chromatin (lane 2), H3K9Me chromatin 
(lane 3), DNA immobilized on paramagnetic beads (lane 4) and beads alone (lane 5). Bound HP1 was 
separated by SDS-15% PAGE and visualized with an HP1 polyclonal antibody. The lower the panel 
shows the corresponding histones are stained with Coomassie blue (B) The same assay as described in 
(C) with histone H1, visualized by Coomassie blue.  
 122
                                                                                                                              Results 
4.6.4 HP1a binds to H3K9Me during chromatin assembly 
 
HP1 has been reported to bind to the histone fold of histone H3 (Nielsen et al., 2001) 
and since the histone fold domain is not easily accessed in the nucleosomal particle 
(Luger et al., 1997), HP1a might bind before histones were assembled into chromatin. 
In order to test whether HP1a binds H3 molecules before chromatin assembly, another 
chromatin assembly method was used since the salt assembly reaction contain high 
salt concentrations (2 M NaCl). A chromatin assembly extract (S150) from 
preblastoderm Drosophila embryos utilizes endogenous core histones and assembly 
factors to assemble cloned DNA (Becker and Wu, 1992). The S150 extract can be 
utilized to assemble nucleosomes on DNA immobilized to paramagnetic beads 
(Sandaltzopoulos et al., 1994) (Figure 4.35.A). Albeit recombinant HP1a was added 
at the start of the assembly reaction, only a weak association of HP1a with the 
assembled chromatin could be observed (Figure 4.35.C, lane 3). Histones from early 
Drosophila embryos contains less than 5% H3K9 methylation (Bonaldi et al., 2004). 
To increase the content of H3K9 methylated molecules, recombinant methylated 
octamer was added to the assembly extract before the assembly.  In comparison, 
unmodified histones were added. Micrococcal nuclease digestions of immobilized 
chromatin assembled with S150 extract (Figure 4.35.B lanes 2-4) or S150 extract 
supplemented with unmodified (lanes 10-12) or methylated (lanes 6-8) histones 
revealed similar nucleosomal spacing. The chromatin with supplemented histones was 
slightly more sensitive to MNase. Under these conditions, HP1a showed weak 
binding towards chromatin supplemented with unmodified histones whereas a much 
stronger binding was observed to chromatin supplemented with methylated histones 
before the assembly reactions (Figure 4.35.C lane 4 versus 5). Using fluorescently 
labeled secondary antibodies for western blot detection, allowed quantification of the 
signals by the Odyssey system. A quantification of Figure 4.35.C is shown in (Figure 
4.35.D). There was a ten-fold increase of HP1a binding to chromatin when 
methylated histones were present compared to unmodified histones. 
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Figure 4.35 Reconstitution of methylated chromatin using a S150 Drosophila assembly extract 
and HP1a binding. (A) A scheme of the assay. (B) Micrococcal digestion pattern of chromatin 
assembly reactions as described in (C) without HP1a added. MNase digestions were stopped after 30-, 
60-, and 300 seconds. Assembly of circular DNA was used as a control. MW indicates lanes containing 
the 123 bp ladder as size marker. (C) Chromatin was reconstituted on 2 μg linearized dsDNA bound to 
paramagnetic beads in the presence or absence of 2 μg of HP1a for 6 hours at 26 °C. 2 μg of 
recombinant octamer (lane 4) or H3K9Me octamer (lane 5) was supplemented to the extract before 
assembly. The paramagnetic beads were washed and proteins remaining on the beads were loaded on a 
SDS-15% PAGE. HP1a is visualized with an HP1a polyclonal antibody. The corresponding histones 
are stained by Coomassie blue. Recombinant and endogenous HP1s are labeled. (D) The graph 
corresponds to a quantification of bound HP1 in (C). Recombinant and endogenous HP1a are included 
in the quantification. The y- axis displays percent input bound. The graph is representative of three or 
more different experiments. 
 
To test whether binding of HP1a to H3K9 enriched chromatin affects nucleosomal 
spacing, increasing amounts of HP1a was added to assembly reactions supplemented 
with methylated histones (Figure 4.36).  
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As a control, the highest concentration of HP1a was added to an assembly reaction 
with unmodified histones. No difference in nucleosomal spacing could be observed. 
                  
Figure 4.36 Binding of HP1 does not affect nucleosomal spacing. Chromatin was assembled of 1 μg 
of circular DNA in presence or absence of 2 μg HP1 for 6 hours at 26 °C. 1 μg of H3K9Me octamer 
(lane 4) or recombinant octamer (lane 5) was supplemented to the extract before assembly. MNase 
digestions were stopped after 30-, 60-, and 120 seconds. MW indicates lanes containing the 123 bp 
ladder as size marker. 
 
4.6.5 HP1a binds H3K9Me chromatin in presence of auxiliary  
factors 
 
HP1a bound to chromatin containing H3 molecules methylated at K9 during 
assembly. However, it was not clear whether HP1a bound histone H3 before assembly 
or if accessory factors in the S150 assembly extract facilitate HP1a binding. To 
distinguish between these two possibilities, recombinant HP1a and S150 extract was 
added to salt- assembled chromatin (Figure 4.37.A). Under these conditions HP1a 
bound to chromatin methylated at K9, even though the amount of assembly extract 
added was not sufficient to assemble chromatin in vitro (Figure4.37.B, lane 5). 
Chromatin assembly is an ATP-dependent process. To investigate whether HP1a 
binding to chromatin was an ATP-dependent effect ATP or the non-hydrolysable 
analog γS-ATP was added to the assay. ATP did not significantly stimulate HP1 
binding to methylated chromatin (Figure 4.37.B, lane 5 versus 7). On the other hand 
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the weaker binding to unmodified chromatin was slightly enhanced by ATP (Figure 
4.37.B, lane 4 versus 6). A quantification of HP1a binding is shown in (Figure 
4.37.C). In the presence of assembly extract, HP1a binds more than 11 times better to 
H3K9 methylated chromatin compared to unmodified chromatin. The ATP dependent 
effect of HP1a binding to unmodified chromatin was 3 times better than for γS-ATP. 
 
Figure 4.37 HP1a bound to salt assembled chromatin in presence of Drosophila assembly extract. 
(A) A scheme of the assay. (B) Salt assembled recombinant or H3K9Me chromatin attached to 
paramagnetic beads was incubated for 1 hour at 26 °C with HP1a, plus and minus Drosophila assembly 
extract. The reactions were in the presence of ATP or non-hydrolysable ATP-gamma-S analog. The 
assembly extract added was less than 5% of what was needed for the assembly reaction in Figure 4.35. 
HP1a was detected by HP1a polyclonal antibody and corresponding histones by Coomassie blue. (C) 
The graph corresponds to quantification of HP1a bound shown in Figure 3B. The y- axis displays 
percent input bound. The graph is representative of at least four individual experiments and displays 
percent input bound. 
 
4.6.6 Characterization of the molecular mechanism of HP1a  
binding to H3K9Me chromatin 
 
As shown above, HP1a binding to methylated chromatin was not dependent on 
chromatin assembly. The chromatin assembly extract contains factors that facilitate 
HP1a binding to methylated chromatin. To better understand the mechanism of HP1 
binding to methylated chromatin two point mutations were generated (Figure 4.38.A).  
A mutation of valine 26 to methionine within the chromo domain of HP1a prevented 
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binding to a H3 peptide methylated at K9 (Jacobs et al., 2001). The chromo shadow 
domain of HP1 is the interacting module for numerous factors that contain a PxVxL 
motif (reviewed in (Li et al., 2002)). If the chromo shadow domain in HP1β carrying 
a W170A mutation (W200A in HP1a) mutation, it no longer interact with the PxVxL 
motif proteins such as TIF1β and CAF1 (Brasher et al., 2000). The HP1a mutants 
were expressed and purified as described for the wild type protein (Zhao and 
Eissenberg, 1999) (Figure 4.38.B). As expected HP1a (V26M) mutant no longer 
bound to H3K9 trimethylated peptides, whereas HP1a (W200A) did (Figure 4.38.C; 
compare lanes 4, 7 and 10). 
 
Figure 4.38 Purified recombinant HP1a mutant proteins. (A) A scheme of HP1a point-mutants 
generated. (B) A 15% Coomassie blue stained SDS PAA gel of the purified untagged HP1a proteins. 
(C) Peptide pull-down of the recombinant HP1 WT and mutants using H3 peptide aa 1-21, unmodified 
(WT) versus trimethylated at K9. Bound HP1a were visualized by Coomassie blue. 
 
The HP1a wild type and mutant proteins (V26M and W200A) were added to S150 
chromatin assembly reactions in the presence of methylated histones (Figure 4.39 A). 
As there was some endogenous HP1a present in the extract, a reaction without 
recombinant HP1a served as control (Figure 4.39.B, lane 4). The endogenous HP1a 
protein runs with an apparent molar mass that was slightly lower than the recombinant 
HP1a. HP1a (V26M) which no longer bound to H3K9 methylated peptide lost the 
ability to bind methylated chromatin (Figure 4.39.B; compare lanes 5 and 6). Despite 
the ability of HP1a (W200A) to interact with methylated peptides, the binding of 
methylated chromatin was also impaired.  Binding of HP1a to methylated chromatin 
was depending on recognition of the methylated H3K9 by the chromo domain and 
protein-protein interactions through the chromo shadow domain. Both domains were 
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necessary to gain a stable interaction of HP1a to chromatin. A quantification of bound 
recombinant and endogenous HP1a is shown in Figure 4.39.C.            
 
Figure 4.39 (A) A scheme of the assay (B) Drosophila assembly reaction with 2 μg H3K9Me octamer 
as described in Figure 4.35. In lane 1, 2.5% input of HP1a (WT), in lane 2, 2.5% input of HP1a 
(V26M), and in lane 3, 2.5% input of HP1a (W200A). Lanes 4-7 corresponds to proteins bound after 6 
hours incubation. HP1a is detected by HP1 polyclonal antibody and the corresponding histones are 
stained with Coomassie blue. Bound exogenous and endogenous HP1a present in the Drosophila 
assembly extract are labeled. (C) The graph corresponds to quantification of bound HP1 in (B). 
Recombinant and endogenous HP1 are included in the quantification. The y- axis displays percent 
input bound. This quantification is representative of at least 3 different experiments. 
 
As described above, HP1 has many interaction partners that interact through the 
chromo shadow domain. In search of proteins that facilitate HP1a binding to H3K9 
methylated chromatin, a candidate approach for proteins involved in heterochromatin 
formation was chosen. 
 
4.6.7 ACF1 interacts with HP1a and facilitates HP1a binding to  
chromatin  
 
Several chromatin-associated factors have been suggested to play a role in 
heterochromatin formation (Reuter and Spierer, 1992; Schotta et al., 2003a). The 
chromatin remodeling factor ACF (ATP- utilizing chromatin assembly and 
remodeling factor) consisting of the ATPase ISWI and the regulatory protein ACF1 
are abundant in early Drosophila embryos (Eberharter et al., 2001; Ito et al., 1999).  
Loss of ACF1 results in suppression of pericentric position effect variegation 
(Fyodorov et al., 2004), which places ACF1 in the same genetic pathway as HP1a 
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(Eissenberg et al., 1990). Mammalian ACF1 has been shown to co-localize with 
HP1β in mammalian cells and it is suggested to have a role in replication of 
heterochromatin (Collins et al., 2002). As binding of HP1a to chromatin was impaired 
when the chromo shadow domain was mutated, we investigated whether ACF 
interacts with HP1a. ACF complex and ACF1 was expressed using a baculoviral 
system. Flag-tagged ACF1 was expressed alone or in presence of untagged ISWI and 
purified over M2-Flag agarose beads (Figure 4.40.A). Immobilized ACF complex or 
ACF1 protein was incubated with HP1a wild type or the two mutants (V26M) and 
(W200A) (Figure 4.40.C and D). ACF complex as well as the ACF1 subunit 
interacted with HP1a wild type and (V26M). The HP1 chromo shadow mutant did not 
interact (Figure 4.40.A and B; compare lanes 3 and 6 with 9). This was consistent 
with previous findings that the chromo shadow domain of HP1 mediates most 
protein-protein interactions (Thiru et al., 2004).  
                  
Figure 4.40 HP1 interacts with the ACF complex and ACF1. (A) Coomassie stained SDS-8% PAA 
gel of Flag affinity purified recombinant ACF1 and ACF complex from Sf9 cells co infected with Flag-
ACF1 in presence or absence of untagged ISWI. (B) HP1a pull down with Flag beads incubated with 
mock Sf9 extract or extract-containing recombinant Flag-ACF1 and untagged ISWI. After extensive 
washing, the protein remaining on the beads were separated by SDS-12% PAGE, imunoblotted and 
detected by HP1 antibody. Asterisks indicate Flag antibody light chain. C) Western blot of HP1a pull 
down using Flag beads incubated with mock Sf9 extract or extract containing Flag- ACF1. Asterisks 
indicate Flag antibody light chain. 
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In order to map the interaction domain of ACF1, a GST-HP1a pull-down was 
performed. The ACF1 constructs were in vitro translated in presence of 35S-
methionine and the pull-downs were detected by autoradiography (Figure 4.41.A and 
B). HP1a interacted with all ACF1 fragments that contained amino acids 202-468. 
This motif contains the evolutionary conserved DDT domain (Doerks et al., 2001) 
suggesting that it may be responsible for the interaction. The same region has been 
shown to be required for ISWI interaction with Drosophila ACF1 (Eberharter et al., 
2004; Fyodorov and Kadonaga, 2002). A quantification of the pull-down experiment 
is shown in Figure 4.41.C. 
 
Figure 4.41 HP1a interacts with a region spanning the DDT domain (A) ACF1 constructs used for 
in vitro translation. (B) GST and GST-HP1a pull down with in vitro translated ACF1 constructs (C) 
Quantification of the binding affinities of the various ACF constructs. Error bars represent variations of 
three independent pull-downs. 
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In order to test if ACF facilitates HP1a binding to chromatin, ACF was added to 
unmodified or methylated salt-assembled chromatin in presence of recombinant HP1a 
(Figure 4.42.A). Consistent with previous observations, that HP1a needs two 
interaction modules for binding to chromatin, ACF complex facilitates binding of 
HP1a to H3K9 methylated chromatin (Figure 4.42.B; compare lanes 4 and 5). This 
was not due to higher affinity of ACF to methylated chromatin, as it bound equally 
well to unmodified chromatin.  The binding of HP1a was independent of the presence 
of ATP (Figure 4.42.B; compare lanes 5 and 7).  A quantification of the HP1a binding 
facilitated by ACF is shown in Figure 4.42.C.  
             
Figure 4.42 ACF facilitate HP1 binding to H3K9Me chromatin. (A) A scheme of the assay. (B) Salt 
assembled recombinant or H3K9Me chromatin bound to paramagnetic beads was incubated with HP1 
in presence or absence of ACF and ATP for 1 hour at 26 ºC. After washing, the proteins remaining on 
the paramagnetic beads were separated by SDS-15% PAGE. ACF1 was detected with a FLAG 
antibody and HP1a with HP1 polyclonal antibody (upper panels). The corresponding histones are 
detected with Coomassie blue (lower panel). Lane 1 is corresponding to 50% ACF input and 2.5% 
HP1a input. (C) The graph displays bound HP1a as percent of input in B. 
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4.6.8 SU(VAR)3-9 interacts with HP1a and facilitates HP1a binding  
to chromatin 
 
Another factor in Drosophila that is a suppressor of position effect variegation and 
interacts with HP1a in vivo is SU(VAR)3-9 (Aagaard et al., 1999; Schotta et al., 
2002).  SU(VAR)3-9 localizes to heterochromatin  and sets the K9 methyl mark for. 
HP1a. The interaction between HP1a and SU(VAR)3-9 was mapped to the N-terminal 
region (amino acids 1-188) of SU(VAR)3-9 and to the C-terminal region of HP1a 
(amino acids 95-206) by yeast two-hybrid screen (Schotta et al., 2002). In vitro 
interaction between mouse SU39H1 and HP1α was mapped to the chromo shadow 
domain (Yamamoto and Sonoda, 2003). In order to biochemically map the interaction 
between recombinant SU(VAR)3-9 and HP1a, protein-protein interaction assays were 
performed (Figure 4.43). Full-length HP1a interacted with full-length SU(VAR)3-9. 
However, the interaction was lost when the N-terminus of SU(VAR)3-9 (Δ213) was 
removed (Figure 4.43.A). On the other hand, the interaction of HP1a with the 
SU(VAR)3-9 N-terminus was impaired when the chromo shadow domain was 
mutated (Figure 4.43.B; compare lanes 3 and 6 with 9). Hence, the chromo shadow 
domain of HP1a was important for protein-protein interaction (Brasher et al., 2000; 
Lechner et al., 2000; Yamamoto and Sonoda, 2003). 
                       
Figure 4.43 HP1a interacts with SU(VAR)3-9. (A) SU(VAR)3-9 constructs used for  in vitro 
translation and GST constructs are shown at the top.  The GST-pull down is shown at the bottom. 
SU(VAR)3-9 is detected by autoradiograph. (B) The upper panel shows GST constructs used for the 
pull down. The lower panel represents a HP1 western blot of GST pull down with recombinant HP1a 
WT (lane 1-3), HP1a (V26M) (lane 4-6) and HP1a (W200A) (lanes 7-9). HP1a was detected with HP1 
polyclonal antibody. 
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Knowing that HP1a and SU(VAR)3-9 interact, it was of interest to find out whether 
SU(VAR)3-9 facilitates HP1 binding to chromatin. Therefore SU(VAR)3-9 and HP1a 
was mixed with unmodified and methylated salt-assembled chromatin (Figure 
4.44.A). SU(VAR)3-9 has methyltransferase activity, and even though external SAM 
was not added, the specific inhibitor chaetocin (Greiner et al., 2005) (Results 4.2),  
was used as a control. SU(VAR)3-9 could couple HP1a to methylated chromatin, and 
the HMTase activity was not required for binding (Figure 4.44.B; compare lanes 4 
and 5 with 6 and 7).  The binding of HP1a to methylated chromatin was dependent on 
interaction with SU(VAR)3-9, as addition of the N-terminal deletion had no effect 
(Figure 4.44.B; compare lanes 5 and 7 with 9). Hence, this again confirms the 
importance of protein-protein interaction through the chromo shadow domain to 
stabilize the interaction of HP1a with methylated chromatin. A quantification of the 
SU(VAR)3-9 facilitated binding of HP1a to chromatin is shown in Figure 4.44.C. The 
binding of HP1a to methylated chromatin was about two times stronger in presence of 
SU(VAR)3-9. 
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Figure 4.44 SU(VAR)3-9 facilitate HP1 binding to H3K9Me chromatin. (A) SU(VAR)3-9 couples 
HP1a to chromatin. HP1 was incubated with recombinant or H3K9Me chromatin in the presence of 
recombinant SU(VAR)3-9 WT (lanes 4-7) or ∆213 (lanes 8 and 9). The SU(VAR)3-9 specific HMTase 
inhibitor Chaetocin was added to 1 µM (lanes 6 and 7). The remaining SU(VAR)3-9 and HP1a on 
paramagnetic beads was detected by Western analysis and the histones by Coomassie blue. Lane 1 is 
corresponding to 100% SU(VAR)3-9 input and 2.5% HP1 input. (B) A quantification of HP1 bound in 
Figure D. The y- axis corresponds to percent input bound. 
 
As shown above, interaction of SU(VAR)3-9 with HP1a was important to stabilize 
the binding to methylated chromatin. To further analyze the effect of stabilization, the 
same assay as described in Figure 4.44.A was performed with HP1a mutants (Figure 
4.45). Under these conditions, the interaction with SU(VAR)3-9 had a greater impact 
on chromatin binding than H3K9 methylation. In other words, the HP1a (W200A) 
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binding to chromatin was more severely interrupted than for HP1a (V26M) (Figure 
4.45.A; compare lane 3 with 6 and 9). It was also noticeable that HP1a (V26M) bound 
slightly stronger to unmodified chromatin, compared with wild type HP1a (Figure 
4.45.A; compare lane 2 with 5). The quantification of the experiment is shown in 
Figure 4.45.B. 
 
Figure 4.45 HP1a binding to H3K9Me chromatin was dependent on the chromo- and chromo 
shadow domain (A) SU(VAR)3-9 was added in the presence of HP1a WT (lanes 1-3), HP1a (V26M) 
(lanes 4-6) and HP1a (W200A) (lanes 7-9) to recombinant and H3K9Me chromatin. Bound 
SU(VAR)3-9 and HP1a were detected by Western analysis and histones were detected by Coomassie 
blue. (B) The graph corresponds to total HP1 binding in Figure F. The y- axis displays percent input 
bound. 
 
4.7 HP1a and HP1c have distinct interaction factors 
 
Drosophila HP1a and HP1c exhibit spatial distinct localization in the nucleus 
(Smothers and Henikoff, 2001). HP1a localizes to heterochromatin, whereas HP1c 
localizes exclusively to euchromatin. As discussed above, binding of HP1a to 
methylated chromatin was enhanced with interaction of auxiliary factors that are 
involved in heterochromatin formation. Hence, HP1c-interaction partners should be 
distinct from HP1a and confer to euchromatin. 
 
4.7.1 Identification of HP1a interacting proteins 
 
In order to examine the interaction partners of HP1a in vivo, an immunopurification 
strategy from transfected SL2 cells were used. Nuclear extract was prepared from 
Flag-HP1a stable cell lines (Figure 4.46.A), and pulled down Flag-HP1a complexes 
were analyzed by Western blotting and MALDI-TOF. To confirm an in vivo 
interaction between HP1a and ACF1, a pull down from a stable Purified Flag-HP1a 
from SL2 cells were probed with specific ACF1 antibody. As a control, nuclear 
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extract from un-transfected cells were used. ACF1 was found to interact weakly with 
Flag-HP1a (Figure 4.46.B). This interaction was stable in up to 500 mM NaCl (data 
not shown).  Also SU(VAR)3-9 interacted specifically with HP1a in SL2 cells. The 
Flag-HP1a complex was analyzed by mass spectrometry (Figure 4.46.C). For several 
associated polypeptides, the apparent molar mass was corresponding to proteins 
previously shown to interact with HP1. Nipped-B is required for sister chromatid 
cohesion, and is therefore a functional adherin (Rollins et al., 1999). The human 
homolog NIPBL has been shown to interact with HP1α in transfected human 
embryonic kidney 293 (HEK293) cells (Lechner et al., 2005). In addition fission yeast 
Swi6/HP1 was required for cohesion at centromeres (Bernard et al., 2001). XNP is a 
homolog of human ATR-X, a nuclear SNF2 ATPase involved in mental retardation 
(Inlow and Restifo, 2004). HP1α interacted with mouse ATR-X in a yeast two-hybrid 
screen (Le Douarin et al., 1996). In addition, ATR-X co localize with HP1β at 
pericentromeric heterochromatin in Hela cells (McDowell et al., 1999), and 
Caenohabditis elegans XNP-1 has been found to act with HP1 during development 
(Cardoso et al., 2005). Dis3 was a novel HP1a-interacting protein. A cold-sensitive 
mutation of dis3 in Schitzosaccharomyces Pombe is implicated in sister chromatid 
separation (Ohkura et al., 1988), linking HP1a and Dis3 with Nipped-B. 
  
Figure 4.46 Identification of HP1a interacting proteins by MALDI-TOF. (A) Nuclear extracts 
derived from SL2 cells or SL2 line stably expressing Flag-HP1a were separated on a SDS-15% PAGE, 
immunoblotted and detected with a α-Flag antibody. (B) ACF1 co-purifies weakly with stably 
transfected Flag-HP1a. Nuclear extracts derived from SL2 cells or SL2 line stably expressing Flag-
HP1a were subjected to immunoprecipitation with α-Flag antibody. Input (Inp) is two and four percent. 
300 mM indicate concentrations of three NaCl washes. (C) A colloidal blue stained SDS-10% PAA gel 
with α-Flag immunoprecipitations as described in Figure B. MW indicates molecular weight markers. 
Co-purifying proteins identified by MALDI-TOF analysis are indicated by asterisk and named (left). 
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4.7.2 Identification of HP1c interacting proteins 
 
In order to examine the interaction partners of HP1c in vivo, an immunopurification 
strategy from transfected SL2 cells as described in Results 4.7.1 were used. Nuclear 
extract was prepared from Flag-HP1c stable cell lines (Figure 4.47.A), and pulled 
down Flag-HP1c complexes were analyzed by mass spectrometry (Figure 4.47.B). 
Two distinct proteins, compared with the HP1a complex were identified.  Without 
children (woc) was shown to be a transcription factor involved in ecdysone synthesis 
(Wismar et al., 2000), but has also recently been implicated in prevention of telomeric 
fusions (Raffa et al., 2005). CG8092 is a novel zink finger protein.  
 
Figure 4.47 Identification of HP1c interacting proteins by MALDI-TOF. Nuclear extracts derived 
from SL2 cells or a SL2 cell-line stably expressing Flag-HP1c were subjected to immunoprecipitation 
with α-Flag antibody. (A) Immunoprecipitations were separated by SDS-15% PAGE, immunoblotted 
and detected with a α-Flag antibody.  (B) A colloidal blue stained SDS-4-20% PAA gel with α-Flag 
immunoprecipitations as described in Figure A. MW indicates molecular weight markers. Co-purifying 
proteins identified by MALDI-TOF analysis are indicated by asterisk and its identity to the left. 
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4.7.3 In vitro GST-HP1a and HP1c pull down experiment 
 
As discussed above, HP1a and c have distinct interacting complexes. To further 
support the theory that distinct proteins are involved in coupling of HP1a and c to 
chromatin, a pull down was performed. GST-HP1a or c was incubated with in vitro 
translated ACF1 and SU(VAR)3-9. HP1c did not interact with ACF-1 nor 
SU(VAR)3-9, hence supporting the theory that these two proteins couples HP1a to 
heterochromatin. It may be that HP1c is coupled to by other factors to H3K9 
methylated 
euchromatin.
 
Figure 4.48 HP1c does not interact with SU(VAR)3-9 or ACF1. (A) A GST pull-down is shown 
with in vitro translated ACF1 full length and GST-HP1a and GST-HP1c. ACF1 is detected with 
autoradiography. (B) A GST pull-down as described in (A) with in vitro translated SU(VAR)3-9 . 
SU(VAR)3-9 is detected by autoradiography. 
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5. Discussion 
 
This work focuses on histone H3 lysine 9 methylation which is associated to 
transcriptional silencing in vivo (Peters et al., 2003; Rice et al., 2003; Schotta et al., 
2004). Here the well known Drosophila H3K9 HMTase SU(VAR)3-9 and a new 
HMTase homologous to G9a were characterized in vitro. H3 lysine 9 was identified 
as their sole or at least main substrate. Supporting the histone code hypothesis, the 
chromo domain of HP1 recognizes and binds H3K9 methyl. However, the binding of 
Drosophila HP1a to methylated H3K9 within a nucleosomal context requires a 
bimodal interaction of the chromo domain with H3K9Me and interaction of the 
chromo shadow domain with an auxiliary factors (SU(VAR)3-9 and ACF).     
 
5.1 SU(VAR)3-9 
 
In summary, full-length recombinant SU(VAR)3-9 adds three methylgroups to full-
length H3 and only two methylgroups to an H3-tail peptide. The transfer of two 
methylgroups to the H3-tail peptide is achieved in a nonprocessive manner. 
SU(VAR)3-9 requires the N-terminus for homodimerization to retrieve full activity in 
vitro. The interaction occurs within two parts of the N-terminus. 
 
5.1.1 Recombinant SU(VAR)3-9 is a nonprocessive enzyme 
 
It has been described that Drosophila SU(VAR)3-9 methylates H3 lysine 9 (Czermin 
et al., 2001; Schotta et al., 2002). Recombinant SU(VAR)3-9 methylates H3K9 and 
preferred free H3 molecules to reconstituted nucleosomes. This indicates that 
SU(VAR)3-9 has a higher activity towards non-nucleosomal histones. However, 
immunostainings of polytene chromosomes of SU(VAR)3-9 null mutant salivary 
glands revealed that SU(VAR)3-9 is required for mono- to dimethylation in the 
chromocenter and trimethylation in the chromocenter core (Ebert et al., 2006; Ebert et 
al., 2004; Schotta et al., 2002). In addition it has been shown that only a small 
proportion of histones in mammalian cells are non-nucleosomal and a significant 
fraction of these carry H3K9 monomethylation (Loyola et al., 2006). This rather 
suggest that in vivo SU(VAR)3-9 methylates H3 within nucleosomes. Interestingly, 
SU(VAR)3-9 has similar affinity toward unmodified and monomethylated H3-tail 
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peptide. Although has been shown that SU(VAR)3-9 mainly di- and trimethylates 
H3K9 in vivo (Ebert et al., 2006; Schotta et al., 2002), it can also add methylgroups to 
unmodified H3. Supporting our finding, is the interaction of SU(VAR)3-9 with 
histone deacetylase HDAC1 (Czermin et al., 2001). SU(VAR)3-9 may directly 
methylate H3K9 after removal of an acetyl group by HDAC1. In vitro trimethylation 
of full-length H3 by SU(VAR)3-9 is less efficient than dimethylation (33% versus 
54% respectively; Figure 4.6). It remains puzzling to observe a poor trimethylation of 
H3-tail peptide by SU(VAR)3-9 in vitro. However, a steric hindrance in the peptide 
binding channel of the SET domain as observed for the monomethylase SET7/9 
(Zhang et al., 2003b) can be excluded because SU(VAR)3-9 trimethylates the H3 
molecule. Supporting this result is the finding that K9 dimethylated H3-tail peptide is 
also a poor substrate for the human SUV39H1 in vitro (Chin et al., 2006; Czermin et 
al., 2001; Rea et al., 2000) despite the fact that Suv39h1 and Suv39h2 double null 
embryonic stem cells display a dramatic decrease in H3K9 trimethylation (Peters et 
al., 2003; Rice et al., 2003). The discrepancy between in vitro and in vivo 
observations could be due to interactions with additional factors (Czermin et al., 
2001; Firestein et al., 2000; Zhang et al., 2006) or post-translational modification of 
SU(VAR)3-9 (Aagaard et al., 2000; Firestein et al., 2000) regulating the 
trimethylation of nucleosomal H3 in vivo. In addition there are uncharacterized SET 
domain proteins that may add a third methylgroup to dimethylated H3K9 (Schotta et 
al., 2004). Several studies describe the mechanism of methyl transfer by different 
HMTases revealing differences in their ability to transfer methyl groups. Human 
SET7/9 for example, mainly monomethylates H3K4 albeit having a low efficiency for 
dimethylation (Kwon et al., 2003; Xiao et al., 2003; Zhang et al., 2003b). On the other 
hand, Neurospora crassa DIM-5 and murine G9a both trimethylate H3K9, in a 
processive manner (Patnaik et al., 2004; Zhang et al., 2002; Zhang et al., 2003b). This 
work shows that SU(VAR)3-9 adds two methylgroups to the H3 peptide in a non-
processive manner. Recently, it was shown that the mammalian homolog, SUV39H1, 
also is a non-processive enzyme (Chin et al., 2006). The processivity of an HMTase 
depends on the exchange of S-Adenosyl methionine (SAM) and the reaction product 
S-Adenosyl homocysteine (SAH) within the SET domain. For example, DIM-5 is a 
processive enzyme because it can exchange SAM and the reaction product S-
Adenosyl homocysteine (SAH) without releasing the peptide (Zhang et al., 2003b). 
Zhang and colleagues solved the crystal structure of the trimethylase DIM-5 and 
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argue that its SAM-binding pocket is larger than necessary due to the highly 
conserved residues (R155, W161, Y204 and R238) within the SET domain facilitating 
exchange of the SAH and SAM (See Figure 5.1.A). Indeed, a DIM-5 R238H mutant 
has impaired catalytic activity, with substantial amounts of unmodified, mono and 
dimethylated peptide even after extended incubation (Zhang et al., 2003b). The 
comparison of SU(VAR)3-9, SUV39H1 and SET7/9 with DIM-5 238RΦΦNHS243  
motif (where Φ indicates a hydrophobic residue) reveal that all have a histidine 
residue instead of an arginine at this position (HΦΦNHS). However, the yeast 
SU(VAR)3-9 homolog Clr4 has arginine at this position (406RΦΦNHS411) arguing for 
it being a trimethylase (Min et al., 2002). Sedimentation transfer difference NMR 
measurements of SU(VAR)3-9 indicate that SAM binds in a similar manner as shown 
by a crystal structure of SET7/9 (Seeger et al., 2005). Indeed, it has been shown that if 
the corresponding histidine is mutated to arginine (H320R) in SUV39H1 the activity 
is strongly increased in vitro (Rea et al., 2000). To test this hypothesis, we generated a 
SU(VAR)3-9 (H557R) mutant (Figure 5.1.B). After incubation with unmodified H3 
peptide (upper panel) and SAM for one hour the reaction products were analyzed by 
MALDI-TOF. All unmodified peptide were converted into di- and trimethylated 
peptides supporting the notion that the arginine makes the SAM-binding pocket larger 
(Compare with figure 4.3.A). Hence, a reason for the H3 peptide to be a poor 
trimethylation substrate for SU(VAR)3-9 may be that binding of the full-length H3 
molecule by SU(VAR)3-9 facilitate a conformational change of the SAM binding 
pocket changing the affinity for the methylated substrate. Although, it is worth 
noticing that the (H557R) mutation did not make SU(VAR)3-9 a processive enzyme. 
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Figure 5.1 Processivity of SET domain enzymes. (A) A part of the SET domain structure of DIM-5 
(Zhang et al., 2002). SAM is bound in a large surface pocket of DIM-5, allowing for processive 
methylation. The green circle indicates the location where SAM and SAH bind. The yellow circle 
indicates the postSET domain. The surface is displayed with charge distribution (blue for positive, red 
for negative and white for neutral). SAM is displayed as a stick model. The figure is taken from (Zhang 
et al., 2003b). (B) A methylation reaction SU(VAR)3-9 H557R with H3 peptide (aa 1-19) and SAM 
analyzed by MALDI-TOF. The point mutation H557R within the SU(VAR)3-9 SET domain 
corresponds to DIM-5 R238, and results in a larger surface pocket for SAM binding and higher 
trimethylase activity. Upper panel, time point zero (t = 0 min); lower panel, after one-hour incubation (t 
= 60 min). 
 
5.1.2 Initial kinetics of SU(VAR)3-9 
 
Full-length SU(VAR)3-9 transfers two methyl groups to the H3 peptide with a high 
turnover number. Indeed, the turnover rate is 4.5 fold higher than for murine G9a 
(Patnaik et al., 2004) and 33 fold higher than for human SUV39H1 (Chin et al., 
2006), suggesting that SU(VAR)3-9 methylates a H3 peptide better than mG9a and 
SUV39H1 in vitro. Deletion of the N-terminus of SU(VAR)3-9 results in a more than 
20 fold reduction of the turnover number. Actually, SU(VAR)3-9 Δ213 has a similar 
turnover rate as full-length human SUV39H1 and SET9 (Chin et al., 2005; Trievel et 
al., 2002). However, both SU(VAR)3-9 and SUV39H1 have significantly higher 
Km[SAM] values than mG9a and hSET7/9, suggesting that the concentration of SAM 
may regulate their catalytic activity in vivo. In a cell, the SAM concentration varies 
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between 20 and 40 μM depending on cell type (Hoffman et al., 1980). With a 
Km[SAM] of 26 μM, SU(VAR)3-9 arguing that in vivo the rate of methylation is 
optimal the higher SAM concentration. In D. melanogaster SU(Z)5 is involved in the 
biosynthesis of SAM (Larsson and Rasmuson-Lestander, 1994). SU(Z)5 suppresses 
position effect variegation in Drosophila, enhances the phenotype of Polycomb 
mutation (Larsson et al., 1996) and is embryonically lethal (Larsson and Rasmuson-
Lestander, 1998).  In other words, SU(Z)5 regulates chromatin structure through 
production of SAM, which is necessary for the activity of histone and DNA 
methyltransferases. It would be interesting to see whether SU(Z)5 directly interacts 
with SU(VAR)3-9 as a regulator of heterochromatin formation.  
 
Higher concentrations of H3 molecules had an inhibitory effect on SU(VAR)3-9, 
which was also shown for SUV39H1 (Chin et al., 2006). Several attempts were made 
to determine the Km of SU(VAR)3-9 for histone H3 molecules without success. The 
double reciprocal plots showed a nonlinear relationship between 1/Velocity and 1/H3 
that became nearly vertical at high concentrations. The inhibitory effect of H3 
observed was above 2.5 μM, which was higher than the values for SUV39H1 (0.55 
μM) (Chin et al., 2006). This might be due to the much higher catalytic activity of 
SU(VAR)3-9. Methylation of H3 in a mixture of all four histones turned out to be 
very efficient (more than 85% methylation). Perhaps the histone octamer would be a 
better substrate to determine the Km for H3.  
 
5.1.3 SU(VAR)3-9 requires the N-terminus for its full enzymatic 
activity 
 
Interestingly, deletion of the N-terminal portion of SU(VAR)3-9 results in a > 90% 
loss of activity. A major finding was that the N-terminus allows the formation of 
homodimers that are necessary for full activity of SU(VAR)3-9 in vitro. This was 
observed by a concentration-dependent increase in specific methylation activity 
expressed as the number of SAM molecules converted per molecule of enzyme. In 
addition, SU(VAR)3-9 migrated with a molecular weight predicted for a dimer on gel 
filtration columns and density gradients. Crystallization of SET domain proteins such 
as Schitzosaccharomyces pombe Clr4, human SET7/9 and Neurospora crassa DIM-5 
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revealed they exist as monomers in vitro (Min et al., 2002; Wilson et al., 2002; Xiao 
et al., 2003; Zhang et al., 2002). However, structural analysis of a viral H3K27 
HMTase showed a butterfly-shaped head to head symmetric dimer (Manzur et al., 
2003). In addition, pea Rubisco LSMT SET domain methyltransferase has been 
shown to form trimers under crystallization conditions through domain swapping 
(Trievel et al., 2002). The mammalian HMTase G9a heterodimerise with GLP (G9a 
like protein) of which it shares share 63% sequence similarity (Ogawa et al., 2002; 
Tachibana et al., 2005). G9a-GLP heterodimerise to exert their enzymatic activity in 
vivo (Ogawa et al., 2002; Tachibana et al., 2005). Hence, dimerisation of HMTases 
may regulate the activity in vivo through by modulating the levels of catalytic activity. 
The dimerisation motifs were mapped by GST pull down to two regions within the N-
terminus of SU(VAR)3-9. More precisely, amino acids 1-152 and 152-213 can 
interact intra- or intermolecularly. This suggest a formation of a dimer by domain 
swapping (Liu and Eisenberg, 2002). 3D domain swapping is a mechanism for two or 
more proteins to create bonds through the exchange of their identical domains (Liu 
and Eisenberg, 2002) as has been observed for the LSMT trimer (Trievel et al., 2002) 
and other proteins. RNAse A, for example forms dimers in vivo (Park and Raines, 
2000), formed by domain swapping and thereby display higher enzymatic activity on 
double-strand RNA than the monomer in vitro (Gotte et al., 1999). Perhaps by domain 
swapping SU(VAR)3-9 displays higher activity because one SET domain can “hand 
over” the monomethylated H3K9 tail to the other SET domain. Supporting this idea is 
the result that the full-length SU(VAR)3-9 has 20 times higher catalytic capacity than 
the N-terminal truncated protein. High concentration of protein favors 3D domain 
swapping and oligomers may form (Liu and Eisenberg, 2002).  
 
Although in vitro under these conditions, SU(VAR)3-9 only dimerises, it can not be 
excluded that in vivo it can oligomerise.  It is well accepted that SU(VAR)3-9 has a 
dosage-dependent effect on PEV (Locke et al., 1988; Wustmann et al., 1989). In 
analogy to SU(VAR)3-9, the over expression of SUV39H1 in mammalian cells 
results in accumulation and formation of nuclear bodies (Firestein et al., 2000). The 
fact that the N-terminus is responsible for dimerisation of SU(VAR)3-9 therefore may 
indicate a role for this domain in the dosage-dependent effect on PEV. 
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Further deletion from the N-terminus including the chromo domain of SU(VAR)3-9 
results in a catalytically inactive protein. Following this observation, Chin and 
coworkers showed that the deletion of the chromo domain of SUV39H1 has the same 
effect on activity (Chin et al., 2006). The chromo domain of HP1 binds H3K9Me 
peptides (Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs et al., 
2001; Lachner et al., 2001; Nielsen et al., 2002). Two point mutations within the 
chromo domain of SUV39H1 that are conserved among most chromo domain proteins 
also resulted in loss of enzymatic activity (Chin et al., 2006). However, the work done 
in this thesis showed that full-length SU(VAR)3-9 did not bind preferentially to 
H3K9Me chromatin in vitro (Figure 4.44). Actually the N-terminal truncation Δ213 
which carries the chromo domain intact, bound very poorly to unmodified and 
H3K9Me chromatin. The in vivo localization of human SUV39H1 depends on the N-
terminus and chromo domain. This was shown in mammalian cells where a 
transfected truncated SUV39H1 protein consisting of only the N-terminus and the 
chromo domain bound efficiently to heterochromatin (Melcher et al., 2000). Whether 
the chromo domain binds H3K9Me, or is necessary for correct folding of SU(VAR)3-
9 and thereby modulating the enzymatic activity needs to be further elucidated. 
 
5.1.4 Inhibitors of SU(VAR)3-9 
 
Inhibitors of histone deacetylases (HDACs) and DNA methyltransferases are used for 
cancer drug therapy (for recent review, see (Santos-Rosa and Caldas, 2005)). 
However, histone methylation can also be linked to cancer (Santos-Rosa and Caldas, 
2005). The SET1 family protein MLL is named after its involvement in leukemia: 
mixed lineage leukemia (Hess, 2004). Most of the chromosomal rearrangements 
involve the N-terminal part of MLL (Hess, 2004), which does not contain the SET 
domain, but it is suggested that its HMTase activity may also play a role. 
Furthermore, Polycomb repressive complex 2 (PRC2) HMTase EZH2 is highly 
expressed in metastatic prostate cancer, lymphomas and breast cancer (Kleer et al., 
2003; Varambally et al., 2002). It has been proposed that the PRC2 complex is central 
to proliferation control acting downstream of the pRB-E2F pathway and therefore 
misexpression of EZH2 seems likely to contribute to cancer (Bracken et al., 2003). In 
addition the H3K9 HMTase RIZ1 has been shown to be a tumour suppressor (Du et 
al., 2001; Kim et al., 2003). HMTases utilizes S-Adenosyl methionine with                
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S-Adenosyl homocysteine (SAH) as the end product formed after methylation. It was 
observed that H3K9 and not H3K4 methylation in U2OS cells were sensitive to 
higher level of SAH (Kim et al., 2003). The authors showed that in vitro the HMTase 
activity RIZ1 was 100% inhibited with 5 μM SAH (Kim et al., 2003).  However, 
SU(VAR)3-9 was not that sensitive to SAH  with 50% inhibition (IC50) at 40 μM. 
Adenosylornithine (AO), is another strong competitive inhibitor of methyltransferases 
that form 5-methylcytosine or N6-methyl adenosine on DNA and RNA (Barbes et al., 
1990). However, AO had an even weaker inhibitory effect on SU(VAR)3-9 than SAH 
with an IC50 of 100 μM.  
 
The finding of specific inhibitor of a histone methyltransferase such as SU(VAR)3-9 
may increase our understanding on transcriptional regulation and disease control.  
Therefore a screen was performed for specific inhibitors of SU(VAR)3-9 by D. 
Greiner  in our lab (Greiner et al., 2005). One of the strongest specific inhibitors 
identified was a mycotoxin, called chaetocin. Chaetocin inhibited SU(VAR)3-9 with 
an apparent IC50 of 0.6 μM but also had a strong inhibitory effect on other K9 histone 
methyltransferases such as SUV39H1, G9a and DIM5 (Greiner et al., 2005). 
Chaetocin was shown to be a competitive inhibitor of SAM (Greiner et al., 2005) as 
has been shown for SAH for mG9a (Patnaik et al., 2004) and for SUV39H1 (Chin et 
al., 2006). When testing the effect of different concentration of chaetocin on 
SU(VAR)3-9 methylation over time,  an inhibition by chaetocin could be observed 
after 2.5 minutes (1.5-4.5 μM). Chaetocin at these concentrations blocks the 
SU(VAR)3-9 active site and thereby the binding of SAM for enzymatic activity. On 
the other hand chaetocin did not prevent binding of SU(VAR)3-9 to chromatin. The 
effect on K9 methylation was also observed in Drosophila SL2 cells although 
chaetocin at a concentration of 0.5 μM caused growth retardation of 24-48 hours 
(Greiner et al., 2005). Synthesis of chaetocin derivatives with less toxicity may have 
experimental and therapeutic applications in the future. 
 
5.1.5 SU(VAR)3-9 monoclonal antibodies 
 
Two monoclonal antibodies against SU(VAR)3-9 were developed by E. Kremmer. 
They antibodies recognized recombinant SU(VAR)3-9 and the epitopes were mapped 
to a region between the chromo and preSET domain (amino acids 285 -492) for clone 
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6C9 and to the SET domain for clone 3D9. Both antibodies were working in 
immunoprecipitation with in vitro translated SU(VAR)3-9. As described above, the 
SET domain is very conserved. Therefore, as expected the 3D9 antibody recognized 
many more bands than the 6C9 antibody in a western blot of nuclear extract from 0-
12 hour embryos. The 6C9 antibody recognized only two bands corresponding to the 
size of endogenous SU(VAR)3-9,  but it was not very sensitive. In order to confirm 
the specificity of the 3D9 antibody, proteins were extracted from Drosophila 
Schneider cells treated with RNA interference against SU(VAR)3-9 and from 
embryos of SU(VAR)3-906 null flies (Schotta et al., 2002).  However, even if the 3D9 
antibody recognized recombinant SU(VAR)3-9 there was no specific recognition of 
endogenous SU(VAR)3-9 on western blots derived from such extracts. It was not 
clear whether other SET domain proteins detected by 3D9 antibody masked the 
SU(VAR)3-9 signal or if 3D9 was less sensitive toward endogenous SU(VAR)3-9. 
These antibodies detects recombinant SU(VAR)3-9 well and can therefore be used for 
this. E. Kremmer has very good experience with GST-tagged proteins, and therefore it 
would be an idea to generate monoclonal antibodies against the N-terminus of 
SU(VAR)3-9 (GST 152-213) since this region is not so conserved. 
 
5.2 dG9a 
 
In mammalian cells, G9a was found to be an euchromatic H3K9 methyltransferase 
(Esteve et al., 2005; Peters et al., 2003; Rice et al., 2003). This work presents the 
characterization of the enzymatic activity of Drosophila G9a (Stabell et al., 2006).  
dG9a adds three methylgroups toward H3K9 and K27, with a preference for K9.  
Surprisingly, dG9a also methylated H4 with specificity for K8, K12 or K16. While 
this work was carried out, another group showed that in vitro dG9a is a H3 
methyltransferase and suppresses PEV in vivo (Mis et al., 2006).  
 
5.2.1 Substrate specificity of dG9a in vitro 
 
Mis and colleagues performed in vitro methylation assays with a truncated GST-dG9a 
(amino acids 1261 – 1637). They observed methylation of H3 and an H3 peptide 
(amino acids 1-20) (Mis et al., 2006). Here we show the in vitro HMTase activity of 
N-terminal Flag-tagged truncated version of dG9a (amino acids 789 – 1637) 
expressed in Sf9 cells using the baculovirus system. In contrast to Mis et al. (2006), 
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Flag-tagged dG9a methylates recombinant and native H3 and H4 molecules. A 
mutation within the conserved SET domain (H1536K) of dG9a confirms the 
specificity toward H3 and H4. However, it cannot be excluded that the H3K27 and 
H4 activity may be due to the deletion of the N-terminus of dG9a. Although, dG9a 
immunoprecipitated from (0-12 h) embryos methylated both histone H3 and H4 
supporting the in vitro data. Furthermore, recombinant dG9a had no detectable 
activity toward nucleosomal arrays. The activity on nucleosomal arrays using 
immunoprecipitated dG9a was only toward histone H4. This argues for a nucleosomal 
H4 methyltransferase co-purifying with dG9a or that specific interaction proteins 
changes the specificity of dG9a to H4 in a nucleosomal environment. 
 
The analysis of dG9a distribution on polytene chromosomes from salivary glands of 
third instar larvae reveals that dG9a localize to euchromatic regions with no staining 
in the chromocenter (Stabell et al., 2006). Therefore, it may be concluded that dG9a 
methylates H3 and H4 within euchromatin.  
 
Mouse G9a has been shown to methylate H3K9 and K27 (Tachibana et al., 2001; 
Tachibana et al., 2002). The specific activity of dG9a on H3 is mapped to K9 and K27 
using H3 molecules carrying a lysine to alanine replacement at position 9 and 27 and 
subsequent MALDI-TOF analysis. Based on these in vitro observations, it can be 
concluded that dG9a specifically methylates K9 and K27 on H3 with a preference 
toward K9. In addition, dG9a can add three methyl groups. Although dG9a can 
trimethylate, the majority is mono- and dimethylation. From the MALDI-TOF 
analysis 72% of total methylated K9 is mono- and dimethylated. This was not the case 
for a processive enzyme like DIM-5 where the majority of H3 peptides were 
trimethylated after 30 minutes (Zhang et al., 2003b). In vitro mammalian G9a was 
also able to transfer three methyl groups in a processive manner, but the turnover rate 
was seven times slower on a H3K9 dimethyl substrate (Patnaik et al., 2004). In mG9a 
knockout embryonic stem cells, euchromatic H3K9 mono- and dimethylation was 
severely reduced (Peters et al., 2003; Rice et al., 2003). Hence, dG9a may also be 
responsible for mono- and dimethylation of K9 within euchromatic regions in 
Drosophila. Methylation of H3K9 and K27 is mainly correlated with silencing 
(Martin and Zhang, 2005), suggesting an involvement of dG9a in transcriptional 
repression in vivo. This needs to be further elucidated. 
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In contrast to mG9a (Tachibana et al., 2001), dG9a also methylates histone H4. So far 
the only lysine residue shown to be methylated in H4 is lysine 20 and the HMTases 
identified with this activity were hPR-Set7/dSET8 (Fang et al., 2002; Rice et al., 
2002), hNSD1/dAsh1 (Beisel et al., 2002; Rayasam et al., 2003) and 
human/Drosophila Suv4-20 (Schotta et al., 2004). It is surprising that dG9a can 
methylate H4 carrying a mutation of lysine 20 to alanine. The MALDI-TOF analysis 
confirms that dG9a trimethylates a lysine residue within amino acid 4 to 17 of the H4 
tail. When using H4 N-terminal deletion mutants in the methylation assay with dG9a, 
dG9a methylates H4 in which the first five amino acids of the N-terminus are deleted. 
However, the activity is lost when the N-terminal 10 amino acids are deleted. This 
suggests that the substrate is K8, but considering that the minimal substrate specificity 
for mG9a surrounding K9 contains seven amino acids (TARKSTG) (Chin et al., 
2005) the substrate could also be K12 or K16.  These three residues have been shown 
to be acetylated in vivo (Santos-Rosa and Caldas, 2005), and a methylation of any of 
these lysines remains to be identified. A MALDI-TOF approach identified a mass 
shift of a calf H4 peptide (amino acid 11-15) containing K12 (Zhang et al., 2003a) 
indicating this may be the methylation site of dG9a. The specific dG9a-methylation 
site on H4 needs to be further characterized. Generating H4 K8, K12 and K16 point 
mutants and testing in vitro activity of dG9a can give an answer to the specificity. 
When knowing the specific H4 lysine that dG9a methylates, an antibody can be raised 
to test on native Drosophila histones in vitro and existence and possible localization 
of this H4 mark in vivo. 
 
Mouse G9a was also shown to methylate histone H1 (Tachibana et al., 2001).  In this 
study both mouse and Drosophila G9a could methylate the single Drosophila H1 
variant. As the histone H1 family is the most divergent class of the histones (for 
review see (Doenecke et al., 1997)), it remains to be seen if a more conserved lysine 
residue is methylated.  
 
5.2.2 dG9a exists in protein complexes 
 
Mouse G9a has been shown to be part of silencing complexes such as the E2F6 
complex (Ogawa et al., 2002), CtBP1 (Shi et al., 2003) and CDP/cut (Duan et al., 
2005; Nishio and Walsh, 2004). This work shows that Drosophila dG9a is present in 
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complexes of 440-670 kDa. The molecular mass of dG9a is 180 kDa; therefore a 
limited number of proteins could be present in these complexes. In contrast to 
SU(VAR)3-9, E(Z) and other HMTase activities purified from the Biorex 70 250 mM 
fraction (Czermin et al., 2001), the dG9a complexes binds more strongly to the cation 
exchange resin and eluted with 500 mM NaCl. The histone deacetylase RPD3 
(HDAC1), which is also present in the E(Z) complex (Czermin et al., 2002),  was 
found to specifically interact with G9a. In contrast, SUZ12 another component of the 
E(Z) complex does not, indicating that RPD3 interacts with dG9a in the absence of 
SUZ12.  Mammalian G9a was found to be part of a repression complex with HDAC1 
and Gfi1 (Growth independent factor 1) (Duan et al., 2005). However, mG9a could 
repress a reporter gene in Hela cells without requiring HDAC activity (Tachibana et 
al., 2002). This suggests that Rpd3 may contribute to the repression of dG9a at 
euchromatic target genes in Drosophila.  
 
Another protein that was co-precipitating with dG9a was the ATPase ISWI, which is 
the catalytic subunit of at least three chromatin remodeling complexes in Drosophila: 
ACF, CHRAC and NURF (for review see (Bouazoune and Brehm, 2006)). ISWI was 
also co-eluting with dG9a on a gelfiltration column. Interestingly, both dG9a and 
NURF301 are involved in the ecdysone regulatory pathway (Badenhorst et al., 2005; 
Stabell et al., 2006). Ecdysone (20-hydroxyecdysone) is a steroid hormone that is 
synthesized from dietary cholesterol, and pulses of ecdysone influence Drosophila 
metamorphosis and differentiation through its life-cycle (Figure 5.2) (Thummel, 
1995).  
Figure 5.2 A theoretical scheme of the ecdysone biosynthesis and the function in Drosophila life-
cycle. NR; ecdysone nuclear receptor, NURF, nucleosome remodeling factor and ISWI, imitation 
switch.  
 
Binding of the nuclear ecdysone receptor to the ecdysone hormone results in 
activation of ecdysone-responsive genes (Thummel, 1995). The NURF complex was 
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shown to be a coactivator of the ecdysone receptor steroid hormone-dependent 
transcription, and the interaction with the ecdysone receptor was dependent on 
ecdysone (Badenhorst et al., 2005). On the contrary, the dG9a RNAi mutants are not 
rescued by feeding ecdysone arguing for a downstream effect of the ecdysone 
biosynthesis and metabolism (Stabell et al., 2006). Another element supporting the 
involvement in ecdysone induced transcription of dG9a is an interaction with 40S 
Ribosomal protein which in immunostainings and in situ hybridization was present at 
sites of ecdysone-induced transcription in the nucleus (Brogna et al., 2002). 
Mammalian G9a was shown to be a coactivator of nuclear androgen receptor target 
genes through cooperation with other coactivators (Lee et al., 2006). Another study 
showed that mammalian SHP (small heterodimer partner), an atypical orphan nuclear 
receptor interacts with high affinity with G9a and HDAC1 (Boulias and Talianidis, 
2004). Repression of certain but not other SHP regulated genes were dependent on 
deacetylation and H3K9 methylation (Boulias et al., 2005; Boulias and Talianidis, 
2004). Whether dG9a interacts with the ecdysone receptor directly or possibly 
through ISWI and NURF, and whether dG9a act as a co-activator or repressor needs 
to be further investigated.  
 
dG9a was also shown to be a suppressor of PEV (Mis et al., 2006). Mis and co-
workers studied a hypomorphic mutation and not a null mutation of dG9a (dG9a13414/ 
dG9a13414) and suggested an overlapping function with SU(VAR)3-9 and may be 
member of the same silencing complexes in heterochromatin (Mis et al., 2006). In 
contrast it was shown that dG9a co-localize to euchromatin (Stabell et al., 2006) and 
SU(VAR)3-9 was not identified as an interacting protein in dG9a 
immunoprecipitation. 
 
5.3 HP1  
 
In the present study, the mechanism for HP1a binding to H3K9Me chromatin has 
been investigated. Specific interaction with another factor through the chromo shadow 
domain stabilizes the binding of the chromo domain with H3K9Me within 
nucleosomal arrays. Since the factors that enhance HP1a binding to H3K9Me 
chromatin should specifically interact with HP1a, new interaction partners were 
identified. The two HP1 paralogs HP1a and HP1c binds to distinct chromatin 
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structures (Smothers and Henikoff, 2001) and this is mirrored in their interaction 
partners. 
 
5.3.1 HP1a binding to H3K9Me chromatin is stabilized by interacting 
factors 
 
HP1a is predominantly associated with centromeric heterochromatin in Drosophila 
(Smothers and Henikoff, 2001), but it is also found at many sites in euchromatin and 
telomeres (de Wit et al., 2005; Fanti et al., 2003; Fanti et al., 1998; Greil et al., 2003; 
James et al., 1989). The HP1 chromo domain binds H3 peptides methylated at lysine 
9 (Bannister et al., 2001; Jacobs and Khorasanizadeh, 2002; Jacobs et al., 2001; 
Lachner et al., 2001; Nielsen et al., 2002) but little is known how HP1 binds to this 
mark within chromatin. 
 
This work shows in vitro reconstituted HP1a containing chromatin fibers containing 
recombinant histones with H3 highly methylated at K9 and two known recombinant 
SU(VAR)s. Both ACF and SU(VAR)3-9 bind chromatin irrespective of its 
methylation state and interact with the chromo shadow domain of HP1a. HP1a did not 
bind efficiently to H3K9Me chromatin alone, but the presence of interacting partners 
anchor HP1 stably to chromatin. 
 
Analysis of recombinant mutant HP1a proteins carrying either a mutation in the 
chromo domain or in the chromo shadow domain, showed that both are necessary for 
HP1a binding to chromatin. The fact that the chromo shadow domain mutant fails to 
bind H3K9Me suggests that HP1a is assisted by a factor within the Drosophila S-150 
chromatin assembly extract. This supports the observation that HP1 molecules 
carrying mutations within the chromo domain and the chromo shadow domain have 
weaker affinity to heterochromatin in vivo (Thiru et al., 2004). Detailed studies of 
single point mutations within HP1β showed that localization and stable association 
with heterochromatin of HP1β needs to form a dimer and interact with other PxVxL 
motif proteins (Thiru et al., 2004). Two candidate factors were tested for their ability 
to stabilize HP1a binding to H3K9 chromatin both having a SU(VAR) phenotype 
Drosophila melanogaster (Fyodorov et al., 2004; Tschiersch et al., 1994).  
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Drosophila ACF was purified from embryos and shown to be a major chromatin 
assembly factor (Fyodorov et al., 2004; Ito et al., 1997; Ito et al., 1999). Acf1-/- flies 
had lower nucleosomal periodicity, supporting a role in assembly of chromatin 
(Fyodorov et al., 2004). Immunostainings of mouse cells revealed that ACF1 co-
localize with HP1β (Collins et al., 2002). Recombinant Drosophila ACF1 interacts 
with the chromo shadow domain of HP1a through a region spanning the DDT motif. 
This region is also interacting with ISWI (Eberharter et al., 2004). The DDT motif 
was identified through homology-based sequence analyses in several PHD finger 
transcription factors and BAZ family chromatin remodelers (Doerks et al., 2001). 
Interaction of HP1a with ACF increased the affinity for HP1a to H3K9Me chromatin 
in an ATP independent manner. It remains to be solved where ACF targets HP1a in 
vivo.  
 
SU(VAR)3-9 methylates H3 at K9 (Schotta et al., 2002) thereby generating a 
potential binding site for HP1a within heterochromatin. SU(VAR)3-9 interacts with 
HP1a via the N-terminus and this interaction has been suggested to serve as a part of 
an autoregulatory loop, which helps maintaining the methylated state of 
heterochromatin (Schotta et al., 2002). The interaction is mapped to the chromo 
shadow domain of HP1a and the N-terminus of SU(VAR)3-9. As observed for ACF, 
SU(VAR)3-9 facilitated the binding of HP1a to H3K9Me chromatin independent of 
its methyltransferase activity. However, binding of HP1a to H3K9Me chromatin 
weakened when the interaction between SU(VAR)3-9 and HP1a was impaired either 
due to a mutation in HP1a or in SU(VAR)3-9. This additional function of SU(VAR)3-
9 in stabilizing HP1a binding could contribute to explain the strong dose dependent 
effect of SU(VAR)3-9 gene duplication which is rather unusual for an enzymatic 
activity.  
 
The weak but specific binding of HP1a to H3K9Me peptide with a dissociation 
constant in the micro molar (µM) range in vitro (Jacobs and Khorasanizadeh, 2002; 
Nielsen et al., 2002) is so low that the physiological relevance in vivo can be 
questioned. In agreement, the binding of HP1a to H3K9Me chromatin was weak and 
only interaction with additional factors can push the affinity toward H3K9Me 
chromatin into a more physiological range. The dynamic nature of HP1 in the nuclei 
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of eukaryotic cells (Cheutin et al., 2003; Festenstein et al., 2003) also indicates that 
the interaction of HP1 with chromatin is not very stable. 
 
Targeting of Drosophila HP1s in vivo is dependent on the chromo shadow domain (or 
hinge for HP1a) (Smothers and Henikoff, 2001). When comparing the chromo 
shadow domain of HP1a with the other paralogs (Figure 2.9), the tryptophan 200 
(W200) important for interaction with SU(VAR)3-9 and ACF1 can only be found in 
HP1b. Indeed HP1b localizes both to heterochromatin and euchromatin (Smothers 
and Henikoff, 2001). HP1c does not interact with ACF1 and SU(VAR)3-9, which 
suggests that the euchromatic localization is due to binding of distinct factors than the 
interaction partners of HP1a. However, the hinge domain of HP1a can also target it to 
heterochromatin (Smothers and Henikoff, 2001). The chromo shadow domains of 
mammalian HP1s are nearly identical and they still feature a spatially distinct 
localization (Minc et al., 1999; Minc et al., 2000). However, the hinge domain among 
mammalian paralogs differs in their length and composition and might function to 
determine their localization in vivo. Indeed, the hinge domain of the mouse HP1α was 
reported to bind nuclear RNA in vitro (Muchardt et al., 2002) and in mouse and 
Xenopus it has also been reported to bind the linker histone H1 (Meehan et al., 2003; 
Nielsen et al., 2001). This work shows that both the chromo domain and the chromo 
shadow domain are necessary to stabilize HP1a binding to H3K9Me chromatin. A 
model for targeting of HP1 proteins to H3K9Me chromatin is that a bimodal 
interaction of the chromo domain and either the chromo shadow or hinge domain is 
necessary for binding and stabilization of HP1. Albeit the evident co-localization of 
SU(VAR)3-9 and HP1a at centromeric heterochromatin, HP1a was shown to bind 
distinct chromatin regions independently of SU(VAR)3-9 (Greil et al., 2003) 
supporting the idea that different interaction partners of HP1a contribute to its specific 
localization in vivo.  
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Figure 5.3 HP1a binding to chromatin is stabilized by auxiliary factors as for example 
SU(VAR)3-9 and ACF. SU(VAR)3-9 methylates H3K9 and both SU(VAR)3-9 and ACF contribute to 
stable anchoring of HP1a to  H3K9Me chromatin. 
 
A recent study showed that a truncated version of HP1α/β lacking the chromo domain 
and fused to a lac repressor is sufficient for heterochromatinization of the region 
surrounding a lac operator-containing gene including H3K9 methylation and 
endogenous HP1 (Brink et al., 2006). This argues for a targeting by the chromo 
shadow and the hinge region. Knowing that HP1 dimerises it might be that the 
truncated HP1 brings endogenous HP1 to the lac operator gene and the chromo 
domain of the endogenous HP1 binds H3K9Me. Another study could show that 
mutation of a single serine within the hinge domain of HP1a that mimic 
phosphorylation resulted in stronger affinity of the protein for H3K9Me and enhanced 
homodimerization (Badugu et al., 2005). This is an interesting observation that post-
translational modifications of the hinge domain can impact both the chromo and the 
chromo shadow domain.   
 
Several studies have shown that H3 serine 10 phosphorylation has a negative (Fischle 
et al., 2005; Hirota et al., 2005; Zhang et al., 2006) or positive (Mateescu et al., 2004) 
effect on HP1 binding to chromatin. Using this recombinant system and introducing a 
S10 phosphorylation with the Aurora Kinase to the H3K9Me chromatin could give a 
detailed analysis of a combinatorial histone code effect on HP1 binding. 
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It will be interesting to see whether the different targeting factors have distinctive 
contribution to the localization of HP1 at different stages of the cell cycle, during 
different stages of development or in different cell types. This in vitro system can be 
used to identify new interaction partners anchoring HP1 to methylated chromatin. 
Another interesting feature that needs to be further investigated is the effect of post-
translational modifications of HP1 and H3 that affects HP1 interaction with H3K9Me 
chromatin. However, this in vitro system can also be used to study the binding to 
chromatin by other chromatin factors. The limitation of such a system is the 
efficiency of the histone-modifying enzyme that sets the mark of interest. As an 
alternative, native histones can be used since MALDI-TOF analysis allows detailed 
information of the modifications present on the different histones. 
 
5.3.2 HP1a and HP1c have distinct interaction partners 
 
The different HP1 homologues interact with a myriad of interaction partners (See 
table 2.7). To identify new interaction partners of HP1a and c in stable Drosophila 
SL2 cell lines were generated expressing N-terminal Flag tagged HP1a/c. The 
proteins identified in this work are listed in table 5.1. 
 
Table 5.1 Drosophila HP1 interaction partners 
Protein HP1 variant Methodology 
HP1 
domain 
Nucleosome Methylated K9 HP1a rPD CD/CSD 
ATR-X HP1a exIP  nd 
Nipped-B HP1a exIP  nd 
Dis3 HP1a exIP  nd 
ACF1 HP1a rPD, transPD, exIP CSD 
woc HP1c exIP  nd 
CG8092 HP1c exIP  nd 
CD, chromo domain; CSD, chromo shadow domain; exIP, co-immunoprecipitation using extract; 
exPD, pull-down assay using in vitro translated extracts; rPD, pull-down assay using recombinant 
proteins; transPD, pull-down assay using in vitro translated protein. 
 
Supporting the finding that ACF stabilizes binding of HP1a to H3K9Me chromatin, 
ACF1 was found to interact weakly with Flag-HP1a. SU(VAR)3-9 interacted 
specifically with HP1a in SL2 cells. The weak interaction of ACF1 with Flag-HP1a 
may reflect the number of binding sites where HP1a is targeted by ACF in vivo.  
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In contrast SU(VAR)3-9 and HP1a are both found at high concentrations on the 
chromocenter of Drosophila chromosomes (Schotta et al., 2002). 
 
HP1 has also been shown to play a role in maintaining the nuclear structure. It was 
previously shown that HP1a is required for correct chromosome segregation (Kellum 
and Alberts, 1995). In Schitzosaccharomyces Pombe, dis3 has been implicated in 
sister chromatid separation (Ohkura et al., 1988) whereas Drosophila Nipped-B is 
required for sister chromatid cohesion (Rollins et al., 1999). The novel finding of 
Nipped-B and Dis3 interacting with HP1a in Drosophila, provide a biochemical link 
HP1a to chromatin cohesion. This is supported by the finding that Swi6 is required for 
efficient cohesion in Schitzosaccharomyces Pombe (Bernard et al., 2001; Ekwall et 
al., 1995; Nonaka et al., 2002) and that human Nipped-B-Like protein (NIPBL) 
interacts with HP1α (Lechner et al., 2005). How HP1a proteins participate in sister 
chromatid cohesion remains to be elucidated. However the direct interaction of Swi6 
with the cohesin complex in yeast has been suggested to be responsible for the high 
concentration of cohesin complex around the centromere and retention of cohesin at 
metaphase (Dorsett, 2006). Perhaps Nipped-B links HP1 to the cohesion complex in 
Drosophila. 
 
The interaction with the SNF2 ATPase ATR-X, shown to be involved in mental 
retardation human (Inlow and Restifo, 2004) is also supported by interaction and co-
localization of mammalian HP1α and HP1β (Le Douarin et al., 1996; McDowell et 
al., 1999).  In C. elegans the ATR-X homolog XNP-1 has been found to act with HP1 
during development (Cardoso et al., 2005). Therefore it would be of interest to see if 
the interaction of HP1 with ATR-X affects developmental gene expression in 
Drosophila. 
 
Flag-HP1c had different interaction partners than HP1a. To our knowledge there have 
not been any Drosophila HP1c interaction proteins identified previously. Two distinct 
proteins, novel protein interactors were identified. Without children (woc) was shown 
to be a transcription factor involved in ecdysone synthesis (Wismar et al., 2000), but 
has also recently been implicated in prevention of telomeric fusions (Raffa et al., 
2005) and CG8092 is a novel zink finger protein. The zink finger protein woc is 
believed to activate expression of a 7,8- dehydrogenase, which is important in the first 
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step of ecdysteriodogenesis (Warren et al., 2001; Wismar et al., 2000). A more potent 
function of a HP1c and woc interaction is in telomeric protection, since woc functions 
in telomeric capping independent of HP1a (Raffa et al., 2005). 
 
5.4 Concluding remarks 
 
Some evidences for a histone code has been unraveled (for review, see (Nightingale et 
al., 2006)). New histone modifications are being discovered and identification of 
enzyme families that add or remove these marks is expanding. The data presented in 
this thesis adds a new Drosophila HMTase to this list and discusses a new potential 
methylation site within histone H4. Except for methylating H4, dG9a behaves very 
similar to the mammalian G9a (Stabell et al., 2006; Tachibana et al., 2001; Tachibana 
et al., 2002). Furthermore, the detailed in vitro characterization of Drosophila 
SU(VAR)3-9 may provide a better understanding for the mechanism of 
heterochromatin formation in vivo. 
 
Specific histone modifications, in particular methylation marks, are recognized by a 
growing number of proteins (Martin and Zhang, 2005). The best studied interaction is 
between H3 lysine 9 methylation and HP1 (Bannister et al., 2001; Cao et al., 2002; 
Jacobs and Khorasanizadeh, 2002; Jacobs et al., 2001; Lachner et al., 2001; Min et al., 
2003; Nielsen et al., 2002). The key finding in this work is that HP1 is depending on 
multiple binding sites that contribute to a stable binding of H3K9Me chromatin. This 
mechanism may be similar for other proteins that recognize histone modifications, 
adding another level to the histone code. It would be intriguing to examine whether 
local concentration of specific interaction proteins affect targeting of HP1 to 
chromatin sites in vivo. 
 
Histone marks are shown to have functional readouts such as the silencing or 
activation of transcription and DNA repair. For example H3K9 and H4K20 
trimethylation has been described as characteristic of transcriptionally silent 
chromatin (Peters et al., 2003; Rice et al., 2003; Schotta et al., 2004). However, the 
combinatorial aspect of modification marks and effect of a histone code on 
transcriptional activation and silencing is not fully understood, in addition the 
heritability of the histone code remains to be demonstrated.  
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7.2 Abbreviations 
 
aa   Amino acid 
ACF   ATP-utilizing chromatin assembly and remodeling factor 
ACF1   large subunit of ACF and CHRAC 
AdoHcy    S-Adenosyl homocysteine 
AdoMet    S-Adenosyl methionine  
ALL-1    acute lymphoblastic leukemia 1 
Ash1    absent small or homeotic discs1 
ATP   Adenosine-5'-triphosphate 
BAZ    Bromodomain Adjacent to Zinc finger domain  
bp   Base pairs 
BSA   Bovine serum albumine 
CD   chromo domain 
CERF    CECR2-containing remodeling factor 
CHIP   Chromatin Immunoprecipitation 
CHRAC   Chromatin accessibility complex 
Ci   Curie 
Cpm   counts per minute 
CSD   chromo shadow domain 
C-terminal   Carboxy-terminal 
CtBP   C-terminal binding proteins  
CV   Column volume 
DEAE    Diethylaminoethyl  
DIM-5    Defect In DNA Methylation 5 
DNA   Deoxyribonucleic acid 
DNase I   Deoxyribonucleosidase I 
DNMT 1/ 3a / 3b   DNA methyl transferase 
dNTP   Deoxyribonucleoside triphosphate 
Dot1    disrupter of telomeric silencing  
Dot1L    Dot1 like 
DREX   Drosophila embryo extract 
DTT   Dithiothreitol 
E. coli   Escherichia coli 
EDTA   Ethylenediaminetetraacetic acid 
EGTA    Ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
ESET    SET domain bifurcated 1  
E(Z)    enhancer of zeste 
Ezh2    E(Z) homolog 2 
FA     fluorescence anisotropy 
FCS   Foetal calf serum 
g   gram or relative centrifugal force 
GST   Glutathione-S-transferase 
H1 / H2A / H2B / H3 / H4  histone proteins 
H3K9Me   histone H3 lysine 9 methylation 
HAT   Histone acetyltransferase 
HDAC   Histone deacetylase 
HMTase   histone methyl transferase 
HP1   heterochromatin protein 1 
HRP   Horse radish peroxidase  
h   hour 
Ig   Immunoglobulin 
IGS   Intergenic spacer 
IP   Immunoprecipitation 
ISWI   Imitation of switch 
ITC    isothermal titration calorimetry and 
kDa   Kilo daltons 
M   Molar 
MBD   methyl binding domain 
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min   minute(s) 
MLL    mixed lineage leukemia  
MNase   Micrococcus Nuclease 
MW   Molecular weight 
NoRC   Nucleolar remodeling complex 
NP-40   Nonidet P-40 
NSD1    nuclear receptor binding SET domain protein 1 
N-terminal   Amino-terminal 
NURF    Nucleosome-remodeling factor 
PAA   Polyacrylamide 
PAGE    Polyacrylamide gelelectrophoresis  
PBS   Phosphate-buffered saline 
PCR   Polymerase chain reaction 
PEV   Position effect variegation 
Pol I, II, III   RNA polymerase I, II, III 
pre-rRNA   precursor of ribosomal RNA 
PRMT   protein arginine methyltransferase 
PR-Set7    PR-SET domain containing protein 7 
PTRF   Polymerase I transcript release factor 
rDNA   Ribosomal DNA 
RIZ    retinoblastoma protein-interacting zinc finger 
RNA   Ribonucleic acid 
RNAi   RNA interference 
rpm   Rounds pro minute 
RT   Room temperature 
SDS   Sodium Dodecyl Sulphate  
sec   second 
SET  Suppressor of position effect variegation 3-9, SU(VAR)3-9;          
Enhancer of zeste, E(Z) and Trithorax, Trx 
Set1/2/9    SET domain containing 1, 2 or 9 
SETDB1    SET domain bifurcated 1 
Sf9   Spodoptera frugiperda 9 cells 
Smyd2    SET and MYND 2 
Snf   Sucrose non-fermenter 
Snf2h   Snf2 homolog protein 
SU(VAR)3-9    suppressor of position effect variegation 3-9 
Suv39    SU(VAR)3-9 homolog 
SUZ12   Suppressor of zeste-12  
SWI   Mating type switching 
TAF   TBP-associated factor 
TBE   Tris borate EDTA buffer 
TBP   TATA-binding protein 
Tip5   TTF-I interacting protein 5  
Tris   Tris(hydroxymethyl)-amino-methane 
Trx    trithorax 
TSA   Trichostatin A 
TTF-I   Transcription termination factor for RNA polymerase I  
Tween-20   Polyoxyethylene-sorbitan monolaurate 
UV   Ultraviolet light 
V   Volts 
Vol   Volume(s) 
WICH   WSTF ISWI chromatin remodeling complex 
WSTF   Williams syndrome transcription factor  
WT   wild type 
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The N-Terminus of Drosophila SU(VAR)3-9 Mediates Dimerization and Regulates
Its Methyltransferase Activity†
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ABSTRACT: In most eukaryotes, the histone methyltransferase SU(VAR)3-9 and its orthologues play a
major role in the function of centromeric heterochromatin. Although the methyltransferase domain is
required for the formation of a fully functional centromere, mutations within other regions of the gene
such as the N-terminus also have a strong impact on its in vivo function. To analyze the contribution of
the N-terminus on the methyltransferase activity, we have expressed the full-length Drosophila
SU(VAR)3-9 (dSU(VAR)3-9) together with various N-terminal deletions in Escherichia coli and analyzed
the structural and enzymatic properties of the purified recombinant enzymes. Full-length dSU(VAR)3-9
specifically methylates lysine 9 within histone H3 on peptides, on intact histones, and, to a lesser extent,
on nucleosomes. A detailed analysis of the reaction products shows that dSU(VAR)3-9 adds two methyl
groups to an unmethylated H3 tail peptide in a nonprocessive manner. The full-length enzyme elutes with
an apparent molecular weight of 160 kDa from a gel filtration column, which indicates the formation of
a dimer. This property is dependent on an intact N-terminus. In contrast to the full-length enzymes, proteins
lacking the N-terminus fail to dimerize, and show a 10-fold lower specific activity and a linear dependence
of methyltransferase activity on enzyme concentration. A N-terminal peptide containing amino acids 1-152
of dSU(VAR)3-9 is sufficient to mediate this interaction in vitro. The dimerization of dSU(VAR)3-9
and the subsequent increase of its methyltransferase activity provide a starting point to understand the
molecular details of the formation of heterochromatic structures in vivo.
Centromeres are conserved structures of eukaryotic chro-
mosomes, which ensure their proper segregation during
mitotic divisions (1, 2). Most centromers are formed by
association of the centromeric DNA with specific proteins
such as CENP-A, -B, and -C (3, 4) and have been shown to
form clusters within interphase chromatin (5, 6). Although
centromeres as well as pericentromeric regions are typically
rich in repetitive DNA, the main determinant of centromers
seems to be of an epigenetic nature as they can also form
ectopically within euchromatic arms (7, 8). Centromeric
regions of chromosomes are generally transcriptionally
quiescent, a property that can “spread” into neighboring
regions (2, 9). The variable transcriptional activity of
normally active genes, after their translocation close to
heterochromatin, has been termed position effect variegation
(PEV)1 (10, 11) (9).
Histones within centromeric regions are usually hypo-
acteylated (12, 13) and methylated at lysine 9 within the H3
tail (14). The enzyme that is critical for this modification is
the histone methyltransferase SU(VAR)3-9 (15). Drosophila
SU(VAR)3-9 (dSU(VAR)3-9) has been initially identified
in a genetic screen for suppressors of PEV (for a review see
ref 16). SU(VAR)3-9 or its orthologue CLR4 are required
for heterochromatin-mediated gene silencing in Drosophila
and Schizosaccharomyces pombe (17). Mouse SUV39 en-
zyme is important to maintain genome stability (18).
Furthermore, it acts as a transcriptional repressor in transient
as well as in stable transfection experiments in tissue culture
cells (19, 20).
Drosophila SU(VAR)3-9 belongs to a large class of
proteins containing a SET domain. The SET domain confers
methyltransferase activity and is crucial for the in vivo
function of most SET-containing proteins. Although the SET
domain is relatively well conserved, SET-methyltransferases
show a remarkable structural and functional variability. SET
domain proteins can exist as monomers (21-25) or dimers
(26). In addition, some need auxiliary factors (27-30) or
require nucleic acids for full activity (31, 32).
In addition to the well-characterized SET domain,
dSU(VAR)3-9 contains a chromo domain (17, 19, 33), a
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EGTA, ethylene glycol-bis(2-aminoethyl ether)-N,N,N′,N′-tetraacetic
acid; EDTA, ethylenediaminetetraacetic acid; DTT, DL-dithiothreitol;
MTase, methyltransferase; HMT, histone methyltransferase; ACN,
acetonitrile; TFA, trifluoroacetic acid; MALDI-TOF, matrix assisted
laser desorption ionization-time-of-flight mass spectrometry; SAM,
S-adenosyl methionine; SAH, S-adenosyl homocystein.
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GTPase domain that is derived from a common exon used
by dSU(VAR)3-9 and the eukaryotic translation initiation
factor 2 and a relatively ill-defined N-terminal domain (15).
The N-terminus is moderately conserved in humans, mice,
and flies and interacts with at least two additional suppressors
of PEV, HP1, and SU(VAR) 3-7 (14, 34). A Structure-
function analysis of the human SUV39H1 indicated that a
deletion of the N-terminus leads to a failure of SUV39 to
bind chromatin in vivo (33). A fragment of SUV39H1
containing just the N-terminus and the chromo domain binds
efficiently to heterochromatin when expressed in tissue
culture cells. This binding is thought to be mediated by HP1
and has been suggested to be a main component in the
maintenance mechanism of histone methylation as the
chromo domain of HP1 binds strongly to a H3 tail, which is
methylated at lysine 9. In the absence of HP1, SU(VAR)3-9
is found at multiple sites along the chromosome arms,
suggesting a role for HP1 in restricting SU(VAR)3-9 to
centromeric heterochromatin. However, the HP1 interacting
region is not sufficient to confer chromatin binding to an
overexpressed fusion protein (33), suggesting an additional
structural component in addition to HP1 binding, which is
important for heterochromatin association. This hypothetical
structural component may well be the conformation of
dSU(VAR)3-9 itself. SUV39H1 forms distinct nuclear
domains when overexpressed in vivo (19), a phenomenon
that has already been described for certain ring finger proteins
which form higher order aggregates in vivo and in vitro (35,
36). In flies, overexpression of dSU(VAR)3-9 or other
suppressors of PEV leads to a strong dosage-dependent
enhancement of PEV independent of the dosage of the other
partners. This strong dosage dependence argues against a
single limiting factor regulating PEV but rather favors a
model in which several factors participate in the assembly
of a specific heterochromatin scaffold (16, 37).
In this report, we show that full-length dSU(VAR)3-9 is
a very active methyltransferase when expressed in bacteria.
It adds two methyl groups to lysine 9 within the H3 tail in
a nonprocessive manner. Moreover, the N-terminus of
dSU(VAR)3-9 mediates an interaction between two
SU(VAR)3-9 molecules, thereby increasing its ability to
methylate H3. The N-terminus of dSU(VAR)3-9 has a
bipartite interaction domain, which allows the formation of
multimers of SU(VAR)3-9 proteins. This interaction be-
tween dSU(VAR)3-9 molecules may contribute to the
clustering of centromers within living cells and the formation
of nuclear substructures in vivo after expressing the N-
terminus of SU(VAR)3-9 alone and may therefore explain
the strong dosage dependence of the dSU(VAR)3-9 medi-
ated enhancement of PEV.
MATERIALS AND METHODS
Cloning of dSU(VAR)3-9. Full-length dSU(VAR)3-9,
deletion mutants, and point mutants were cloned into pET15b
(Novagen) via NdeI and XhoI. The pET15b plasmid adds a
6 his-tag on the N-terminus. All inserts were created by
PCR from a plasmid carrying the dSU(VAR)3-9 cDNA
(kind gift of G. Reuter, Halle, Germany) and verified by
DNA sequencing. GST fusion proteins were cloned by
inserting a PCR generated EcoRI-XhoI fragment into a
pGEX 4T-2 vector (Amersham).
Protein Purification. His-tagged dSU(VAR)3-9 and
dSU(VAR)3-9 mutant polypeptides were expressed in E.
coli BL21(DE3)pLys, and purified with Talon (Clontech)
resin according to the manufacturer’s instructions. For the
molecular weight analysis, the Talon-purified proteins were
loaded on a Superdex 200 column (HR 10/30, Amersham)
or on a 5-20% sucrose gradient. The column was run
isocratically in BC100 buffer (25 mM HEPES/KOH (pH
7.3), 100 mM NaCl, 1 mM MgCl2, 0.5 mM EGTA, 0.1 mM
EDTA, 10% glycerol (v/v), 1 mM DTT, and 0.2 mM PMSF)
for 1.4 CV. 0.5 mL fractions were collected and 15 íL of
each fraction were analyzed on a 10% SDS PAA gel. 5-20%
(w/v) sucrose gradients were prepared in BC100 buffer with
or without 3 M urea. The gradient was prepared using a
Gradient Master 105/106 (BioComp) set at 2.40 min/
81.5 deg/15 rpm. A 500 íL sample containing 10 íg of
dSU(VAR)3-9 wild type or ¢213 or 20 íg of BSA was
loaded on top of the gradient. Centrifugation was performed
using a SW41 rotor (Beckman) at 41 000 rpm for 28 h at 4
°C. 0.5 mL fractions were collected and analyzed by 10%
SDS-PAGE.
For activity assays, the enzyme was stabilized by addition
of BSA to a final concentration of 100 ng/íL followed
by dialysis against BC100 buffer. All recombinant
dSU(VAR)3-9 were quantified by Coomassie staining with
the ImageMaster 1D Elite v3.01 software package (Amer-
sham) using BSA as a standard. Bacterially expressed HP1
was purified according to ref 38 and dialyzed against BC100.
Methyltransferase ActiVity. H3 peptides used contained
amino acid 1-19 plus a C-terminal cysteine (ARTKQTARK-
STGGKAPRKQC) and were either unmodified, dimethylated
at K4, monomethylated at K9, acetylated at K9, or dimethy-
lated at K9 (Peptide Speciality Laboratories, Heidelberg).
Recombinant Drosophila histones were expressed and puri-
fied from E. coli, and reconstituted into octamers as described
previously (39). Nucleosomes were reconstituted by salt
dialysis. Recombinant histone H3 carrying the mutations
K9A, K27A, or both, were expressed in bacteria from
plasmids kindly provided by D. Reinberg. HMT assays were
done in ddH2O using H3-peptide, histone H3, octamer, or
nucleosomes as substrates and S-adenosyl-[methyl-3H]-L-
methionine (25 íCi/mL) and/or S-adenosylmethionine (New
England BioLabs) as methyl donor. Reactions were per-
formed at 30 °C for 1-80 min. To stop the reaction, acetic
acid was added to a final concentration of 5-10% (v/v).
Kinetic assays were carried out in triplicates by varying the
concentration of the H3 peptide (1-16 íM) or SAM (5-60
íM) at saturating amounts of SAM/peptide and analyzed by
double reciprocal plots.
GST Pulldown. dSU(VAR)3-9 and mutants were trans-
lated in vitro from pET15b vectors, [35S]methionine-labeled.
GST-pulldowns were carried out as described earlier (40).
In vitro translated proteins and HP1 (1 íg) were incubated
in a total volume of 200 íL containing NTEN100 (20 mM
TrisHCl (pH 8), 100 mM NaCl, 1 mM EDTA, 0.5% (v/v)
Nonidet P-40), 100 íg of BSA, and 5 íg of ethidium
bromide. Washes were performed two times in NTEN100 and
four times in the NTEN200. The bound proteins were eluted
with SDS sample buffer and analyzed using a phosphoimager
or a specific antibody in the case of HP1.
MALDI-TOF Analysis. To purify the methylated peptides
from contaminating salts, the peptide solution was passed
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over a pipet tip containing small amounts of C18 reversed
phase material (ZipTip, Millipore). After three 10 íL wash
steps with 0.1% TFA, the bound peptides were eluted with
1 íL of prepared matrix solution (saturated R-cyanohydroxy-
cinnamic-acid (Sigma) dissolved in 50% ACN (v/v)/0.3%
TFA (v/v)) directly onto the target plate. Samples were air-
dried to allow cocrystallization of the peptides and the matrix,
and the target plate was loaded in a Voyager DE STR
spectrometer and analyzed.
RESULTS
Full-Length dSU(VAR)3-9 Is an ActiVe Methyltransferase.
To analyze the enzymatic properties of dSU(VAR)3-9, we
expressed a recombinant full-length protein containing six
histidine residues at the N-terminus in bacteria and purified
it by affinity chromatography (Figure 1A). Recombinant
dSU(VAR)3-9 methylates histone H3 in a mixture of his-
tones as well as in reconstituted nucleosomes (Figure 1B).
We defined the site of methylation using by using peptides
premodified at lysine 4 or lysine 9 (Figure 1C). As lysine
27 is surrounded by almost identical amino acids and can
be methylated by methyltransferases that also methylate
lysine 9 (30, 41, 42), we also tested whether dSU(VAR)3-9
is able to methylate a histone H3 molecule carrying a
mutation at lysine 9 or at lysine 27. The fact that
dSU(VAR)3-9 only methylates the wildtype H3 molecule
and the H3 mutated at lysine 27 but does not methylate
mutants in which lysine 9 is mutated further confirmed our
specificity analysis (Figure 1D). This is in good agreement
with the finding that dSU(VAR)3-9 isolated from Droso-
phila embryos (43) as well as a N-terminally truncated
version of dSU(VAR)3-9 (14) are able to methylate lysine
9 within the N-terminus of H3.
dSU(VAR)3-9 Is a NonprocessiVe Enzyme with Similar
Affinity for Unmethylated and Monomethylated H3K9.
Lysines within histones exist in mono-, di-, and trimethylated
forms and the different isoforms can have different molecular
functions (44). Experiments using antibodies specific for
either di- or trimethylated lysine 9 demonstrate that
dSU(VAR)3-9 function is required for di- as well as
trimethylation of histone H3 in Drosophila polytene chro-
mosomes (14, 30). We therefore analyzed the reaction
products of an in vitro methylation reaction using full-length
dSU(VAR)3-9 and a H3 peptide by MALDI-TOF (Figure
2A). A time course experiment of the methylation reaction
using unmodified peptide shows that after 5 min about 20%
of the peptides are found to be monomethylated and none
of it is dimethylated. The dimethylated form only appears
after 10 min of reaction time when almost 50% of all peptide
has been converted into the monomethylated form. After 80
min, almost all of the unmethylated peptide is converted into
either the mono- or the dimethylated form. We have not
observed a significant amount of trimethylation by
dSU(VAR)3-9 under those conditions (Figure 2A). We also
used peptides that were either mono- or dimethylated at
lysine 9 as substrate to exclude the possibility that dSU-
(VAR)3-9 could trimethylate a peptide that is already
premodified. In both cases, we do not observe significant
trimethylation of the peptide (Figure 2B,C). Only at a very
high enzyme-to-substrate ratio or at extended reaction times
we could observe a small fraction (less than 1%) of
trimethylated peptide (data not shown). This is in good
agreement with experiments using the human orthologue of
dSU(VAR)3-9 SUV39H1, which also methylates a di-
methylated peptide only with a very low efficiency (15).
A possible explanation for the slow appearance of the
dimethylated peptide could be a dramatically reduced reac-
tion velocity of the methylation reaction after the peptide
has been monomethylated. To test this, we repeated the same
experiments using the monomethylated peptide as a substrate
and found very similar kinetics (Figure 2B,D). From these
FIGURE 1: Characterization of recombinant dSU(VAR)3-9. (A)
Elution of recombinant, His tagged dSU(VAR)3-9 from Talon
beads. Ten microliters of the first eight fractions (lanes 1-8) was
loaded onto a gel and subjected to 10% SDS-PAGE, and the gel
was stained with Coomassie blue R250. (B) In vitro methylation
reactions using different protein substrates. Nucleosomal arrays
(lane 1) were reconstituted on pBS(KS) (Stratagene) by salt dialysis
using recombinant octamers (lane 2), which were reconstituted from
equimolar amounts of histones produced in E. coli and purified by
gel-filtration chromatography. H3 (lane 3) was expressed and
purified as described. The reaction products were then loaded and
run on a 18% SDS PAA gel, and the gel was stained with
Coomassie blue R250, dried, and exposed to a X-ray film
(autoradiograph) for 24 h. (C) Peptides containing the first 19 amino
acids of H3 were methylated by recombinant dSU(VAR)3-9 and
radioactive SAM (Amersham). We used the unmodified peptide
(wt), a peptide dimethylated at K4 (K4me2) or at K9 (K9me2) and
a peptide acetylated at K9 (K9ac) as substrates. Incorporated
radioactivity was measured by a filter-binding assay. (D) In vitro
methylation reaction using either wt recombinant H3 (lane 1), H3
mutated at lysine 9 (lane 2), H3 mutated at lysine 27 (lane 3), or
a H3 molecule mutated at both sites (lane 4). Histones were
methylated by recombinant dSU(VAR)3-9 in the presence radio-
active SAM, separated by SDS-PAGE, and analyzed by auto-
radiography.
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experiments, we conclude that dSU(VAR)3-9 adds a single
methyl group to the peptide, after which it dissociates from
the SET domain and has to reassociate for a second meth-
ylation reaction. This behavior is in marked contrast to the
trimethylase DIM5 of Neurospora, which processively meth-
ylates lysine 9 within a H3 peptide to the trimethylated form
without releasing it into the solution (45) or to SET7/9, which
has been shown to only monomethylate lysine 4 on the H3
tail (25).
The N-Terminus of dSU(VAR)3-9 Is Required for Full
Catalytic ActiVity. To analyze the influence of the N-terminus
of dSU(VAR)3-9 on its enzymatic activity, we expressed
various mutant dSU(VAR)3-9 proteins in E. coli and studied
their catalytic activity (Figure 3A,B). As expected, a mutation
of dSU(VAR)3-9 in the SET domain (H561K) renders the
enzyme inactive. Enzymes in which the N-terminal 152 or
213 amino acids were deleted are still able to methylate H3
peptides and histones albeit with an over all 10-fold lower
methyltransferase activity (Figure 3C,D). Further deletion
of the N-terminus including the chromo domain (¢279)
resulted in an additional decline of methylation activity,
which we have not further analyzed.
Kinetic Parameters for Full-Length Recombinant
dSU(VAR)3-9. To further quantify the effect of the N-
terminus on the HMT activity of dSU(VAR)3-9, we used
a standard filter-binding assay to analyze the kinetics of dSU-
(VAR)3-9 methyltransferase reaction. Under standard reac-
tion conditions, the reaction is linear for at least 60 min
(Figure 2D). To prevent possible product inhibition effects,
we measured the incorporated radioactivity after 1 min, when
less than 5% of product was formed (see Figure 2). In test
experiments, we verified that this amount of S-adenosyl
homocystein (SAH) or of the methylated H3 peptide did not
significantly inhibit the reaction in our assays when added
externally (data not shown). In the reminder of the paper,
the reaction velocity is therefore expressed as pmol of CH3
incorporated min-1. Determination of the kinetic parameters
of the full-length dSU(VAR)3-9 revealed a Vmax for the
methylation reaction of 95.2 nmol min-1 mg-1 and a Km-
[SAM] of 25.9 íM (Figure 4A), assuming that all molecules
are active. This translates into a kcat of 0.11 s-1, which is
2-fold higher than the reported kcat of the full-length Rubisco
methyltransferase LSMT (0.05 s-1) (23). More importantly,
full-length dSU(VAR)3-9 is approximately 20 times faster
than another SET containing histone methyltransferase
enzyme SET9 (kcat ) 0.005 s-1) (23). Deletion of the
N-terminal domain does not change the Km for SAM or the
H3 peptide, indicating that there is no major change in
substrate affinity. Strikingly, the Vmax and the kcat of the
N-terminally truncated version ¢213 are about 20 times
FIGURE 2: MALDI analysis of reaction products. MALDI-TOF analysis of the reaction products using 600 ng of dSU(VAR)3-9 and 460
pmol of a H3 peptide (see Figure 1), which was unmethylated (A), monomethylated (B), or dimethylated (C) at K9. The methylation
reaction was stopped at different time points after starting the reaction and reaction products analyzed by MALDI-TOF. In case of the
dimethylated peptide, only the 80-min time point is shown. (D) Time course of a methylation reaction as measured by a filter-binding
assay.
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lower than the ones observed for the full-length enzyme and
more similar to the kinetic parameters of SET9 (6.8 nmol
min-1 mg-1 and 0.005 s-1, respectively) (Figure 4A). This
substantial increase in the catalytic efficiency of the full-
length enzyme may be due to a conformational change or
an association of monomeric enzymes into multimers. As
multimeric enzymes often show a concentration-dependent
increase of specific activity as expressed in substrate
molecules converted per molecule of enzyme (46), we
determined the relationship between the velocity of the
reaction and the enzyme concentration. When the rate of
methyl peptide formation was plotted against the correspond-
ing enzyme concentration, a nonlinear plot was obtained
(Figure 4B). This behavior is not observed when using the
N-terminally truncated proteins, which only show a linear
dependence of methyltransferase activity on enzyme con-
centration. Replotting the number of CH3 groups incorporated
per enzyme molecule revealed a steady increase of activity
until the specific activity reached a plateau at an enzyme
concentration of approximately 0.5 íM for the wild type. In
contrast, virtually no change was observed for the N-
terminally truncated enzyme (Figure 4C). On the basis of
these observations, we reasoned that under our assay
conditions the full-length enzyme is indeed able to form
multimers, which have a higher specific activity than the
monomers and that at a concentration of 0.5 íM and above
virtually all molecules exist as multimers.
The N-Terminus Is Important for Dimerization and ActiVity
of dSU(VAR)3-9 in Vitro. To test this hypothesis, we
analyzed the molecular weight of the recombinant protein
by gel filtration chromatography and density gradient
centrifugation. The full-length dSU(VAR)3-9 elutes with
an apparent molecular weight of 160 kDa, which is indicative
of a dimer from a Superdex 200 gel filtration column (Figure
5A). The deletion of the N-terminus of dSU(VAR)3-9
results in a complete loss of this dimerization as the
N-terminally truncated protein elutes with an apparent
molecular weight of 60 kDa corresponding to a monomeric
species (Figure 5A bottom panel). To further confirm the
dimerization of dSU(VAR)3-9, we loaded the purified,
recombinant enzyme on a 5-20% sucrose gradient under
denaturing and nondenaturing conditions. As expected, under
native conditions the full-length dSU(VAR)3-9 is found in
fractions corresponding to higher molecular weight when
compared to the ¢213, whereas it behaves virtually identical
under denaturing conditions (Figure 5B). The N-terminally
deleted protein as well as the BSA standard display a minor
shift to an apparently smaller molecular weight in the
presence of urea, which is probably due to a change in
density of the denaturing solution (arrows in Figure 5B).
The N-Terminus Mediates Interactions within
dSU(VAR)3-9. As the deletion of the first 152 amino acids
leads to a loss of dimer formation, we expressed the
N-terminal 152 amino acids of dSU(VAR)3-9 as a GST
fusion protein in bacteria and used it as an affinity resin in
GST pull-down experiments. The bound fusion protein was
incubated either with recombinant HP1 or with in vitro
translated dSU(VAR)3-9 proteins. As has been shown
previously (14, 34), the N-terminus is able to interact with
HP1 in vitro (Figure 6A, right panel). This domain also inter-
FIGURE 3: Expression and purification of dSU(VAR)3-9 mutants. (A) Scheme of dSU(VAR)3-9 mutants generated and expressed. In
Drosophila dSU(VAR)3-9 mRNA is generated by alternative splicing of the translation initiation factor (eIF2) RNA leading to an additional
81 amino acids at the N-terminus of the protein, which are common between eIF2 and dSU(VAR)3-9. For the point mutation within the
SET domain (H561K) histidine 561 was mutated into a lysine. (B) Coomassie-stained gel of Talon purified dSU(VAR)3-9 mutant proteins.
(C) Comparison of HMT activity of various dSU(VAR)3-9 mutants on a H3 peptide and on recombinant H3 molecules (D). For a better
comparison, the inset of panel C shows the activities of the N-terminal deletions and a point mutation within the SET domain only. To
compare different activities on intact H3 molecules, an autoradiograph of a 1-day (top panel) and a 7-day (bottom panel) exposure is
shown.
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acts very efficiently with in vitro translated dSU(VAR)3-
9, suggesting a role of this domain in inter- or intramolecular
interactions. Surprisingly, this domain is also able to interact
with a polypeptide lacking the first 152 amino acids. To map
the region within dSU(VAR)3-9 that interacts with the first
152 amino acids, we have generated a series of mutations
within dSU(VAR)3-9 and analyzed their capability to bind
to the N-terminus (Figure 6A,B). Using these mutant
proteins, we could narrow down the interaction domain to
amino acids 152-213 (Figure 6C). This suggests the
existence of a bipartite interaction motif that can potentially
mediate a intra- as well as an intermolecular interaction. To
further confirm this result, we expressed the amino acids
152-213 as a GST fusion protein and did another series of
GST pull down experiments. As expected, the GST(152-
213) protein is able to interact with the full-length protein
FIGURE 4: Kinetic properties of recombinant dSU(VAR)3-9. (A) Double reciprocal plots of in vitro methylation reactions using a H3 tail
peptide and either wt (500 ng) or a N-terminally truncated protein (¢213; 1 íg) using various concentrations of SAM under saturating
peptide concentrations were used to determine the Km for SAM. (B) Concentration-dependent increase of enzyme activity. Different
concentrations of wt and N-terminally truncated dSU(VA)3-9 were incubated with H3 peptide and SAM at saturating concentrations for
30 min. After stopping the reaction, the amount of incorporated radioactivity was measured and plotted against the concentration of enzyme.
(C) The ratio of the incorporated radioactivity to the concentration of enzyme present was replotted against the enzyme concentration to
determine the increase in specific activity.
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but only weakly binds to a protein lacking the first 152 amino
acids (Figure 7A,B). On the basis of this result, we strongly
favor a model in which dSU(VAR)3-9 interacts with itself
via a domain swapping mechanism similar to what has been
described for other dimeric proteins (47).
DISCUSSION
Recombinant dSU(VAR)3-9 is a catalytically active
methyltransferase and is able to methylate lysine 9 within
histone H3. The main conclusions from our experiments are
that the full-length enzyme transfers two methyl groups to
lysine 9 within an H3 tail peptide in a nonprocessive manner
and that the enzyme requires the N-terminus for homodimer-
ization and for full activity in vitro. The N-terminus of dSU-
(VAR)3-9 can be subdivided into two parts, which can
interact with each other.
The initial rate kinetics of the methylation reaction show
that dSU(VAR)3-9 has a very similar Km for the protein
substrate and a similar turnover rate as another SET
containing methyltransferase, Rubisco LSMT (23), but a
significantly higher Km for SAM. This suggests that to have
full catalytic activity the concentration of SAM has to be
kept at a relatively high concentration within the cell. The
intracellular SAM concentration varies between 20 and 40
íM (48) depending on the cell type used, which is in the
range of the Km of dSU(VAR)3-9. Under these conditions,
the rate of methylation by dSU(VAR)3-9 is directly
proportional to the SAM concentration and can therefore
directly respond to variations of cofactor concentration. This
high SAM concentration is maintained by the main SAM
synthase enzyme, SU(Z)5, which, like dSU(VAR)3-9, is a
suppressor for position effect variegation in Drosophila (49).
It will be interesting to see whether the Su(z)5 gene product
is randomly distributed throughout the cell or if it shows a
specific localization maybe directing it to the sites of
dSU(VAR)3-9 action. The concentration of SAM could
therefore be an important regulator of heterochromatin
spreading.
Recently several labs have characterized the processivity
of various SET containing enzymes revealing remarkable
differences in their ability to add one, two, or three methyl
groups to their corresponding substrate (25, 45). Furthermore,
mono-, di-, and trimethylated histones have different func-
tions (44). By analyzing the reaction products of recombinant
dSU(VAR)3-9 in vitro, we find that it very efficiently adds
two methyl groups to its substrate but is very poor in adding
a third one. Moreover, we only see a trimethylated peptide
(less than 1% of total product) at a high enzyme-to-substrate
ratio (Figure 2D and data not shown). However, deletion of
dSU(VAR)3-9 in vivo leads to a disappearance of tri-
methylated H3 molecules at the chromocenter of polytene
chromosomes (30). The fact that we can observe a small
trimethylating activity of recombinant dSU(VAR)3-9 argues
against a sterical inhibition of trimethylation within the active
center by the enzyme as it is the case for SET9 (50).
SET domain containing enzymes have been classified in
several different classes based on their primary amino acid
sequence (51). The only enzyme of the SU(VAR)3-9 class
that has been kinetically characterized in detail is the
Neurospora enzyme DIM5. Our experiments show that
dSU(VAR)3-9, in contrast to DIM5, is not processive and
mainly dimethylates a peptide containing lysine 9. Further
analysis of additional point mutations within the SET domain
will reveal the structural basis of this intriguing difference.
An obvious candidate for an amino acid important for this
difference is the R238 of DIM5, which is replaced by a
histidine in dSU(VAR)3-9 and its orthologues in mouse and
humans (15). In fact, it has been shown that a mutation within
SUV39H1 converting H320 into an arginine residue strongly
increases activity in vitro (15).
It has been speculated that a targeted recruitment of SET1
to the promoter region of an active gene can lead to a limited
trimethylation due to a very high local concentration of
enzyme (44, 52), whereas the reminder of the chromatin is
only dimethylated. As we observe a nonlinear increase of
HMT activity dependent on the enzyme concentration in
vitro, it is possible that comparable mechanisms of the
regulation of the methylation state also affect the methylation
capability of dSU(VAR)3-9 in vivo. Alternatively, the
ability of dSU(VAR)3-9 to trimethylate may be regulated
by phosphorylation of the protein (19, 53), or through
interaction with additional cofactors (19) as has been shown
recently in the case of ESET (54). Furthermore, the tri-
methylation of K9 could be mediated by a different HMT
enzyme, which is able to add a third methyl group to already
dimethylated H3. One of the potential enzymes with such a
trimethylating activity is the polycomb group protein en-
hancer of zeste (30).
Besides this kinetic observation, the most interesting
observation we have made in analyzing the recombinant
dSU(VAR)3-9 protein is the fact that it requires the
FIGURE 5: Molecular weight determination of dSU(VAR)3-9. (A)
Elution profiles of wt dSU(VAR)3-9 (top) and the N-terminal
deletion construct ¢213 (bottom). Retention of the molecular weight
standards is indicated at the top. (B) Profile of a 5-20% sucrose
gradient in the presence (panels 2 and 4) or absence of 3 M urea
(panels 1 and 3). The position of the 66-kDa marker protein is
indicated as a black triangle at the top of each gel. Note the slight
shift (1 fraction) of the 66-kDa marker and the ¢213 protein, which
is due to the presence of urea in the buffer compared to the
significant shift in case of the wt protein (>3 fractions).
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N-terminus for its full in vitro activity. Our experiments
strongly suggest that this N-terminus allows the recombinant
protein to form dimers in solution, which greatly enhances
its activity. However, we cannot fully exclude the possibil-
ity that intramolecular interactions within the N-terminus
induce a major conformational shift that causes the full-
length protein to migrate with an apparent molecular weight
of a dimer on a gel filtration column as well as a density
gradient. The observed concentration-dependent increase in
specific enzyme activity, as expressed in molecules SAM
converted per molecule of enzyme, argues against this
possibility as the different conformation should not change
as a function of enzyme concentration. Interestingly, the
arginine methyltransferase PRMT1 and the SET domain
containing lysine methyltransferase vSET also form oligo-
mers in vitro (26, 55, 56). Both enzymes are nonproces-
sive and the multimerization of the protein has been
suggested to facilitate the methylation reaction by increas-
ing the probability of the monomethylated product to bind
to a second enzyme molecule. This is in contrast to other
SET domain proteins such as DIM-5 and SET7/9, which
are either processive or only transfer one methyl group
respectively and do not dimerize in vitro. Interestingly,
the catalytic capacity of full-length dSU(VAR)3-9 is
about 20 times higher than the one of SET9 or a N-
terminally truncated version of dSU(VAR)3-9, which
both fail to dimerize in solution suggesting that the dimer-
ization can indeed be used to significantly enhance HMT
activity.
The mapping of the dimerization domain via GST pull
down experiments revealed a bipartite dimeriztaion motif.
This organization points to a dimerization via a domain
swapping mechanism in which identical domains are ex-
changed between two proteins to form a homodimer (57).
On the basis of our experiments, we would suggest that the
amino acids 1-152 can interact with the residues 152-213
either intra- or intermolecularly and that the domain swapped
dimer has a higher catalytic capacity than the monomer. The
different conformation of a loop between two swapped
domains in the monomeric and the dimeric form of an
enzyme can have a significant effect on the function of a
remote active site (47). Such an induced conformational
change may provide an alternative explanation for the higher
activity of the dimeric form of dSU(VAR)3-9. Domain
swapping has also been implicated in the formation of
oligomeric assemblies of proteins (58). Although we have
strong evidence for dimer formation and could not identify
higher order oligomers in gel filtration chromatography or
density gradient experiments, at present we cannot fully
exclude the existence of oligomeric species that may as-
sembly from dimers and are disrupted in the course of our
analysis.
FIGURE 6: In vitro interaction assays to map the dimerization domain. The first 152 amino acids of dSU(VAR)3-9 are expressed as a GST
fusion proteins and used to affinity purify either recombinant HP1 (A, right panel) or in vitro translated dSU(VAR)3-9 (A, left panel).
HP1 was detected by Western blotting using a monoclonal antibody against HP1 (C1A9, kind gift of S. Elgin) and dSU(VAR)3-9 was
detected by autoradiography. (B) Quantification of the binding affinities of the various dSU(VAR)3-9 proteins. Error bars represent the
variations of at least three different experiments. (C) Schematic representations of the dSU(VAR)3-9 proteins used and the position of the
dimerization domain.
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The concentration-dependent self-interaction of
dSU(VAR)3-9 may also be a way to regulate its function
within the cell. One well-known features of dSU(VAR)3-9
is its strict dosage-dependent effect on PEV. Our observation
that dSU(VAR)3-9’s specific HMT activity increases in a
nonlinear way provides a possible explanation for this effect.
The human orthologue of dSU(VAR)3-9, SUV39H1, forms
distinct nuclear bodies when overexpressed in tissue culture
cells (19), which can be dispersed by modulating the
phosphorylation state of the enzyme. From our in vitro
experiments, we would suggest that the N-terminus plays
an important role in the formation of those nuclear bodies.
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A large portion of the eukaryotic genome is packaged into transcriptionally silent heterochromatin. Several
factors that play important roles during the establishment and maintenance of this condensed form have been
identified. Methylation of lysine 9 within histone H3 and the subsequent binding of the chromodomain protein
heterochromatin protein 1 (HP1) are thought to initiate heterochromatin formation in vivo and to propagate
a heterochromatic state lasting through several cell divisions. For the present study we analyzed the binding
of HP1 to methylated chromatin in a fully reconstituted system. In contrast to its strong binding to methylated
peptides, HP1 binds only weakly to methylated chromatin. However, the addition of recombinant SU(VAR)
protein, such as ACF1 or SU(VAR)3-9, facilitates HP1 binding to chromatin methylated at lysine 9 within the
H3 N terminus (H3K9). We propose that HP1 has multiple target sites that contribute to its recognition of
chromatin, only one of them being methylated at H3K9. These findings have implications for the mechanisms
of recognition of specific chromatin modifications in vivo.
Chromatin within the eukaryotic nucleus can be cytologically
divided into active euchromatin and silent heterochromatin
(19, 32, 56). Genetic analysis of position effect variegation in
Drosophila melanogaster identified the methylation of lysine 9
within the H3 N terminus (H3K9) as a crucial factor for het-
erochromatin formation (60, 61, 68). The main histone methyl
transferase (HMTase) responsible for this mark is SU(VAR)3-9
(60). This modification can be found at pericentric heterochro-
matin in virtually all higher eukaryotes and is currently viewed
as a hallmark of silenced chromatin (13, 29, 56). Methylation at
H3K9 (H3K9Me) is essential for the binding of heterochro-
matin protein 1 (HP1), a major constituent of heterochromatin
(5, 40). HP1 homologues can be found in almost all eukaryotes
ranging from Schizosaccharomyces pombe (18, 39, 43) to mam-
mals and higher plants (26, 58, 62). Higher eukaryotes have at
least three different isoforms of HP1 (HP1, HP1, and HP1
in mammals and HP1a, HP1b, and HP1c in Drosophila) (47,
63), which differ in their subnuclear localization. HP1/a and
HP1/b are primarily found within centromeric heterochroma-
tin, whereas HP1/c is enriched at euchromatic sites (27, 48,
63). All HP1 molecules share a conserved architecture consist-
ing of a chromo domain (CD), a flexible hinge region, and a
chromo shadow domain (CSD) (2, 38). Genetic complemen-
tation assays (54) as well as structural data (67) showed that
both globular domains (CD and CSD) are required for proper
targeting of HP1. This is confirmed by experiments showing
that a chimeric protein containing the CD of polycomb and the
CSD of HP1 is targeted not only to heterochromatin but also
to binding sites of the endogenous polycomb protein (53).
The CD of HP1 interacts specifically with a peptide resem-
bling the N terminus of H3 that is di- or trimethylated at K9 (5,
34, 35, 40, 52). The interaction surface is highly conserved
among different HP1 isoforms, and a mutation that abolishes
binding results in a loss of function allele of HP1/a (5, 40, 53).
More recently, the CD of HP1 has also been shown to interact
specifically with isoform 1.4 of the H1 linker histone when it is
methylated at K26 (12). Although the CD of HP1 and its ability
to recognize methylated histones are necessary for heterochro-
matin binding in vivo, they are not sufficient to support chro-
matin binding in vitro. Pulldown experiments using bacterially
expressed glutathione S-transferase (GST)-HP1 showed that
the CD alone could not efficiently pull down native soluble
oligonucleosomes from chicken nucleated erythrocytes (46).
The binding of recombinant HP1 to mononucleosomes re-
quired the presence of the full-length protein, suggesting that
individual domains are not able to maintain a stable binding to
a nucleosome (74). Moreover, in contrast to what is seen in
vivo, the interaction of HP1 with chromatin is independent of
the histone tails (46, 74) and could be mediated by an inter-
action between HP1 and the core region of H3 (51). This type
of binding is contradictory to most data obtained in vivo that
point out H3K9Me as a major factor in targeting. However,
alternate ways of binding of HP1 to chromatin in vivo have
been suggested as well. Treatment of nuclei with RNAses leads
to a release of bound HP1 in mammalian tissue culture cells
(45, 49). The putative RNA binding activity of HP1 could be
assigned to a conserved region within the hinge domain, which
binds RNA in vitro (49). The involvement of an RNA compo-
nent in the targeting of HP1 to heterochromatin is further
strengthened by the observation that mutations in components
of the RNA interference (RNAi) machinery prevent SWI6/
HP1-mediated formation of heterochromatin in fission yeast
(30). The hinge region of HP1 has also been shown to directly
interact with the linker histone H1 (51) and with native H1
containing chromatin (46). In addition, HP1 was shown to
interact with the histone variant H2A.Z when incorporated
into a nucleosomal array (21).
Besides the CD and the hinge domain, the CSD of HP1 is
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also crucial for targeting of HP1 to its site of action. The
CSD mediates dimerization of HP1 and its binding to small
peptide regions that can be recognized by key residues at the
surface of an HP1 dimer (8). A consensus sequence that
interacts with the CSD of HP1a has been identified by using
a phage display method to enrich for peptides that have a
high affinity to the CSD (64). This small motif can be found
in many proteins, several of which have been shown to
interact with the CSD and are thought to target HP1 to
specific promoters (42, 65) in order to establish a silenced
chromatin domain. The CSD of HP1 is also required to
mediate its interaction with the large subunit of CAF1 (50).
This interaction provided a link to the replication machinery
and led to a model in which HP1 is targeted to replication
foci by its interaction with CAF-1 and subsequently “handed
over” to methylated chromatin (50).
Our goal was to reconstitute highly H3K9-methylated chro-
matin in vitro and to study the binding of recombinant Dro-
sophila HP1a to methylated and nonmethylated chromatin. We
found that HP1a binds to a unmodified chromatin array only
weakly even though more than 85% of all H3 molecules within
the reconstituted array were methylated at K9. The addition of
auxiliary factors such as ACF1 or SU(VAR)3-9, which interact
with the CSD of HP1a, facilitated its binding to methylated
chromatin. Mutations inhibiting the interaction between HP1a
and these factors abolished the binding, suggesting a bimodal
binding of HP1 to methylated chromatin.
MATERIALS AND METHODS
Plasmids and cloning. J. C. Eissenberg kindly provided HP1a in expression
vector pET11a. Site-directed mutagenesis of full-length HP1a was performed
using the QuickChange kit (Stratagene). To generate HP1 (V26M) we used
primers HP1V26MNcoIfwd (5-GAGGAGGAGTACGCCATGGAAAAGA
TCATCG-3) and HP1V26MNcoIrew (5-CGATGATCTTTTCCATGGCGT
ACTCCTCCTC-3), and to generate HP1 (W200A) we used primers
HP1aW200ABstNI (5-CGAAGAGCGCCTATCCGCGTACTCTGATAAT
GAAG-3) and HP1aW200ABstNIrev (5-CTTCATTATCAGAGTACGCG
GATAGGCGCTCTTCG-3). HP1a (amino acids [aa] 2 to 206) was sub-
cloned into XmaI and XhoI sites of pGEX4T-1 (Amersham) using primers
pgexHP1aNtXmaI5 (5-GTAGACCCGGGTGGCAAGAAAATCG-3) and
pgexHP1aCtXhoI3 (5-TCTCACTCGAGTTAATCTTCATTATC-3). SU(VAR)3-9
constructs were previously described in reference 20.
Antibodies and immunoblotting. The HP1 (C1A9) mouse monoclonal anti-
body (36) and the HP1 rabbit polyclonal antibody (58) were kind gifts from
S. C. R. Elgin. Dilutions for Western blots were 1:200 for C1A9 and 1:1,500
for polyclonal HP1. For all quantifications the HP1 polyclonal antibody was
used. The FLAG antibody (Sigma) was used at a concentration of 1:2,000.
SU(VAR)3-9 rat monoclonal antibody (SU3D9) was generated by E. Kremmer
against purified His-tagged SU(VAR)3-9 213. The supernatant was used at a
concentration of 1:5. Proteins were transferred onto polyvinylidene fluoride
(PVDF) membranes (Millipore), probed with the indicated antibodies, detected
with fluorescently labeled secondary antibodies, and quantified with an Odyssey
system (Li-Cor). For quantification the background method was set to median
with a border of 1 and a Top/Bottom segment. In Fig. 1C, the secondary antibody
FIG. 1. Bacterially expressed HP1 dimerizes and binds H3 peptides methylated at lysine 9. (A) Untagged recombinant HP1 was purified over
four successive columns. A Coomassie-stained SDS–12% polyacrylamide (PAA) gel of 5 l of fractions 9 to 19 from the last column, a MonoQ,
is depicted. fxn, fractions. (B) Purified recombinant HP1 was loaded onto a gel filtration column (Superdex 200), and the elution profile (A280) of
HP1 is shown. Molecular mass (MM) standards (bovine serum albumin [66 kDa] and carbonic anhydrase [29 kDa]) are labeled with arrows. (C) In
vitro cross-linking of HP1 using DTSSP (DSS). Recombinant HP1 before (lane 3) or after (lanes 1 and 2) cross-linking was subjected to SDS–12%
PAGE, transferred to a PVDF membrane, and detected with HP1 (C1A9) antibody. The DTSSP cross-linking can be partially reversed by
reductive cleavage of the disulfide-containing cross-linking molecule (lane 2). The cross-linking revealed dimeric HP1. (D) Recombinant HP1 was
assayed for binding to H3 peptides containing the first 19 amino acids of H3 immobilized onto Sulfolink Sepharose. The substrates were
unmodified peptide (lane 3), peptide dimethylated at K4 (K4Me2; lane 4), and peptide dimethylated at K9 (K9Me2; lane 5). Bound HP1 was
visualized by Coomassie staining.
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was conjugated to horseradish peroxidase (Amersham), and the detection was
performed with chemiluminescence (Amersham).
Expression and purification of recombinant DrosophilaHP1 and SU(VAR)3-9.
Bacterially expressed HP1 and point mutants were purified according to the
method detailed in reference 73 and dialyzed against BC100 (25 mM HEPES
[pH 7.6], 100 mM NaCl, 1 mM MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 10%
[vol/vol] glycerol, 1 mM dithiothreitol [DTT], and 0.2 mM phenylmethylsulfonyl
fluoride [PMSF]). All HP1s were quantified by Bradford (Bio-Rad), and Coo-
massie-stained proteins were quantified using the ImageMaster 1D Elite version
3.01 software package (Amersham), with bovine serum albumin (BSA) as a
standard. SU(VAR)3-9 wild type (WT) and 213 were expressed and purified as
described in reference 20.
H1 purification. H1 was purified from Drosophila embryos (0 to 12 h) accord-
ing to the method of Croston et al. (11a), and its identity was verified by mass
spectrometry. For incorporation into chromatin, H1 was added after chromatin
assembly, when the chromatin was linked to paramagnetic beads. H1 incubation
with chromatin or DNA was performed for 1 h at 26°C. Washing steps were the
same as those described below for HP1.
Histone purification and nucleosome assembly by salt dialysis. Recombi-
nant Drosophila histones were expressed and purified from Escherichia coli
BL21(DE3)pLys and reconstituted into octamers as described previously
(44). Nucleosomes were reconstituted by salt dialysis overnight at 4°C using
NaCl concentrations of 2 M to 0.1 M (44). The dialysis buffer contained 10
mM Tris-HCl (pH 8), 1 mM EDTA, 0.1 M NaCl, 0.05% (vol/vol) NP-40, and
1 mM -mecaptoethanol. Two micrograms of nucleosome particles was di-
gested with 45 Boehringer units of micrococcal nuclease (MNase; Sigma), and
reactions were stopped at 20, 60, and 120 s with 0.2 volumes of stop buffer
(4% sodium dodecyl sulfate [SDS] and 10 mM EDTA). The reaction mixtures
were digested with proteinase K (Genaxxon), and the DNA was separated on
a 1.3% agarose gel.
Gel filtration. Recombinant HP1 (128 M/145 g) was loaded onto a Super-
dex 200 column (HR 10/30; Amersham Pharmacia). The column was run iso-
cratically with 0.2 ml/min in BC200 buffer at 1.4 column volumes, and 0.5-ml
fractions were collected.
Cross-linking assay. Bacterially expressed HP1 (0.17 M) was cross-linked
using 250 M DTSSP [3,3-dithiobis(sulfosuccinimydal propionate)] (Pierce)
and incubated on ice for 2 h in BC100 buffer without DTT. The reaction was
stopped by adding 100 mM Tris-HCl (pH 7.6) and boiled in SDS-polyacrylamide
gel electrophoresis (PAGE) sample buffer with or without -mercaptoethanol.
After separation by SDS electrophoresis, the proteins were transferred to a
PVDF membrane (Millipore) and incubated with -HP1 (C1A9).
Peptide pulldown. Various H3 peptides (aa 1 to 19) were coupled to Thiolink
beads (Bio-Rad) and resuspended as 1:1 slurry in BC100. Twenty microliters of
this slurry was incubated with 1 g of recombinant HP1 in a total volume of 200
l BC100. The incubation was performed on a rotating wheel at 4°C for 2 h.
After washing three times with BC100 (containing 0.05% [vol/vol] NP-40) for 10
min each, the bound protein was eluted with 30 l acidic elution buffer (100 mM
Glycine [pH 2.5], 500 mM NaCl) for 20 min at 4°C. The eluted proteins were
analyzed by SDS–12% PAGE and Coomassie stained. One microgram of bio-
tinylated H3 peptides, unmodified from aa 1 to 21 (WT) and trimethylated at K9
aa 1 to 21 (Upstate), were mixed with 2 g HP1 (WT or mutant proteins) and
incubated for 1 h at 4°C. Then 10 l of a 1:1 slurry of paramagnetic beads
(Dynal) (preblocked in BSA) was added and incubated for 1 h at 26°C in BC100
(containing 0.05% [vol/vol] NP-40). The paramagnetic beads were concentrated
on a magnetic concentrator (Dynal) and washed once with BC100 plus 0.05%
(vol/vol) NP-40 and twice with BC200 plus 0.05% (vol/vol) NP-40. Bound pro-
teins were separated on an SDS–12% PAGE gel and Coomassie stained.
H3K9-methylated octamer. One hundred twenty micrograms of recombinant
octamer was incubated in the presence of 9 g of active recombinant Drosophila
SU(VAR)3-9 (20) to retrieve 60 g of a 70 to 80% H3K9 di- and trimethylated
octamer. The reaction mixture was incubated at 30°C for 90 min in the presence
of 40 M S-adenosylmethionine (New England BioLabs) as methyl donor and 40
mM NaCl. After incubation concentrations were adjusted to 100 mM NaCl, and
0.2 mM PMSF and 2 mM DTT were added. To a 1-ml total volume, 80 l (1:1
slurry) of Biorex70 beads (Bio-Rad) was added. The reaction mixture was ro-
tated at 4°C for 4 h and washed five times with TEN200 (200 mM NaCl, 10 mM
Tris, 1 mM EDTA, 0.2 mM PMSF, 1 mM DTT) and five times with TEN400. The
methylated octamer was eluted with TEN2500, and 4 l (2 g) was analyzed by
SDS–15% PAGE and stained with Coomassie blue.
MALDI-TOF analysis. The Coomassie stained band corresponding to H3 was
excised and subjected to chemical modification by treating with propionic anhy-
dride to convert free amino groups to propionic amides of lysine residues as
described (66). H3 was digested over night with 100 ng of sequencing-grade
trypsin (Promega) in a total volume of 40 l according to manufacturers proto-
col. In order to purify the methylated peptides from contaminating salts or acryl
amide the peptide solution was passed over a pipette tip containing SCX material
(ZipTip, Millipore) and eluted as previously described (20). The matrix-assisted
laser desorption ionization–time of flight (MALDI-TOF) spectra were acquired
and analyzed according to the method described in reference 7. Quantification
was performed as previously described in reference 28.
Chromatin assembly extract. S150 chromatin assembly extract was prepared
from 0- to 90-min Drosophila embryos according to the method described in
reference 6.
Chromatin assembly on immobilized DNA and micrococcal nuclease diges-
tion. The assembly reactions for immobilized DNA were performed according to
reference 57. In short, 2 g DNA was immobilized to 0.8 mg paramagnetic
streptavidin beads (Dynal) and, after extensive washing, blocked for 30 min at
4°C with BSA (1 g/l) in EX50 (10 mM HEPES [pH 7.6], 50 mM NaCl, 1.5 mM
MgCl2, 0.5 mM EGTA, 10% [vol/vol] glycerol, 0.2 mM PMSF, 1 mM DTT)
containing 0.05% (vol/vol) NP-40 before assembly. Unmodified or H3K9Me
histone octamers (2 g) were mixed with the assembly extract at time point zero
together with an ATP regenerating system (3 mM ATP, 30 mM creatine phos-
phate, 10 g creatine kinase/ml, 3 mM MgCl2, and 1 mM DTT). HP1 was then
added at a concentration of 2 g (8.3 ng/l), and the reaction mixture was left to
rotate for 6 h at 26°C. MNase digestions was performed as described in reference
57, with 30 Boehringer units of MNase (Sigma). For MNase digestion of chro-
matin assembled onto circular DNA, 150 Boerhringer units were used. A 123-bp
ladder (Invitrogen) was used as a size marker.
Immobilization of salt-assembled chromatin and HP1 binding assays. Salt-
assembled unmodified or H3K9Me chromatin (1 g) was immobilized onto
0.4-mg paramagnetic streptavidin beads (Dynal) in TEN100 buffer containing
0.05% (vol/vol) NP-40 and 250 ng/l BSA. After 2 h of rotation at 4°C, the
chromatin on paramagnetic beads was concentrated on a magnetic concentrator
(Dynal) and washed once with EX100 buffer containing 0.05% (vol/vol) NP-40.
Chromatin was immediately resuspended in a total volume of 80 l containing 60
l EX100 plus 0.05% (vol/vol) NP-40, BSA (100 ng/l), ATP regenerating
system (3 mM ATP, 30 mM creatine phosphate, 10 g creatine kinase/ml, 3 mM
MgCl2, and 1 mM DTT) and 2 g (25 ng/l) HP1. Purified SU(VAR3-9) WT
and 213 were added in a total concentration of 100 ng in the presence of 1 M
Chaetocin dissolved in dimethyl sulfoxide or an equal volume of dimethyl sulf-
oxide only. FLAG-eluted ACF at a total concentration of 50 ng was added in the
presence or absence of ATP. Drosophila assembly extract was added at a con-
centration of 100 g in the presence of ATP or nonhydrolyzable ATP--S analog.
Chromatin washes and HP1 detection. Assembled chromatin was concen-
trated on a magnetic concentrator (Dynal), and the supernatant was removed.
The chromatin beads were washed once with 100 l EX100 (10 mM HEPES [pH
7.6], 100 mM NaCl, 1.5 mM MgCl2, 0.5 mM EGTA, 10% [vol/vol] glycerol, 0.2
mM PMSF, 1 mM DTT) containing 0.05% (vol/vol) NP-40 and twice with the
same buffer containing 200 mM NaCl. The bound proteins were eluted with 10
l SDS loading dye and separated by SDS–15% PAGE. The proteins on the gel
that were smaller than 20 kDa, including the histones, were subjected to Coo-
massie staining, whereas the rest of the gel was transferred to a PVDF membrane
(Millipore). Blots were probed with HP1 polyclonal rabbit antibody and incu-
bated with fluorescently labeled secondary antibodies and visualized using the
Odyssey system (Li-Cor) as described above.
ACF and ACF1 pulldowns. ACF1-FLAG and imitation switch (ISWI) were
expressed in Sf9 cells as described previously (15) The ACF complex was gen-
erated by coexpression of ACF1-FLAG with untagged ISWI. Sf9 cells were
suspended in BC500 containing 0.05% (vol/vol) NP-40, 1 mM DTT, 0.2 mM
PMSF, and protease inhibitors. The cells incubated on ice were sonicated two
times for 15 s at 50% amplitude and centrifuged at maximum speed on a tabletop
centrifuge for 30 min. A total of 500 ng of the expressed proteins was immobi-
lized on M2 anti-FLAG agarose beads, washed with BC500 and BC1000 con-
taining 0.05% (vol/vol) NP-40, and blocked with 1-g/l BSA. Recombinant HP1
or HP1 mutants were added at a concentration of 1 g in a total volume of 200
l BC100 containing 0.05% (vol/vol) NP-40, 100 g BSA, and 5 g ethidium
bromide. After 30 min of incubation at room temperature, the beads were
washed two times in the same buffer without ethidium bromide and BSA, con-
taining 100 mM NaCl, and four times in a buffer containing 200 mM NaCl. The
bound proteins were eluted with SDS sample buffer, analyzed by SDS-PAGE,
and transferred onto a PVDF membrane (Millipore).
GST pulldowns. GST pulldowns were performed as described in reference 20.
ACF1 constructs were translated in vitro according to the method described in
reference 31.
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RESULTS
In order to generate chromatin fibers that contain HP1, we
have expressed Drosophila HP1a (HP1) in bacteria and puri-
fied it to homogeneity over four consecutive columns (74) (Fig.
1A). Throughout the present article we will refer to this re-
combinant HP1a protein as HP1 unless stated otherwise. The
purified HP1 dimerizes and interacts specifically with peptides
that resemble the H3 N terminus dimethylated at K9 (Fig. 1).
For the chromatin binding studies, we assembled recombinant
Drosophila histones (16) onto DNA fragments containing 11
repeats of the 5S nucleosome positioning sequence using salt
dialysis (9). The level of assembly was tested by micrococcal
nuclease digestion (Fig. 2B, right panel). The DNA fragments
were asymmetrically labeled with biotin and immobilized using
streptavidin-coupled paramagnetic beads. Fully assembled ar-
rays were coupled and used for binding assays after washing
with a buffer containing 100 mM salt. The addition of the
highly purified HP1 dimer at a 4:1 molar ratio of HP1/nucleo-
some to the immobilized chromatin fiber resulted in only weak
binding (Fig. 2C, lane 2) of HP1. This is consistent with pre-
vious observations that report binding of HP1 only at HP1-to-
nucleosome ratios of more than 500:1 (74). In contrast to HP1,
the linker histone H1 binds very efficiently to chromatin fibers
even at a molar ratio of 2:1 (Fig. 2D, lane 3). From these
experiments we concluded that HP1 requires high-affinity
docking sites in order to bind with a recognizable strength to
chromosomal arrays.
One of the best-characterized binding sites for HP1 in
vivo is an H3 molecule that is methylated at K9 (40, 52). The
enzyme responsible for creating the site in a living cell is the
histone methyltransferase SU(VAR)3-9, which interacts
with HP1 and has been suggested to create an autoregula-
tory loop that helps in maintaining the methylated state of
heterochromatin (60). We wanted to generate a high-affinity
binding site for HP1 by reconstituting chromatin using in
vitro-methylated recombinant histones. To do this we used
recombinant SU(VAR)3-9 (20) to methylate a mixture of
four recombinant expressed core histones that were recon-
stituted into octamers (44). Subsequently, the recombinant
SU(VAR)3-9 as well as the cofactors S-adenosylmethionine
and S-adenosylhomocysteine were separated from the his-
tone octamer using a cation exchange resin (70). Only his-
tone preparations that contained no detectable SU-
(VAR)3-9 protein (as measured by Western blotting) were
used for subsequent experiments. The purified histones
were analyzed by mass spectrometry, which showed that
more than 85% of all H3 molecules were methylated at K9,
with more than 80% carrying two or three methyl groups
(Fig. 2A, right panel and MALDI-TOF spectrum). No other
lysine in H3, H2A, H2B, or H4 was found to be methylated,
and no SU(VAR)3-9 was detectable in the purified histones
(data not shown). The highly methylated histone octamers
were then used to assemble chromatin fibers as described
above. Micrococcal nuclease digestion showed that the
methylated chromatin has a similar spacing and sensitivity
toward the nuclease (Fig. 2B, right panel, compare lanes 2
to 4 and 5 to 7). However, despite the high content of
methylated H3, recombinant HP1 showed only a weak bind-
ing that was independent of histone methylation and was
even weaker than its affinity to free DNA (Fig. 2C). From
these experiments we concluded that HP1 either binds to
methylated histones before assembly of chromatin or it re-
quires additional factors for the binding to its substrate.
In addition to its interaction with the methylated H3 tail,
HP1 has also been shown to interact with core residues of H3
and H1 (51), which are buried within chromatin, suggesting
that HP1 may bind to H3 before assembly. In order to test this
hypothesis, we had to use a different assembly method, as we
reasoned that the HP1 binding would not sustain the high salt
concentration during the salt assembly reaction. Therefore, we
used a S150 chromatin assembly extract from early Drosophila
embryos (6) that allowed us to assemble chromatin at lower
salt concentrations (less than 100 mM) (Fig. 3A). However,
even though recombinant HP1 was added at the same time as
the assembly extract, we could detect only a weak association
of HP1 with the assembled chromatin (Fig. 3C, lane 3). As we
have previously shown that histones from early Drosophila
embryos contain less than 5% H3K9 methylation (7), we added
either unmodified or in vitro-methylated histones to the extract
before the assembly reaction (Fig. 3C, lanes 4 and 5). The
addition of exogenous histones led to a slight decrease in
sensitivity towards MNase (Fig. 3B, compare lanes 2, 3, and 4
with lanes 6, 7, 8, 10, 11, and 12). However, we could not
observe any difference in nucleosomal repeat length when sup-
plementing the S150 with either unmodified or H3K9Me
octamers. MS analysis of the chromatin after assembly showed
that it contained K9-methylated chromatin only when the in
vitro-methylated histones were added (data not shown), indi-
cating that the exogenously added histones are incorporated by
the assembly extract. Under these conditions, HP1 bound to
chromatin arrays where methylated octamers were added be-
fore the assembly reaction but only weakly interacted with
chromatin to which unmodified histones were added (Fig. 3C,
compare lanes 4 and 5). A quantification of this experiment
is shown in Fig. 3D. There is 10 times more HP1 bound to
H3K9Me chromatin than to unmodified chromatin. As we
assembled chromatin using a heterogeneous extract we
could not directly conclude from these experiments whether
HP1 bound to the methylated H3 before the assembly or
whether the binding was enhanced by the action of accessory
factors. To distinguish between these two possibilities, we
assembled chromatin from unmodified or methylated his-
tones by salt dialysis and added S150 extract together with
recombinant HP1 after the assembly reaction. It turned out
that the S150 extract was able to facilitate HP1 binding to
methylated chromatin even at concentrations that were not
sufficient to assemble nucleosomes in vitro (Fig. 4). As chro-
matin assembly is ATP dependent, we wondered whether
the loading process required ATP hydrolysis. The addition
of ATP stimulated binding of HP1 to the nucleosomal array
irrespective of its methylation state (Fig. 4B, compare lanes
4 and 6). The stimulation of HP1 binding to the methylated
chromatin, however, was not dependent on ATP hydrolysis
(Fig. 4B, compare lanes 5 and 7). A quantification of this
HP1 binding experiment is shown in Fig. 4C. In the presence
of an assembly extract HP1 is bound more than 11 times
better to H3K9Me chromatin compared to unmodified chro-
matin. From these results we reckoned that the assembly
extract does indeed contain factors that facilitated HP1
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FIG. 2. Generation of H3K9-methylated chromatin. (A) To the left is a Coomassie blue-stained SDS–15% PAA gel of reconstituted unmod-
ified (lanes 1 and 2) and H3K9-methylated (lanes 3 and 4) octamers. Displayed in the lower panel is a MALDI-TOF analysis of H3 peptide 9-17
from unmodified H3 (top) and H3 methylated at K9 (bottom). As an internal standard we show H3 peptide 41-49. Unmodified and mono-, di-,
and trimethylated peptides with corresponding mass are labeled with arrows. The masses of unmodified and monomethylated peptide 9-17 are
higher than those of di- and trimethylated peptide because the free N-terminal amines are propionylated. The quantification of the MALDI-TOF
analysis is shown in the upper right panel. (B) Scheme of our chromatin reconstitution protocol. The DNA used for chromatin reconstitution is
a linearized biotinylated fragment containing 12 repeats of the 5S nucleosome positioning sequence (69). A micrococcal digestion pattern of
salt-reconstituted chromatin with unmodified or in vitro methylated histones is shown on the right. MW, molecular weight. (C) HP1 was assayed
for binding to unmodified chromatin (lane 2), H3K9Me chromatin (lane 3), DNA immobilized on paramagnetic beads (lane 4), and beads alone
(lane 5). Bound HP1 was separated by SDS–15% PAGE and visualized with an HP1 polyclonal antibody. The bottom panel shows the
corresponding histones stained with Coomassie blue. Boiling of the streptavidin-coated beads resulted in the release of a strongly stained band with
an apparent molecular weight similar to that of H4, which is therefore labeled H4/streptavidin (strep.). InP, input. (D) The same assay as described
for panel C was performed with histone H1, also visualized by Coomassie blue. MM, molecular mass.
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binding to the methylated H3 tail and that can assist HP1
binding to assembled chromatin. The presence of ATP in
the reaction moderately stimulates the affinity of HP1 to
chromatin but does not increase the specific binding to
methylated chromatin.
As discussed above, HP1 has three domains, all of which are
involved in HP1 function. The CD binds histone H3 methyl-
ated at K9, the hinge domain is important for DNA and RNA
binding, and the CSD carries a protein-protein interaction
domain. In order to get more insight into the nature of HP1
binding to methylated chromatin, we expressed and purified
mutant HP1 proteins (Fig. 5A and B) and added them to a
chromatin assembly reaction as shown in Fig. 3A. As has been
reported before (35), a V26M mutation within the CD of HP1
prevented binding to a peptide containing methylated K9 (Fig.
5C, lane 7). This mutation also resulted in a reduction of HP1
binding to the methylated chromatin (Fig. 5D, lane 6). A point
mutation of W to A at position 200 in the CSD of HP1 that has
FIG. 3. Reconstitution of methylated chromatin using an S150 Dro-
sophila assembly extract and HP1 binding. (A) Scheme of the assay.
(B) Micrococcal digestion pattern of chromatin assembly reactions as
described for panel C, without HP1 added. MNase digestions were
stopped after 30, 60, and 300 s. Assembly of circular DNA was used as
a control. MW indicates lanes containing the 123-bp ladder as size
marker. Unmod., unmodified. (C) Chromatin was reconstituted on a
2-g linearized biotinylated fragment containing 12 repeats of the 5S
nucleosome positioning sequence bound to paramagnetic beads in the
presence or absence of 2 g of HP1 for 6 h at 26°C. Before assembly,
2 g of unmodified (lane 4) or H3K9Me (lane 5) histone octamers was
supplemented to the extract. The paramagnetic beads were washed,
and proteins remaining on the beads were separated on an SDS–15%
polyacrylamide gel. HP1 was visualized with an HP1 polyclonal anti-
body. The corresponding histones were stained by Coomassie blue.
Endogenous (endog.) HP1 from the assembly extract and recombi-
nantly added HP1 are labeled. InP, input. (D) The graph corresponds
to quantification of bound HP1 from panel C. Recombinant and en-
dogenous HP1 are included in the quantification. The y axis displays
the percentage of input bound. The graph is representative of three or
more different experiments.
FIG. 4. HP1 is bound to salt-assembled chromatin in the presence
of Drosophila assembly extract. (A) Scheme of the assay. (B) Salt-
assembled unmodified or H3K9Me chromatin attached to paramagnetic
beads was incubated for 1 h at 26°C with HP1, plus and minus Drosophila
(D.) assembly extract. The reactions were carried out in the presence of
ATP or nonhydrolyzable ATP--S analog (S ATP). The assembly extract
added was less than 5% of what is needed for the assembly reaction in Fig.
3. HP1 was detected with HP1 polyclonal antibody, and corresponding
histones were detected with Coomassie blue. Nucl, nucleosome.
(C) The graph corresponds to quantification of bound HP1 as shown
in Fig. 3B. The y axis displays the percentage of input bound. The
graph is representative of at least four individual experiments.
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been shown to selectively interfere with the interaction be-
tween HP1 and associated proteins (8) also resulted in a loss
of HP1 binding to methylated chromatin (Fig. 5D, lane 7),
despite its ability to interact with the methylated peptide
(Fig. 5C, lane 10). A quantification of this experiment is
shown in Fig. 5E. These results pointed towards a protein-
protein interaction rather than an HP1 DNA or HP1 RNA
interaction playing a key role in the loading of HP1 to
heterochromatin.
Several chromatin-associated factors have been suggested to
play a role in heterochromatin formation and its function (55,
59). The chromatin-remodeling factor ACF consisting of the
ISWI ATPase and the regulatory ACF1 protein is very abun-
dant in early Drosophila embryos. A mutation in the gene
ACF1 of Drosophila has been identified as a suppressor of
position effect variegation, which places ACF1 in the same
genetic pathway as HP1 (24). Mammalian ACF1 has been
shown to colocalize with HP1 in NIH 3T3 cells and is sug-
gested to have a role in replication of heterochromatin (11). As
we have observed a strong impairment of chromatin binding of
HP1 mutants that carry a mutation within the CSD, we first
investigated whether recombinant ACF was able to interact
directly with HP1 and whether this interaction was mediated by
the CSD. We purified an ACF complex using a baculoviral
system expressing a FLAG-tagged ACF1 protein together
with untagged ISWI (Fig. 6A), and the immobilized complex
was then incubated with various HP1 mutant proteins. We
could detect binding of HP1 to the reconstituted ACF com-
plex (Fig. 6B) as well as to the isolated ACF1 subunit (Fig.
6C). Consistent with previous findings showing that most
heterotypic protein-protein interactions with HP1 are me-
diated by the CSD (67), the ACF1-HP1 interaction was also
mediated by this domain, as the point mutation within the
CSD motif impaired the interaction (Fig. 6B and C, com-
pare lanes 3 and 6 with lane 9). The fact that the isolated
ACF1 subunit is sufficient for the HP1 binding may explain
the specific effect of an ACF1 mutation on heterochromatin
formation (24). In order to map the interaction domain
within ACF1 that is responsible for the HP1 interaction, we
performed GST pulldown experiments using GST-HP1 and
in vitro-translated ACF1 fragments (Fig. 6D). In these ex-
periments we could detect binding of all fragments contain-
ing amino acids 202 to 468 (Fig. 6E and F).
The region responsible for ACF1 binding to HP1 contains
the evolutionarily conserved DDT motif (14), suggesting that
this motif most likely represents an HP1 interaction domain.
For Drosophila ACF1, the region containing the DDT motif
has been shown to be required for ISWI interaction (16, 25).
Another prominent factor that is known to interact with
HP1 in vivo and which plays an important role in hetero-
chromatin formation is the histone methyltransferase
SU(VAR)3-9 (1, 60). We performed protein-protein inter-
action assays using different SU(VAR)3-9 or HP1 mutants
in order to biochemically map the interaction regions for
each protein. The N terminus of SU(VAR)3-9 was necessary
for its association with HP1 (Fig. 7A), while the CSD of HP1
was required for SU(VAR)3-9 binding (Fig. 7B). This further
demonstrated the importance of the HP1 CSD for protein-
protein interaction (8, 41, 72). The in vivo target loci of HP1
and SU(VAR)3-9 have been mapped in Drosophila Kc cells
FIG. 5. Expression of HP1 mutant proteins and binding of these to
H3K9Me chromatin during assembly. (A) Scheme of HP1 mutants gen-
erated. (B) Coomassie blue-stained 15% SDS-polyacrylamide gel of the
purified HP1 proteins. MM, molecular mass. (C) Peptide pulldown of the
recombinant HP1 WT and mutants using H3 peptide aa 1 to 21, unmod-
ified (WT) versus trimethylated at K9 (H3K9triMe). Bound HP1s were
visualized by use of Coomassie blue. InP, input. (D) Drosophila assembly
reaction with 2 g H3K9Me octamer as described for Fig. 3A. In lanes 1
to 3, 2.5% HP1 input was used. Lanes 4 to 7 correspond to proteins bound
after 6 h of incubation. HP1 was detected with HP1 polyclonal antibody,
and the corresponding histones were stained with Coomassie blue. Bound
exogenous and endogenous (endog.) HP1 present in theDrosophila assem-
bly extract are labeled. (E) The graph corresponds to quantification of bound
HP1 from panel D. Recombinant and endogenous HP1 are included in the
quantification. The y axis displays percentage of input bound. This quantifi-
cation is representative of at least three different experiments.
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(27). HP1 and SU(VAR)3-9 colocalized at multiple sites, sug-
gesting a possible targeting of HP1 by SU(VAR)3-9, but the
fact that HP1 can also be found at other chromatin sites sup-
ports the idea that SU(VAR)3-9 binding is not the sole way of
stabilizing HP1 binding to chromatin. We therefore tested
whether the known SU(VAR) proteins ACF1 and
SU(VAR)3-9 could facilitate HP1 binding to methylated chro-
matin in vitro. In order to do this, we used salt-assembled
FIG. 6. HP1 interacts with the ACF complex and ACF1. (A) Coomassie-stained SDS–8% PAA gel of FLAG affinity-purified recombinant
ACF1 and ACF complex from Sf9 cells coinfected with FLAG-ACF1 in the presence or absence of untagged ISWI. MM, molecular mass. (B) HP1
pulldown with FLAG beads incubated with mock Sf9 extract or extract containing FLAG-ACF1 and untagged ISWI. After extensive washing, the
protein remaining on the beads was separated by SDS–12% PAGE, imunoblotted, and detected with HP1 antibody. Asterisks indicate FLAG
antibody light chains. Inp, input. (C) Western blot of HP1 pulldown using FLAG beads incubated with mock Sf9 extract or extract containing
FLAG-ACF1. Asterisks indicate FLAG antibody light chains. (D) ACF1 constructs used for in vitro translation. (E) GST and GST-HP1 pulldown
with in vitro translated ACF1 constructs. (F) Quantification of the binding affinities of the various ACF constructs. Error bars represent standard
deviations from three independent pulldown experiments.
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chromatin that contained either methylated or nonmethylated
histones and added recombinant HP1 together with recombinant
SU(VAR)3-9 or ACF (Fig. 8A). Consistent with the model that
HP1 requires multiple binding sites for efficient chromatin bind-
ing, we observed an increased association of HP1 with methylated
chromatin when ACF complex (Fig. 8B, lane 5, and 8C [quanti-
fication]) or SU(VAR)3-9 (Fig. 8D, lane 5, and 8E [quantifica-
tion]) was present. This was not due to an intrinsically higher
affinity of the auxiliary factors to methylated chromatin, as both
bound efficiently to the chromatin fiber independently from its
modification state (Fig. 8B, compare lanes 4 and 5, and 8D,
compare lanes 4 and 5). We also found that neither ATP nor
HMTase activity was required for preferential binding of
HP1 to methylated chromatin (Fig. 8B and 8D, compare
lanes 5 and 7).
This evidence suggests that only the protein-protein inter-
action served as a second binding site within chromatin and
stabilized the interaction of HP1 and the methylated chroma-
tin. This finding is further strengthened by the observation that
a mutation in the CSD of HP1 (W200A) that no longer inter-
acts with SU(VAR)3-9 has a reduced binding affinity towards
methylated chromatin (Fig. 8F, compare lanes 3 and 9).
DISCUSSION
It is of critical importance to understand how epigenetic
information is stored and maintained. The finding that a com-
binatorial aspect of histone modification can contribute to this
epigenetic information processing therefore represents a very
attractive model (37, 71). However, it has not been shown so
far how epigenetic marks in the form of specific histone mod-
ifications can be “read” within a defined chromatin context and
how the factors that can bind specifically to these marks access
them. We reconstituted HP1 containing chromatin fibers in the
test tube using a highly purified reconstituted system contain-
ing unmodified histones with H3 molecules that are methyl-
ated at K9, recombinant HP1 and two known SU(VAR) pro-
teins, ACF and SU(VAR)3-9. Both factors bind chromatin in
a methylation-independent manner and can interact simulta-
neously with HP1 via the CSD of HP1. These findings suggest
a bimodal interaction of HP1 with chromatin, in which a single
binding site is not sufficient to stably anchor HP1 to chromatin.
It is important to mention that the binding assay we are using
throughout the study is not an equilibrium binding assay. As
HP1 could bind to methylated chromatin with high affinity but
FIG. 7. HP1 interacts with SU(VAR)3-9. (A) SU(VAR)3-9 constructs used for in vitro translation and GST constructs are shown at the top.
The GST pulldown is shown at the bottom. SU(VAR)3-9 was detected by autoradiography. CHROMO SH., chromo shadow. (B) The upper panel
shows GST constructs used for the pulldown experiment. The lower panel represents an HP1 Western blot of GST pulldown with recombinant
HP1 WT (lanes 1 to 3), HP1 (V26M) (lanes 4 to 6), and HP1 (W200A) (lanes 7 to 9). HP1 was detected with HP1 polyclonal antibody.
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FIG. 8. SU(VAR) 3-9 and ACF facilitate HP1 binding to H3K9Me chromatin. (A) Scheme of the assay. (B) Salt-assembled unmodified or
H3K9Me chromatin bound to paramagnetic beads was incubated with HP1 in the presence or absence of ACF and ATP for 1 h at 26°C. After
washing, the proteins remaining on the paramagnetic beads were separated by SDS–15% PAGE. ACF1 was detected with FLAG antibody, and
HP1 was detected with HP1 polyclonal antibody (upper panels). The corresponding histones were detected with Coomassie blue (bottom panel).
Lane 1 corresponds to 50% ACF input (InP) and 2.5% HP1 input. Nucl, nucleosome. (C) The graph displays bound HP1 as a percentage of input
as shown in panel B. The y axis corresponds to percent input bound. The graph is representative of at least two individual experiments.
462 ESKELAND ET AL. MOL. CELL. BIOL.
with rapid association and dissociation rates, we actually de-
tected the rate of dissociation of HP1 from chromatin. The
auxiliary factors may increase the average time HP1 resides at
methylated chromatin, which may be essential for heterochro-
matin formation.
These findings are in accordance with observations in vivo
showing that HP1 can be released from its binding sites either
by a peptide resembling the H3 N terminus that is methylated
at K9 (5, 49), by treatment with RNase (45), or by a peptide
that mediates the interaction with an associated factor (4). Our
data provide a biochemical explanation for these seemingly
contradictory observations.
HP1 is considered a major component of constitutive het-
erochromatin (56). Despite an enormous wealth of data re-
garding the localization of HP1 in vivo, the molecular details of
how HP1 recognizes pericentric heterochromatin have been
sparse. Our data show that even though HP1 is able to bind
histones that are methylated at K9 when they are incorporated
into chromatin, the affinity is rather weak and presumably not
sufficient to maintain a heterochromatic structure in vivo or in
vitro. This is in perfect agreement with biophysical studies that
have measured a dissociation constant for H3K9-methylated
peptides between 2 M (nuclear magnetic resonance) (52) and
100 M (isothermal titration calorimetry) (34), which is rather
high compared to other protein-protein or protein-DNA inter-
actions. Considering the picomolar constant for dissociation of
a histone tail from the DNA (33) and the fact that histone tails
can be UV cross-linked to DNA in vivo and in vitro (3), it is
difficult to envision efficient binding of HP1 to the methylated
tail only. The weak interaction and the corresponding low
occupancy time at a given binding site is presumably also the
reason for the dynamic nature of HP1 in the nuclei of eukary-
otic cells (10, 23).
Our data also suggest that an efficient binding of HP1 to
chromatin can be achieved only when several binding sites are
present within the chromatin substrate. It had previously been
reported that the general affinity of HP1 to mononucleosomes
is rather low and independent of the histone tails (74). In
contrast to this, native chromosomal fibers can be purified with
reasonably efficiency using immobilized HP1 molecules (46).
In our fully defined reconstituted system we also detected only
weak binding of HP1 to chromatin that was moderately stim-
ulated when the H3 tail is fully methylated at K9. This binding
of HP1 to methylated chromatin was stimulated by the addi-
tion of factors that were able to bind HP1 and chromatin at the
same time, thereby enhancing the affinity of HP1 to chromatin.
A mutational analysis of the ability of the factors to load HP1
to methylated chromatin showed that the physical interaction
with HP1 is required for their activity to assist HP1 binding. It
may be that the native fibers still contain such additional fac-
tors and therefore increase the affinity of HP1 for heterochro-
matin.
HP1 has been shown to interact with several factors via its
CSD (64), and the binding site is reconstituted by both HP1
molecules within the HP1 dimer (67). This interaction domain
is required for heterochromatin localization in vivo as mutant
HP1 proteins that can no longer form this domain also do not
associate stably with centromeric heterochromatin or telo-
meric regions (22, 67). We also observe this failure of a HP1
mutant in the CSD to bind K9-methylated chromatin when
assisted by a Drosophila S-150 chromatin assembly extract. This
observation led us to the conclusion that HP1 has to interact
with a factor present in this extract to bind methylated chro-
matin.
The two candidate factors that we used in order to test their
ability to assist HP1 in its binding to K9-methylated chromatin
both show a SU(VAR) phenotype when mutated in Drosophila
melanogaster (24, 68). One, ACF1, has been shown to be a
major chromatin assembly factor in Drosophila and has an
effect on position effect variegation (24). In human cells, ACF1
has also been shown to colocalize with HP1 (11). ACF1 has
been shown to bind DNA via its WAC domain (25) and to
interact with histone molecules via its PHD fingers (16). Those
two domains are presumably responsible for its interaction
with the chromatin template. It is intriguing that the region
spanning the DDT motif, which we found crucial for interac-
tion with HP1, does not seem to be involved in binding to the
chromatin substrate and could therefore be used to recruit
HP1 to chromatin. It is tempting to speculate that ACF1-HP1
interaction may increase the local concentration of HP1 within
heterochromatin, where the binding could be stabilized by its
interaction via the CD with chromatin methylated at K9.
The second factor that we have tested is the histone meth-
yltransferase SU(VAR)3-9. SU(VAR)3-9 is responsible for
methylating H3 at K9 (60), thereby generating a potential
binding site for HP1 within heterochromatin. SU(VAR)3-9
interacts with HP1 via the N terminus, and it has been sug-
gested that this interaction serves as an autoregulatory loop,
helping to maintain the methylated state of heterochromatin
(60). We observed a high affinity of full-length SU(VAR)3-9
for in vitro assembled chromatin irrespective of its methylation
state. Similar to our observations for ACF, described above, we
also see increased binding of HP1 after adding SU(VAR)3-9
that is independent of its ability to methylate H3. However,
when the interaction between SU(VAR)3-9 and HP1 was im-
paired due to a mutation either in HP1 or in SU(VAR)3-9, no
increase in binding of HP1 to methylated chromatin could be
observed. This additional function of SU(VAR)3-9 in stabiliz-
(D) SU(VAR)3-9 couples HP1 to chromatin. HP1 was incubated with unmodified or H3K9Me chromatin in the presence of recombinant
SU(VAR)3-9 WT (lanes 4 to 7) or 213 (lanes 8 and 9). The SU(VAR)3-9-specific HMTase inhibitor Chaetocin was added to a concentration
of 1 M (lanes 6 and 7). The remaining SU(VAR)3-9 and HP1 on paramagnetic beads was detected by Western analysis, and the histones were
detected with Coomassie blue. Lane 1 corresponds to 100% SU(VAR)3-9 input and 2.5% HP1 input. (E) Quantification of HP1 bound as shown
in panel D. The graph is representative of at least three individual experiments and displays percent input bound. (F) SU(VAR)3-9 was added in
the presence of HP1 WT (lanes 1 to 3), HP1 (V26M) (lanes 4 to 6), and HP1 (W200A) (lanes 7 to 9) to unmodified and H3K9Me chromatin.
Bound SU(VAR)3-9 and HP1 were detected by Western analysis, and histones were detected with Coomassie blue. (G) The graph corresponds
to total HP1 binding as shown in panel F. The y axis displays percent input bound. The graph is representative of at least two individual
experiments.
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ing HP1 binding could help explain the strong dose depen-
dency the gene has, which is rather unusual for enzymatic activity.
This may also be an explanation that some hypomorphic alleles of
SU(VAR)3-9 can be isolated that show a Su(var) phenotype
despite having normal HMTase activity (17).
The finding that HP1 binding is not only dependent on
methylation at H3K9 but also requires additional auxiliary
factors explains many in vivo observations that have been pre-
viously considered to be contradictory. It would also enable a
cell to fine-tune its level of heterochromatin in response to
external signals by modulating the different binding sites of
HP1 within chromatin. We tested two known chromatin-asso-
ciated factors for their ability to help increasing the affinity of
HP1 to methylated chromatin. However, there may be addi-
tional factors and probably redundant mechanisms that can
help loading HP1 to chromatin. It will be interesting to see
whether the different targeting factors have different contribu-
tions to the localization of HP1 at different stages of the cell
cycle, during different stages of development, or in different
cell types. Our in vitro system for looking at HP1 binding to
methylated chromatin will certainly be useful for identification
of additional targeting factors in the future.
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ABSTRACT
Mammalian G9a is a histone H3 Lys-9 (H3–K9)
methyltransferase localized in euchromatin and
acts as a co-regulator for specific transcription
factors. G9a is required for proper development in
mammals as g9a/g9a mice show growth retar-
dation and early lethality. Here we describe the
cloning, the biochemical and genetical analyses of
the Drosophila homolog dG9a. We show that dG9a
shares the structural organization of mammalian
G9a, and that it is a multi-catalytic histone methyl-
transferase with specificity not only for lysines 9
and 27 on H3 but also for H4. Surprisingly, it is not
the H4–K20 residue that is the target for this methy-
lation. Spatiotemporal expression analyses reveal
that dG9a is abundantly expressed in the gonads
of both sexes, with no detectable expression in
gonadectomized adults. In addition we find a low
but clearly observable level of dG9a transcript in
developing embryos, larvae and pupae. Genetic and
RNAi experiments reveal that dG9a is involved in
ecdysone regulatory pathways.
INTRODUCTION
Modifications of histones are an important mark for transcrip-
tional regulation during embryonic development. The pro-
truding tales of the histones are modified by acetylation,
phosphorylation, ubiquitination and arginine and lysine
methylation, and the combinations are hypothesized to form
a histone code (1,2). The best-characterized substrates for
lysine methylation in eukaryotic cells are histone proteins,
although methylation of several non-histone proteins, such
as the tumor suppressor p53, has been reported as well (3).
Histone H3 has been shown to be methylated on lysine
residues K4, K9, K27, K36 and K79 whereas in histone
H4, K20 is methylated (4,5). Each of these lysine side chains
can be mono-, di- or tri-methylated by histone lysine methyl-
transferases (HKMTases), which, except for Dot1 (6), carry a
catalytic SET [Su(var), Enhancer of Zeste, Trithorax] domain
(7). The SET domain is a conserved 130 amino acid
sequence, which is flanked by the less conserved pre-SET
and post-SET regions at the amino and C-termini, respec-
tively. The specificity of a HKMTase, as well as the number
of methyl residues that attaches to a lysine residue, depends
on the structure of the HKMTase or the presence of additional
co-factor proteins (8). On the other hand Ezh2 requires the
presence of the co-factors suppressor of zeste-12 (SUZ12)
and embryonic ectoderm development (Eed) for tri-
methylation of H3–K27 (9). The HKMTase ERG-associated
protein (ESET) di-methylates H3–K9, but is converted into
a tri-methylating enzyme by its association with a mouse-
activating transcription-factor-associated modulator (mAM)
(10). The methylated histones recruit proteins that carry
CHROMO, TUDOR or WD40 domains and are capable of
specific interactions with differently methylated lysine resi-
dues reviewed in Ref. (11). This recruitment step is likely
to define a unique functional readout for individual lysine
methylations. Thus, tri-methylation of lysine 9 in histone
H3 by Suv39H1 and Suv39H2 creates a binding site for the
chromodomain-containing heterochromatic protein HP1
which is thought to induce heterochromatin formation (12).
Di-methylation of H3–K9 by G9a is associated with the
silencing of euchromatic genes (13).
Mammalian G9a mono- and di-methylates H3–K9 at
euchromatic loci (14,15), and has recently also been found
at heterochromatic loci (16). In g9a/g9a mice H3–K9
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methylation is drastically reduced resulting in severe growth
retardation and early lethality (17). The loss of G9a primarily
affects the methylation of H3–K9 in euchromatic regions
(14). G9a is the major euchromatic histone H3–K9 methyl-
transferase in higher eukaryotes but in Drosophila the
euchromatic H3–K9 HKMTase has not been characterized.
Although the H3–K9 methylation is strongly reduced in
Su(var)3–9 null mutants, a small amount of H3 molecules
remain methylated at K9 suggesting the existence of other
K9 specific HKMTases in Drosophila (18).
There are several reports demonstrating the silencing
effects from H3–K9 methylation, including the inactive X
chromosome of female mice and humans (19), and develop-
mentally regulated genes (20).
In a search for SET domain containing genes in Drosophila
that might code a K9 specific HKMTase, we performed
a bioinformatics search of the Drosophila melanogaster
genome and found the gene CG2995 which share significant
homology to mammalian G9a. In this paper we describe the
cloning, and the biochemical and genetical analyses of
CG2995. We show that it encodes a histone methyltransferase
specific for H3–K9, K27 and H4, and that it shares the
structural organization of mammalian G9a. Therefore, we
suggest that CG2995 is renamed dG9a. It adds up to three
methyl groups to unmethylated H3 and H4. Our results
indicate a role for dG9a in germ cell formation. Using
RNAi we show that dG9a is critical for development, very
likely by being involved in the ecdysone regulated gene
expression.
MATERIALS AND METHODS
Fly handling and generation of transgenic flies
All genetic crosses were carried out at 25C. Fly lines were
obtained from the Bloomington Drosophila stock centre.
Generation of double stranded (ds) RNA was performed by
using the pHIBS and pUds-GFP vectors as described in
Ref. (21). A 756 bp fragment of dG9a cDNA was PCR
amplified with the 2995UBamHI (50-CAAGGATCCTGTCG-
CACTTCTCGTTCATC-30) and 2995LKpnI (50-TGCGGTA-
CCTGCTGGATAATGCATTGTGTT-30) primers.
Transgenic flies were generated by P-element mediated
transformation, and nine independent lines on different
chromosomes were established, including the 2995-18 line
used in this study. The GAL4-UAS system (22) was used
to express dG9a.IR construct, and Act5C-GAL4 (BL 4414),
da-GAL4 (BL 5460), P{GawB}c698a (BL 3739), and
ap-GAL4 (BL 3041) were used as drivers. As control the
2995-18 line without driver was used.
The ap-GAL4,UAS-dG9a.IR/EcRM554fs flies were generated
by standard genetic procedures.
Bioinformatics tools
Database searches were performed using BLASTP,
TBLASTN and PSI-BLAST (http://www.ncbi.nlm.nih.gov/
BLAST/). Protein domains were identified using the
programs RPS-BLAST (NCBI) and ProfileScan (http://hits.
isb-sib.ch/cgi-bin/PFSCAN) searching the Pfam-A, Prosite
profiles and Smart databases (NCBI). Nuclear localization
signal was detected by using PredictNLS (http://cubic.bioc.
columbia.edu/predictNLS/). Amino acid sequence alignments
were created using ClustalX 1.8 (http://www-igbmc.
u-strasbg.fr/BioInfo/ClustalX) with default parameters and
manual adjustments from GeneDoc 2.6.001 (http://www.
psc.edu/biomed/genedoc/).
Rapid amplification of cDNA ends (RACE) analyses
50-RACE and 30-RACE were performed using a Marathon
cDNA Amplification Kit (Clontech) with 2 mg of total RNA
isolated from adult female flies as template and Advantage
2 Polymerace Mix in accordance with the manufacturer’s rec-
ommendations. RACE PCR products were sequenced using a
MegaBACE 1000 sequencer.
Sequences of primers used for RACE analyses are
available on request. DNA and amino acid sequences derived
from the cDNAs were compared and analyzed with the
GenBank database.
RT–PCR
Testes and ovaries from adults were dissected in Ringer’s
solution (6.5 g NaCl, 0.14 g KCl, 0.2 g NaHCO3, 0.12 g
CaCl2 and 0.01 g NaH2PO4 per liter). Total RNA was isolated
from indicated tissues or stages by the use of TRIzol reagent
(Invitrogen), and 5 mg of total RNA were reverse transcribed
with SuperScript III RNase H-free reverse transcriptase
(RT) (Invitrogen). A random primer pd(N)6 was used for
first-strand synthesis. PCR was performed with 2995left
(50-GATGAACGAGAAGTGCGACA-30, located in exon 5)
and 2995right (50-GATGAACGAGAAGTGCGACA-30,
located in exon 9) primers and with rp49 primers (23)
as loading control for 35 cycles at an annealing temperature
of 56C.
Immunostainings and immunofluorescence
The anti-dG9a polyclonal antiserum was raised in rabbits
(Eurogentec S.A) against a synthetic peptide containing
dG9a residues 1623–1637. The antiserum was affinity
purified.
Polytene chromosomes from the salivary glands of third
instar larvae were prepared and stained essentially as
described in Ref. (24).
Tissues were stained with anti-dG9a (1:25). As secondary
antibodies, goat anti-rabbit IgG, conjugated with AlexaFluor
555 (MedProbe, diluted 1:200) were used. Materials were
co-stained with DAPI for visualization of DNA. Preparations
were analyzed by using a Zeiss Axiophot microscope
equipped with a KAPPA DX20C charge-coupled device
camera. Staining of larval tissues, ovaries and embryos
were performed using standard techniques with anti-dG9a,
as described above. Preparations were analyzed by using a
ZeissAxioplan2 microscope equipped with a Zeiss AxioCam
HRc camera, software: AxioVision3.1. Images were assem-
bled, contrasted and merged electronically by using
Photoshop 7.0 (Adobe Systems).
Whole-mount in situ hybridization
RNA in situ hybridization using digoxigenin-labeled anti-
sense RNA probes was performed as described previously
(25,26). A cDNA containing dG9a was linearized with
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BamHI and used as template to make a 674 bp dG9a RNA
probe.
Western analysis
Nuclear extract from 0–12 h dechorionated embryos (27) was
separated on a SDS–PAGE (8%). Proteins were transferred
onto PVDF membrane (Amersham) and probed with an
anti-dG9a antibody (1:500) using standard procedures. Sec-
ondary antibodies conjugated to HRP (Amersham) were
used according to the manufacturer’s instructions. Detection
of antibody signals was performed with chemiluminescence
(Pierce).
Generation of baculovirus, viral transfection and
dG9a purification
Amino acids 789–1637 of dG9a was PCR amplified with the
primers 2995 SpeIFlag (50-GACTACAAGGACGACGATG-
ACAAGATTTGTCTATGTCAGAAGCCTTCC-30, FLAG tag
sequence underlined) and 2995 KpnI (50-TGCGGTACCCTA-
CGCGTGTCCAATTTTCT-30) cloned into pFastBac(tm)1
(Invitrogen) as a SpeI/KpnI fragment. Site-directed mutage-
nesis of flag-dG9a (789–1637 amino acid) was performed
using the QuickChange kit (Stratagene) with primers
CG2995H1536KBstNIfwd (50-ATGGAAATGTAACCAGG-
TTTTTTAACAAGTC GTGTGAGCCGAATG-30) and
CG2995H1536KBstNIrew (50-CATTCGG CTCACACGAC-
TTGTTAAAAAACCTGGTTACATTTCCAT-30).
FLAG tagged dG9a in pFastBacTM1 was transformed into
DH10Bac (Invitrogen) and bacemid purified according to
protocol (Invitrogen). A monolayer of SF9 (Spodoptera
frugiperda) (9 · 105) was transfected with 1 mg of bacemid
using Cellfectin Reagent (Invitrogen) and cells were left for
7 days at 26C. The supernatant was amplified 2–3 times
and recombinant viruses were used for test expression. Cell
extracts were checked, 48 h post-transfection, for fusion pro-
tein expression using anti-FLAG monoclonal antibody
(Sigma). For routine protein expression 10 · 150 mm Petri
dishes were infected and the cells kept at 26C. The cells
were harvested 48 h post-infection and washed once with
1· phosphate-buffered saline. For purification of FLAG-
dG9A protein, infected cells (1.2 · 108) were resuspended
in 4 ml of BC300 [25 mM HEPES (pH 7.6), 300 mM
NaCl, 1 mM MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 10%
(v/v) glycerol, 1 mM DTT and protease inhibitors] containing
0.05% (v/v) NP40. The cells were sonicated on ice two times
for 15 s at 50% amplitude using a Branson sonifier and
centrifuged at 15 000 r.p.m. for 30 min and 100 ml 1:1 slurry
of M2 anti-FLAG agarose beads (Sigma) was added to the
supernatant followed by incubation for 2 h at 4C. After
washing three times with BC300 [containing 0.05% (v/v)
NP40] for 10 min each, and once with BC100 [0.05% (v/v)
NP40] the bound protein was eluted with 0.5 mg/ml FLAG
peptide BC100 [0.05% (v/v) NP40] for 2 h. The purity of
the protein was checked by SDS–PAGE. Eluates were stored
at 80C.
Histone purification and nucleosome assembly
Recombinant Drosophila histones were expressed and puri-
fied from Escherichia coli BL21(DE3)pLys, and recons-
tituted into octamers as described previously (28).
Recombinant histone H3 carrying the mutations K9A,
K27A or K9A/K27A were expressed from plasmids kindly
provided by D. Reinberg, and histone H4 carrying a
K20A mutation was expressed from a plasmid given by
T. Jenuwein. Recombinant H4 N-terminal mutant proteins
D5, D10, D15, D19 were expressed and purified as described
previously (29). Native histones were purified from 0–12 h
Drosophila embryos essentially as described in Ref. (30).
Nucleosomes were reconstituted on circular pBS(KS) (Strata-
gene) by salt dialysis over night from 2 to 0.1 M NaCl (31).
Histone methyltransferase assay
Histone methyltransferase assays were performed as
described in Ref. (32). In short, 100 ng of eluted dG9a was
mixed with 1 or 2 mg of histone H3, H4, octamer or nucleo-
somes and S-adenosyl-[methyl-3H]-l-methionine (25 mCi/ml)
(Amersham) in a buffer containing 12.5 mM Tris–HCl, pH
8.8, 1 mM DTT, 50 mM NaCl, 50 ng/ml BSA and 2.5 mM
MgCl2. The reaction was incubated at 30
C for 1 h and
stopped by adding SDS–PAGE loading buffer. The histones
were separated by 15% SDS–PAGE, Coomassie stained,
amplified and dried. The autoradiograph was developed
after 1 and 2 weeks. For experiments with mouse G9a, we
used 250 ng of protein and the incubation time was 30 min.
Exposure time for autoradiograph was 1 and 2 days.
MALDI-TOF analysis
Methylation reactions were carried out as described above
with 0.5 mg of histone H3 or H4 and 250 mM of
S-Adenosylmethionine (New England BioLabs). The reaction
was stopped by addition of SDS–PAGE loading buffer and
the histones were separated by 15% SDS–PAGE. The
Coomassie stained bands corresponding to H3 and H4 were
excised and subjected to chemical modification to derive
free amino groups of lysine residues as described previously
(33). H3 and H4 were digested over night with 100 ng of
sequencing-grade trypsin (Promega) in a total volume of
40 ml according to manufacturer’s protocol. In order to purify
the methylated peptides from contaminating salts or acry-
lamide the peptide solution was passed over a pipette tip
containing C18 material (ZipTip, Millipore) and eluted as
described previously (32). The MALDI spectra were acquired
and analyzed as described previously (34). Reaction mix
without enzyme was used for calibration. Quantification
was performed as previously described in Ref. (35).
Ecdysone feeding experiments
The feeding experiments were performed essentially as
described in Ref. (36).
RESULTS
CG2995 is the Drosophila homolog of the mouse
G9a HKMTase
We performed a bioinformatics search of the D. melanogaster
genome with the Su(var)3–9, E(Z) and Trithorax SET
domains and found novel genes encoding putative SET pro-
teins. Performing a BLASTP search with the SET domain
of one of these proteins, the annotated CG2995 protein,
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against the mouse and human database identified it as the
Drosophila homolog of the G9a protein. This SET domain
alone shares 61% identity (76% similarity) with the corre-
sponding domain of the mouse G9a protein (Figure 1A). In
comparison, the SET domain of CG2995 shares 45% identity
with the SET domain of the Su(var)3–9 protein of
Drosophila, suggesting that CG2995 is the only homolog of
G9a in the Drosophila genome. This is emphasized when
looking at the pre-SET/SET/post-SET regions, where it is
notable that CG2995 is more similar to mouse G9a than to
Su(var)3–9 or dSET2. Thus, dSu(var)3–9 versus G9a shows
37% identity, 55% similarity, dSET2 versus G9a displays
36% identity, 50% similarity, and CG2995 versus G9a has
47% identity, 68% similarity. CG2995 is located as the
third gene in region 1A1 on the X chromosome, and a further
comparative analysis of the CG2995 protein with the mouse
G9a shows that the CG2995 has 33% identity and 49% simi-
larity to the mouse protein (1172–1263 amino acid). The fly
protein is longer at the N-terminus but otherwise shares the
same module organization as its mouse counterpart. The
CG2995 protein contains multiple putative domains in addi-
tion to the SET domain, like the adjacent cysteine-rich
regions [the pre-SET (also called SAC); (37)], and conserved
cysteine residues in the C-terminal region of the SET domain
that corresponds to the post-SET domain (Figure 1A), which
has shown to be required for enzymatic activity (38).
Within the SET domain, a H(R)FFNHSC motif (where F
indicates a hydrophobic residue) has previously been shown
to be an important catalytic site. For SUV39H1 protein, a
histidine-to-arginine mutation of the first histidine (His320)
in the 320HFFNHSC326 motif resulted in a 20-fold higher
catalytic activity (38). This observation suggests that the
H(R)FFNHSC motif is correlated with the HKMTase
activity. The CG2995 protein contains a 1532RFFNHSC1538
motif (Figure 1A, underlined), together with another motif
reported to be needed for HKMTase activity, GE(x)5Y,
located in the C-terminal end of the SET domain (38;
Figure 1A, underlined).
In addition, the CG2995 protein harbors contiguous copies
of a 33-amino acid repeat (Figure 1B). This repeat, originally
identified in the Notch protein of Drosophila and known as
the ankyrin repeat, is also found in G9a and in a number of
other proteins involved in intracellular protein–protein
interactions (39).
An AT-hook also is found in the N-terminus part of the
CG2995 protein. The AT-hook is a small DNA-binding
protein motif that was first described in the high mobility
group non-histone chromosomal protein HMG-I(Y). Since
its discovery, this motif has been observed in other DNA-
binding proteins from a wide range of organisms. Further-
more, AT-hook motifs are frequently associated with
known functional domains seen in chromatin proteins and
in DNA-binding proteins (e.g. histone folds, homeodomains
and zinc fingers). In general, it appears that the AT-hook
motif is an auxiliary protein motif co-operating with other
DNA-binding activities and facilitating changes in the
structure of the DNA either as a polypeptide on its own
[e.g. HMG-I(Y)] (40) or as part of a multidomain protein
Figure 1. The domain organization is conserved between dG9a and G9a. (A) Alignment of SET domains and flanking cysteine-rich regions of mouse and
Drosophila dG9a protein. The degree of conservation is distinguished at four levels (100, 80 and 60%, and not conserved), where 100% has the darkest shade of
grey. The upper and lower case letters in the consensus line indicate 100 and 80% conservation within all groups, respectively. Numbers in the consensus line
represent conserved similarity groups as defined by the Blossum 62 scoring table. The conserved R(H)FFNHSC and the FDYG motifs are underlined.
(B) Domain organization within Drosophila protein dG9a. An AT-hook and an ankyrin motif are found in addition to the SET domain.
4612 Nucleic Acids Research, 2006, Vol. 34, No. 16
[e.g. Swi2p in Saccharomyces cerevisiae or HRX (ALL-1) in
Homo sapiens] (41). It is most interesting that this motif
seems to be specific to known or predicted chromosomal/
DNA-binding proteins, suggesting that it may act as a
versatile minor groove tether (41). A nuclear localization
signal is found in the N-terminal of the protein. In conclusion,
CG2995 has a high level of similarity to mouse G9a and we
suggest CG2995 is the Drosophila homolog of G9a and will
refer to it as dG9a.
Full-length cDNA was cloned by RACE and RT–PCR.
This cDNA revealed that the dG9a gene consists of
10 exons with a 4911 bp open reading frame (ORF) encoding
a protein of 1637 amino acid. The coding region ends by an
in-frame stop codon that is followed by a poly(A) signal 1173
downstream, suggesting that it is full-length and consistent
with the annotated sequence in FlyBase (http://flybase.bio.
indiana.edu/; Figure 1B). Northern analysis also showed
that there is only one transcript of expected size (data not
shown).
The dG9a protein localizes to euchromatin
Antibodies specific to dG9a were generated by immunization
of rabbits with a peptide corresponding to the last 14 amino
acids (1623 through 1637 amino acid). This antibody
recognized a band of the predicted size of 180 kDa
(Figure 2A). The localization of dG9a protein was investi-
gated by analysis of polytene chromosomes from salivary
glands (Figure 2B). The immunostaining showed discrete
banding pattern in euchromatic regions with no staining
observed in the chromocenter.
Spatiotemporal expression of dG9a
To investigate the spatiotemporal expression of dG9a we first
used semi-quantitative RT–PCR. As shown in Figure 3A, a
low but measurable amount of dG9a transcript is present in
0–3-h-old embryos. In 3–6-h-old embryos the expression of
dG9a is barely detectable, indicating that the dG9a transcripts
seen in 0–3-h-old embryos are of maternal origin. Between 6
and 21 h of embryogenesis the expression of dG9a is low but
clearly discernible, and about the same level of expression
is observed throughout larval development, with a slightly
elevated expression during the third larval instar. Then, in
12–46-h-old pupae there is no or very little expression of
dG9a. In adult flies the expression of dG9a is restricted
to the gonads in both sexes (Figure 3A, last four lanes).
However, we cannot rule out the possibility that dG9a is
expressed in one or more tissues of the gonadectomized
flies, but at a level too low to be detected by the RT–PCR
settings used here.
Next, in order to study the spatiotemporal expression of
dG9a in more detail, we stained ovaries and embryos with
the dG9a antibody. The immunostainings revealed that
dG9a is expressed in all cells of the ovary, including the
germarium (Figure 3C) where especially the nurse cells,
Figure 2. The dG9a protein localizes to distinct chromosome bands. (A) Antibodies against dG9a raised in rabbit are specific and recognize a single band of
180 kDa as predicted on a western blot of Drosophila nuclear extract. (B) dG9a protein (in red) localizes to chromatin and gives a distinct banding pattern on
polytene chromosomes. There is no staining in the chromocenter (arrow), and dG9a localizes predominantly to euchromatic regions. DNA is counterstained with
DAPI (in blue).
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Figure 3. Spatiotemporal expression of dG9a. (A) Developmental RT–PCR shows that dG9a is maternally deposited in the egg, and that there is moderate
expression during the larval development. dG9a is present in all developmental stages investigated. (B–K) dG9a is present from the very start of oogenesis
through the end of oogenesis in wild-type ovarioles. Anterior is to the left, posterior to the right. dG9a in red (right column) and the nuclei is counter stained with
DAPI in blue (left column). (B and C) The early stages of oogenesis development. The dG9a protein is present from the very start. (D and E) Stage 10B ovaries.
dG9a localizes to nuclei in both nurse and follicle cells. An accumulation of protein is observed in the region where the anterior polar cells and the centripetal
follicle cells are located, arrowheads and in the posterior follicle cells, arrow. (F and G) Stage 11. Shortly after centripetal migration (stage 10B), the nurse cells
rapidly transfer their contents into the oocyte (stage 11) then begin to degenerate and undergo apoptosis (stages 12–14). (H and I) Stage 12. Dumping complete,
no or very little dG9a is detectable in the degenerating nurse cell nuclei, but is still present in the follicle cells. Notice the accumulation of dG9a protein in the
extreme posterior part of the egg, arrowheads, where the posterior polar cells located. (J and K) Stage 14. The egg is fully developed and dG9a protein is
maternally deposited. (L–S) Lateral views of wild-type embryos hybridized with digoxigenin-labeled RNA probes (L and N with Nomarski optics) or with a
dG9a antibody (M, O, Q and S). Anterior is to the left and dorsal is up. The nuclei are counter stained with DAPI in blue. (L and M) Embryo at syncytial
blastoderm stage (stage 4, 1.5–2.5 h). dG9a is localized to the nuclei. In early embryos the message and the protein are ubiquitously distributed due to its
maternal contribution. (N andO) Embryo during germband extension (stage 9). (P andQ) Stage 12. In late-stage embryos, expression is strongest in the CNS and
the neuroectoderm. (K and S) Stage 13. Surface view of embryo at the completion of germband shortening.
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which undergo a dramatic endoreplication, stain heavily. It
also clearly shows that dG9a is localized to the nucleus. In
stage 10B egg chambers it appears that dG9a is markedly
upregulated in what appears to be the centripetal follicle
cells (Figure 3E, arrowheads). At this stage, a moderate
upregulation is also discernible in the posterior follicle cells
(arrow). During stage 11 nurse start dumping their content
into the oocyte, which is revealed by an accumulation of
dG9a at the border between the growing oocyte and the
degenerating nurse cells (Figure 3G). At this stage an
increased expression of dG9a is also found in the posterior
follicle cells (Figure 3G, arrow head). In stage 12 the amount
of dG9a has increased considerably and has started to move
into the oocyte. An accumulation in the posterior follicle
cells is now prominent (Figure 3I, arrow). At stage 14,
dG9a appears to be evenly distributed in the mature oocyte
(Figure 3K).
In blastoderm embryos (stage 4, 1.5–2.5 h) dG9a
transcript as well as protein are present in the syncytial
nuclei (Figure 3L and M). During stages 9 and 12, dG9a
expression appears to be more abundant in the central nerv-
ous system (CNS) and the neuroectoderm (Figure 3N, O
and Q). Figure 3S shows a surface view of embryo at the
completion of germband shortening, with all cells evenly
stained.
Expression and purification of recombinant histone
methyltransferase dG9a
In order to investigate the enzymatic properties of dG9a we
expressed a FLAG tagged N-terminal fragment (789–1637
amino acid) using a baculovirus expression system. The
purified dG9a was soluble and had the expected molecular
size of 95 kDa (Figure 4A). To confirm that dG9a has HKM-
Tase activity we incubated it in presence of H3-S-adenosyl-
methionine (SAM) and different substrates (Figure 4B).
dG9a methylates H3 and H4 present as free histones
but had no detectable activity on nucleosomal arrays.
In contrast to the recombinant dG9a, mouse G9a only methy-
lates H3 even when other histones are present (Figure 4C).
In order to exclude the possibility that the unexpected H4
HMT activity is due to a contaminating activity co-purifying
with the recombinant dG9a we expressed the enzyme carry-
ing a point mutation within the SET domain (H1536K) that
dramatically impairs its catalytic activity. The mutated
enzyme was not able to methylate either H3 or H4 indicating
that both methylations are a result of dG9a activity
(Figure 4D). In order to determine the substrate specificity
we performed a quantitative MALDI-TOF analysis of H3
molecules methylated by dG9a. Similarly to the activity of
the mouse ortholog (42), dG9a methylates exclusively K9
and K27 with K9 being the preferred substrate in wild-type
(wt) H3. As shown for mG9a (43) dG9a is able to add up
to three methyl groups to H3 (Figure 4H). This finding is
confirmed by using H3 molecules carrying a lysine to alanine
replacement at position 9 and 27 or both (Figure 4E).
We observe decreased methylation efficiency on H3 K9A
and H3 K27A compared to wt H3. In a filter binding assay
we observed a 70% reduction when K9 was mutated and
a 50% reduction when K27 was mutated. When both H3
lysine residues were mutated (K9A and K27A) we
observe a lower activity (efficiency of 27%) indicating
that in absence of K9 and K27 dG9a is also able to methylate
other lysines. Mouse G9a also showed a decreased activity
(27%) towards the double mutant (K9A/K27A) (Figure 4F).
When we use highly active mG9a (43), it methylates wt
H3 and the H3 molecules carrying a single mutation on
K9 or K27 with a similar efficiency. However, as we
use relatively long reaction times we can not exclude the
possibility that K9 is methylated faster than K27, which
explains the larger differences observed in previous
publications (16,44).
Interestingly dG9a was also able to methylate histone H4
(Figure 4B). This is in marked contrast to the mouse G9a
where we do not observe such an activity (Figure 4C) (42).
The only lysine residue of H4 shown to be methylated
in vivo is K20 and the first HKMTase identified with this
activity was hPR-Set7/dSET8 (45,46). Other HKMTases in
Drosophila shown to methylate H4 lysine 20 are Ash1 and
Suv4–20 (47,48). Ash1 is in addition able to methylate lysine
4 and 9 in histone H3 (47). From these experiments we
concluded that dG9a also is a multi-catalytic histone methyl-
transferase with specificity for lysine 9 and 27 on H3 and
possibly lysine 20 on histone H4. However, when we
incubated dG9a with H4 carrying a mutation of lysine 20 to
alanine we observed no reduction of activity (Figure 4G). To
further investigate the specificity, we tested whether dG9a
was able to methylate H4 molecules carrying different
N-terminal deletions (29). We observed that dG9a could
methylate the H4 N-terminus when the first five amino
acids were deleted, excluding K5 as a possible substrate.
However, the activity was lost when we used the H4 D10
mutant (Figure 4G). This suggests that the substrate is K8,
but considering that the minimal substrate specificity for
mG9a surrounding K9 contains seven amino acids (TARK-
STG) (49) we cannot exclude that another downstream lysine
can serve as a substrate. MALDI-TOF analysis of H4 methy-
lated by dG9a, showed that only the peptide containing amino
acids 4–17 was methylated in vitro (Figure 4H). We conclude
from these experiments that dG9a can methylate lysine 8, 12
or 16 of H4 in vitro. It remains to be seen to what level these
lysines are methylated in vivo and what the function of this
methylation is.
dG9a is required for normal development
To investigate the in vivo function of dG9a, transgenic flies
with an inverted-repeat UAS-dG9a.IR construct were crossed
to different GAL4-driver lines (22). The vector used for mak-
ing the inverted repeats has an independent UAS-GFP marker
so that a tissue exposed to RNAi will simultaneously show
GFP expression [pUds-GFP; (21)] as an internal control to
RNAi expression. In addition, down regulation of dG9a
was confirmed by RT–PCR (Figure 5A).
Using the ubiquitously expressed da-GAL4 driver with the
UAS-dG9a.IR flies, the progeny developed normally until
the end of the third larval instar. However, these RNAi larvae
did not form their puparium and crawling larvae were found
after 7–8 days (Figure 5B). The majority of these larvae
developed melanotic tumors, either one or two larger ones
or several smaller. The larvae finally stopped moving, and
in the few cases where ‘pseudo-prepupae’ were formed,
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these maintained the elongated larval form and failed to evert
the anterior spiracles; there was only slight melanization of
these ‘pseudo-prepupae’ (Figure 5C).
The defects in puparium formation seen in dG9a RNAi
animals could result from either a decrease in the ecdysone
titer or a decrease in the ability of the ecdysone signal to
be transduced. To distinguish between these possibilities we
examined the effects of feeding ecdysone to dG9a RNAi
larvae. This method has been shown to effectively rescue
phenotypes associated with ecdysone-deficient mutations
(36). Mid- and late-third instar larvae were transferred to
food either with or without 20-hydroxyecdysone (20E) for
6–8 h and scored on a 12-h basis. Feeding 20E to dG9a
RNAi larvae did not rescue them to puparium formation.
Therefore, we conclude that ecdysone is not limiting in the
da-GAL4/UAS-dG9a.IR animals and that dG9a functions
downstream of ecdysone biosynthesis and release.
When the ubiquitously expressed, but weaker, Act5C-
GAL4 driver was used, development of progeny of genotype
Act5C-GAL4/UAS-dG9a.IR proceeded up to and through
puparium formation (data not shown). However, most of
the pupal cases were only lightly tanned and no flies eclosed
from these cases. Upon dissection, dead and partially
differentiated pharates with no eye pigmentation or legs
were found (data not shown). Development appeared to
have proceeded further in the posterior part of fly. Of all
pupae formed (N ¼ 133), 17% developed normally, and
the eclosed flies were without exception females.
As immunostaining indicated a role for dG9a in neuro-
ectoderm and CNS, a driver which expresses GAL4 in
brain and throughout CNS, but not in discs, of third instar
larvae, P{GawB}c698a, was used. The phenotypes observed
were similar to those observed with the Act5C-GAL4 driver.
Here, however, most of the pupae were partly more mela-
nized (Figure 5D), without differentiation proceeding any
further than that described for the Act5C-GAL4 driver
(Figure 5E). A small portion (5%) of the pupae actually
developed normally but of these almost all failed to escape
from the pupal case. The very few that succeeded were all
normal females and lived for at least 2 weeks.
The results described above strongly suggest a defect in
ecdysone responses at puparium formation, similar to those
reported earlier for mutants in the ecdysone pathway (50).
Also, using RNAi very similar results were obtained with
the H3–K36 HKMTase dSet2 gene (M. Stabell, unpublished
data).
Ecdysone controls wing morphogenesis and cell adhesion
by regulating integrin expression during metamorphosis
(51). Therefore, to test further the possible involvement of
dG9a in the ecdysone regulation hierarchy, we triggered
dG9a RNAi in the wing disc by the ap-GAL4 driver. This
resulted in slightly held-out/up wings with an anterior–
posterior compression (Figure 5F), and occasionally in blister
formation (Figure 5G). We next generated flies of genotype
ap-GAL4,UAS-dG9a.IR/EcRM554fs. EcRM554fs is a loss of
function mutation where only half the amount of the ecdy-
sone receptor is present in mutant flies. As shown in
Figure 5I, these animals show a wing phenotype of a more
extreme character, with both wings having a blister and
being clearly smaller than normal, most likely because the
wings never completely unfold. This phenotype has 100%
penetrance. Taken together, these results support the notion
that dG9a functions in ecdysone signaling pathways during
development.
DISCUSSION
dG9a is a euchromatic histone methyltransferase
In this study we show that CG2995 is the Drosophila
homolog of the HKMTase G9a, and that it specifically
mono-, di- and trimethylates H3–K9, H3–K27 and K8, 12
or 16 in H4. This methylation pattern is mainly correlated
with silencing (11) suggesting that dG9a is involved in
transcriptional repression. Further, we showed that dG9a
methylates free histones but has no detectable activity on
nucleosomal arrays. As revealed by the staining of polytene
chromosomes, the centromeric region, where Su(var)3–9 pre-
dominantly stains (52), is devoid of dG9a. We therefore con-
clude that dG9a is a euchromatic histone methyltransferase
that acts on loosely packed DNA and that methylation by
dG9a may occur on pre-assembled histones.
Figure 4. Characterization of recombinant dG9a. (A) Eluted FLAG tagged dG9a (789–1637 amino acid) was separated on a 12% SDS–PAGE and stained with
Coomassie blue G250. (B) In vitro methylation reactions using dG9a (lanes 1–6), no enzyme (lane 7) and dSu(var)3–9 (lane 8). In the reaction we used 1 mg of
different histones: recombinant histone H3 (lane 1), recombinant histone H4 (lane 2), recombinant (lane 3) and native histone octamer (lane 5) and recombinant
and native nucleosomes (lanes 4 and 6) reconstituted on circular pBS(KS) from equimolar amounts of histones. The upper panel shows Coomassie stained gel
and the lower panel the autoradiograph. (C) Activity of recombinant mouse G9a expressed in baculovirus infected cells (a kind gift from S. Pradhan). HKMTase
activity on 1 mg of different histone substrates: recombinant histone H3 (lane 1), recombinant histone H4 (lane 2), recombinant and native histone octamers (lanes
3 and 5) and recombinant and native nucleosomes (lanes 4 and 6). Mock control (lane 7) is incubation of recombinant octamer without enzyme. The Coomassie
gel is shown at the top and the corresponding autoradiograph at the bottom. (D) FLAG dG9a wild type versus H1536K mutation of the conserved region of the
SET domain. The upper panels shows a western blot of the two proteins. Recombinant octamer (2 mg) was used as substrate for 25. 50 and 100 ng of wt (lanes 1–
3) and H1536K mutant (lanes 4–6). The corresponding autoradiograph is shown in the lower panel. (E) In vitro methylation of 2 mg of recombinant H3 (lane 1),
H3 mutated at lysine 9 (lane 2), H3 mutated at lysine 27 (lane 3) or both (lane 4) using dG9a and a mock purification. Coomassie stained H3 is shown in the upper
panel and a corresponding autoradiography in lower panel. A corresponding filter binding assay is shown to the right. The y-axis displays the percent
radioactivity incorporated on 2 mg of histone H3 and H3 mutants K9A, K27A and K9/K27A with radioactivity incorporated on wt H3 set to 100% and the
background is subtracted. (F) HKMTase activity of mG9a on histone H3 molecules and H3 K9A, H3 K27A and the double mutant K9A/K27A. A gel of
Coomassie stained histones and the corresponding autoradiography is shown. On the right, a filter binding assay showing percent radioactivity incorporated on 2
mg of histone H3 and H3 mutants K9A, K27A and K9/K27A. The y-axis displays the percent radioactivity incorporated with activity on wt H3 set to 100% and
the background is subtracted (G) Amino acid sequence of the H4 N-terminus is shown at the top. Asterisks indicate possible substrates for dG9a in vitro.
Methylation of 2 mg of recombinant H4 (lane 1), H4 K20A (lane 2), H4D5 (lane 3), H4D10 (lane 4), H4D15 (lane 5) and globular H4 (lane 6). Mock control (lane
7) is incubation of wt H4 without enzyme. (H) Quantitative MALDI-TOF analysis of 500 ng of H3 and H4 methylated by 100 ng of dG9a. Peptides spanning
amino acids 9–17 and 27–40 of H3 and 4–17 of H4 is represented by graphs. No signals were observed in other peptides. Mono-, di- and trimethylation are shown
as percent of total H3 or H4. This figure is representative for at least three different methyltranferase assays.
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dG9a is expressed throughout development
Immunostaining revealed that the dG9a protein is found
throughout oogenesis, embryogenesis, and larval develop-
ment. During these stages, large cells (like nurse cells and
salivary gland cells) are metabolically very active, and having
multiple copies of genes (polyteny) permits a high level of
gene expression; that is, abundant transcription and transla-
tion to produce the gene products. (53). In adult flies the
dG9a transcript and protein are solely found in the gonads,
where cells are undergoing extensive endo- and mitotic rep-
lication. One can assume that is important that certain
genes are kept silent in these cells, and one possible function
of dG9a could be to maintain repression of a subset of genes
in cells that otherwise have a high gene expression level.
In the RNAi knock down studies, no lethality was observed
during embryogenesis, but this can be ascribed to the fact that
the RNAi construct was made using a pUAST based vector
that is defect in the germline during oogenesis (22). Condi-
tional knock down of dG9a in the female germline was there-
fore not possible in this study, but should be subject for future
investigation. An interesting observation is that the escapers
from the RNAi studies are exclusively females. This result
suggests that dG9a may have different roles in males versus
females. It is possible that conditional depletion of dG9a in
transgenic flies may affect the expression of genes that are
required for chromatin stability, chromosome segregation
and proper histone modifications resulting in a preferential
lethality in male flies. This has recently been reported for
Su(var)205 (also called HP1) (54), and bonus (bon), encoding
a homolog of the vertebrate TIF1 transcriptional cofactors
and required for male viability (55). Interestingly, bon is
associated with genes that are implicated in the ecdysone
pathway.
dG9a is involved in ecdysone mediated signaling
Next, we provide evidence that dG9a is required for impor-
tant transitions during Drosophila development. Our results
suggest a role for dG9a in regulation of genes, especially dur-
ing the onset of metamorphosis, and wing development, pro-
cesses tightly correlated to ecdysone responsive signaling
(56). Additional evidence for dG9a being involved in the
ecdysone hierarchy is the formation of melanotic tumors in
the larvae that do not form their puparium. Several
chromatin-modifying or chromatin-associated complexes
(57) as well as ecdysone have been implicated in hemocyte
development and melanotic tumor formation (58,59). Further-
more, our genetic studies revealed that the EcRM544fs is able
to dominantly affect the wing phenotype in ap-GAL4,UAS-
dG9a.IR/EcRM554fs flies. Genetic interactions between mutant
alleles of different genes are indicative of these genes belong-
ing to the same functional pathway. Thus, the genetic studies
support the results from the RNAi experiments, and together
provide strong evidence of dG9a being involved in the ecdy-
sone signaling hierarchy. As the RNAi mutants are not res-
cued by hormone feeding, dG9a must exert its effect
downstream of ecdysone biosynthesis and metabolism. One
possible scenario is that dG9a acts as a co-regulator for the
ecdysone receptor mediating downstream gene regulation as
a response to ecdysone pulses. A similar scenario has been
reported for mammalian G9a, where a reduction of endoge-
nous G9a reduced hormonal activation of an endogenous
target gene by the androgen receptor (60).
Figure 5. Knock down of dG9a give phenotypic effects. RNAi experiments show that dG9a is important for development. (A) RT–PCR shows that dG9a is down
regulated by RNAi; rp49 is used as loading control. (B and C) Using a ubiquitously expressed driver, da-GAL4, to induce the IR construct shows that dG9a is
required for proper transition from larva to pupa. Penetrance is 100%. In (B) the larva is 6 days, in (C) 8 days. The IR construct is tagged with an independent
UAS-GFP, which can be used as control (insert). Melanotic tumors are frequently observed in these larvae. (D and E) Using a larval CNS-GAL4 (BL 3739) driver
the progeny makes it up to and through pupariation (F), but fails to hatch. Differentiation seems more complete in posterior part of the animal (G). A similar
phenotype is observed when using Act5C-GAL4 as driver. Remarkably, in both cases, the escapers observed to hatch (10%) are females. (H and I) When using
the ap-GAL4 driver defects in the wings are observed. This phenotype is highly pleiotropic, with one or both wings affected. Among the phenotypes are narrow
wings held in a Dichaeate-like fashion, wings standing straight up and blistered wings. Progeny with no apparent defects are also observed. (J) Progeny of
genotype ap-GAL4,UAS-dG9a.IR/EcRM544fs show a wing phenotype of severe character and 100% penetrance.
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The genetic interaction between EcRM554fs and ap-
GAL4,UAS-dG9a.IR on wing development may suggest a
molecular interaction between the EcR receptor and dG9a.
Activation and repression of transcription involve
the recruitment of many co-regulator (co-repressor or
co-activator) proteins to the regulated gene promoter
by sequence-specific DNA binding transcription factors. As
dG9a contains an AT-hook, it could tether the ecdysone
receptor to the DNA, or, more plausible, the DNA binding
activity of EcR by could bring dG9a to the promoter. Two
models could explain the EcR-dG9a relationship observed:
(i) dG9a act as a co-repressor of the early puffs according to
the Ashburner model for the hormonal control of
polytene chromosome puffing (61). Briefly, this model
proposed that ecdysone, bound to its specific receptor,
directly induces the expression of a small set of early
regulatory genes. The protein products of these genes, in
turn, repress their own expression and induce a much
larger set of late target genes. dG9a could be involved in
this repression.
(ii) dG9a act as a co-activator coupled to the transcription
apparatus during activation of ecdysone regulated genes.
Vakoc and co-workers (62) reported recently that H3–K9
methylation was found at high levels in the transcribed region
of four genes while they were transcribed. This observation is
rather remarkable in that it implies a coupling of the tradition-
ally accounted H3–K9 silencing mark to active transcription.
Therefore, the possibility that dG9a plays a role in maintain-
ing transcription should be further investigated. In addition,
there are observations that murine G9a acts both as a
co-repressor (63–65), and a co-activator (60), depending on
promoter context and/or regulatory environment, along with
the observation that the zinc finger protein wiz links G9a/
GLP histone methyltransferases to the co-repressor molecule
CtBP (66). Furthermore, NSD1, which methylates both
H3–K36 and H4–K20 in vitro (67), acts as a co-activator
and a co-repressor for NRs (37).
As a complement to the RNAi approach, we have tried to
generate null mutants (deletions) by re-mobilization of the P-
element inserted in the 50-untranslated region (50-UTR) of
dG9a in the dG9a13414 stock. Whereas several independent
lines with precise excision of the P-element were obtained
we failed to find any imprecise excision (deletion) events
(M. Stabell, unpublished data). During the course of the pre-
paration of this manuscript, Mis et al. (68) also identified
CG2995 as being the Drosophila homolog of mammalian
G9a. This group also reported unsuccessful mobilization of
the P-element, and suggested that this may be due to a defec-
tive P-element. Instead, they investigated the dG9a13414/
dG9a13414 mutant and report only a minor phenotype without
characterizing the nature of the mutant. On the other hand,
they showed that this dG9a13414 mutant suppresses position
effect variegation (PEV) and that it interacts genetically
with Su(var)3–9, suggesting that the two proteins have an
overlapping role in heterochromatic gene silencing and may
be members of protein complexes involved gene silencing.
In contrast to Mis et al. (68) who concluded that dG9a is a
H3–K9 HKMTase, we provide evidence that dG9a (i) methy-
lates H4 as well as H3, (ii) is able to add three methyl groups,
(iii) methylates K9 and K27 on histone H3 with a preference
for K9 and (iv) has a specificity towards K8, K12 or K16 on
the H4 N-terminus. In polytene chromosomes dG9a is
excluded from the chromocenter (Figure 3), indicating a
euchromatic role for dG9a. But as the majority of full-length
GFP-mG9a fusion proteins has been found in pericentric
heterochromatin (16), we cannot rule out a conceivable func-
tion for dG9a during facultative heterochromatinization in
other tissues and/or stages of development.
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